Document RpyKeqQ6r61GYejxJ5J8E7r8E
M m6 -
417
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
AMU-
Revised Page DuPont-5386
TRADE SECRET
Study Title H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revision No. 1
Volume 2 o f 5
Test Guidelines: U.S. EPA Health Effects Test Guidelines OPPTS 870.3100(1998)
Author: Gregory S. Ladies, Ph.D., D.A.B.T.
Original Completed on: December 3, 2001 Revision No. 1 Completed on: April 5, 2002
Performing Laboratory: E.I. du Pont de Nemours and Company Haskell Laboratory for Toxicology and Industrial Medicine Elkton Road, P.O. Box 50 Newark, Delaware 19714-0050
Work Request Number
Service Code Number1
Sponsor Study Number
Company Sanitized. Does not contain TSCA CBI Page 317 of 1503
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT (mg/kg/day)
o
1I
25 100 250
III V
VII
DIGESTIVE SYSTEM LIVER NO ABNORMALITY DETECTED NECROSIS, FOCAL.
INFLAMMATION, SUBACUTE/CHRONIC.
! | HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR. | j j | 1 1 1
(10) GO) (10) (11)
643272
643311 643259
643260
643309
643143 643173 643224 643174
643150 643179 643243 643193
643185 643180 643247 643194
643189 643228 643250 643201
643204 643240 643257 643215
643205 643264 643275 643252
643235 643290 643311 643259
643241 643292 643314 643260
643288 643308 643318 643298
643300
643315
643175 643174
643224 643193
643243 643194
643247 643201
643257 643215
643275 643252
643311 643259
643314 643260
643318 643298
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates .the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
318
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
LIVER HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
FATTY CHANGE, MEDIAN CLEFT.
FATTY CHANGE, CENTRILOBULAR.
(10)
(10)
(10) (11) 643309
643315
643189 643180 643250
643300 643264 643257
643189 643180 643224 643174
643290 643243 643259
643257 643309
643275
643311
643318
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBt 319
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
| TREATMENT 0
25 100 250
, | (mg/kg/day)
1 I III V VII
PANCREAS NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. ATROPHY. 1j
(10) 643143 643150 643185 643189 643204 643205 643235
643241 643288 643241 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643260 643298 643309 643315 643252
643259
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBt
320
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 25 100 250
1 I III V
VII
ESOPHAGUS NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. EDEMA.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643174 643193 643194 643201 643215 643252 643260 643298 643315
643175 643259 64^309 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
jmpany Sanitized. Does not contain TSCA CBt 321
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
| TREATMENT
0
25 100 250
| (mg/kg/day)
1
I I III V VII
STOMACH NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
1 TREATMENT 1 (mg/kg/day)
LESION INCIDENCE (NUMERIC)
o 1 25
100 250
1 I 1 III V
VII
1
DUODENUM NO ABNORMALITY DETECTED
(10) 6431431 643150 I 6431851 6431891 6432041 643205 1 643235 1 6432411 643288 1 6433001
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT 0 (mg/kg/day)
1I
25 100 1 250
III V
1 1 VII
JEJUNUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
1 (1) 1 (11) 6431751643174
1643193 1643194 1643201 1643215 1643252 1643259 1643260 1643298 1643309 !643315 1
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
M ICROSCOPIC OBSERVATIONS IN MALE RATS LASTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| TREATMENT (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250
1 I III V
VII
ILEUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS IGESTIVE SYSTEM
| TREATMENT | (mg/kg/day) i
LESION INCIDENCE (NUMERIC)
0 25 100 250
1 I III V
VII
CECUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA C B i
326
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT
0
(mg/kg/day)
1I
25 100
1 III V
250 VII
COLON NO ABNORMALITY DETECTED
(10) 1 643143 1 6431501 6431851 6431891 643204 1 643205 6432351 6432411 6432881 6433001
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
uinpany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| TREATMENT | (mg/kg/day) 1
LESION INCIDENCE (NUMERIC)
0 25 100 250 |
I III V VII
RECTUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (ID 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
'im pany Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT
o
25 100 250
(mg /kg /day )
1
1 I III V VII
SALIVARY GLANDS NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
ompany Sanitized. Does not contain TSCA CBI 329
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS URINARY SYSTEM
KIDNEYS NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
HYPERTROPHY, TUBULAR.
1 TREATMENT 1 (mg/kg/day)
1
o I
25 100 250
III v
VII
(10) (10) GO) (11)
643143 643173 643224
643185 643179 643243
643189 643240 643250
643205 643264 643257
643235 643272 643318
643288 643290
643308
643150 643180 643175 643193
643204 643228 643247 643194
643241 643292 643311 643215
643300
643314 643252
643298
643309
643275 643174
643193
643194
643201
643215
643252
643259
643260
643298
643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBf 330
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS URINARY SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
KIDNEYS HYPERTROPHY, TUBULAR. HYDRONEPHROSIS, UNILATERAL. HYDRONE PHRO SIS, BILATERAL.
(10) (10)
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(10)
(11) 643315 643259 6431741
1
Company Sanitized. Doss not contain TSCA CBI 331
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS URINARY SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT
o
(mg/kg/day)
1I
25 100 250
1 III
V
VII
URINARY BLADDER NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
| TREATMENT
| (mg/kg/day) j
o I
25 III
RESPIRATORY SYSTEM LUNGS NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. INFLAMMATION, GRANULOMATOUS. 1
1 1 1 (10) 1 643143 j 643150 j 643185| 643189| 6432351 643241| 643288| 643300| 643204| 643205|
1 i
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
100 250
V VII
(1) (11) 643174 643194 643201 643215 643252 643259 643298 643315 643260 643309
643175 643193 1
Company Sanitized. Does not contain TSCA
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
I
)
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 25 100 250 |
I III V VII
TRACHEA NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB 334
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
I III V VII
PHARYNX/LARYNX NO ABNORMALITY DETECTED
HEMORRHAGE.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643315 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Doss not contain TSCA CBI 335
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
I LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
RESPIRATORY SYSTEM NOSE NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA/HYPERTROPHY, TRANSITIONAL CELL, EPITHELIUM. DEGENERATION/NECROSIS, RESPIRATORY, EPITHELIUM. DEGENERATION, AMELOBLASTS.
(10) (10) (10) (11) 643143 643173 643224 643150 643179 643243 643185 643180 643250 643189 643228 643314 643204 643240 643205 643264 643235 643272 643241 643290 643288 643292 643300 643308
643175 643201 643309 643309 643315
643175 643247 643174 643257 643193 643275 643194 643311 643201 643318 643215
643252 643259 643260
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized.
Poss not contain TSCA CBi 336
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
NOSE DEGENERATION, AMELOBLASTS.
(10)
(10)
(10)
(11) 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TS C A CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
M ICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 25 100 250
1 I III V
VII
I
HEART NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643241 643288
CARDIOMYOPATHY. INFLAMMATION, SUBACUTE/CHRONIC.
643189 643204 643205 643235 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(1) (11) 643174 643193 643201 643215 643252 643260 643298 643309 643194 643259 643315
i 1 |643175
1
t-omoany Sanitized. Does confa>n TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM
I LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
AORTA NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
1
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
1 11 | LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM
| TREATMENT (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 |
I III V VII
SPLEEN NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
340
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
1
i LESIONS ! i __ . LYMPHATIC AND HEMATOPOIETIC SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
I III V VII
THYMUS NO ABNORMALITY DETECTED
ATROPHY.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643315 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Joriipany Sanitized. Does not contain TS C A C W
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
1 1
| LESIONS
i 1 i_
LYMPHATIC AND HEMATOPOIETIC SYSTEM
1
J MANDIBULAR LYMPH NODE NO ABNORMALITY DETECTED
I 1 1 ! 1 1 1 1 I
J
.
LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) 1I
___
1
III
V
VII
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
impany Sanitized. Does not contain TSCA CBI
342
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
M ICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
MESENTERIC LYMPH NODE NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
smpany Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
1
BONE MARROW NO ABNORMALITY DETECTED
HYPERPLASIA, GRANULOCYTIC.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11} 1 643174
1 643193 643194
1 643201
1 643215 1 643252 1 643259 j 643260
! 643298 1 643315 1643175 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS ENDOCRINE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 1 25 1 100 1 250 1 1 III 1 V 1 VII
PITUITARY GLAND NO ABNORMALITY DETECTED
1 1 |
GO) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(1) O D 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Company Sanitized. Does not contain TSCA CBI 345
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
| LESION INCIDENCE (NUMERIC)
LESIONS
ENDOCRINE SYSTEM THYROID GLAND NO ABNORMALITY DETECTED INFLAMMATION, SUBACUTE/CHRONIC. HYPERTROPHY, FOLLICULAR.
ALTERATION, COLLOID.
TREATMENT (mg/kg/day)
0 I
25 100 250
III v
VII
(10) (10) (10) (11) 643150 643179 643175 643235
643224 643174 643318 643193
643194 643201 643252 643259 643260 643298 643309 643315 643143 643173 643224 643174 643185 643180 643243 643193 643189 643228 643247 643194 643204 643240 643250 643201 643205 643264 643257 643215 643235 643272 643275 643252 643241 643290 643311 643259 643288 643292 643314 643260 643300 643308 643318 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI346
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM TFIE REPRODUCTION EVALUATION)
11 LESION INCIDENCE (NUMERIC)
j LESIONS
1 1 1
|ENDOCRINE SYSTEM
I 1 | PARATHYROID GLANDS | NO ABNORMALITY DETECTED
1 1 1 1 |
1 1 i i
i
TREATMENT (mg/kg/day)
0
1I
25
1 III
100 250 1
V VII
(8) 643143 643150 643185 643204 643205 643235 643241 643300
(10) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
ENDOCRINE SYSTEM ADRENAL GLANDS NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
| TREATMENT | 0 | (mg/kg/day) |
1 11
|
I 1 | (10) |643143 j643150 643185 j643189 j643204 j643205 |643235 j643241 |643288 |643300
25 III
100 250
V VII
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
348
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS NERVOUS SYSTEM
| TREATMENT (mg/kg/day)
1
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
BRAIN NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitised. Does not contain TSCA C
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
1 |NERVOUS SYSTEM 1 1 | SPINAL CORD 1 NO ABNORMALITY DETECTED | 1 1 | 1 1 1 | |
!!
__
TREATMENT (mg/kg/day)
0 I
25 |
III
100 V
250 VII
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS NERVOUS SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 25 100 250 11
I III V VII
SCIATIC NERVE NO ABNORMALITY DETECTED
1 1 1 1 i 1
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
cmpany Sanitized. Does ot contain TSCA CB 351
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
I
I
Revised Page ______________________________ _______ DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS MUSCULAR AND SKELETAL SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
I III V VII
SKELETAL MUSCLE NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) O U 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
*>mpany Sanitized. Does not contain TSCA CBi 352
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
| LESIONS MUSCULAR AND SKELETAL SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC) 0 | 25 | 100 | 250 1 ! Ill | V | VII
FEMUR/KNEE JOINT NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194
643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
"ompany Sanitized. Does not contain TSCA CBI 353
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS MUSCULAR AND SKELETAL SYSTEM
TREATMENT (mg/kg/day)
o
1I
25 1
III
100 1 250
1 V 1 VII
STERNUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
1 (1) 1 (11) 6431751643174
643193 1643194 j643201 1643215 1643252 1643259 1643260 1643298 I643309 1643315
Company Sanitized. Does not contain TSCA CBl
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS MUSCULAR AND SKELETAL SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
MANDIBLE NO ABNORMALITY DETECTED
1
DEGENERATION, AMELOBLASTS.
(10) (10)
(9) (10)
643143 643173 643224
643150 643179 643243
643185 643180 643247
643189 643228 643250
643204 643240 643257
643205 643264 643311
643235 643272 643314
643241 643290 643318
643288 643292
643300 643308
643275 643174
643193 I
643194
643201
643215
643252
643259
643260
643298
643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does no! contain TSCA CBI
355
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
I
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS REPRODUCTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
TESTES NO ABNORMALITY DETECTED
1 1 ! 1
SPERMATID RETENTION, SEMINIFEROUS TUBULES. !
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(1) (11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
643175
<mpany Sanitized. Does no! contain TSCA CB1
356
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS REPRODUCTIVE SYSTEM
| LESION INCIDENCE (NUMERIC)
| TREATMENT j (mg/kg/day) 1
o I
25 100 250
III V
VII
EPIDIDYMIDES NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
'mpany Sanitized. Done net contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS REPRODUCTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
o 25 100 250
1 I III V
VII
|
PROSTATE NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC.
(10) 643143| 643150 | 643185| 643189 643204| 643205 643235 643241 643300
643288
(1) (11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643309
643175 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
^mpany Sanitized. Does no! contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS REPRODUCTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT
o
25 100 250
(mg/kg/day)
1
' 1 I III V VII
SEMINAL VESICLES NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194
643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB! 359
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CUTANEOUS SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 | 250
1j
I
III V
| VII
|
SKIN NO ABNORMALITY DETECTED
1 1
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(U ! d u 643175 j643174
|643193 |643194 j643201 j643215 j643252 643259 |643260 I643298 1643309 643315
i
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
j LESIONS
|
SPECIAL SENSES SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 j 25 | 100 | 250
1
| III j V
1 VII
EYE(S) WITH OPTIC NERVE NO ABNORMALITY DETECTED
i 1 1
1 1
[ OPTIC NERVE NOT PRESENT.
1
] FOLD/ROSETTE, RETINAL.
(10) 643143 643150 643185 643189 643204 643235 643241 643288 643300
643205
(1) (11) 643175 643174
643194 643201 643215 643252 643259 643260 643298 643315 643252 643309 643193
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
ipany Sanitized. Does not contain TSCA CBI 361
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Males
LESIONS
DIGESTIVE SYSTEM LIVER
NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
| TREATMENT 1 (mg/kg/day)
1
0 I
250 VII
(10) (10) 643316
643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643296 643303 643316 643304
643151 643165 643220 643225 643234 643236 643258 643266 643296 643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBl 362
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NCN-NEOPLASTIC
(ONE-MONTH RECOVERY EVALUATION)
LESIONS
DIGESTIVE SYSTEM LIVER
FOCUS OF CELLULAR ALTERATION, BASOPHILIC. FATTY CHANGE, MEDIAN CLEFT. FATTY CHANGE, CENTRILOBULAR.
LESION INCIDENCE (NUMERIC)
Males
| TREATMENT (mg/kg/day)
I
0 1
250 VII
(10) (10) 643151
643253 643316 643246
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
^22S no contain TSCA CBI 363
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(ONE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
HYPERTROPHY, TUBULAR. HYDRONEPHROSIS, UNILATERAL.
LESION INCIDENCE (NUMERIC) 1-------------
1 Males
TREATMENT | 0 (mg/kg/day) |
11
| 250 | 1 VI1
(10) (10) 643162 643165 643172 643220 643262 643225 643303 643258 643304 643296 643195 643234 643226 643236 643237 643266 643246 643316 643253
643151 643266 643234
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does no! contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
ODONTODYS PLASIA. DEGENERATION, AMELOBLASTS.
LESION INCIDENCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
| 250 | I VII
(10)
(10)
643172 643266
643195
643226
643237
643246
643253
643262
643303
643304
643162
643151
643165
643220
643225
643234
643236
643258
643296
643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
1 1 1 1 | LESIONS 1
LYMPHATIC AND HEMATOPOIETIC SYSTEM
SPLEEN NO ABNORMALITY DETECTED
THYMUS NO ABNORMALITY DETECTED
MANDIBULAR LYMPH NODE ERYTHROCYTOSIS/ERYTHROPHAGOCYTOSIS, SINUS.
LESION INCIDI:NCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 1
250 VII
(1) 643304
(1) (1) 643304 643236
(1) 643304
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBf 366
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
ENDOCRINE SYSTEM THYROID GLAND
ALTERATION, COLLOID.
LESION INCIDENCE (NUMERIC)
Males
| TREATMENT | (mg/kg/day)
1
0 I
250 VII
(10) (10) 643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643266 643303 643296 643304 643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCACBI 367
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
MUSCULAR AND SKELETAL SYSTEM MANDIBLE
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
1 Males
TREATMENT 0 (mg/kg/day) |
11
| 250 |
1 VI1
(10) (10) 643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643266 643303 643296 643304 643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
C o m p a n y Sanitized. Does not contain TSCA CBf 368
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Males
LESIONS
TREATMENT
(mg/kg/day) 0 1I
250 VII
REPRODUCTIVE SYSTEM
TESTES DEGENERATION/ATROPHY, SEMINIFEROUS TUBULES, UNILATERAL.
DEGENERATION/ATROPHY, SEMINIFEROUS TUBULES, BILATERAL.
1
1 1 (2 ) 1643226
1643253
(1) 643220
EPIDIDYMIDES NO ABNORMALITY DETECTED OLIGOSPERMIA/GERM CELL DEBRIS, UNILATERAL.
1 (2)
(1)
1643226
1643253 643220
SEMINAL VESICLES NO ABNORMALITY DETECTED
(1) 643220 !
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 369
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
1 1 | LESIONS |
!1___________________ DIGESTIVE SYSTEM
...... ..
|LIVER | NECROSIS, FOCAL. |
| INFLAMMATION, SUBACUTE/CHRONIC.
1 | 1
1 | HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR. | FATTY CHANGE, MEDIAN CLEFT. j FATTY CHANGE, CENTRILOBULAR.
-------------| TREATMENT
(mg/kg/day)
_ j _____________
LESION INCIDENCE (NUMERIC) 0 | 25 | 100 | 250 1 | III | V | VII
(5) 643210
643145 643210 643232 643265 643268
643232
(5) (5) 643169 643283 643206 643159 643149 643169 643152 643181 643178 643206 643283 643286 643295
643152 643149
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized, D oes no! contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED CALCULUS\CALCULI. NEPHROPATHY, CHRONIC PROGRESSIVE.
INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA, TRANSITIONAL CELL.
LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
o
1I
25
! III
100
1 v
250 VII
(5) 643232 643265
643145 643210 643268
(5)
643149 643152 643178 643283 643295 643149 643149
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
.
LESIONS
| TREATMENT j (mg/kg/day)
I1 |RESPIRATORY SYSTEM Ii NOSE
^
| NO ABNORMALITY DETECTED
1
1 | INFLAMMATION, SUBACUTE/CHRONIC, NASOLACRIMAL DUCT.
INFLAMMATION, SUBACUTE/CHRONIC.
i 1
1 | HYPERPLASIA/SQUAMOUS METAPLASIA, RESPIRATORY, EPITHELIUM.
| HYPERPLASIA/HYPERTROPHY, TRANSITIONAL CELL, EPITHELIUM.
I i1 j FRACTURE/CALLUS, TOOTH. | DEGENERATION/NECROSIS, RESPIRATORY, EPITHELIUM. | DEGENERATION, AMELOBLASTS.
1 | SCHWANNOMA [B].
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
(5) (5) (5) (5)
643210 643306 643169
643232
643206
643265
643286
643305 643181
643145 643202 643159 643149
643268 643293 643181 643178
643310
643283
643295
643145 643202 643159 643149
643268
643181
643202
643178
643293
643283
643310
643159
643295
643159 643152
643295
643202
[B] Benign tumour Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 372
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS ENDOCRINE SYSTEM
| LESION INCIDENCE (NUMERIC)
| TREATMENT | (mg/kg/day) j
o I
25 100 250
III V
VII
THYROID GLAND ALTERATION, COLLOID.
1 1 1 ! 1
(5) (5) (5) (5) 643145 643202 643159 643149 643210 643293 643169 643152 643232 643305 643181 643178 643265 643306 643206 643283 643268 643310 643286 643295
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
1 1 LESIONS
!
_____
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
DIGESTIVE SYSTEM LIVER
NO ABNORMALITY DETECTED NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
FATTY CHANGE, MEDIAN CLEFT.
(10) (10) (10) (11)
643354 643321 643322 643340
643368
643362
643489
643361 643324 643323 643359
643362 643364 643366 643370
643374 643380 643367 643404
643398 643389 643392 643408
643406 643390 643409 643435
643436 643396 643461 643446
643463 643410 643462 643466
643477 643433 643472
643486 643458 643489
643332
643341
643359
643370
643404
643408
643435
643446
643466
643374 643458
N-l1 in Group VIII reflects one reproduction designated animal that died on test day 53. Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBl 374
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
LIVER FATTY CHANGE, MEDIAN CLEFT.
(10) (10) 643398
(10)
(11)
PANCREAS NO ABNORMALITY DETECTED
ATROPHY.
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 i643466
i 643435 1643446
1
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 375
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM ESOPHAGUS
NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/'CHRONIC.
| TREATMENT | (mg/kg/day)
HO H
LESION INCIDENCE (NUMERIC) 25 100 250 IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643370 643404 643408 643435 643446 643466 643368
Figure in parentheses is number of aniinals niicroscopicfilly examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM STOMACH
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
| TREATMENT 0 1 25 1 100 1 250 | (mg/kg/day) 1 II 1 IV 1 VI 1 VIII
1 1 (10) 1 (1) 6433541643321 6433611 643362 1 6433741 6433981 6434061 643436 643463 6434771 6434861
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 377
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM DUODENUM
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) o 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS DIGESTIVE SYSTEM
| TREATMENT
o
25 100 250
| (mg/kg/day)
1
1 II IV VI VIII
JEJUNUM NO ABNORMALITY DETECTED
1 i
j
s
AUTOLYSIS:
1
NECROPSY AND
HISTOLOGY
PERFORMED.
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 1643466 1643340 1643368
i
C o m p a n y S a n itize d . D o e s not contain TSCA CBI 379
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM ILEUM
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB" 380
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
I
)
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM CECUM
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day) 1
LESION INCIDENCE (NUMERIC)
0 | 25 | 100 | 250 111
II 1 IV I VI I VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Fiyure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB 381
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM COLON
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NXMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA,
382
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM RECTUM
NO ABNORMALITY DETECTED
I TREATMENT I (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 I 25
I II I IV
I 100
I I VI
250 VIII
( 10) 643354 643361 643362 643374 643398 643406 643436 643463 643477 643486
(1 )
643321
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
mpany Sanitized. Does not contain TS C A CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM SALIVARY GLANDS
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 1 25 1 100 I 250 111
II 1 IV 1 VI 1 VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS URINARY SYSTEM
1 TREATMENT 0
25 100 250
1 (mg/kg/day)
1 II IV VI VIII
KIDNEYS NO ABNORMALITY DETECTED
1 1 1
1
! 1 NEPHROPATHY, CHRONIC PROGRESSIVE. 1!
1 !1 1 NECROSIS, TUBULAR.
INFLAMMATION, ACUTE.
i1
1
T ATI? J.XM
XD
P
m1
.
[ HYPERPLASIA, TRANSITIONAL CELL.
HYDRONEPHROSIS, BILATERAL.
CYST.
1 AUTOLYSIS: NECROPSY AND HISTOLOGY PERFORMED.
1
(10) (10) GO) (11)
643354 643324 643322 643332
643361 643380 643366 643340
643374 643389 643367 643341
643406 643390 643409 643359
643463 643410 643461 643368
643486 643433 643462 643435
643458 643472 643446
643362 643364 643323 643370
643398 643396 643392 643404
643477
643489 643408
643466
643321
643321
643370
643321
643321
643436
643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
385
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT 0 1 25 1 100 1 250
(mg/kg/day)
111
ii i v ! vi 1 v i n
URINARY SYSTEM URINARY BLADDER
NO ABNORMALITY DETECTED
HYPERPLASIA, SIMPLE, TRANSITIONAL CELL.
! 1 (10) 1 (1) 6433541 6433611 6433621 6433741 643398 j 643406 j 643436| 6434631 643477 j 643486 j j643321
1
(10) 643332 643340 643341 643359 643368 643370 643404 643408 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 386
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS RESPIRATORY SYSTEM
TREATMENT 0
25 100 250
(mg/kg/day)
1 II IV VI VIII
LUNGS NO ABNORMALITY DETECTED
THROMBUS. 1i
(10) (1) (1) (11)
643354 643321 643392 643332
643361
643340
643362
643341
643374
643359
643398
643368
643406
643370
643436
643404
643477
643408
643486
643435
643446
643466
643463
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does nof contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
______________________ RESPIRATORY SYSTEM
TRACHEA NO ABNORMALITY DETECTED
| TREATMENT (mg/kg/day)
'
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals mii-rotscopical ly tJXdirixned. for this tissue The absence of a number indicates the lesion specified was not identified
C o m p a n y S an itize d . D o e s not contain TSCA CBf 388
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
RESPIRATORY SYSTEM PHARYNX/LARYNX
NO ABNORMALITY DETECTED
| TREATMENT j (mg/kg/day) 1
LESION INCIDENCE (NUMERIC)
0 25 100 250
1 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
|
1 (ID 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBf
H-24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT 0 1 25 1 100 1 250
(mg/kg/day)
!11
II 1 IV 1 VI 1 VIII
RESPIRATORY SYSTEM
NOSE NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. FRACTURE/CALLUS, TOOTH. DEGENERATION, AMELOBLASTS. !i
(10) (10) (10) (11)
643354 643321 643323
643361 643324 643392
643362 643364 643462
643374 643380 643489
643398 643390
643406 643396
643436 643410
643463 643433
643477 643458
643486
643389
643340
643389
643322 643332
643366 643340
643367 643341
643409 643359
643461 643368
643472 643370
643404
643408
643435
643446
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI'
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| LESION INCIDENCE (NUMERIC)
I TREATMENT |0 I (mg/kg/day) | I jII
|25 |100 j| IIV jVI
250 VIII
NOSE DEGENERATION, AMELOBLASTS.
(10)
(10)
(10) I (11) I643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Doss no, contain TSCA CB, 391
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM HEART
NO ABNORMALITY DETECTED
CARDIOMYOPATHY.
LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0
1 11
25 100
1 IV VI
250 VIII
(10) 643354 643361 643374 643406 643463 643477 643486
(1)
643362 643321 643398 643436
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
CARDIOVASCULAR SYSTEM AORTA
NO ABNORMALITY DETECTED
TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM SPLEEN
NO ABNORMALITY DETECTED
DEPLETION, LYMPHOID.
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
o 25 100 250 1
II IV VI VIII
(10)
(1)
643354
643361
643362
643374
643398
643406
643436
643463
643477
643486
643321
(10) 643332 643359 643370 643404 643408 643435 643446 643466
643340 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
| TREATMENT
0
25 100 1 250
| (mg/kg/day)
1
1 II IV VI 1 VIII
LYMPHATIC AND HEMATOPOIETIC SYSTEM
1
THYMUS NO ABNORMALITY DETECTED
ATROPHY.
(10) 643354
(1)
643361
643362
643374
643398
643406
643436
643463
643477
643486
643321
1 (11) 1643332 1643341 1643359 1643370 1643404 1643408 1643435 1643446 1643466 1
1643340 1643368
1
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM MANDIBULAR LYMPH NODE
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 396
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM MESENTERIC LYMPH NODE
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0
1 II
25 100
1 IV VI
250 VIII
(9) (1) 643354 643321 643361 643362 643374 643398 643406 643436 643463 643477
(9) 643332 643340 643341 643359 643368 643404 643408 643435 643446
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM BONE MARROW
NO ABNORMALITY DETECTED
HYPERPLASIA, GRANULOCYTIC. ATROPHY.
LESION INCIDENCE (NUMERIC)
TREATMENT
o
25 100 250
(mg/kg/day)
1
1 II IV VI VIII
(10) 643354 643361 643362 643374 643398 643406 643436 643463 643477 643486
(1)
643321
(ID 643332 643340 643341 643359 643370 643404 643408 643435 643446 643466 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 398
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
ENDOCRINE SYSTEM PITUITARY GLAND
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
| LESIONS |
ENDOCRINE SYSTEM
| TREATMENT
0
25 100 250
(mg/kg/day)
1 II IV VI VIII
THYROID GLAND NO ABNORMALITY DETECTED
HYPERTROPHY, FOLLICULAR. ALTERATION, COLLOID.
GO) (10) (10) (11) 643354 643321 643322 643340
643361 643364 643323 643368
643362 643390 643367 643370
643374 643396 643392
643398
643409
643406
643472
643436
643463
643477
643486
643359
643404
643408
643435
643446
643466
643324 643366 643332
643380 643461 643341
643389 643462 643359
643410 643489 643408
643433
643435
643458
643446
Figure ir. parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 400
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
ENDOCRINE SYSTEM THYROID GLAND
ALTERATION, COLLOID. PARATHYROID GLANDS
NO ABNORMALITY DETECTED
| TREATMENT (mg/kg/day)
1
LESION INCIDENCE (NUMERIC) o 25 100 250 II IV VI VIII
(10)
(10)
(10) (11) 643466
(6) (1) 643354 643321 643362 643374 643406 643436 643463
(7) 643332 643341 643368 643404 643408 643435 643466
igure in parentheses is number of animals microscopically examined for this tissue he absence of a number indicates the lesion specified was not identified
mpany Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NGN-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
ENDOCRINE SYSTEM ADRENAL GLANDS
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477 643486
1
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TS C A CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
NERVOUS SYSTEM BRAIN
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
TREATMENT 0
25 100 250
(mg/kg/day)
1
1 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Poes not co nta in T S C A c m
403
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
NERVOUS SYSTEM SPINAL CORD
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
1
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Cmpany Sanitized. Does no! contain TSCA BI 404
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
NERVOUS SYSTEM SCIATIC NERVE
NO ABNORMALITY DETECTED
| LESION INCIDENCE (NUMERIC)
TREATMENT | 0
25 100 250
(mg/kg/day) |
1
1 11 IV VI VIII
11 1 1 (10)
(1)
1643354 643321
1643361
1643362
1643374
1643398
1643406
1643436
1643463
643477
1643486
(ID 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number ot animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
| LESION INCIDENCE (NUMERIC)
| LESIONS
1
1 11 |MUSCULAR AND SKELETAL SYSTEM |1 |SKELETAL MUSCLE
j NO ABNORMALITY DETECTED
1 1
1
1 1 1 |
1
|
1 1
TREATMENT | 0
25 100 250
(mg/kg/day) |
1 11 IV VI VIII
1 (10)
(1)
1643354 643321
1643361
j643362
1643374
1643398
j643406
j643436
j643463
1643477
1643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
.figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
C o m p an y Sanitized. Does not contain TSCA CBI 406
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
MUSCULAR AND SKELETAL SYSTEM FEMUR/KNEE JOINT
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 |
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
apany Sanitized. D o es
n t contain TSCACBI 407
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION))
LESIONS
MUSCULAR AND SKELETAL SYSTEM STERNUM
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 | 25 | 100 | 250 111
II I IV I VI I VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
mpany Sanitized. Does not contain TSCA CBI 408
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS MUSCULAR AND SKELETAL SYSTEM
| TREATMENT 1 (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)|
1 0 25 100 250 1
1 IV VI VIII
MANDIBLE NO ABNORMALITY DETECTED
DEGENERATION, AMELOBLASTS.
1 !
(10)
(9) (10)
(8)
643354 643324 643322 643404
643361 643364 643323
643362 643380 643366
643374 643389 643367
643398 643390 643392
643406 643396 643409
643436 643410 643461
643463 643433 643462
643477 643458 643472
643486
643489
643332
643341
643359
643370
643435
643446
643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 409
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
)
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
REPRODUCTIVE SYSTEM OVARIES
NO ABNORMALITY DETECTED
j TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
!1 i ou 1643332 I643340 1643341 I643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 410
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NGN-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS REPRODUCTIVE SYSTEM UTERUS
NO ABNORMALITY DETECTED
DILATATION, LUMEN.
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643340 643359 643368 643370 643404 643408 643446 643466
643332 643341 643435
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 411
>
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
I
)
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
REPRODUCTIVE SYSTEM MAMMARY GLAND (FEMALE)
NO ABNORMALITY DETECTED
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 25 100 | 250 1
II IV VI I VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
j
1 (11) 1643332 j643340 |643341 |643359 |643368 |643370 |643404 |643408 j643435 |643446 |643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 412
!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
I
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
CUTANEOUS SYSTEM SKIN
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250 1
II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CB1
413
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS SPECIAL SENSES SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
EYE(S ) WITH OPTIC NERVE NO ABNORMALITY DETECTED
OPTIC NERVE NOT PRESENT. AUTOLYSIS: NECROPSY AND HISTOLOGY PERFORMED.
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
643463
a a *3 / n n UHjl / /
TFhigeuraebseinncepaorefnathenusemsbeirs inndumicbaetresofthaenimleaslisonmiscproesccifoiepdicawlalys nexoatmiidneedntfiofiredthis tissue
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466 643370 643446 643466 643340
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| TREATMENT | (mg/kg/day)
1
LESION INCIDENCE (NUMERIC)
o 50 250 1000 1
II IV VI VIII
PANCREAS NO ABNORMALITY DETECTED
(10)
641240 641245 641249 641283 641293 641384
ATROPHY.
641257 1 6412901 6413351 6413441
!
FThigeuraebseinncepaorefnathensuemsbeirs inndumicbaetresofthaenimleaslisonmiscproesccifoiepdicawlalys nexoatmiidneedntfiofiredthis tissue
1 1
(10)
641237 641275 641279 641299 641300 641314 641326 641327 641380 641390
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
DIGESTIVE SYSTEM LIVER
NO ABNORMALITY DETECTED NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
FATTY CHANGE, MEDIAN CLEFT.
LESION INCIDENCE (NUMERIC)
Female
| TREATMENT j (mg/kg/day)
1
0 II
250 VIII
(10) (10) 643415 643351 643405 643444 643330 643345 643336 643347 643377 643358 643387 643423 643405 643441 643426 643444 643448 643456 643453 643474
643481 643425 643441
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Doe not contain TSCA C B f 416
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
Female
| TREATMENT | (mg/kg/day)
1
o II
250 VIII
PANCREAS NO ABNORMALITY DETECTED
ESOPHAGUS NO ABNORMALITY DETECTED
STOMACH NO ABNORMALITY DETECTED
DUODENUM NO ABNORMALITY DETECTED
JEJUNUM NO ABNORMALITY DETECTED
(1) 643336
(1) 643336
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals m i c r o s copically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 417
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
DIGESTIVE SYSTEM
ILEUM NO ABNORMALITY DETECTED
CECUM NO ABNORMALITY DETECTED
COLON NO ABNORMALITY DETECTED
RECTUM NO ABNORMALITY DETECTED
SALIVARY GLANDS NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC) |-------------
| Female
| TREATMENT | 0 | (mg/kg/day) | | 1 II
| 250 |
VIII
(1) 643336
(1) 643336
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 418
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Female
LESIONS URINARY SYSTEM
1 TREATMENT 1 (mg/kg/day) 1
0 II
250 VIII
KIDNEYS NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
1 NECROSIS, TUBULAR. MINERALIZATION.
1 INFLAMMATION, ACUTE. 1 HYPERPLASIA, TRANSITIONAL CELL. 1 HYDRONEPHROSIS, BILATERAL.
CYST. !
TFhigeuraebseinncepaorefnathensuemsbeirs inndumicbaetresofthaenimleaslisonmiscproesccifoiepdicawlalys nexoatmiidneedntfiofiredthis tissue
(10) (10) 643387 643345 643405 643347 643448 643351
643474 643330 643358 643377 643423 643415 643441 643426 643444 643453 643456
643481 643336 643336 643336 643336 643425 643453
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM
URINARY BLADDER INFLAMMATION, SUBACUTE/CHRONIC.
1 HYPERPLASIA, SIMPLE, TRANSITIONAL I HEMORRHAGE.
CELL.
LESION INCIDENCE (NUMERIC)
Female
I TREATMENT |0 I (mg/kg/day) | I III
| 250 | || IVIII I
| (1) | |643336j )643336| |643336|
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
CompanySanili* Doas no, M,,,ain ^ ^
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
RESPIRATORY SYSTEM LUNGS
NO ABNORMALITY DETECTED TRACHEA
NO ABNORMALITY DETECTED PHARYNX/LARYNX
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC)
Female
| TREATMENT j (mg/kg/day)
!
0 II
250 VIII
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Don, M,,ta|n TSCACBr
421
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Female
LESIONS
ITREATMENT I (mg/kg/day) I
|0 | III
| 250 | I VIII
RESPIRATORY SYSTEM
NOSE NO ABNORMALITY DETECTED
SQUAMOUS HYPERPLASIA, NASOLACRIMAL DUCT. INFLAMMATION, SUBACUTE/CHRONIC, NASOLACRIMAL DUCT. DEGENERATION, AMELOBLASTS.
( 10)
(10)
643330 643351
643336 643423
643377 643474
643387
643405
643425
643426
643448
643453
643415
643456
643345
643347
643358
643441
643444
643456
643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
C o m p an y Sanitized. Does not contain TSCA CBr 422
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
CARDIOVASCULAR SYSTEM HEART
NO ABNORMALITY DETECTED AORTA
NO ABNORMALITY DETECTED
LESION INCIDINCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
250 VIII
H1 O H!
(l)
643336
(1)
643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 423
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM
SPLEEN NO ABNORMALITY DETECTED
THYMUS ATROPHY.
MANDIBULAR LYMPH NODE NO ABNORMALITY DETECTED
MESENTERIC LYMPH NODE NO ABNORMALITY DETECTED
BONE MARROW HYPERPLASIA, GRANULOCYTIC.
LESION INCIDENCE (NUMERIC)
Female
| TREATMENT | (mg/kg/day)
1
0 II
250 VIII
(1) 643336
(1) 643336
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does
-HP?,Contain TSOA CBf 424
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDI]NCE (NUMERIC)
Female
LESIONS
ENDOCRINE SYSTEM PITUITARY GLAND
NO ABNORMALITY DETECTED | HYPERPLASIA, DIFFUSE.
| TREATMENT | (mg/kg/day)
1
0 II
250 VIII
(2) 643336 643415
THYROID GLAND | NO ABNORMALITY DETECTED
| i
!
! ALTERATION,
COLLOID.
i i
1
1 1 !
(10) (10) 643336 643347 643387 643415 643448 643453 643330 643345 643377 643351 643405 643358 643425 643423 643426 643441
643444 643456 643474 643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Female
LESIONS ENDOCRINE SYSTEM
| TREATMENT | (mg/kg/day)
1
0 II
250 VIII
PARATHYROID GLANDS NO ABNORMALITY DETECTED
(1) 643336
ADRENAL GLANDS | NO ABNORMALITY DETECTED 1
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(1) 643336
ompany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Female
LESIONS
NERVOUS SYSTEM BRAIN
NO ABNORMALITY DETECTED
| TREATMENT 0 | 250
j (mg/kg/day)
1
1 II | VIII
1
(U 1 643336|
SPINAL CORD NO ABNORMALITY DETECTED
(U 1 643336|
SCIATIC NERVE NO ABNORMALITY DETECTED
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(1) | 643336|
1
.npany Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDINCE (NUMERIC)
Female
LESIONS MUSCULAR AND SKELETAL SYSTEM
TREATMENT (mg/kg/day)
1
0 II
250 VIII
SKELETAL MUSCLE NO ABNORMALITY DETECTED
(1) 643336
FEMUR/KNEE JOINT NO ABNORMALITY DETECTED
(1) 643336
STERNUM NO ABNORMALITY DETECTED
(1) 643336
MANDIBLE NO ABNORMALITY DETECTED
(10) (10) 643330 643345 643336 6433471 643377 643351 643387 643358 643405 643423 643415 643441 643425 643444 643426 643456 643448 643474 643453 643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
;mpany Sanitized. Does not contain TS C A CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
REPRODUCTIVE SYSTEM OVARIES
NO ABNORMALITY DETECTED UTERUS
NO ABNORMALITY DETECTED MAMMARY GLAND (FEMALE)
NO ABNORMALITY DETECTED
LESION INCIDENCE (NUMERIC) |-------------
| Female
| TREATMENT | 0 | (mg/kg/day) | | 1 II
| 250 j | VIII
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
hipany Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS CUTANEOUS SYSTEM
LESION INCIDENCE (NUMERIC)
Female
TREATMENT |0 (mg/kg/day) |
I II
| 250 | I VIII
SKIN NO ABNORMALITY DETECTED
(1 )
643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBI 430
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NGN-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS SPECIAL SENSES SYSTEM
LESION INCIDENCE (NUMERIC)
Female
1 TREATMENT 1 o J (mg/kg/day)
II
1 250 1 VIII
EYE(S ) WITH OPTIC NERVE NO ABNORMALITY DETECTED
(1 )
643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CW 431
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA/SQUAMOUS METAPLASIA, TRANSITIONAL CELL. DEGENERATION, AMELOBLASTS.
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(5) 643384 643402
643383 643465 643484 643383 643465 643484
(5) (5) 643373 643487 643382 643412 643360 643356 643381 643450
643360 643356 643381 643388
643450 643329 643356
Fiyuie in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
ENDOCRINE SYSTEM THYROID GLAND
NO ABNORMALITY DETECTED ALTERATION, COLLOID.
s LESION INCIDENCE (NUMERIC)
| TREATMENT
0
25 100 250
| (mg/kg/day)
1 II IV VI VIII
(5) (4) (5) (5)
643382
643383 643379 643360 643329
643384 643391 643373 643356
643402 643437 643381 643388
643465 643483 643412 643450
643484
643487
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBv 433
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 46
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF P, MALE RATS
GROUP DOSE (mg/kg/day)
N
TEST DAY
78 85 92 99 106
1-0 III-O V-0 VII-0 0 25 100 250
20 20 20 19
MEAN BODY WEIGHT (grams)
555.6(62.6)<a 569.5(63.3) 583.4(64.4) 595.7(63.2) 607.6(64.7)
543.9(52.9) 555.3 (54.7) 568.8(56.5) 582.2(58.0) 590.5(62.5)
547.5(36.3) 559.3(39.0) 569.5(40.7) 579.1(45.6) 574.2(52.3)
495.0(48.1) 516.1(47.0) 531.1(51.7) 539.0(59.8) 547.2 (65.3)
GROUP 1-0 III-O V-0 VII-0
DOSE (mg/kg/day)
0
25 100 250
N 20 20 20 19
TEST DAYS
MEAN BODY WEIGHT GAIN (grams)
78-85 85-92 92-99 99-106
13.9(6.1)a 13.9(6.7) 12.3(5.5) 12.0(5.0)
11.4(8.5) 13.5(5.8) 13.4(6.4)
8.4(7.5)
11.7 (7.3) 10.2 (8.0)
9.7(10.3) -5.0(21.7)*
21.2(11.3) 14.9(8.4)
7.9(15.2) 8.3 (8.9)*
78-106
52.0(7.1)
46.7(16.5)
26.6(30.1)
a Standard deviation is reported in parentheses
52.2(32.7)
* Statistically significant difference from control by Jonckheere-Terpstra test (p < 0.05).
Company Sanitized. Does not contain TSCA CBt 434
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 47
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Pi FEMALE RATS DURING GESTATION
GROUP DOSE (mg/kg/day)
N
GESTATION DAY
0 7 14 21
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
MEAN BODY WEIGHT (grams)
305.7(31.8)a 333.9(33.3) 367.0(35.1)
453.2 (39.0)c
315.2(23.3) 344.4(28.1) 370.0(22.4)
454.9(55.4)d
302.1(18.5) 333.4(17.1) 366.0(19.2)
432.7 (40.0)d
300.3(22.0) 329.2(28.6)
367.2(22.0)b 444.5(35.5)d
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
GESTATION DAYS
MEAN BODY WEIGHT GAIN (grams)
0-7 7-14 14-21
28.2(6.0)a 33.1(5.4)
86.5(16.1)c
29.2(8.8) 25.5(14.2) 82.4(44.5)^
31.3(6.9) 32.5(5.0) 71.9 (28.3)
28.9(23.0)
32.9(6.1)^ 82.0(33.5)b
0-21
146.1(19.3)c 135.8(45.7)d 135.1 (29.7)
a Standard deviation is reported in parentheses, fa N = 13. c N = 10. d N = 11.
146.2(34.6)d
There were no statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
Company Sanitized. Does not contain TSCA CBI 435
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 48
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF P, FEMALE RATS DURING LACTATION
GROUP DOSE (mg/kg/day)
N
LACTATION DAY
0 7 14 21
II-O 0
13
IV-0 25
17
VI-0 100
14
MEAN BODY WEIGHT (grams)
345.5(36.2)3 346.9(31.0) 360.6(33.4) 351.2 (30.6)
351.6(29.8) 351.3(30.7) 380.9(18.9) 365.9(18.4)
337.2 (32.9) 350.0(21.0) 371.4(18.1) 360.4(14.8)
VIII-0 250 13
341.7(21.2) 349.3(25.3) 362.7(28.9) 341.1(41.2)
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
17
VI-0 100
14
VIII-0 250
13
LACTATION DAYS
MEAN BODY WEIGHT GAIN (grams)
0-7 7-14 14-21
1.4(22.1)^ 13.7 (20.7) -9.4(10.9)
-0.3(22.6) 29.6(19.7) -15.0(14.2)
12.8(27.7) 21.4(11.2) -11.1(13.1)
7.6(17.0) 13.3(29.9) -21.5 (43.5)
0-21
5.7(20.8)
14.2(21.3)
23.1(28.5)
a Standard deviation is reported in parentheses.
-0.6(38.4)
* Statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
Company Sanitized. Does not contain TSCA CBi 436
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 49
MEAN DAILY FOOD CONSUMPTION AND MEAN FOOD EFFICIENCY OF P, FEMALE RATS DURING GESTATION
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
V I -0 100
15
VIII-0 250
14
GESTATION DAYS
MEAN DAILY FOOD CONSUMPTION (grams)1
0-7 7-14 14-21
24.8(3.9)3 29.5(3.7) 26.1(5.7)
25.2(2.9) 26.6(3.2) 27.2(3.4)
25.8(2.1) 28.4(1.9) 27.0(3.1)
26.8(4.5) 29.2(3.1)
26.5(4.5)^
0-21
26.8(3.6)
26.4 (2.7)
27.1(1.8)
a Standard deviation is reported in parentheses. b N = 13 .
27.6(2.5)^
There were no statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
GESTATION DAYS
MEAN FOOD EFFICIENCY (grams weight gain/grams food consumed)
0-7 7-14 14-21
0.167(.046)a 0.162(.028) 0.553(.312)
0.163 (.039) 0.141 (.072) 0.365 (.238)
0.172( .031) 0.163 (.022) 0.395( .178)
0.134(.172) 0.165(.032)
0.440 (.206 )-k
0-21
0.268 (.053)
0.224 (.088)
0.241 (.057)
a Standard deviation is reported in parentheses. b N = 13 .
0.254 (.056 )-b
There were no statistically significant differences from control by One-Way Analysis of Variance (p < 0.05) .
Company Sanitized. Does not contain TSC A CB1 437
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 50 SUMMARY OF CLINICAL OBSERVATIONS IN P, RATS
Pi MALE RATS
GROUP DOSE (mg/kg/day)
N
Number of Rats with Observation 1-0 III-O V-0 VII-0
0 25 100 250 20 20 20 19
OBSERVATIONS
Alopecia Colored Discharge Eye{s) Colored Discharge Nose Teeth Clipped Teeth Crooked
1 0 21 0 0 02 0 0 01 0 0 0 5* 0 0 01
Total No. of Rats with Masses
000
Statistically significant trend by Cochran-Armitage test; p < 0.05.
0
Company Sanitized. Does not contain TSCA CBI 438
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 50 (CONTINUED)
SUMMARY OF CLINICAL OBSERVATIONS IN P[ RATS
Pi FEMALE RATS DURING GESTATION
OBSERVATIONS
Alopecia Diarrhea Sore Stained Abdomen Stained Face Stained Perineum Teeth Clipped Weak Wet Perineum Wet Underbody
GROUP DOSE (mg/kg/day)
N
Number of Rats with Observation
II-O
IV-0
VI-0 VIII-0
0 25 100 250
18 19 19 17
1122 0001 1000 0 01 0 0001 0011 0001 0001 0001 0001
Total No. of Rats with Masses
0000
Note: This table includes clinical observations from pregnant animals only.
Pi FEMALE RATS DURING LACTATION
GROUP DOSE (mg/kg/day)
N
OBSERVATIONS
Abnormal Gait or Mobility Alopecia Colored Discharge Nose Discharge Vaginal Opening Hunched Over Teeth Clipped
O
1
H H
Number of Rats with Observation
IV- 0
VI-0
VIII-0
0 25 1 0 0 250
13 17 14 14
0010
134 1
0010
0 110
0010
000-
Total No. of Rats with Masses
0000
There were no statistically significant trends by Cochran-Armitage test; p < 0.05.
Company Sanitized. Does not contain TSCA CBI 439
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 51
MEAN ESTROUS CYCLE PARAMETERS AND PRECOITAL INTERVAL IN P, FEMALE RATS
Percent Percent Percent
o f Days of Days of Days Mean Cycle
Dose
in in in Length
Group (mg/kg/day) N Estrus Diestrus Proestrus
(days)
Mean Precoital Interval
(days)
II-O
0 20 29
60
11 4.7(1.54)a '* 3.8(2.46)c
IV-0
25 19 22
65
13 4.5(0.81)
3.3(2.86)
VI-0
100 20 25
63
12 4.6(0.73)* 2.5(1.31)*
VIII-0 250 18 20
69
12
a Standard deviation is presented in parentheses. b N=19 c N=18 d N=17
4.7(1.35)
3.6(2.21)*
There were no significant trends (Jonckheere's test); p < 0.05.
Company Sanitized. Does not contain TSCA CB! 440
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 52
SUMMARY OF SPERM PARAMETERS IN Pi MALE RATS
Group Dose (mg/kg/day)
1-0 0
III-O 25
V-0 100
MOTILITY Percent Motile S.D.
93.3 3.6(10)a
92.2 5.8(10)
93.3 4.0(10)
MORPHOLOGY Percent Normal S.D.
98.8 0.8(10)
99.0 1.1(10)
99.2 0.7(10)
EPIDIDYMAL SPERM (Millions )
Per Cauda
298.7
S.D.
32.3(10)
279.8 39.8(10)
278.0 44.9(10)
Per gram Cauda S.D.
1030.9 171.6(10)
998.3 144.3(10)
949.8 178.4 (10)
TESTICULAR SPERMATIDS (Millions)
Per Testis
130.1
S.D.
17.1(10)
121.8 13.6(10)
159.9* 10.3(10)
Per gram Testis S.D.
84.5 12.3(10)
84.5 12.0(10)
101.1* 9.1(10)
VII-0 250
90.3 6.1(10)
98.9 1.1(10)
299.2 66.9(10)
945.7 150.5(10)
146.5* 17.3(10) 93.2* 9.5(10)
a Number in group is in parentheses. Statistically significant trend by Jonckheere-Terpstra test; p < 0.05.
Company Sanitized. Does not contain TSCA CBt 441
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 53
SUMMARY OF REPRODUCTIVE INDICES: P, GENERATION
MATERNAL GROUP II-O
DOSE (mg/kg/day)
0
IV-0 25
VI-0 100
VIII-0 250
MATING INDEX (%) (# copulated/cohoused)
90.0
100.0
95.0
94.7
(18/20) (20/20) (19/20) (18/19)
FERTILITY INDEX (%) (# delivered/copulated)
72.2
85.0
73.7
77.8
(13/18) (17/20) (14/19) (14/18)
GESTATION LENGTH (days)
22.3
22.2
22.4
22.4
Number of Implantation Sites per pregnant female
14.0
13.4
(4.53)3 (4.58)
13.9 (2.95)
14.1 (2.93)
Implantation Efficiency (%)*
96.6 (3.33)
90.5
83.4*
84.5*
(13.47) (16.16) (19.10)
a Standard deviation is reported in parentheses. b Number of pups born/number of implantation sites X 100.
There were no statistically significant trends in mating or fertility indices by Cochran-Armitage test; p < 0.05.
There was no statistically significant difference from control in gestation length by One-Way Analysis of Variance; p < 0.05.
* Statistically significant trend by Jonckheere's test; p < 0.05.
Company Sanitized. Does not contain TSCA CBI 442
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 54
MEAN PUP NUMBERS AND SURVIVAL: Fj GENERATION
O 1 H>
MATERNAL GROU P DOSE (mg/kg/day)
N
11-0 0 13
IV-0 25 17
viii-o 100 250 14 13
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF PUPS/LITTER 14.7 14.6 14.6 8.0
8.0
8.0
8.0
13.4 13.2 12.9
7.6
7.6
7.6
7.6
12.4 11.3 10.0*
6.3 6.3
6.3
6.3
12.5* 12.1* 11.8*
7.5
7.4
7.4
7.4
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF MALE PUPS/LITTER 8.7 7.2 5.9 7.1 8.6 7.1 5.4 6.7 8.6 7.1 4.7 6.5 4.2 3.6 3.3 3.6 4.2 3.6 3.3 3.9 4.2 3 .6 3 .3 3.6 4.2 3 .6 3.3 3.6
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF FEMALE PUPS/LITTER 6.0 6.1 6.5 5.5 6.0 6.1 5.9 5.4 6.0 5.8 5.3 5.3 3.8 4.0 3 .0 3.8 3.8 4.0 3 .0 3.8 3.8 4.0 3.0 3.8 3.8 4.0 3.0 3.8
Sex Ratio (males)
Gestation Index3 Mean % Born Alive 0-4 Day Viability Lactation I n d e x - 6
Litter Survival0
SURVIVAL
(% ) 0.59
100.0 99.5
100.0
100.0
100.0
0.50 100.0
99.2 97.6 100.0
100.0
a Percent litters delivered having at least one live pup. b Mean percent survival from day 4 postculling to day 21. c Percent litters born with at least one pup alive on day 21.
0.50 92 .9 88.4 90.6 100.0
92.3
0.56 100.0
92.4 97.3 92.3
92.3
* Statistically significant trend by Jonckheere-Terpstra test; p < 0.05.
Statistics were performed on combined pups per litter only. Male and female data are presented for information only.
Company Sanitized. Does not contain TSCA CBt 443
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 55
MEAN PUP WEIGHTS: Fj GENERATION
MATERNAL GROUP DOSE (mg/kg/day)
N
II-O 0 13
IV-0 25 17
VI-0 100 13
VIII-0 250 13
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
MEAN PUP WEIGHTS (grams)
6.9 (0.7)a 11.3 (1.5) 11.4 (1.6) 18.3 (1.9) 37.9 (3.4) 60.9 (6.9)
6.7 (0.6) 11.4 (1.6) 11.4 (1.7) 18.0 (2.2) 37.0 (3.0) 60.3 (5.5)
6.8 (0.7 )-k 11.9 (1.8) 11.9 (1.9) 18.3 (2.4) 36.1 (3.2) 58.3 (4.3)
6.4 (0.6) 10.1 (1.7)* 10.1 (1.7)* 15.5 (2.1)* 29.5 (3.4)* 45.4 (7.7)*
MEAN MALE PUP WEIGHTS (grams)
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
7.0 (0.7) 11.6 (1.5) 11.7 (1.5) 18.8 (2.0) 38.7 (3.6) 62.5 (7.4)
6.9 (0.7) c 11.5 (1.7) 11.5 (1.7) 18.2 (2.3) 37.7 (3.2) 61.7 (6.2)
6.9 (0.8)b 12.3 (1.9) 12.3 (2.0) 18.9 (2.3) 37.1 (3.1) 60.2 (4.3)
6.7 (0.5) 10.7 (0.8) 10.8 (0.7) 15.7 (2.3) 29.6 (3.8) 45.7 (7.7)
MEAN FEMALE PUP WEIGHTS (grams)
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
6.6 (0.7) 10.9 (1.5) 11.0 (1.6) 17.6 (1.9) 37.0 (3.2) 59.1 (6.3)
6.5 (0.6) 11.1 (1.8) 11.2 (1.8) 17.6 (2.2) 36.5 (3.0) 59.0 (5.5)
a Standard deviation is reported in parentheses. b N = 12. c N = 14.
6.5 (0.7 )-b 11.5 (1.7) 11.4 (1.9) 17.5 (2.7) 35.0 (3.6) 56.0 (4.7)
6.2 (0.6) 9.8 (1.7) 9.9 (1.8) 15.3 (2.0) 29.3 (3.1) 45.0 (8.0)
* Statistically significant trends by linear contrast of least square means; p < 0.05.
Note; Statistical analyses were conducted on the combined pup weights. Male and female data are presented for information only.
mpany Sanitized. Does not contain TSCA CBI 444
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 56
SUMMARY OF PUP CLINICAL OBSERVATIONS: F, GENERATION
MATERNAL GROUP II-O
DOSE (mg/kg/day)
0
IV-0 25
VI-0 100
VIII-0 250
OBSERVATIONS
Discharge Nose Weak
0 0 0 3 ( l)a 0 0 0 2 ( 1)
TOTAL NUMBER OF OBSERVATIONS NUMBER OF LITTERS AFFECTED TOTAL NUMBER OF LITTERS
0 00 5 0001 13 17 13 13
a Numbers outside the parentheses are the number of pups affected; the numbers in parentheses are the number of litters affected.
There were no statistically significant trends by Cochran-Armitage test; p < 0.05.
Company Sanitized. Does rot contain TSCA CB1 445
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 57
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Fi MALE RATS
GROUP DOSE (mg/kg/day)
N
DAYS ON
TESTS
1 8 15 22 29 36
1-1 0
13
63.3(7.5)* 108.7 (12.8) 172.2 (18.0) 236.3(21.9) 294.7 (31.0) 333.4(33.5)
III-l 25
16
V-l 100
12
MEAN BODY WEIGHT (grams)
62.5(7.0) 103.9(10.3) 163.9(15.3) 224.0(16.9) 278.7(23.6)
331.8 (31.3)c
58.6(5.6) 100.5(8.9) 161.3(13.0) 223.0(11.5) 279.2(20.4) 310.5(35.5)
VII-1 250
12
47.0(5.3)* 88.0(6.8)* 144.5(11.6)* 206.0(11.4)* 264.0(28.4)* 310.2(40.2)*
GROUP
DOSE (mg/kg/day)
N
1-1 0
13
III-l 25
16
V-l 100
12
DAYS ON TEST3
MEAN BODY WEIGHT GAIN (grams)
1-8 8-15 15-22 22-29 29-36
45.3(6.4)* 63.5(6.8) 64.1(7.0) 58.4(13.8) 38.7(31.8)
41.5(5.0) 60.0(6.0) 60.1(5.5) 54.7(16.5)
54.6 (20.1)c
41.9(4.4) 60.8(5.2) 61.7(5.0) 56.3(15.6) 31.2(19.3)
1-36
270.1(30.2)
269.7 (28.9)c 251.9 (33.3)
a Day of Weaning = Test Day 1. b Standard deviation is reported in parentheses, c N = 15.
VII-1 250
12
41.0(7.4) 56.5(6.7)* 61.5(5.7) 58.0 (22.5) 46.1(25.5) 263.2(42.3)
* Statistically significant trend by Jonckheere-Terpstra test p < 0.05.
Company Sanitized. Does not contain TSCA C 446
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 58
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF F, FEMALE RATS
GROUP DOSE (mg/kg/day)
N
DAYS ON TESTa
1 8 15 22 29 36
II-l 0
13
57.3 (6.3 ) b 94.0(7.8) 135.8(9.6) 167.5(13.4) 190.0(17.5) 206.4(16.3)
IV-1 25
17
V I -1 100
12
VIII-1 250
12
MEAN BODY WEIGHT (grams)
58.6(6.3) 94.8(8.3) 139.6(13.9) 173.7(21.6) 195.6(24.2)
218.8(30.7)c
56.7(4.9) 90.4(7.0) 133.6(8.3) 167.5(10.8) 191.4(15.8) 212.6((17.7)
44.7(8.1)* 80.0(9.6)* 124.8 (9.1)* 161.7(9.8) 187.7 (13.4) 206.3(13.9)
GROUP
DOSE (mg/kg/day)
N
II-l 0
13
IV-1 25
17
VI-1 100
12
DAYS ON TESTS
MEAN BODY WEIGHT GAIN (grams )
1-8 8-15 15-22 22-29 29-36
36.8(4.2)^ 41.8(6.4) 31.7(8.4) 22.5(6.1) 16.4(7.0)
36.2(3.8) 44.7(7.1) 34.2(9.1) 21.9(7.7)
22.6 (9.1)c
33.7(5.4) 43.2(5.7) 33.9(5.4) 23.9(6.9) 21.1(4.2)
1-36
149.1(17.7)
160.3 (26.7)c 155.9 (16.3)
a Day of Weaning = Test Day 1. b Standard deviation is reported in parentheses. c N = 16 .
VIII-1 250
12
35.2 (6.4) 44.8(4.1) 36.9(5.6) 26.0(8.3) 18.6(13.1) 161.5(18.7)
Statistically significant trend by Jonckheere-Terpstra test ; p < 0.05.
Company Sanitized. Does not contain TSCA CBI 447
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 59
SUMMARY OF CLINICAL OBSERVATIONS IN Fi RATS
Fj. MALE RATS
Number of Rats with Given Observation
GROUP 1-1 III-l V-l VII-1
DOSE (mg/kg/day) 0
25 100 250
N 13
16 12 12
OBSERVATIONS
There were no abnormal clinical observations observed in the Fx Male Rats.
Total No. of Rats with Masses
Fj FEMALE RATS
Number of Rats with Given Observation
GROUP DOSE (mg/kg/day)
N
II-l 0 13
IV-1 25 17
VI-1 100 12
VIII250 12
OBSERVATIONS
Alopecia
0100
Total No. of Rats with Masses
0000
There were no statistically significant trends by Cochran-Armitage test; p < 0.05.
Company Sanitized. Does not contain TSCA CBI 448
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 60 SUMMARY OF DEVELOPMENTAL LANDMARKS IN F, RATS
PREPUTIAL SEPARATION - Fi MALE RATS
GROUP 1-1 III-l V-l VII-1
DOSE (mg/kg/day)
0
25 100 250
N 13 16 12 12
(Days)a
39.9 (2.22)
41.5 (2.90)
43.2 (3.16)
42.7 (2.10)
VAGINAL OPENING - Fx FEMALE RATS
GROUP DOSE (mg/kg/day)
N
II-l 0 13
IV-1 25 17
V I -1 100 12
VIII-1 250 12
(Days)a
32.1 (2.43)
32.2 (2.28)
Data summarized as: Mean Standard Deviation
32.1 (1.93)
32.5 (2.58)
a Age was calculated as follows using data presented in Appendix L L : Test day + 20 days = Age (days).
There were no statistically significant trends by linear contrast of least square means (covariate:body weight).
tmpany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 61
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - P, ADULTS
GROUP DOSE (MG/KG/DAY) THYROID
FINAL BODY
1-0 0
0.021 0.003(12 )
604.692 62.781(12 )
III-O 25
0.020 0.004(17 )
594.429 57.077(17 )
V-0 100
0.022 0.005(14 )
557.193 61.905(14 )
VII-0 250
0.025 0.007(14
541.471# 65.972(14
THYROID/FINAL BODY * 100
0.004 0.000(12 )
0.003 0.001(17 )
Data summarized as:
Mean Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra).
# Statistically significant difference at p < 0.05.
0.004 0.001(14 )
0.005# 0.001(14
Revised Page DuPont-5368
Company Sanitized. Does not contain TSCACBI
450
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 62 MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Pi ADULTS
GROUP DOSE (MG/KG/DAY)
II-O 0
IV-0 25
THYROID
0.019 0.004(11 )
0.021 0.004(17 )
FINAL BODY
351.700
365.888
33.050(11 ) 18.416(17 )
THYROID/FINAL BODY * 100
0.006 0 .001(11 )
0.006 0.001(17 )
Data summarized as:
Mean Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra)
No statistically significant difference at p < 0.05.
VI-0 100
0.020 0.004(12 }
359.208 15.076(12 )
0.006 0 .001(12 )
VIII-0 250
0.022 0.005(12 )
338.008 41.391(12 )
0.006 0 .002(12 )
Revised Page DuPont-5368
Company Sanitized, Does not contain TSCA CBI
451
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 63
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - Fi ADULTS
MEAN FINAL BODY AND ABSOLUTE ORGAN WEIGHTS (grams)
GROUP DOSE (MG/KG/DAY)
1-1
III-l
V-l
VII-1
0 25 100 250
BRAIN
1.996 0.093(13 )
1.949 0.069(16 )
1.966 0.106(12 )
1.978 0.072(12
EPIDIDYMIDES
0.760 0.067(13 )
0.738 0.092(16 )
0.739 0.048(12 )
0.686# 0.065(12
TESTES
3.300 0.228(13 )
3.154 0.177(16 )
3.220 0.254(12 )
3.039# 0.439(12
SEMINAL VESICLES PROSTATE THYROID
1.200 0.205(13 )
0.460 0.126(13 )
0.019 0.004(13 )
1.074 0.202(16 )
0.409 0.083(16 )
0.017 0.003(16 )
1.085 0.257(12 )
0.368 0.087(12 )
0.015 0.004(12 )
1.084 0.187(12
0.406 0.116(12
0.018 0.004(12
KIDNEYS
3.283 0.291(13 )
3.154 0.264(16 )
3.199 0.293(12 )
3.253 0.270(12
LIVER
17.488 1.869(13 )
16.938 1.829(16 )
17.100 2.729(12 )
16.037# 1.240(12
FINAL BODY
384.823
372.338
376.133
360.375#
31.437(13 ) 25.695(16 ) 26.968(12 ) 36.754(12
Revised Page DuPont-5368
Company Sanitfeed. Does noi contain TSCA CB1
452
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - F, ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weight)
GROUP DOSE (MG/KG/DAY)
1-1
III-l
V-l
VII-1
0 25 100 250
BRAIN/FINAL BODY * 100 0.521 0.034(13 )
EPIDIDYMIDES/FINAL BODY * 100 0.198 0.014(13 )
0.525 0.028(16 )
0.198 0.019(16 )
0.525 0.049(12 )
0.197 0.014(12 )
0.553 0.048(12
0.191 0.015(12
TESTES/FINAL BODY * 100 0.860 0.044(13 )
SEMINAL VESICLES/FINAL BODY * 100 0.311 0.037(13 )
0.848 0.034(16 )
0.288 0.045(16 )
0.860 0.091(12 )
0.287 0.055(12 )
0.843 0.077(12
0.303 0.057 (12
PROSTATE/FINAL BODY * 100 0.119 0.029(13 )
0.110 0.020(16 )
0.098 0.022(12 )
0.112 0.024(12
THYROID/FINAL BODY * 100 0.005 0.001(13 )
KIDNEYS/FINAL BODY * 100 0.854 0.051(13 )
0.005 0.001(16 )
0.848 0.061(16 )
0.004 0.001(12 )
0.851 0.059(12 )
0.005 0.001(12
0.906 0.068(12
Revised Page DuPont-5368
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - Fi ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weight)
GROUP DOSE (MG/KG/DAY)
1-1 III-l 0 25
V-l 100
VII-1 250
LIVER/FINAL BODY * 100 4.543 0.290(13 )
4.546 0.327(16 )
4.525 0.479(12 )
4.468 0.329(12
MEAN RELATIVE ORGAN WEIGHTS (organ to brain weight ratio)
GROUP DOSE (MG/KG/DAY)
1-1 III-l 0 25
LIVER/BRAIN*100
875.891
868.962
82.315(13 ) 90.420(16 )
KIDNEYS/BRAIN*10 0 164.486 12.752(13 )
161.723 11.469(16 )
PROSTATE/BRAIN*10 0 23.017 5.990(13 )
20.936 4.034(16 )
SEMINAL VESICLES/BRAIN*100 59.952 8.655(13 )
55.060 10.071(16 )
TESTES/BRAIN*100
165.435
161.842
9.973(13 )
8.064(16 )
V-l 100 873.051 149.566(12 )
163.152 17.372(12 )
18.712 4.085(12 )
55.069 12.064(12 )
164.109 14.137(12 )
VII-1 250 811.923 70.037(12
164.691 14.841(12
20.513 5.677 (12
54.769 9.181(12
153.809 22.378(12
Revised Page DuPont-5368
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - Fi ADULTS
EPIDIDYMIDES/BRAIN*100
38.113 3.175(13 )
37.831 4.196(16 )
37.650
34.712#
2.899(12 )
3.437(12 )
THYROID/BRAIN*100 _____________________
0.953
0.861
0.215(13 )
0.163(16 )
Data summarized as:
Mean Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra).
# Statistically significant difference at p < 0.05.
0.775 0.192(12 )
0.933 0.221(12 )
Revised Page DuPont-5368
Company Sanitized. Does not contain TSCACBl 455
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 64
MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - F[ ADULTS
MEAN FINAL BODY AND ABSOLUTE ORGAN WEIGHTS (grams)
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
VI-1 100
VIII-1 250
BRAIN
1.829 0.061(13 )
1.849 0.082(17 )
1.799 0.091(12 )
1.810 0.057(12
UTERUS
0.429 0.087(13 )
0.470 0.140(17 )
0.450 0.115(12 )
0.583 0.604(12
THYROID
0.016 0.003(13 )
0.015 0.003(17 )
0.016 0.003(12 )
0.013 0.002(12
KIDNEYS
1.886 0.154(13 )
2.038 0.249(17 )
2.051 0.247(12 )
2.039 0.211(12
LIVER
9.063 1.385(13 )
9.589 1.727(17 )
9.593 1.329(12 )
9.986 0.958(12
FINAL BODY
218.431
226.071
223.750
222.475
19.969(13 ) 29.359(17 ) 19.600(12 ) 15.014(12
Revised Page DuPont-5368
Company Sanitized. Does no, contain TSCA CB,
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 64 (Continued) MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Fi ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weight)
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
BRAIN/FINAL BODY * 100 0.844 0.083(13 )
0.829 0.096(17 )
UTERUS/FINAL BODY * 100 0.198 0.040(13 )
0.210 0.065(17 )
THYROID/FINAL BODY * 100 0.007 0.001(13 )
0.007 0.002(17 )
KIDNEYS/FINAL BODY * 100 0.867 0.079(13 )
0.904 0.052(17 )
LIVER/FINAL BODY * 100 4.136 0.403(13 )
4.227 0.406(17 )
VI-1 100
0.810 0.085(12 )
0.203 0.057(12 )
0.007 0.002(12 )
0.921 0.119(12 )
4.281 0.361(12 )
VIII-1 250
0.817 0.061(12 )
0.258 0.251(12 )
0.006 0.001(12 )
0.917 0.079(12 )
4.492# 0.372(12 )
MEAN RELATIVE ORGAN WEIGHTS (orqan to brain weight ratio)
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
LIVER/BRAIN*100
496.052
517.938
77.065(13 ) 86.356(17 )
VI-1 100
534.812 80.407(12 )
VIII-1 250
552.297# 55.783(12 )
Revised Page DuPont-5368
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 64 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Fj ADULTS
MEAN RELATIVE ORGAN WEIGHTS (organ to brain weight ratio)
GROUP DOSE (MG/KG/DAY)
H-l 0
IV-1 25
VI-1 100
VIII-1 250
KIDNEYS/BRAIN*10 0 103.192 8.825(13 )
110.086 11.594(17 )
114.319# 15.371(12 )
112.713# 12.284(12 )
THYROID/BRAIN*100
0.867 0.164(13 )
0.804 0.187(17 )
0.898 0.189(12 )
0.718 0.128(12 )
UTERUS/BRAIN*100 23.473
_________________________________ 4.657(13 )
Data summarized as: Mean Standard Deviation (n)
25.407 7.477(17 )
Statistical Methods: Trend test (Jonckheere-Terpstra). # Statistically significant difference at p < 0.05.
24.873 5.632(12 )
32.194 33.171(12 )
Revised Page DuPont-5368
Com pany Sanitized. Desnoi contain TSCAcBf
458
H-24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
SITE/LESION:
TABLE 65
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - P, ADULTS
H 1 O
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
0 20
III-O 25 20
V-0 100 20
EPIDIDYMIDES LARGE
O'3
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
0
0
Revised Page DuPont-5368
VII-0 250 19
1
Company Sanitized.
Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
SITE/LESION:
TABLE 66
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - Pi ADULTS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
II-O 0 20
IV-0 25 20
VI-0 100 20
LIVER DISCOLORATION
13
STOMACH DISTENDED WITH GAS
0
SMALL INTESTINE DISTENDED WITH GAS
0
KIDNEYS DILATATION
0
UTERUS HEMORRHAGE OBSTRUCTION
0 0
SKIN STAIN ALOPECIA
0 1
INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
0
0
0
0
0 0
0 0
0
0
0
0
0 0
1 0
Revised Page DuPont-5368
VI 25 19
0 1 1 1 1 1 2 0
Company Sanitized. Does nof contain TSCA CB1
460
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION:
TABLE 67
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Fi PUPS
DAM GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER PUPS/LITTERS:
II-O 0 1/1
IV-0 25 2/2
VI-0 100 7/3
VIII-0 250 5/3
STOMACH NO MILK SPOT
PERITONEAL CAVITY CANNIBALIZED
LUNGS NOT EXPANDED
0 ( 0) 0 ( 0) 0 ( 0)
2 ( 2) 0 ( 0) 2 { 2)
4 ( 1) 0 ( 0) 4 ( 1)
3 { 3) 1 ( 1) 3 ( 3)
TOTAL LITTERS AFFECTED TOTAL PUPS AFFECTED
0213 0244
For each group: The count of pups only includes those which underwent pathological examination. The count of litters only includes those in which pups underwent pathological examination.
For each site/lesion: Numbers outside the parentheses are the number of pups affected. Numbers in parentheses are the number of litters affected.
Company Sanifeed. Dona no. nomata TSCA CBI
461
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION:
TABLE 68
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - F, PUPS
DAM GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER PUPS/LITTERS:
II-O 0 0/0
IV-0 25 0/0
VI-0 100 8/3
VIII-0 250 4/2
STOMACH NO MILK SPOT
LUNGS NOT EXPANDED
0 ( 0) 0 ( 0)
0 ( 0) 0 ( 0)
5 ( 1) 5 ( 1)
1( U 1 ( 1)
TOTAL LITTERS AFFECTED TOTAL PUPS AFFECTED
0011 0051
For each group: The count of pups only includes those which underwent pathological examination. The count of litters only includes those in which pups underwent pathological examination.
For each site/lesion: Numbers outside the parentheses are the number of pups affected. Numbers in parentheses are the number of litters affected.
Company Sanitteed. Does not contain TSCA CBI
462
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION:
TABLE 69
INCIDENCES OF GROSS OBSERVATIONS IN RATS - Fi UNSEXABLE PUPS
DAM GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER PUPS/LITTERS:
II-O 0 0/0
IV-0 25 0/0
VI-0 100 0/0
VIII-0 250 13/1
WHOLE BODY AUTOLYSIS
0 ( 0)
0 ( 0}
0 ( 0)
10 ( 1)
TOTAL LITTERS AFFECTED TOTAL PUPS AFFECTED
0001 0 0 0 10
For each group: The count of pups only includes those which underwent pathological examination. The count of litters only includes those in which pups underwent pathological examination.
For each site/lesion: Numbers outside the parentheses are the number of pups affected. Numbers in parentheses are the number of litters affected.
Company Sanitized. Does not contain TSCA CBF 463
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION:
TABLE 70
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - F, WEANLINGS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
1-1 0 42
III-l 25 45
V-l 100 34
KIDNEYS
LARGE SMALL________
0a 1
0
0 10
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
VII-1 250 35
0 0
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION:
TABLE 71
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - Fi WEANLINGS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NIMBER IN GROUP:
II-l 0 36
IV-1 25 51
VI-1 100 30
VIII-1 250 37
THERE WERE NO GROSS OBSERVATIONS
Company Sanitized. Does not contain TSCA CBI 465
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
SITE/LESION:
TABLE 72
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Fi ADULTS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
1-1 0 13
III-l 25 16
V-l 100 12
KIDNEYS DILATATION
ia
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
3
6
Revised Page DuPont-5368
VII-1 250 12
0
Company Sanitized. Does not contain TSCA CBI 466
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
SITE/LESION :
TABLE 73
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - F, ADULTS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
II-l 0 13
IV-1 25 17
V I -1 100 12
VIII-1 250 12
KIDNEYS DILATATION_____________________________________________ 0___________ 0___________ 2___________ 0
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
Company Sanitized, does not contain Ts c a C B t
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 74
INCIDENCES AND LESION GRADES OF MICROSCOPIC OBSERVATIONS IN MALE REPRODUCTION RATS - P, ADULTS
LESION GRADES TISSUE/LESION (P,1,2,3,4)
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
1-0 0 20
III-O 25 20
v-o 100 20
VII250 19
TESTIS3 TESTES
4132 3233
EPIDIDYMIS3
EPIDIDYMIDES
PROSTATE INFLAMMATION, SUBACUTE/CHRONIC
SEMINAL VESICLES
4
3
7 1 (-,1,-,-, -) 7
1 2 3
3
3
3
6 1 (-,1, 6
2
3
5 1( 5
COAGULATING GLAND
7365
OTHER
0000
O THE NUMBER OF ORGANS EXAMINED FOR EACH GROUP IS UNDERLINED. o LESION GRADES: P = PRESENT; 1 = MINIMAL; 2 = MILD; 3 = MODERATE; 4 = SEVERE. o LESION GRADES CORRESPOND BY POSITION WITH THE NUMBERS IN PARENTHESES, WHICH INDICATE HOW OFTEN EACH GRADE
WAS OBSERVED. FOR EXAMPLE: (-,1,2,-,-) MEANS NO LESIONS WERE GRADED "PRESENT" (NON-GRADED LESIONS), 1 LESION WAS GRADED "MINIMAL", 2 LESIONS WERE GRADED "MILD", NO LESIONS WERE GRADED "MODERATE" AND NO LESIONS WERE GRADED "SEVERE".
a One of the pair available for microscopic examination. Sperm parameter evaluation was performed on the second of the pair.
Company Sanitized. Does not contain TSCA CEI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5368
TABLE 75
INCIDENCES AND LESION GRADES OF MICROSCOPIC OBSERVATIONS IN FEMALE REPRODUCTION RATS - Pi ADULTS
GROUP DESIGNATION: LESION GRADES DOSE (MG/KG/DAY): TISSUE/LESION (P,1,2,3,4) NUMBER IN GROUP:
II-O
0 20
IV-0 25
20
v i -o 100 20
VIII-0 250 19
OVARIES
83 85
UTERUS DILATATION, GLAND/LUMEN
VAGINA
83 85
-
1 (-,1,
3 (-,1,2,-,-)
-
8385
OTHER LIVER: NECROSIS, FOCAL SKIN: NO ABNORMALITIES DETECTED
2 1 (-,1, 1 (1,
0
-
-
00
~-
--
o THE NUMBER OF ORGANS EXAMINED FOR EACH GROUP IS UNDERLINED. o LESION GRADES: P = PRESENT; 1 = MINIMAL; 2 = MILD; 3 = MODERATE; 4 = SEVERE. o LESION GRADES CORRESPOND BY POSITION WITH THE NUMBERS IN PARENTHESES, WHICH INDICATE HOW OFTEN EACH GRADE
WAS OBSERVED. FOR EXAMPLE: (-,1,2,-,-) MEANS NO LESIONS WERE GRADED "PRESENT" (NON-GRADED LESIONS), 1 LESION WAS GRADED "MINIMAL", 2 LESIONS WERE GRADED "MILD", NO LESIONS WERE GRADED "MODERATE" AND NO LESIONS WERE GRADED "SEVERE".
Company S anitized. Does n o t co n ta in TSCA C
469
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURES
Company Sanitized. Does not contain TSCkC&f 470
H -24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURES
EXPLANATORY NOTES
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co-housed. Body weights collected during the cohabitation and post-mating periods are reported in the Reproductive Toxicology section.
Day 90 Recovery period begins for rats designated for one-month and 3-month recovery periods. Day 91 Male rats designated for the 90-day exposure period were sacrificed. Day 92 Last day o f test substance administration for female rats designated for the
90-day exposure period. Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day o f non-fasted body weight data collection for rats designated for the one-month recovery
period. Day 125 Male and female rats designated for the one-month recovery period were sacrificed Day 175 Last day of non-fasted body weight data collection for rats designated for the 3-month recovery period. Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
Company Sanitized. Does not contain TSCA CBI 471
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 1 MEAN BODY WEIGHTS OF MALE RATS
Revised Page DuPont-5386
* On test day 74, male and female rats designated for reproduction evaluations were co-housed. On test day 77, all rats in the 250 mg/kg/day dose group were placed on ground chow.
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 2 MEAN BODY WEIGHTS OF FEMALE RATS
Revised Page DuPont-5386
* On test day 74, male and female rats designated for reproduction evaluations were co-housed. On test day 77, all rats in the 250 mg/kg/day dose group were placed on ground chow. Company Sanitized. Does not contain TSCA CB1
473
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURE 3 MEAN FORELIMB GRIP STRENGTH FOR MALE RATS
Forelimb Grip Strength (kg)
2.00 -i 1.80 1.60 1.40
1.20
1.00 0.80 0.60 -| 0.40 J
|0.20 -
0.00 j
Baseline
Week 13 Assessment Period
0 mg/kg/day D 25 mg/kg/day
I II100 mgkgday 250 mg/kg/day
Company Sanitized. Does not contain TSCA
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 4 MEAN FORELIMB GRIP STRENGTH FOR FEMALE RATS
1.60
Revised Page DuPont-5386
Forelimb Grip Strength (kg)
1.40
1.20
1.00
0 mg/kg/day 25 mg/kg/day 0.80 i 100 mgkgday IB 250 mg/kg/day 0.60
0.40
0.20
0.00
Baseline
Week 13 Assessment Period
Recovery
Company Sanitized. Does not contain TSCA CB
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 5 MEAN HINDLIMB GRIP STRENGTH FOR MALE RATS
Revised Page DuPont-5386
Hindlimb Grip Strength (kg)
0 mg/kg/day 25 mg/kg/day I 100 mgkgday [ 250 mg/kg/day
Week 13 Assessment Period
476
Recovery
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURE 6 MEAN HINDLIMB GRIP STRENGTH FOR FEMALE RATS
0.90
0.80 -J
0.70 -
0.60 H
W) 0.50 j
S-.
55 g 0.40 : =3 0.30 e
0.20 -!
0.10
0.00 T
Baseline
Week 13 Assessment Period
I 0 mg/kg/day I 25 mg/kg/day ^ 1 0 0 mgkgday ! 250 mg/kg/day
Recovery
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Revised Page DuPont-5386
FIGURE 7 MOTOR ACTIVITY ASSESSMENT: MEAN DURATION OF MOVEMENTS FOR MALE RATS
2000
0 mg/kg/day 25 mg/kg/day H 100 mgkgday 250 mg/kg/day
Baseline
Week 13 Assessment Period
478
Recovery
Company Saniltaed. Does m l contato TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURE 8 MOTOR ACTIVITY ASSESSMENT: MEAN DURATION OF MOVEMENTS FOR FEMALE RATS
Duration o f Movements (sec)
2000 1800 1600 1400
1200 1000
800 600 400 200
0
Baseline
0 mg/kg/day 25 mg/kg/day 100 mgkgday 250 mg/kg/day
Week 13 Assessment Period
479
Recovery
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Revised Page DuPont-5386
FIGURE 9 MOTOR ACTIVITY ASSESSMENT: MEAN NUMBER OF MOVEMENTS FOR MALE RATS
Number of Movements
900
800
700
600 500 ! 0 mg/kg/day
; 25 mg/kg/day H 100mgkgday 400
300
I200
100
0 Baseline
Week 13 Assessment Period
480
tsc a cbi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Revised Page DuPont-5386
FIGURE 10 MOTOR ACTIVITY ASSESSMENT: MEAN NUMBER OF MOVEMENTS FOR FEMALE RATS
900
0 mg/kg/day 25 mg/kg/day 100mgkgday M 250 mg/kg/day
Baseline
Week 13 Assessment Period
481
Recovery
Com pany S an itize d . D oes
n t co n ta in TSCA OBJ
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDICES
m p a n y S a n itize d . Does not contain TSCA CBt 482
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX A ANALYTICAL DATA
Cstttpany Sanitized. Does not contain TSCA CBI 483
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table I. Initial Homogeneity and Stability o f H-24516 in Dosing Suspensions
Sample
mg/mL H-24516
Type
Nominal
Measured
Test Day 0
Homogeneity Control
0.00
n d (a )
Top M iddle B ottom
2.5 2.30 2.5 2.47 2.5 2.40
M e a n iB); 2 .3 9 + 0 .0 8 C.V. 3%
Percent Nominal
--
92.0 98.8 96.0 (95.6% )
T op M iddle
Bottom(c )
10 8.97 10 10.2 10 14.0
M eanfX- 11-1+2.6 C.V. 24%
89.7 102.0 140.0
(111.0% )
T op M iddle B ottom
25 26.8 25 24.8 25 23.5
Mea(B); 25.01.6
C.V. 7%
107.2 99.2 94.0 (100.0% )
Stabilitv(D)
2.5 10 25
2.06 82.4 8.89 88.9 24.1 96.4
Test Day 6 Homogeneity Control
T op M iddle B ottom
0.00 n d (a )
10 9.26 10 9.58 10 9.23
M e a n W : 9.36+0.19 C. V. 2%
--
92.6 95.8 92.3 (93.6% )
Stability(D)
10 9.03 90.3 (A) Denotes not detected. (B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level. (C) Duplicate re-analysis o f original sample supports the original analysis and will not be reported. (D) Stability samples held 5 hours a room temperature.
Company Sanitized. Does not contain TSCA CBi 484
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table II. Mixing and Stability Study o f H-24516 in Dosing Suspensions
Sample Type
mg/mL H-24516
Dose Volume
Nominal
Measured
Homogeneity 7.5 mL/Kg Control
0.00 n d (a )
Percent Nominal
--
T op M iddle Bottom
5.0 mL/Kg Control
3.33 2.88 3.33 2.54 3.33 2.67
M ea n iB); 2.70+0.2 C.V. 6 %
0.00 n d (a )
86.5 76.3 80.2 (81.1% )
--
Top M iddle Bottom
T op M iddle B ottom
T op M iddle B ottom
5.0 4.53 5.0 4.25 5.0 4.39
M ean& ):4-390.14
C.V. 3 % 20.0 19.9 20.0 17.7 20.0 18.6
Afean(B); 18.7+1.1
c. v. 6 %
50.0 53.4 50.0 52.6 50.0 54.0
M e a n ^ h 53.4+0.7 C. V. 1 %
90.6 85.0 87.8 (87.8% )
99.5 88.5 93.0 (93.5% )
106.8 105.2 108.0 (106.8% )
Stability 7.5 mL/Kg 0-D ay Room T emperature
5-Hour Room T emperature 4 -D ay Refrigerated
3.33 2.70 3.33 2.66 3.33 2.94 3.33 2.88
M ean{C ).2.91+0.04
81.1 79.9 88.3 86.5 (87.4% )
C.V. 1%
4 -D a y R efrigkrated/5 Ho u r RT
3.33
2.74 82.3
(A) Denotes not detected. (B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level. (C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f duplicate samples are based on measured concentration for each level.
Company Saniffzed. Does not contain TSCA CBi 485
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table II. Mixing and Stability Study o f H-24516 in Dosing Suspensions (continued)
Sample Type Dose Volume
Stability 5.0 mL/Ke 0-D ay Room Temperature
mg/mL H-24516
Nominal
Measured
5.0 4.39
5-Hour Room T emperature
5.0
4.60
2-D ay Refrigerated
5.0 4.77 5.0 4,76
M ean )): 4-77+0.01
3-D ay Refrigerated
5.0 5.0
C.V. 0.2% 4.74 4,48
M eant): 4.61+0.2
4-D ay Refrigerated 4-D ay Refrigerated/5 Hour RT
5.0 5.0
C.V. 4% 4.81 4.85
Percent Nominal
87.8 92.0 95.4 95.2 (95.4% )
94.8 89.6 (92.2% )
96.1 97.1
0 -D ay Room T emperature 5-Hour Room T emperature
2-D ay Refrigerated
3-D ay Refrigerated
4-D ay Refrigerated 4-D ay Refrigerated/5 Hour RT
20.0 20.0 20.0 20.0
20.0 20.0
20.0 20.0
18.7 17.2 18.7 18.0
M ean '): TM -30.5 C.V. 3% 39.3 19,6
; t W C ,D ) . 29.414
C.V. 47% 19.6 17.6
93.5 86.0 93.5 90.0 (91.5% )
196.4 97.8 (147.0% )
97.8 88.2
0-D ay Room Temperature
50.0
53.4 106.8
5-Hour Room T emperature
50.0
48.3 96.6
2-D ay R efrigerated
50.0 50.0
47.3 94.7 48.4 96.8
M ean'): 47.9+0.8
(95.8% )
3-D a y Refrigerated
50.0 50.0
C. V. 2% 46.5 46.9
93.0 93.8
M e a n ); 46.7+0.3
(93.4% )
4-D ay Refrigerated
50.0
C.V. 1% 48.9
97.8
4-D ay Refrigerated/5 Hour RT
50.0
47.9 95.7
A) Denotes not detected.
(B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level.
(C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and coefficient o f variation o f duplicate samples are based on measured concentration for each level.
(D) Result is the mean o f the duplicate re-analysis o f the original sample. Original analysis indicated aliquot error and will not be reported.
Company Sanitized. Does not contain TSCA CBI 486
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table 111. Final Homogeneity/Concentration Verification o f H-24516 in Dosing Suspensions
Sample
mg/mL H-24516
Percent
Type
Nominal
Measured
Nominal
Test Day 49
Homogeneity
C o n tro l
0.00
n d (a )
--
T op M id d l e B ottom
T op M id d l e B ottom
T op M id d l e B ottom
3.33 3.33 3.33
13.33 13.33 13.33
33.33 33.33 33.33
M ean^h M ean(^\M ean^h
2.71 2.99 3.42 3.04+0.4 C. V. 12 % 10.8 12.7 12,8
12.1+1.1 C.V. 9% 31.0 32.4 33,4 3 2 .3 1 .2 C.V. 4%
81.4 89.8 102.8 (91.3% )
81.0 95.3 96.3 (90.8% )
92.9 97.1 100.3 (96.8% )
Test Day 91
C ontrol
Homogeneity
T op M id d l e B ottom
0.00 n d (a )
3.33 3.05 3.33 3.00 3.33 3.01
M ean(B \- 3.02+0.03 C. V. 1 %
--
91.6 90.1 90.4 (90.7% )
Concentration Verification
13.33 13.33
M ea n ic ):
12.8 12,2 12.50.4 C.V. 3%
96.0 91.5 (93.8% )
33.33
32.7
98.1
33.33
32,3
96.6
M ean (c \- 32.50.3
(97.5% )
C.V. 1%
(A) Denotes not detected. (B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level. (C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f duplicate samples arc based on measured concentration for each level.
Company Sanitized. Does not contain TSCA CB1 487
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Figure 1 Representative Analytical Calibration Curve
DuPont-5386
(a)
(b)
Concentration mg/mL (c)
Figure 1: Calibration curve show ing linear fit (line) to replicate peak height ratio
measurements (squares) for calibration solutions o f H-24516 diluted over a concentration range o f 0.0302 to 0.1511 mg/mL. [(a) Retention time = 3.5 minutes, (b) Retention = 4.17 minutes, (c) Retention time = 4.77 minutes.]
C o m p a n y S a n itize d . Does not contain 488
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Figure 2 Representative High Performance Liquid Chromatography Chromatograms
F1D1 B. (001212SR\002F0201 .D) pA 1
60 -1
Figure 2a: Representative GC chromatogram o f 0 mg/mL (control) sample with internal
s t a n d a r d ^ P B B B j j ^ l J J J ^ J J j J P ^ I I J J P ^ t d d e d . Retention
for
H -24516 is approxim ately 3.5, 4.1, 4.7 minutes. Retention time for internal
standard is approximately 3.9 minutes.
FIDI B. (001212SR\008FQB01.D> pA 1
60 -
50 -
40 -
Figure 2b: Representative GC chromatogram o f 2.5 mg/mL H -24516 dosing solution diluted to a nominal concentration o f 0.06 mg/mL. The measured concentration o f the representative solution is 2.51 mg/mL
Company Sanitized. Does not contain TSCACB 489
H-24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Figure 2 (continued) Representative High Performance Liquid Chromatography Chromatograms
F1D1 8. (001212SR\004F0401.D) pA Tj
60 -
50 ~
40 -
30 -
X"T IO
Jt20
10 -
- ' ! ....... ' - - ' l ' ' I ' - ' ' l
......... .......... Q______________________________ 2______________________________ i.... .. _ ............... ............................6______________________________ 8________
Figure 2c: Representative GC chromatogram o f 0.0756 mg/mL H -24516 analytical
reference solution.
Company Sanitized. Does not contain TSCA CBI 490
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX B INDIVIDUAL DOSE VOLUMES (ML)
Company Sanitized. Does not contain TSCA CBl 491
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (ML)
EXPLANATORY NOTES
DuPont-5386
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co housed. Dose volumes administered during the cohabitation and post-mating periods are documented in the study records.
Day 89 Last day o f test substance administration for male and female rats designated for one-month and 3-month recovery periods.
Day 90 Last day o f test substance administration for male rats designated for the 90day exposure period.
Day 92 Last day o f test substance administration for female rats designated for the 90-day exposure period.
Footnotes
a. Due to error, data are missing. b. Animal may not have received total dose. c. Due to error, rat was dosed with vehicle only. d. On test day 18, all male rats and the first 11 female rats in the 25 mg/kg/day group received
37-39 mg/kg/day.
Abbreviations
AK Accidentally Killed FD Found Dead SE Sacrificed in extrem is
Company Sanitized. Does not contain TSCA CBl 492
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUME
Day 0
Day 1
Male, I - 0 mg/kg/day
643241 2.8 2.8
643300 2.4 2.4
643143 2.4 2.4
643205 2.6 2.6
643235 2.8 2.8
643288 2.5 2.5
643150 2.4 2.4
643189 2.5 2.5
643185 2.5 2.5
643210 2.5 2.5
643268 2.6 2.6
643232 2.6 2.6
643265 2.4 2.4
643239 2.7 2.7
643270 2.4 2.4
643148 2.5 2.5
643284 2.8 2.8
643229 2.4 2.4
643196 2.1 2.1
643176 2.5 2.5
643218 2.7 2.7
643207 2.4 2.4
643280 2.3 2.3
643271 2.6 2.6
643211 2.5 2.5
643163 2.7 2.7
643197 2.5 2.5
643242 2.4 2.4
643251 2.4 2.4
643155 2.4 2.4
643147
2 6 2.5
643276 2.8 2.8
643237 2.4 2.4
643226 2.5 2.5
643195 2.4 2.4
643246 3.0 3.0
643253 2.4 2.4
643262 2.5 2.5
643172 2.6 2.6
643303 2.3 2.3
643304 2.1 2.1
643162 2.3 2.3
643254 2.2 _ a
643145
2.5
a
643204
2.7
a
Day 2
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3
2.2
2.5
2.7
Day 3
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3
2.2
2.5
2.7
Day 4
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3
2.2
2.5
2.7
Day 5
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3 2.2
2.5
2.7
Day 6
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3
2.2
2.5
2.7
493
IS (mL)
7
Day 8
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0 2.9 31 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3 .2 3.1 3.0 2.9 3.1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
DuPont-5386
9 Day 10 Day 11
35 30 29 31 35 31 29 32 32 30 32 31 29 34 29 30 34 28 26 30 31 29 28 32 31 34 32 31 30 29 3i 35
28 29 30 36 30 31 32 29 26 28
27
29
32
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0 2.9 3 .1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0 2.9 3 .1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
Company Sanitized. Does not contain TSCA CBI
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12 Day 13
Male, I - 0 rng/kg/day
643241 3.5 3.5
643300 3.0 3.0
643143 2.9 2.9
643205 3.1 3.1
643235 3.5 3.5
643288 3.1 3.1
643150 2.9 2.9
643189 3.2 3.2
643185 3.2 3.2
643210 3.0 3.0
643268 3.2 3.2
643232 3.1 3.1
643265 2.9 2.9
643239 3.4 3.4
643270 2.9 2.9
643148 3.0 3.0
643284 3.4 3.4
643229 2.8 2.8
643196 2.6 2.6
643176 3.0 3.0
643218 3.1 3.1
643207 2.9 2.9
643280 2.8 2.8
643271 3.2 3.2
643211 3.1 3.1
643163 3.4 3.4
643197 3.2 3.2
643242 3.1 3.1
643251 3.0 3.0
643155 2.9 2.9
643147
3 .1 3.1
643276 3.5 3.5
643237 2.8 2.8
643226 2.9 2.9
643195 3.0 3 .0
643246 3.6 3.6
643253 3.0 3.0
643262 3.1 3.1
643172 3.2 3.2
643303 2.9 2.9
643304 2.6 2.6
643162 2.8 2.8
643254 2.7 2.7
643145 2.9 2.9
643204 3.2 3.2
Day 14
4.1 3.5 3.4 3.6 4.1 3.6 3.4 3.8 3.8 3.5 3.8 3.4 3.4 3.8 3.4 3.5 3.9 3.2 3.0 3.5 3.6 3.3 3.4 3.8 3.5 3.9 3.6 3.6 3.5 3.5 3.6 4.2 3.2 3.4 3.5 4.3 3.5 3.7 3.7 3.4 3.0 3.3 3.1 3.3 3.7
Day 15
4.1 3.5 3.4 3.6 4.1 3.6 3.4 3.8 3.8 3.5 3.8 3.4 3.4 3.8 3.4 3.5 3.9 3.2 3.0 3.5 3.6 3.3 3.4 3.8 3.5 3.9 3.6 3.6 3.5 3.5 3.6 4.2 3.2 3.4 3.5 4.3 3.5 3.7 3.7 3.4 3.0 3.3 3.1 3 .3 3.7
INDIVIDUAL DOSE VOLUME
Day 16 Day 17 Day 18
4.1 4.1 4.1
3.5 3.5 3.5
3.4 3.4 3.4
3.6 3.6 3.6
4.1 4.1 4.1
3.6 3.6 3.6
3.4 3.4 3.4
3.8 3.8 3.8
3 .8 3.8 3.8
3.5 3.5 3.5
3.8 3.8 3.8
3.4 3.4 3.4
3.4 3.4 3.4
3.8 3.8 3.8
3.4 3.4 3.4
3.5 3.5 3.5
3.9 3.9 3.9
3.2 3.2 3.2
3.0 3.0 3.0
3.5 3.5 3.5
3.6 3.6 3.6
3.3 3.3 3.3
3.4 3.4 3.4
3.8 3.8 3.8
3.5 3.5 3.5
3.9 3.9 3.9
3 .6 3.6 3.6
3.6 3.6 3.6
3.5 3.5 3.5
3.5 3.5 3.5
3.6 3.6 3.6
4.2 4.2 4.2
3.2 3.2 3.2
3.4 3.4 3.4
3 .5 3.5
3.5
4.3 4.3 4.3
3.5 3.5 3.5
3.7 3.7 3.7
3.7 3.7 3.7
3.4 3.4 3.4
3.0 3.0 3.0
3.3 3.3 3 .3
3.1 3.1 3.1
3.3 3.3 3.3
3.7 3.7 3.7
494
S (mL)
Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
4.1 4.1 4.5 4.5 4.5 3.5 3.5 3.9 3.9 3.9 3.4 3.4 3.8 3.8 3.8 3.6 3.6 4.1 4.1 4.1 4.1 4.1 4.6 4.6 4.6 3.6 3.6 4.1 4.1 4.1 3.4 3.4 3.6 3.6 3.6 3.8 3.8 4.3 4.3 4.3 3.8 3.8 4.2 4 . 2 4.2 3.5 3.5 3.9 3.9 3.9 3.8 3.8 4.3 4.3 4.3 3.4 3.4 3.8 3.8 3.8 3.4 3.4 4.0 4.0 4.0 3.8 3.8 4.3 4.3 4.3 3.4 3.4 3.8 3.8 3.8 3.3 3.5 3.8 3.8 3.8 3.9 3.9 4.3 4.3 4.3 3.2 3.2 3.5 3.5 3.5 3.0 3.0 3.3 3.3 3.3 3.5 3.5 3 .9 3.9 3.9 3.6 3.6 4.0 4.0 4.0 3.3 3.3 3.6 3.6 3.6 3.4 3.4 3.8 3.8 3.8 3.8 3.8 4.3 4.3 4.3 3.5 3.5 3.9 3.9 3.9 3.9 3.9 4.4 4.4 4.4 3.6 3.6 4.2 4.2 4.2 3.6 3.6 4.0 4.0 4.0 3.5 3.5 3.9 3.9 3.9 3.5 3.5 3.9 3.9 3.9 3.6 3.6 4.0 4.0 4.0 4.2 4.2 4.7 4.7 4.7 3.2 3.2 3.6 3.6 3.6
3.4 3.4 3.7 3.7 3.7
3.5 3.5 3.8 3.8 3.8
4.3 4.3 4.7 4.7 4.7
3.5 3.5 4.0 4.0 4.0 3.7 3.7 4.2 4.2 4.2 3.7 3.7 4.3 4.3 4.3 3.4 3.4 3.9 3.9 3.9 3.0 3.0 3.4 3.4 3.4 3.3 3.3 3.7 3.7 3.7 3.1 3.1 3.3 3.3 3.3 3.3 3.3 3.7 3.7 3.7 3.7 3.7 4.1 4.1 4.1
Company Sanitized. Does not contain TSCAC
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 24 Day 25
Male, I - 0 mg/kg/day
643241 4.5 4.5 643300 3.9 3.9 643143 3.8 3.8 643205 4.1 4.1 643235 4.6 4.6 643288 4.1 4.1 643150 3.6 3.6 643189 4.3 4.3 643185 4.2 4.2 643210 3.9 3.9 643268 4.3 4.3 643232 3.8 3.8 643265 4.0 4.0 643239 4.3 4.3 643270 3.8 3.8 643148 3 .8 3.8 643284 4.3 4.3 643229 3.5 3.5 643196 3.3 3.3 643176 3.9 3.9 643218 4.0 4.0 643207 3.6 3.6 643280 3.8 3.8 643271 4.3 4.3 643211 3.9 3.9 643163 4.4 4.4 643197 4.2 4.2 643242 4.0 4.0 643251 3.9 3.9 643155 3.9 3.9 643147 4.0 4.0 643276 4.7 4.7 643237 3.6 3.6 643226 3.7 3.7 643195 3.8 3.8 643246 4.7 4.7 643253 4.0 4.0 643262 4.2 4.2 643172 4.3 4.3 643303 3.9 3.9 643304 3.4 3.4 643162 3.7 3.7 643254 3.3 3.3 643145 3.7 3.7 643204 4.1 4.1
Day 26
4.5 3.9 3.8 4.1 4.6 4.1 3.6 4.3 4.2 3.9 4.3 3.8 4.0 4.3 3.8 3.8 4.3 3.5 3.3 3.9 4.0 3.6 3.8 4.3 3 .9 4.4 4.2 4.0 3.9 3.9 4.0 4.7 3.6 3.7 3.8 4.7 4.0 4.2 4.3 3.9 3.4 3.7 3.3 3.7 4.1
Day 27
4.5 3.9 3.8 4.1 4.6 4.1 3.6 4.3 4.2 3.9 4.3 3.8 4.0 4.3 3.8 3.8 4.3 3.5 3.3 3.9 4.0 3.6 3.8 4.3 3.9 4.4 4.2 4.0 3.9 3.9 4.0 4.7 3.6 3.7 3.8 4.7 4.0 4.2 4.3 3.9 3.4 3.7 3.3 3.7 4.1
INDIVIDUAL DOSE VOLUMES
Day 28 Day 29 Day 30
5.0 5.0 5.0 4.2 4.2 4.2 4.2 4.2 4.2 4.5 4.5 4.5 5.1 5.1 5.1 4.6 4.6 4.6 3.8 3.8 3.8 4.7 4.7 4.7 4.6 4.6 4.6 4.3 4.3 4.3 4.7 4.7 4.7 4.0 4.0 4.0 4.2 4.2 4.2 4.6 4.6 4.6 4.1 4.1 4.1 4.1 4.1 4.1 4.7 4.7 4.7 3.7 3.7 3.7 3.5 3.5 3.5 4.3 4.3 4.3 4.3 4.3 4.3 3.9 3.9 3.9 4.1 4.1 4.1 4.7 4.7 4.7 4.2 4.2 4.2 4.8 4.8 4.8 4.5 4.5 4.5 4.3 4.3 4.3 4.2 4.2 4.2 4.2 4.2 4.2 4.3 4.3 4.3 5.0 5.0 5.0 3.9 3.9 3.9 4.0 4.0 4.0 4.1 4.1 4.1 5.0 5.0 5.0 4.3 4.3 4.3 4.5 4.5 4.5 4.6 4.6 4.6 4.3 4.3 4.3 3.7 3.7 3.7 3.9 3.9 3.9 3.7 3.7 3.7 4.0 4.0 4.0 4.5 4.5 4.5
495
DuPont-5386
33 Day 34 Day 35
5.0 5.0 5.2 4.2 4.2 4.6 4.2 4.2 4.4 4.5 4.5 4.7 5.1 5.1 5.4 4.6 4.6 4.9 3.8 3.8 4.1 4.7 4.7 4.9 4.6 4.6 4.8 4.3 4.3 4.4 4.7 4.7 5.0 4.0 4.0 4.1 4.2 4.2 4.4 4.6 4.6 4.9 4.1 4.1 4.4 4.1 4.1 4.5 4.7 4.7 5.0 3.7 3.7 3.9 3.5 3.5 3.7 4.3 4.3 4.5 4.3 4.3 4.6 3.9 3.9 4.2 4.1 4.1 4.4 4.7 4.7 5.0 4.2 4.2 4.5 4.8 4.8 5.2 4.5 4.5 4.7 4.3 4.3 4.6 4.2 4.2 4.4 4.2 4.2 4.3 4.3 4.3 4.6 5.0 5.0 5.4 3.9 3.9 4.1 4.0 4.0 4.1 4.1 4.1 4.3 5.0 5.0 5.3 4.3 4.3 4.6 4.5 4.5 4.9 4.6 4.6 4.9 4.3 4.3 4.7 3.7 3.7 3.9 3.9 3.9 4.2 3.7 3.7 4.0 4.0 4.0 4.3 4.5 4.5 4.7
Com pany S an ifeed . Doe s noi co,, ,, ,,n ^
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36 Day 37
Male, i - 0 mg/kg/day
643241 5.2 5.2 643300 4.6 4.6 643143 4.4 4.4 643205 4.7 4.7 643235 5.4 5.4 643288 4.9 4.9 643150 4.1 4.1 643189 4.9 4.9 643185 4.8 4.8 643210 4.4 4.4 643268 5.0 5.0 643232 4.1 4.1 643265 4.4 4.4 643239 4.9 4.9 643270 4.4 4.4 643148 4.5 4.5 643284 5.0 5.0 643229 3.9 3.9 643196 3.7 3.7 643176 4.5 4.5 643218 4.6 4.6 643207 4.2 4.2 643280 4.4 4.4 643271 5.0 5.0 643211 4.5 4.5 643163 5.2 5.2 643197 4.7 4.7 643242 4.6 4.6 643251 4.4 4.4 643155 4.3 4.3 643147 4.6 4.6 643276 5.4 5.4 643237 4.1 4.1 643226 4.1 4.1 643195 4.3 4.3 643246 5.3 5.3 643253 4.6 4.6 643262 4.9 4.9 643172 4.9 4.9 643303 4.7 4.7 643304 3.9 3.9 643162 4.2 4.2 643254 4.0 4.0 643145 4.3 4.3 643204 4.7 4.7
Day 38
3.9 3.4 3.3 3.5 4.0 3.7 3.1 3.7 3.6 3.3 3.8 3.1 3.3 3.7 3.3 3 .3 3.8 2.9 2.8 3.4 3.4 3.2 3.3 3.7 3.3 3.9 3 .5 3.5 3.3 3.2 3.5 4.1 3.0 3.1 3.2 4.0 3.4 3.7 3.7 3.5 2.9 3 .1 3.0 3.3 3 .5
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 41
Day 42
3.9 3.9 3.9 4.1 3.4 3.4 3.4 3.6 3.3 3.3 3.3 3.5 3.5 3.5 3.5 3.8 4.0 4.0 4.0 4.3 3.7 3.7 3.7 3.9 3.1 3.1 3.1 3.2 3.7 3.7 3.7 3.9 3.6 3.6 3.6 3.8 3.3 3.3 3.3 3.5 3.8 3.8 3.8 3.9 3.1 3.1 3.1 3.2 3.3 3.3 3.3 3.6 3.7 3.7 3.7 3.9 3.3 3.3 3.3 3.5 3.3 3.3 3.3 3.4 3.8 3.8 3.8 4.0 2.9 2.9 2.9 3.1 2.8 2.8 2.8 3.0 3.4 3.4 3.4 3.6 3.4 3.4 3.4 3.6 3.2 3.2 3.2 3.3 3.3 3.3 3.3 3.5 3.7 3.7 3.7 4.0 3.3 3.3 3.3 3.5 3.9 3.9 3.9 4.1 3.5 3 .5 3 .5 3.7 3.5 3.5 3.5 3.7 3.3 3.3 3.3 3.4 3.2 3.2 3.2 3.4 3.5 3.5 3.5 3.7 4.1 4.1 4.1 4.2 3.0 3.0 3.0 3.2 3.1 3.1 3.1 3.3 3.2 3.2 3.2 3.5 4.0 4.0 4.0 4.2 3.4 3.4 3.4 3.7 3.7 3.7 3.7 3.9 3.7 3.7 3.7 3.9 3.5 3.5 3.5 3.8 2.9 2.9 2.9 3.1 3.1 3.1 3.1 3.2 3.0 3.0 3.0 3.2 3.3 3.3 3.3 3.4 3.5 3.5 3.5 3.7
Day 43
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3 .2 3.4 3.7
DuPont-5386
Day 44
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
Cm Vm y S m "b e g - "0t contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3 .8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3 .5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
Day 46
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9
3.1 3.2 3.2 3.4 3 .7
CO PO
Day 47
INDIVIDUAL DOSE VOLUMES
Day 48
Day 49
4.1 4.1 4.3 3.6 3.6 3.8 3.5 3.5 3.6 3 .8 3.8 3.9 4.3 4.3 4.4 3.9 3.9 3.9 3.2 3.2 3.2 3.9 3.9 3.9 3.8 3.8 3.9 3.5 3.5 3.7 3.9 3.9 4.1 3.2 3.2 3.4 3.6 3.6 3.7 3.9 3.9 4.1 3.5 3.5 3.6 3.4 3.4 3.6 4.0 4.0 4.2 3.1 3.1 3.2 3.0 3.0 3.1 3.6 3.6 3.7 3.6 3.6 3.8 3.3 3.3 3.4 3.5 3.5 3.7 4.0 4.0 4.2 3.5 3.5 3.7 4.1 4.1 4.3 3.7 3.7 3.9 3.7 3.7 3.9 3.4 3.4 3.6 3.4 3.4 3.7 3.7 3.7 3.8 4.2 4.2 4.5 3.2 3.2 3.3 3.3 3.3 3.6 3.5 3.5 3.6 4.2 4.2 4.3 3.7 3.7 3.8 3.9 3.9 4.1 3.9 3.9 4.0 3.8 3.8 4.0 3.1 3.1 3.3 3.2 3.2 3.3 3.2 3.2 3.3 3.4 3.4 3.6 3.7 3.7
GJ CO
497
(mL)
50
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3 .3 3.6 3.8
Day 51
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4 .3 3.9 3.9 3.6 3 .7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3.3 3.6 3.8
Day 52
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3.3 3.6 3.8
DuPont-5386
Day 53
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3.3 3.6 3.8
Company Sanitized Poes not contain Ts c a c b I
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Male, I -- 0 mg/kg/day
543241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3 .3 3 .3 3 .3 3.6 3.8
Day 55
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3.3 3.6 3.8
Day 56
INDIVIDUAL DOSE VOLUMES
Day 57
Day 58
4.4 4.4 4.4 4.0 4.0 4.0 3.7 3.7 3.7 4.0 4.0 4.0 4.5 4.5 4.5 4.1 4.1 4.1 3.3 3.3 3.3 4.1 4.1 4.1 4.0 4.0 4.0 3.7 3.7 3.7 4.2 4.2 4.2 3.4 3.4 3.4 3.7 3.7 3.7 4.2 4.2 4.2 3.7 3.7 3.7 3.7 3.7 3.7 4.3 4.3 4.3 3.3 3.3 3.3 3.2 3.2 3.2 3.8 3.8 3.8 4.0 4.0 4.0 3.5 3.5 3.5 3.9 3.9 3.9 4.4 4.4 4.4 3.8 3.8 3.8 4.5 4.5 4.5 4.0 4.0 4.0 4.1 4.1 4.1 3.7 3.7 3.7 4.0 4.0 4.0 4.0 4.0 4.0 4.7 4.7 4.7 3.5 3.5 3.5 3.7 3.7 3.7 3.8 3.8 3.8 4.4 4.4 4.4 4.0 4.0 4.0 4.2 4.2 4.2 4.3 4.3 4.3 4.1 4.1 4.1 3.4 3.4 3.4 3.1 3.1 3.1 3.4 3.4 3.4 3.6 3.6 3.6 3.9 3.9 3.9
498
I
(mL)
59
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9 4.4 3.8 4.5 4.0 4.1 3.7 4.0 4.0 4.7 3.5 3.7 3.8 4.4 4.0 4.2 4.3 4.1 3.4 3.1 3.4 3.6 3.9
Day 60
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9 4.4 3.8 4.5 4.0 4.1 3.7 4.0 4.0 4.7 3.5 3.7 3.8 4.4 4.0 4.2 4.3 4.1 3.4 3 .1 3.4 3.6 3.9
Day 61
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9 4.4 3.8 4.5 4.0 4.1 3.7 4.0 4.0 4.7 3.5 3.7 3.8 4.4 4.0 4.2 4.3 4.1 3.4 3.1 3.4 3.6 3.9
DuPont-5386
Day 62
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9 4.4 3.8 4.5 4.0 4.1 3.7 4.0 4.0 4.7 3.5 3.7 3.8 4.4 4.0 4.2 4.3 4.1 3.4 3.1 3.4 3.6 3.9
c o n p m y S anitized, D o e , not contain TSCA CB
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES
Day 63
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 64
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 65
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 66
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 67
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
499
(mL)
68
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 69
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 70
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
DuPont-5386
Day 71
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
Company Sanitized. Does not contain TSCA CBt
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 72 Male, I -- 0 mg/kg/day
643241
643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.7
4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 D.x 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
ay 73
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1 37 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3 .1 3.6 3.8 4.2
Day 74
INDIVIDUAL DOSE VOLUMES
Day 75
Day 76
4.7 4.7 4.7
4.3 4.3 4.3 3.8 3.8 3.8 4.2 4.2 4.2 4.7 4.7 4.7 4.4 4.4 4.4 3.6 3.6 3.6 4.4 4.4 4.4 4.2 4.2 4.2 4.0 4.0 4.0 4.4 4.4 4.4 3.7 3.7 3.7 3.8 3.8 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1 3.7 3.7 3.7 4.0 4.0 4.0 4.1 4.1 4.1 4.8 4.8 4.8 4.3 4.3 4.3 4.4 4.4 4.4 4.6 4.6 4.6 4.3 4.3 4.3 3.6 3.6 3 .6 3.1 3.1 3.1 3.6 3.8 3.8 3.8 4.2 4.2 4.2
500
(mL)
77
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
Day 78
Day 79
4.7 b 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
DuPont-5386
Day 80
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 3.8 3.8 3.8 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.8 4.8 4.8 4.8 4.3 4.3 4.3 4.3 4.5 4.5 4.5 4.5 4.7 4.7 4.7 4.7 4.5 4.5 4.5 4.5 3.7 3.7 3.7 3.7
2.8 2.8 2.8
3.7 3.7 3.7 3.7 4.2 4.2 4.2 4.2
Company Sanitized. Dom oot coiaio TSCA CEI
CO CM
i
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 81
Male, I - 0 oeg /kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 6432-76 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3 .8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8 3.7 4.2
Day 82
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8 3.7 4.2
Day 83
INDIVIDUAL DOSE VOLUMES
Day 84
Day 85
4.7 4.8 4.8 4.4 4.5 4.5 3.9 3.9 3 .9 4.3 4.4 4.4 4.8 4.9 4.9 4.5 4.6 4.6 3.6 3.6 3.6 4.5 4.6 4.6 4.4 4.5 4.5 4.0 4.1 4.1 4.3 4.4 4.4 3.8 3.9 3.9 3.8 3.8 3.8
3.8 3.8 3.8 4.1 4.1 4.1 4.1 4.2 4.2 4.8 4.8 4.8 4.3 4.5 4.5 4.5 4.5 4.5 4.7 4.7 4.7 4.5 4.6 4.6 3.7 3.8 3.8 2.8 3.0 3.0
3.7 3.9 3.9 4.2 4.4 4.4
501
(mL)
86
4.8 4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
Day 87
4.8 4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
Day 88
4.8 4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
DuPont-5386
Day 89
4.8 4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
3.8 3.8 3.8 3.8 4.1 4.1 4.1 4.1 4.2 4.2 4.2 4.2 4.8 4.8 4.8 4.8 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.7 4.7 4.7 4.7 4.6 4.6 4.6 4.6 3.8 3 .8 3.8 3.8 3.0 3.0 3.0 3.0
3.9 3.9 3.9 3.9 4.4 4.4 4.4 4.4
Company Sanitized. Does not contain TSC A CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 90
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 64327 6 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.8 4.5 3.9 4.4 5.0 4.5 3.7 4.7 4.6
4.5
INDIVIDUAL DOSE VOLUMES (mL)
502
DuPont-5386
'ompany Sanitized. Does not contain TSCA CBt
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Male, Ii 1 - 2 5 mg/kg/day
643173 2.4 2.4 643290 2.1 2.1 643272 2.3 2.3 643292 2.5 2.5 643228 2.8 2.8 643308 2.6 2.6 643264 2.7 2.7 643240 2.5 2.5 643180 2.4 2.4 643179 2.6 2.6 643202 2.3 2.3 643310 2.6 2.6 643306 2.2 2.2 643305 2.7 2.7 643293 2.5 2.5 643287 2.1 2.1 643188 2.6 2.6 643230 2.6 2.6 643170 2.6 2.6 643144 1.9 1.9 643277 2.5 2.5 643214 2.6 2.6 643261 2.6 2.6 643166 2.3 2.3 643153 2.4 2.4 643177 2.4 2.4 643198 2.7 2.7 643291 2.6 2.6 643184 2.4 2.4 643167 2.5 2.5 643223 2.6 2.6 643233 2.4 2.4 643183 2.6 2.6 643219 2.7 2.7
643263 2.3 2.3
Day 2
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3 2.4 2.4 2.7 2.6 2.4 2.5 2.6 2.4 2.6 2.7 2.3
Day 3
INDIVIDUAL DOSE VOLUMES
Day 4
Day 5
Day 6
2.4 2.4 2.4 2.4
2.1 2.1 2.1 2.1
2.3 2.3 2.3 2.3
2.5 2.5 2.5 2.5
2.8 2.8 2.8 2.8
2.6 2.6 2.6 2.6
2.7 2.7 2.7 2.7
2.5 2.5 2.5 2.5
2.4 2.4 2.4 2.4
2.6 2.6 2.6 2.6
2.3 c
2.3
2.3
2.3
2.6 c
2.6
2.6
2.6
2.2 c
2.2
2.2
2.2
2.7 c
2.7
2.7
2.7
2.5 c
2.5
2.5
2.5
2.1 2.1 2.1 2.1
2.6 2.6 2.6 2.6
2.6 2.6 2.6 2.6
2.6 2.6 2.6 2.6
1.9 1.9 1.9 1.9
2.5 2.5 2.5 2.5
2.6 2.6 2.6 2.6
2.6 2.6 2.6 2.6
2.3 2.3 2.3 2.3
2.4 2.4 2.4 2.4
2.4 2.4 2.4 2.4
2.7 2.7 2.7 2.7
2.6 2.6 2.6 2.6
2.4 2.4 2.4 2.4
2.5 2.5 2.5 2.5
2.6 2.6 2.6 2.6
2.4 2.4 2.4 2.4
2.6 2.6 2.6 2.6
2.7 2.7 2.7 2.7
2.3 2.3 2.3 2.3
503
! DuPont-5386
Day 8
Day 9
Day 10 Day 11
0 3.0 3.0 3.0 3.0 7 2.7 2.7 2.7 2.7 8 2.8 2.8 2.8 2.8 0 3.0 3.0 3.0 3.0 5 3.5 3.5 3.5 3.5 3 3.3 3.3 3.3 3.3 3 3.3 3.3 3.3 3.3 0 3.0 3.0 3.0 3.0 0 3.0 3.0 3.0 3.0 1 3.1 3.1 3.1 3.1 8 2.8 2.8 2.8 2.8 2 3.2 3.2 3.2 3.2 6 2.6 2.6 2.6 2.6 2 3.2 3.2 3.2 3.2 0 3.0 3.0 3.0 3.0 6 2.6 2.6 2.6 2.6 3 3.3 3.3 3.3 3.3 1 3.1 3.1 3.1 3.1 2 3.2 3.2 3.2 3.2 4 2.4 2.4 2.4 2.4 1 3.1 3.1 3.1 3.1 3 3.3 3.3 3.3 3.3 2 3.2 3.2 3.2 3.2 8 2.8 2.8 2.8 2.8 9 2.9 2.9 2.9 2.9 1 3.1 3.1 3.1 3.1 4 3.4 3.4 3.4 3.4 2 3.2 3.2 3.2 3.2 0 3.0 3.0 3.0 3.0 2 3.2 3.2 3.2 3.2 1 3.1 3.1 3.1 3.1 9 2.9 2.9 2.9 2.9 2 3.2 3.2 3.2 3.2 3 3.3 3.3 3.3 3.3 8 2.8 2.8 2.8
CO CN
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12 Day 13
Male, III - 25 mg/kg/day
643173 3.0 3.0 643290 2.7 2.7 643272 2.8 2.8 643292 3.0 3.0 643228 3.5 3.5 643308 3.3 3.3 643264 3.3 3.3 643240 3.0 3.0 643180 3.0 3.0 643179 3.1 3.1 643202 2.8 2.8 643310 3.2 3.2 643306 2.6 2.6 643305 3.2 3.2 643293 3.0 3.0 643287 2.6 2.6 643188 3.3 3 .3 643230 3.1 3.1 643170 3.2 3.2 643144 2.4 2.4 643277 3.1 3.1 643214 3.3 3.3 643261 3.2 3.2 643166 2.8 2.8 643153 2.9 2.9 643177 3 .1 3.1
643198 3.4 3.4 643291 3.2 3.2 643184 3.0 3.0 643167 3.2 3.2 643223 3 .1 3.1 643233 2.9 2.9 643183 3.2 3.2 643219 3 .3 3.3 643263 2.8 2.8
Day 14
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6 3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3 .8 3.4 3.5 3.6 4.0 3.8 3.4 3.8 3.6 3.3 3.7 3.8 3 .2
Day 15
3 .5
3 .2
3 .3
3 .5
4 .1
3 .9
3 .9
3 .6
3 .6 3 .7
3 .3
3 .6
3 .0
3 .7
3 .5
3 .0
4 .0
3 .5 3 .7
2 .9
3 .7
3 .7
3 .8
3 .4
3 .5
3 .6
4 .0
33
.8 .4
3 .8
3 .6
3 .3
3 .7
3 .8
3 .2
INDIVIDUAL DOSE VOLUMES
Day 16 Day 17 Day 18d
3.5 3.5 3.5 3.2 3.2 3.2 3.3 3.3 3.3 3.5 3.5 3.5 4.1 4.1 4.1 3.9 3.9 3.9 3.9 3.9 3.9 3.6 3.6 3.6 3.6 3.6 3.6 3.7 3.7 3.7 3.3 3.3 3.3 3.6 3.6 3.6 3.0 3.0 3.0 3.7 3.7 3.7 3.5 3.5 3.5 3.0 3.0 3.0 4.0 4.0 4.0 3.5 3.5 3 .5 3.7 3.7 3.7 2.9 2.9 2.9 3.7 3.7 3.7 3.7 3.7 3.7 3 .8 3 .8 3.8 3.4 3.4 3.4 3.5 3.5 3.5 3.6 3.6 3.6 4.0 4.0 3.8 3.8 3.8 3.4 3.4 3.4 3.8 3.8 3.8 3.6 3.6 3.6 3.3 3.3 3.3 3.7 3.7 3.7 3.8 3.8 3.8 3.2 3.2 3.2
o O'
(mL) Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
3.5 3.5 3 8 3.8 3.8 3.2 3.2 3 6 3.6 3.6
3.3 3.3 3 5 3.5 3.5 3.5 3.5 3 9 3.9 3.9 4.1 4.1 4 5 4.5 4.5 3.9 3.9 4 2 4.2 4.2
3.9 3.9 4 3 4.3 4.3 3.6 3.6 3 8 3.8 3.8 3.6 3.6 4 0 4.0 4.0
3.7 3.7 4 1 4.1 4.1
3.3 3.3 3 6 3.6 3.6 3.6 3.6 4 1 4.1 4.1 3.0 3.0 3 3 3.3 3.3 3.7 3.7 4 0 4.0 4.0 3.5 3.5 3 9 3.9 3.9
3.0 3.0 3 4 3.4 3.4
4.0 4.0 4 4 4.4 4.4
3.5 3.5 3 8 3.8 3.8 3.7 3.7 4 1 4.1 4.1
2.9 2.9 3 3 3.3 3.3
3.7 3.7 4 2 4.2 4.2 3.7 3.7 4 2 4.2 4.2
3.8 3.8 4 2 4.2 4.2 3.4 3.4 3 7 3.7 3.7 3.5 3.5 3 8 3.8 3.8
3.6 3.6 4 0 4.0 4.0
4.0 4.0 4 .5 4.5 4.5
3.8 3.8 4 2 4.2 4.2
3.4 3.4 3 7 3.7 3.7
3.8 3.8 4 2 4.2 4.2
3.6 3.6
Q 3.9
3.9
3.3 3.3 3 6 3.6 3.6
3.7 3.7 4 0 4.0 4.0
3.8 3.8 4 2 4.2 4.2
3.2 3.2 3 6 3.6 3.6
Company Sanitized. Does not contain TSCA CB!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24 Day 25
Male, III - 25 mg/kg/day
643173 3.8 3.8
643290 3.6 3.6
643272 3.5 3.5
643292 3.9 3.9
643228 4.5 4.5
643308 4.2 4.2
643264 4.3 4.3
643240 3.8 3.8
643180 4.0 4.0
643179 4.1 4.1
643202 3.6 3.6
643310 4.1 4.1
643306 3 .3 3.3
643305 4.0 4.0
643293 3.9 3.9
643287 3.4 3.4
643188 4.4 4.4
643230 3.8 3.8
643170 4.1 4.1
643144 3.3 3.3
643277 4.2 4.2
643214 4.2 4.2
643261 4.2 4.2
643166 3.7 3.7
643153 3.8 3.8
643177 4.0 4.0
643198 4.5 4.5
643291
4 .2 4.2
643184 3.7 3.7
643167 4.2 4.2
643223 3.9 3.9
643233 3.6 3.6
643183
r
.A n V
643219 4.2 4.2
643263 3.6 3.6
Day 26
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4 3.8 4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0 4.5 4.2 3.7 4.2 3.9 3.6 4.0 4.2 3.6
Day 27
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4 3.8 4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0 4.5 4.2 3.7 4.2 3.9 3.6 4.0 4.2 3.6
INDIVIDUAL DOSE VOLUM]
Day 28
Day 29
Day 30
4.2 4.2 4.2 4.0 4.0 4.0 3.9 3.9 3.9 4.2 4.2 4.2 4.9 4.9 4.9 4.6 4.6 4.6 4.7 4.7 4.7 4.1 4.1 4.1 4.4 4.4 4.4 4.4 4.4 4.4 3.8 3.8 3.8 4.5 4.5 4.5 3.7 3.7 3.7 4.2 4.2 4.2 4.2 4.2 4.2 3.7 3.7 3.7 4.8 4.8 4.8 4.1 4.1 4.1 4.5 4.5 4.5 3.7 3.7 3.7 4.6 4.6 4.6 4.6 4.6 4.6 4.5 4.5 4.5 4.1 4.1 4.1 4.2 4.2 4.2 4.4 4.4 4.4 4.9 4.9 4.9 4.6 4.6 4.6 3.8 3.8 3.8 4.5 4.5 4.5 4.2 4.2 4.2 3.8 3.8 3.8 4.4 4.4 4.4 4.6 4.6 4.6 3.9 3.9 3.9
505
i
3S (mL)
Day 31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
4.2 4.2 4.2 4.2 4.7 4.0 4.0 4.0 4.0 4.3 3.9 3.9 3.9 3.9 4.1 4.2 4.2 4.2 4.2 4.6 4.9 4.9 4.9 4.9 5.4 4.6 4.6 4.6 4.6 5.Q 4.7 4.7 4.7 4.7 5.0 4.1 4.1 4.1 4.1 4.3 4.4 4.4 4.4 4.4 4.8 4.4 4.4 4.4 4.4 4.6 3.8 3.8 3.8 3.8 4.1 4.5 4.5 4.5 4.5 4.8 3.7 3.7 3.7 3.7 3.9 4.2 4.2 4.2 4.2 4.6 4.2 4.2 4.2 4.2 4.6 3.7 3.7 3.7 3.7 4.0 4.8 4.8 4.8 4.8 5.1 4.1 4.1 4.1 4.1 4.3 4.5 4.5 4.5 4.5 4.8 3.7 3.7 3.7 3.7 3.9 4.6 4.6 4.6 4.6 4.9 4.6 4.6 4.6 4.6 4.9 4.5 4.5 4.5 4.5 4.9 4.1 4.1 4.1 4.1 4.4 4.2 4.2 4.2 4.2 4.5 4.4 4.4 4.4 4.4 4.7 4.9 4.9 4.9 4.9 5.2 4.6 4.6 4.6 4.6 4.9 3.8 3.8 3.8 3.8 4.0 4.5 4.5 4.5 4.5 4.9 4.2 4.2 4.2 4.2 4.4 3.8 3.8 3.8 3.8 4.1 4.4 4.4 4.4 4.4 4,8 4.6 4.6 4.6 4.6 4.9 3.9 3.9 3.9 3.9 4.2
ompany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36 Day 37
Male, III - 25 mg/kg/day
643173 4.7 4.7 643290 4.3 4.3 643272 4.1 4.1 643292 4.6 4.6 643228 5.4 5.4 643308 5.0 5.0 643264 5.0 5.0 643240 4.3 4.3 643180 4.8 4.8 643179 4.6 4.6 643202 4.1 4.1 643310 4.8 4.8 643306 3.9 3.9 643305 4.6 4.6 643293 4.6 4.6 643287 4.0 4.0 643188 5.1 5.1 643230 4.3 4.3 643170 4.8 4.8 643144 3.9 3.9 643277 4.9 4.9 643214 4.9 4.9 643261 4.9 4.9 643166 4.4 4.4 643153 4.5 4.5 643177 4.7 4.7 643198 5.2 5.2 643291 4.9 4.9 643184 4.0 4.0 643167 4.9 4.9 643223 4.4 4.4 643233 4.1 4.1 643183 4.8 4.8 643219 4.9 4.9 643263 4.2 4.2
Day 38
3.5 3.2 3.1 3.4 4.1 3.7 3.8 3.3 3.6 3.5 3.1 3.6 2.9 3.4 3.5 3.0 3.8 3.3 3.6 2.9 3.7 3.7 3.7 3.3 3.4 3.6 3.9 3.7 3.0 3.7 3.3 3.1 3.6 3.7 3.1
INDIVIDUAL DOSE VOLUMES (mL)
ay 39
Day 40
Day 41
Day 42
3.5 3.5 3.5 3.6 3.2 3.2 3.2 3.5 3.1 3.1 3.1 3.3 3.4 3.4 3.4 3.6 4.1 4.1 4.1 4.2 3.7 3.7 3.7 3.9 3.8 3.8 3.8 4.0 3.3 3.3 3.3 3.3 3.6 3.6 3.6 3.8 3.5 3.5 3.5 3.6 3.1 3.1 3.1 3.2 3.6 3.6 3.6 3.7 2.9 2.9 2.9 3.1 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.6 3.0 3.0 3.0 3.1 3.8 3.8 3.8 3.9 3.3 3.3 3.3 3.3 3.6 3.6 3.6 3.7 2.9 2.9 2.9 3.1 3.7 3.7 3.7 3.9 3.7 3.7 3.7 3.8 3.7 3.7 3.7 3.8 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.5 3.6 3.6 3.6 3.7 3.9 3.9 3.9 4.0 3.7 3.7 3.7 3.9 3.0 3.0 3.0 3.1 3.7 3.7 3.7 3 .8 3.3 3.3 3.3 3.5 3.1 3.1 3.1 3.2 3.6 3.6 3.6 3.8 3.7 3 .7 3.7 3.8 3 .1 3.1 3.1 3.2
Day 43
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3 .1 3.5 3.6 3.1 3.9 3.3 3.7 3 .1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3.8 3.5 3.2 3.8 3.8 3.2
DuPont-5386
Day 44
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3.8 3.5 3.2 3.8 3.8 3.2
Company Sanitized. Doe. not contain TSCACBI
506
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Day 46
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3 .8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3 .8 3.5 3.2 3 .8 3.8 3.2
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3 .8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3 .1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3 .8 3.5 3.2 3.8 3.8 3.2
Day 47
INDIVIDUAL DOSE VOLUMES
Day 48
Day 49
3.6 3.6 3.7 3.5 3.5 3.5 3.3 3.3 3.3 3.6 3.6 3.7 4.2 4.2 4.3 3.9 3.9 4.0 4.0 4.0 4.0 3.3 3.3 3.3 3.8 3.8 3.9 3.6 3.6 3.6 3.2 3.2 3.4 3.7 3.7 3.8 3.1 3.1 3.1 3.5 3.5 3.7 3.6 3.6 3.7 3.1 3.1 3.2 3.9 3.9 4.1 3.3 3.3 3.5 3.7 3.7 3.8 3.1 3.1 3.2 3.9 3.9 4.0 3.8 3.8 3.8 3.8 3.8 3.9 3.4 3.4 3.6 3.5 3.5 3.5 3.7 3.7 3.9 4.0 4.0 4.2 3.9 3.9 4.0 3.1 3 .1 3.2 3.8 3.8 3 .8 3.5 3.5 3.6 3.2 3.2 3.2 3.8 3.8 4.0 3.8 3.8 4.0 3.2 3.2 3.4
507
(mL)
50
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
Day 51
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
Day 52
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3 .8 3.6 3.2 4.0 4.0 3.4
DuPont-5386
Day 53
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
Company Sanitized. Does not contain T SCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, III -- 25 mg /kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3 .9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3 .9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
Day 56
INDIVIDUAL DOSE VOLUMES
Day 57
Day 58
3.8 3.8 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.8 3.8 3.8 4.5 4.5 4.5 4.1 4.1 4.1 4.2 4.2 4.2 3.4 3.4 3.4 4.0 4.0 4.0 3.7 3.7 3.7 3.3 3.3 3.3 3.9 3.9 3.9 3.2 3.2 3.2 3.7 3.7 3.7 3.9 3.9 3.9 3.3 3.3 3.3 4.4 4.4 4.4 3.6 3.6 3.6 3.9 3.9 3.9 3.3 3.3 3.3 4.1 4.1 4.1 4.0 4.0 4.0 4.1 4.1 4.1 3.8 3.8 3.8 3.7 3.7 3.7 4.0 4.0 4.0 4.4 4.4 4.4 4.1 4.1 4.1 3.3 3.3 3.3 3.9 3.9 3.9 3.7 3.7 3.7 2.9 2.9 2.9 4.1 4.1 4.1 4.1 4.1 4.1 3.5 3.5 3 .5
508
(mL)
59
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
Day 60
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
Day 61
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
DuPont-5386
Day 62
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
Company Sanitized. Does not contain TSCA CB!
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 63
Day 64
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4 4.1 4.3 3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3 .3 4.2 4.3 3.6
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4 4.1 4.3 3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3.3 4.2 4.3 3.6
Day 65
INDIVIDUAL DOSE VOLUMES
Day 66
Day 67
3.9 3.9 3.9 3.9 3.9 3.9 3.7 3.7 3.7 3.9 3.9 3.9 4.7 4.7 4.7 4.2 4.2 4.2 4.4 4.4 4.4 3.5 3.5 3.5 4.2 4.2 4.2 3.7 3.7 3.7 3.4 3.4 3.4 4.0 4.0 4.0 3.2 3.2 3.2 3.8 3.8 3.8 4.1 4.1 4.1 3.4 3.4 3.4 4.5 4.5 4.5 3.7 3.7 3.7 4.1 4.1 4.1 3.4 3.4 3.4 4.4 4.4 4.4 4.1 4.1 4.1 4.3 4.3 4.3 3.9 3.9 3.9 3.8 3.8 3.8 4.1 4.1 4.1 4.4 4.4 4.4 4.3 4.3 4.3 3.2 3.2 3.2 4.0 4.0 4.0 3.8 3.8 3.8 3.3 3.3 3.3 4.2 4.2 4 2 4.3 4.3 4.3 3.6 3.6 3.6
509
(mL)
Day 68
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4 4.1
4.3
3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3.3 4.2 4.3 3.6
Day 69
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4 4.1 4.3 3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3.3
A . O.
4.3 3.6
Day 70
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4 .1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4
4.1
3.9 4.2 4.5 4.4 3.3 4.2 3.9
3.5
4.3 4.4 3.7
DuPont-5386
Day 71
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
Company Sanitized. Dees nol contain TSCA
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 72
Day 73
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
Day 74
INDIVIDUAL DOSE VOLUMES
Day 75
Day 76
4.0 4.0 4.0
4.0 4.0 4.0
3.8 3.8 3.8
4.0 4.0 4.0
4.8 4.8 4.8
4.4 4.4 4.4
4.5 4.5 4.5
3.6 3.6 3.6
4.1 4.1 4.1
3.9
3.9.
3.9
3.4 3.4 3 .4
4.2 4.2 4.2
3.3 3.3 3.3
4.0 4.0 4.0
4.2 4.2 4.2
3.5
4.6
3.7
4.2
3.6
4.5
4.2
4.4
4.1
3.9
4.2
4.5
4.4
3.3
4.2
3.9
3.5
4.3
4.4
3.7
510
(inL)
77
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
Day 78
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
Day 79
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
DuPont-5386
Day 80
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
Company Sanitized. Does
not contain TSCACBI
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 81
Day 82
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3 .3 4.0 4.1
Day 83
INDIVIDUAL DOSE VOLUMES
Day 84
Day 85
4.1 4.1 4.1 4.1 4.2 4.2 3.9 4.0 4.0 4.0 4.0 4.0 5.0 5.1 5.1 4.5 4.7 4.7 4.7 4.8 4.8 3.7 3.7 3.7 4.2 4.3 4.3 3.9 4.1 4.1 3.5 3.5 3.5 4.1 4.2 4.2 3.3 3.5 3.5 4.0 4.1 4.1 4.1 4.2 4.2
511
(mL)
86
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
Day 87
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
Day 88
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
DuPont-5386
Day 89
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 90
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.9 4.3 4.1 4.1 5.2 4.7 4.9 3.8 4.3 4.1
INDIVIDUAL DOSE VOLUMES (mL)
DuPont-5386
Company Sanilfced. Does no, certain TSCA CB,
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Kale, V - 100 mg/kg/day
643250 2.3 2.3
643243 2.3 2.3
643311 2.4 2.4
643318 2.6 2.6
643247 2.8 2.8
643175 2.6 2 . 6
643314 2.6 2.6
643275 2.7 2.7
643257 2.4 2.4
643224 2.5 2 . 5
643169 2.3 2.3
643159 2.7 2.7
643286
2.1
2.1
643181 2.8 2.8
643206 2.4 2.4
643313 2 . 1 2.1
643182 2.5 2.5
643146 2.8 2 . 8
643312 2.4 2.4
643199 2.4 2.4
643267 2.5 2 . 5
643216 2.7 2.7
643244 2.5 2.5
643245 2.3 2.3
643301 2.6 2 . 6
643200 2.4 2.4
643255
2.6
2.6
643157 2.4 2.4
643238 2 . 6 2.6
643227 2.6 2 . 6
643164 2.5 2.5
643154 2.4 2 . 4
643156
2.7
2.7
643208 2.5 2.5
643190 2.7 2.7
Day 2
2.3 2 .3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4 2.7 2.5 2.7
Day 3
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2 .4 27 2.5 2.7
INDIVIDUAL DOSE VOLUMES
Day 4
Day 5
Day 6
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6
2.5 2.4
2n
2.5 2.7
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4
"> . ni
2 .5 2.7
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4 oM . nI
2.5 2.7
)
DuPont-5386
Day 8
Day 9
Day 10 Day 11
8 2.8 2.8 2.8 2.8 9 2.9 2.9 2.9 2.9 0 3.0 3.0 3.0 3.0 2 3.2 3.2 3.2 3.2 5 3 .5 3.5 3.5 3.5 2 3.2 3.2 3.2 3.2 3 3.3 3.3 3.3 3.3 2 3.2 3.2 3.2 3.1 0 3.0 3.0 3.0 3.0 0 3.0 3.0 3.0 3.0 8 2.8 2.8 2.8 2.8 1 3.1 3.1 3.1 3.1 5 2.5 2.5 2.5 2.5 3 3.3 3.3 3.3 3.3 9 2.9 2.9 2.9 2.9 7 2.7 2.7 2.7 2.7 1 3.1 3.1 3.1 3.1 3 3.3 3.3 3.3 3.3 0 3.0 3.0 3.0 3.0 1 3.1 3.1 3.1 3.1 1 3.1 3.1 3.1 3.1 4 3.4 3.4 3.4 3.4 0 3.0 3.0 3.0 3.0 8 2.8 2.8 2.8 2.8 1 3 .1 3 .1 3.1 3.1 1 3.1 3.1 3.1 3.1 1 3.1 3 .1 3.1 3.1 0 3.0 3.0 3.0 3.0 x 3.1 3.1 3.1 3.1 3 3.3 3.3 3.3 3.3 3 3.3 3.3 3.3 3.3 0 3.0 3.0 3.0 3.0 3 3.3 3.3 3.3 3.3 0 3.0 3.0 3.0 3.0 3 3.3 3.3 3.3 3.3
Company Sanitized. Does not contain TSCA CBI
') I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12 Day 13
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
2.8 2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0 3.0 2.8 3.1
2.5 3 .3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4 3.0 2.8 3.1 3.1 3.1 3 .0 3.1 3 .3 3.3 3.0
-)._-)>
3.0 3.3
2.8 2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0 3.0 2.8 3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4 3.0 2.8 3.1 3.1 3 .1 3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
Day 14
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3 .5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6 3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
Day 15
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6 3.1 3 .6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
INDIVIDUAL DOSE VOLUMI
Day 16 Day 17 Day 18
3.1 3.1 3.1 3.5 3.5 3.5 3.6 3.6 3.6 3.7 3.7 3.7 4.1 4.1 4.1 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.5 3.5 3.5 3.4 3.4 3.4 3.3 3.3 3.3 3.6 3.6 3.6 2.9 2.9 2.9 3.8 3.8 3.8 3.2 3.2 3.2 3.2 3.2 3.2 3.7 3.7 3.7 3.7 3.7 3.7 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.7 3.7 4.0 4.0 4.0 3.6 3.6 3.6 3.1 3.1 3.1 3.6 3.6 3.6 3.6 3.6 3.6 3.7 3.7 3.7 3.5 3.5 3.5 3.5 3.5 3.5 3.8 3.8 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.8 3.8 3.8 3.5 3.5 3.5 3.8 3.8 3.8
514
)
ES (mL) Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
3.1 3.1 3.5 3.5 3.5 3.5 3.5 3.9 3.9 3.9 3.6 3.6 3.9 3.9 3.9 3.7 3.7 4.3 4.3 4.3 4.1 4.1 4.5 4.5 4.5 3.7 3.7 4.2 4.2 4.2 3.7 3.7 4.1 4.1 4.1 3.7 3.7 4.1 4.1 4.1 3.5 3.5 3.9 3.9 3.9 3.4 3.4 3.7 3.7 3.7 3.3 3.3 3.7 3.7 3.7 3.6 3.6 3.9 3.9 3.9 2.9 2.9 3.3 3.3 3.3 3.8 3.8 4.1 4.1 4.1 3.2 3.2 3.7 3.7 3.7 3.2 3.2 3.6 3.6 3.6 3.7 3.7 4.2 4.2 4.2 3.7 3.7 4.2 4.2 4.2 3.5 3.5 3.8 3.8 3.8 3.7 3.7 4.2 4.2 4.2 3.7 3.7 4.2 4.2 4.2 4.0 4.0 4.5 4.5 4.5 3.6 3.6 3.9 3.9 3.9 3.1 3.1 3.5 3.5 3.5 3.6 3.6 4.0 4.0 4.0 3.6 3.6 4.0 4.0 4.0 3,7 3.7 4.2 4.2 4.2 3.5 3.5 3.9 3.9 3.9 3.5 3.5 4.0 4.0 4.0 3.8 3.8 4.1 4.1 4.1 3.8 3.8 4.3 4.3 4.3 3.4 3.4 3.9 3.9 3.9 3.8 3.8 4.3 4.3 4.3 3.5 3.5 3.9 3.9 3.9 3.8 3.8 4.2 4.2 4.2
' am pany
"O. contain TSCA c B1
)!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24 Day 25
Male, V - 100 mg/kg/day
643250 3.5 3.5 643243 3.9 3.9 643311 3.9 3.9 643318 4.3 4.3 643247 4.5 4.5 643175 4.2 4.2 643314 4.1 4.1 643275 4.1 4.1 643257 3.9 3.9 643224 3.7 3.7 643169 3.7 3.7 643159 3.9 3.9 643286 3.3 3.3 643181 4.1 4.1 643206 3.7 3.7 643313 3.6 3.6 643182 4.2 4.2 643146 4.2 4.2 643312 3.8 3.8 643199 4.2 4.2 643267 4.2 4.2 643216 4.5 4.5 643244 3.9 3.9 643245 3.5 3.5 643301 4.0 4.0 643200 4.0 4.0 643255 4.2 4.2 643157 3.9 3.9 643238 4.0 4.0 643227 4.1 4.1 643164 4.3 4.3 643154 3.9 3.9 643156 4.3 4.3 643208 3.9 3.9 643190 4.2 4.2
Day 26
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
Day 27
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
INDIVIDUAL DOSE VOLUM:
Day 28
Day 29
Day 30
3.9 3.9 3.9 4.2 4.2 4.2 4.2 4.2 4.2 4.6 4.6 4.6 4.8 4.8 4.8 4.5 4.5 4.5 4.3 4.3 4.3 4.5 4.5 4.5 4.1 4.1 4.1 4.0 4.0 4.0 4.0 4.0 4.0 4.3 4.3 4.3 3.6 3.6 3.6 4.4 4.4 4.4 3.8 3.8 3.8 3.9 3.9 3.9 4.6 4.6 4.6 4.5 4.5 4.5 4.0 4.0 4.0 4.7 4.7 4.7 4.5 4.5 4.5 4.9 4.9 4.9 4.3 4.3 4.3 3.8 3.8 3.8 4.4 4.4 4.4 4.4 4.4 4.4 4.6 4.6 4.6 4.2 4.2 4.2 4.1 4.1 4.1 4.5 4.5 4.5 4.7 4.7 4.7 4.2 4.2 4.2 4.7 4.7 4.7 4.1 4.1 4.1 4.5 4.5 4.5
515
)
ES (mL) Day 31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
3.9 3.9 3.9 3.9 4.0 4.2 4.2 4.2 4.2 4.5 4.2 4.2 4.2 4.2 4.4 4.6 4.6 4.6 4.6 4.9 4.8 4.8 4.8 4.8 5.0 4.5 4.5 4.5 4.5 4.8 4.3 4.3 4.3 4.3 4.5 4.5 4.5 4.5 4.5 4.7 4.1 4.1 4.1 4.1 4.4 4.0 4.0 4.0 4.0 4.2 4.0 4.0 4.0 4.0 4.2 4.3 4.3 4.3 4.3 4.7 3.6 3.6 3.6 3.6 3.9 4.4 4.4 4.4 4.4 4.6 3.8 3.8 3.8 3.8 4.0 3.9 3.9 3.9 3.9 4.2 4.6 4.6 4.6 4.6 5.0 4.5 4.5 4.5 4.5 4.8 4.0 4.0 4.0 4.0 4.2 4.7 4.7 4.7 4.7 4.8 4.5 4.5 4.5 4.5 4.8 4.9 4.9 4.9 4.9 5.2 4.3 4.3 4.3 4.3 4.5 3.8 3.8 3.8 3.8 3.9 4.4 4.4 4.4 4.4 4.7 4.4 4.4 4.4 4.4 4.7 4.6 4.6 4.6 4.6 4.8 4.2 4.2 4.2 4.2 4.5 4.1 4.1 4.1 4.1 4.3 4.5 4.5 4.5 4.5 4.7 4.7 4.7 4.7 4.7 5.0 4.2 4.2 4.2 4.2 4.4 4.7 4.7 4.7 4.7 4.9 4.1 4.1 4.1 4.1 4.3
4.5 4.5 4.5
CO
LO s
COmpaV SanbK l- D<* "01 contain TSCA C8I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36 Day 37
Male, V - 100 mg/kg/day
643250 4,0 5.9 643243 4.5 4.5 643311 4.4 4.4 643318 4.9 4.9 643247 5.0 5.0 643175 4.8 4.8 643314 4.5 4.5 643275 4.7 4.7 643257 4.4 4.4 643224 4.2 4.2 643169 4.2 4.2 643159 4.7 4.7 643286 3.9 3.9 643181 4.6 4.6 643206 4.0 4.0 643313 4.2 4.2 643182 5.0 5.0 643146 4.8 4.8 643312 4.2 4.2 643199 4.8 4.8 643267 4.8 4.8 643216 5.2 5.2 643244 4.5 4.5 643245 3.9 3.9 643301 4.7 4.7 643200 4.7 4.7 643255 4.8 4.8 643157 4.5 4.5 643238 4.3 4.3 643227 4.7 4.7 643164 5.0 5.0 643154 4.4 4.4 643156 4.9 4.9 643208 4.3 4.3 643190 4.8 4.8
Day 38
3.0 3.4 3.3 3.7 3.7 3.6 3.4 3.5 3.3 3.2 3.2 3.5 2.9 3.5 3.0 3.2 3.7 3.6 3.1 3.6 3.6 3.9 3.4 2.9 3.5 3.5 3.6 3.4 3.3 3.5 3.7 3.3 3.7 3.3 3.6
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 41
Day 42
3.0 3.0 3.0 3.1 3.4 3.4 3.4 3.5 3.3 3.3 3.3 3.5 3.7 3.7 3.7 3.8 3.7 3.7 3.7 3.9 3.6 3.6 3.6 3.8 3.4 3.4 3.4 3.6 3.5 3.5 3.5 3.7 3.3 3.3 3.3 3.4 3.2 3.2 3.2 3.3 3.2 3.2 3.2 3.3 3.5 3.5 3.5 3.6 2.9 2.9 2.9 3.1 3.5 3.5 3.5 3.7 3.0 3.0 3.0 3.1 3.2 3.2 3.2 3.3 3.7 3.7 3.7 3.9 3.6 3.6 3.6 3.7 3.1 3.1 3.1 3.2 3.6 3.6 3.6 3.7 3.6 3.6 3.6 3.8 3.9 3.9 3.9 4.1 3.4 3.4 3.4 3.5 2.9 2.9 2.9 3.0 3.5 3.5 3.5 3.6 3.5 3.5 3.5 3.7 3.6 3.6 3.6 3.8 3.4 3.4 3.4 3.6 3.3 3.3 3.3 3.5 3.5 3.5 3.5 3.8 3.7 3.7 3.7 3.9 3.3 3.3 3.3 3.4 3.7 3.7 3.7 3.9 3.3 3.3 3.3 3.4 3.6 3.6 3.6 3.8
Day 43
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0 3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3.4 3.8
DuPont-5386
Day 44
3 .1
3 .5 3. 5 3 .8 3 .9 3 .8 3 .6 3 .7 3 .4 3. 3 3. 3 3. 6
3 .1
3 .7
3 .1
3 .3 3 .9 3 .7 3 .2 3 .7 3 .8
4. 1
3 .5
3 .0
3 .6 3 .7 3 .8 3. 6 3 .5 3 .8 3 .9 3 .4 3 .9 3. 4 3 .8
Company Sanitized. Does not contain TSCACB1
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 45
Day 46
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3 .1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0 3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3.4 3.8
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0 3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3.4 3.8
Day 47
INDIVIDUAL DOSE VOLUMES
Day 48
Day 49
3.1 3.1 3.2 3.5 3.5 3.6 3.5 3.5 3.6 3.8 3.8 3.9 3.9 3.9 3.6 3.8 3.8 3.8 3.6 3.6 3.7 3.7 3.7 3.8 3.4 3.4 3.4 3.3 3.3 3.3 3.3 3.3 3.4 3.6 3.6 3.7 3.1 3.1 3.3 3.7 3.7 3.9 3.1 3.1 3.3 3.3 3.3 3.5 3.9 3.9 4.0 3.7 3.7 3.8 3.2 3.2 3.3 3.7 3.7 3.8 3.8 3.8 4.0 4.1 4.1 4.2 3.5 3.5 3.7 3.0 3.0 3.1 3.6 3.6 3.8 3.7 3.7 3.8 3 .8 3.8 4.0 3.6 3.6 3.8 3.5 3.5 3.7 3.8 3.8 4.0 3.9 3.9 4.1 3.4 3.4 3.6 3.9 3.9 4.1 3.4 3.4 3.6 3.8 3.8 3.9
517
(mL)
50
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4 .i 3.6 3.9
Day 51
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
Day 52
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
DuPont-5386
Day 53
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
COmPa"y Sani"'Z e i
M conte,,, TSCA C B ,
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, V - 100 mg /kg /day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3 .8 4.0 4.2 3.7 3.1 3 .8 3 .8 4.0 3 .8 3.7 4.0 4.1 3 .6 4.1 3.6 3.9
Day 56
INDIVIDUAL DOSE VOLUMES
Day 57
Day 58
3.3 3.3 3.3 3.7 3.7 3.7 3.6 3.6 3.6 4.0 4.0 4.0 3.8 3.8 3.8 4.0 4.0 4.0 3.8 3.8 3.8 3.9 3.9 3.9 3.6 3.6 3.6 3.4 3.4 3.4 3.4 3.4 3.4 3.9 3.9 3.9 3.4 3.4 3.4 4.0 4.0 4.0 3.3 3.3 3.3 3.6 3.6 3.6 4.1 4.1 4.1 4.0 4.0 4.0 3.5 3.5 3.5 3.9 3.9 3.9 4.0 4.0 4.0 4.3 4.3 4.3 3.7 3.7 3.7 3.3 3.3 3.3 3.9 3.9 3.9 4.0 4.0 4.0 4.2 4.2 4.2 3.9 3.9 3.9 3.8 3 .8 3 .8 4.1 4.1 4.1 4.2 4.2 4.2 3.7 3.7 3.7 4.3 4.3 4.3 3.8 3.8 3.8 4.0 4.0 4.0
518
(mL)
59
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
Day 60
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3 .8 4.1 4.2 3.7 4.3 3.8 4.0
Day 61
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
)
DuPont-5386
Day 62
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
Company Sanitized. Does not contain TSCA CBt
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 64
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3 .8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4 3.8 4.5 3.9 4.3
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4 3 .8 4.5 3.9 4.3
Day 65
INDIVIDUAL DOSE VOLUMES
Day 66
Day 67
3.4 3.4 3.4 3.9 3.9 3.9 3.7 3.7 3.7 4.1 4.1 4.1 4.0 4.0 4.0 3.9 3.9 3.9 3.9 3.9 3.9 4.1 4.1 4.1 3.6 3.6 3.6 3.5 3.5 3.5 3.4 3.4 3.4 4.0 4.0 4.0 3.5 3.5 3.5 4.1 4.1 4.1 3.5 3.5 3.5 3.8 3.8 3.8 4.3 4.3 4.3 4.1 4.1 4.1 3.7 3.7 3.7 4.0 4.0 4.0 4.1 4.1 4.1 4.5 4.5 4.5 3.9 3.9 3.9 3.4 3.4 3.4 4.1 4.1 4.1 4.1 4.1 4.1 4.4 4.4 4.4 4.2 4.2 4.2 4.0 4.0 4.0 4.2 4.2 4.2 4.4 4.4 4.4
3.8 3.8 3.8 4.5 4.5 4.5 3.9 3.9 3.9 4.3 4.3 4.3
519
(mL)
68
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4 3.8 4.5 3.9 4.3
Day 69
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4 3.8 4.5 3.9 4.3
Day 70
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
DuPont-5386
Day 71
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
Company Sanitized. Does not contain TS C A CBJ
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 72
Day 73
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1 4.3 4.5 3.3 4.6 4.0 4.2
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.Q 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
Day 74
INDIVIDUAL DOSE VOLUMES
Day 75
Day 76
3.5 3.5 3.5 4.0 4.0 4.0 3.8 3.8 3.8 4.2 4.2 4.2 4.1 4.1 4.1 3.4 3.4 3.4 4.0 4.0 4.0 4.2 4.2 4.2 3.7 3.7 3.7 3.5 3.5 3.5 3.5 3.5 3.5 4.0 4.0 4.0 3.6 3.6 3.6 4.3 4.3 4.3 3.6 3.6 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4. 5 4.3 4.1 4.3 4.5 3.9 4 .6 4.0 4.2
520
(mL) Day 77
Day 78
3.5 3.5 4.1 4.1 3.8 3.8 4.3 4.3 4.2 4.2 AK TEST DAY 77
4.0 4.0 4.2 4.2 3.8 3.8 3.6 3.6 3.6 3.6 4.1 4.1 3.7 3.7 4.4 4.4 3.5 3.5
Day 79
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7 4.4 3.5
DuPont-5386
Day 80
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7 4.4 3.5
Company Sanitized. Does not contain TSCA CBt
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations______________
Day 81
Day 82
Male, V -- 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286
643181
643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7
4.4b 3.5
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7
4.4 3.5
Day 83
INDIVIDUAL DOSE VOLUMES
Day 84
Day 85
3.5 3.6 3.6 4.1 4.1 4.1 3.8 3.9 3.9 4.3 4.3 4.3 4.2 4.2 4.2
4.0 3.6 3.6 4.2 4.1 4.1 3.8 3.8 3.8 3.6 3.7 3.7 3.6 3.6 3.6 4.1 4.0 4.0 3.7 3.8 3.8 4.4 4.5 4.5 3.5 3.7 3.7
521
(mL)
86
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 87
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 88
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
DuPont-5386
Day 89
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 90
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.7 4.2 3.9 4.4 4.3
4.0 4.1 3.9 3.7
INDIVIDUAL DOSE VOLUMES (mL)
DuPont-5386
Company Sanitized. Does not contain TSCA CB!
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 0
Day 1
Male, VII - 250 mg/kg/day
643194 2.4 2.4 643252 2.2 2.2 643260 2.3 2.3 643315 2.4 2.4 643215 2.7 2.7 643193 2.7 2.7 643298 2.5 2.5 643201 2.7 2.7 643259 2.4 2.4 643174 2.8 2.8 643283 2.4 2.4 643149 2.6 2.6 643178 2.3 2.3
643152 2.9 2.9 643295 2.5 2.5 643289 2.1 2.1 643171 2.6 2.6 643158 2.6 2.6 643249 2.5 2.5 643161 2.6 2.6 643309 2.9 2.9 643248 2.6 2.6 643285 2.5 2.5 643278 2.4 2.4 643299 2.4 2.4 643274 2.4 2.4 643192 2.6 2.6 643222 2.6 2.6 643160 2.4 2.4 643191 2.7 2.7
643203 2.5 2.5 643282 2.8 2.8 643302 2.5 2.5 643317 2.5 2.5 643225 2.6 2.6 643296 2.7 2.7 643258 2.3 2.3 643316 2.4 2.4 643220 2.5 2.5 643236 2.5 2.5 643165 2.4 2.4 643266 2.5 2.5 643151 2.3 2.3 643234 2.8 2.8 643281 2.4 2.4
Day 2
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3 2.9 2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5 2.4 2.5 2.3 2.8 2.4
Day 3
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9 2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5 2.4 2.5 2.3 2.8 2.4
INDIVIDUAL DOSE VOLUMI
Day 4
Day 5
Day 6
2.4 2.4 2.4 2.2 2.2 2.2 2.3 2.3 2.3 2.4 2.4 2.4 2.7 2.7 2.7 2.7 2.7 2.7 2.5 2.5 2.5 2.7 2.7 2.7 2.4 2.4 2.4 2.8 2.8 2.8 2.4 2.4 2.4 2.6 2.6 2.6 2.3 2.3 2.3
2.9 2.9 2.9
2.5 2.5 2.5 2.1 2.1 2.1 2.6 2.6 2.6 2.6 2.6 2.6 2.5 2.5 2.5 2.6 2.6 2.6 2.9 2.9 2.9 2.6 2.6 2.6 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.6 2.6 2.6 2.6 2.6 2.6 2.4 2.4 2.4 2.7 2.7 2.7 2.5 2.5 2.5 2.8 2.8 2.8 2.5 2.5 2.5 2.5 2.5 2.5 2.6 2.6 2.6 2.7 2.7 2.7 2.3 2.3 2.3 2.4 2.4 2.4 2.5 2.5 2.5 2.5 2.5 2.5 2.4 2.4 2.4 2.5 2.5 2.5 2.3 2.3 2.3 2.8 2.8 2.8 2.4 2.4 2.4
523
)
ES (mL) Day 7
Day 8
Day 9
DuPont-5386
Day 10 Day 11
3.0 3.0 3.0 3.0 3.0 2.9 2.9 2.9 2.9 2.9 2.8 2.8 2.8 2.8 2.8 2.9 2.9 2.9 2.9 2.9 3.3 3.3 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3
2.9 2.9 2.9 2.9 2.9 3.5 3.5 3.5 3.5 3.5 2.9 2.9 2.9 2.9 2.9 3.1 3.1 3.1 3.1 3.1 2.7 2.7 2.7 2.7 2.7
3.5
3.5
3.5
3.5 b
3.5
3.0 3.0 3.0 3.0 3.0 2.7 2.7 2.7 2.7 2.7 3.3 3.3 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.1 3.1 3.1 3.1 3.1 3.2 3.2 3.2 3.2 3.2 3.7 3.7 3.7 3.7 3.7 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 2.9 2.9 2.9 2.9 2.9 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.2 3.2 3.2 3.2 3 .2 3.2 3.2 3.2 3.2 3.2 3.0 3.0 3.0 3.0 3.0 3.4 3.4 3.4 3.4 3.4 3.2 3.2 3.2 3.2 3.2 3.5 3.5 3.5 3.5 3.5 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.3 3.3 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.0 3.0 3.1 3.1 3.1 3.1 3.1 2.8 2.8 2.8 2.8 2.8 3.4 3.4 3.4 3.4 3.4 3.0 3.0 3.0 3.0 3.0
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12 Day 13
Male, VII - 250 mg/kg/day
643194 3.0 3.0
643252 2.9 2.9
643260 2.8 2.8
643315 2.9 2.9
643215 3.3 3.3
643193 3.4 3.4
643298 3.3 3.3
643201 3.3 3.3
643259 2.9 2.9
643174 3.5 3.5
643283 2.9 2.9
643149 3.1 3.1
643178 2.7 2.7
643152 3.5 3.5
643295 3.0 3.0
643289 2.7 2.7
643171 3.3 3.3
643158 3.4 3.4
643249 3.1 3.1
643161 3.2 3.2
643309 3.7 3.7
643248 3.1 3.1
643285 3.1 3.1
643278 2.9 2.9
643299 3.0 3.0
643274 3.0 3.0
643192 3.2 3.2
643222 3.2 3.2
643160 3.0 3.0
643191 3.4 3.4
643203 3.2 3.2
643282 3.5 3.5
643302 3.0 3.0
643317 3.0 3.0
643225 3.3 3.3
643296 3.4 3.4
643258 3.0 3.0
643316 3.0 3.0
643220 3.1 3.1
643236 3.1 3.1
643165 3.0 3.0
643266
3 .1 3.1
643151 2.8 2.8
643234 3.4 3.4
643281 3.0 3.0
Day 14
3.4 3.3 3.2 3 .3 3.7 3.8 3.8 3.8 3.4 3.9 3.4 3.6 3.1 4.1 3.4 3.1 3.9 3.9 3.6 3.6 4.2 3.5 3.5 3.4 3.5 3.5 3.7 3.7 3.3 3.8 3.7 4.1 3.5 3.5 3.7 3 .9 3.5 3.5 3.6 3.6 3 .5 3.7 3.3 3.8 3.4
Day 15
3.4 3.3 3.2 3.3 3.7 3.8 3.8 3.8 3.4 3.9 3.4 3.6 3.1 4.1 3.4 3.1 3.9 3.9 3.6 3.6 4.2 3.5 3.5 3.4 3.5 3.5 3.7 3.7 3.3 3.8 3.7 4.1 3.5 3.5 3.7 3.9 3.5 3.5 3.6 3.6 3.5 3.7 3.3 3.8 3.4
INDIVIDUAL DOSE VOLUMES
Day 16 Day 17 Day 18
3.4 3.4 3.4 3.3 3.3 3.3 3.2 3.2 3.2 3.3 3.3 3.3 3.7 3.7 3.7 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.9 3.9 3.9 3.4 3.4 3.4 3.6 3.6 3.6 3.1 3.1 3.1 4.1 4.1 4.1 3.4 3.4 3.4 3.1 3.1 3.1 3.9 3.9 3.9 3.9 3.9 3.9 3.6 3.6 3.6 3.6 3.6 3.6 4.2 4.2 4.2 3.5 3.5 3.5 3.5 3.5 3.5 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.7 3.7 3.3 3.3 3.3 3.8 3.8 3.8 3.7 3.7 3.7 4.1 4.1 4.1 3.5 3.5 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.9 3.9 3.9 3.5 3.5 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.6 3.6 3.5 3.5 3.5 3.7 3.7 3.7 3.3 3.3 3.3 3.8 3.8 3.8 3.4 3 .4 3.4
524
DuPont-5386
Day 21
Day 22
Day 23
4 3.8 3.8 3.8 3 3.7 3.7 3.7 2 3.5 3.5 3.5 3 3.7 3.7 3.7 7 4.2 4.2 4.2 8 4.3 4.3 4.3 8 4.2 4.2 4.2 8 4.3 4.3 4.3 4 3.9 3.9 3.9 9 4.5 4.5 4.5 4 3.7 3.7 3.7 6 4.0 4.0 4.0 1 3.4 3.4 3.4 1 4.6 4.6 4.6 4 3.8 3.8 3.8 1 3.5 3.5 3.5 9 4.5 4.5 4.5 9 4.4 4.4 4.4 6 3.9 3.9 3.9 6 4.2 4.2 4.2 2 4.7 4.7 4.7 5 3.9 3.9 3.9 5 3.9 3.9 3.9 4 3.8 3.8 3.8 5 3.9 3.9 3.9 5 3.9 3.9 3.9 7 4.2 4.2 4.2 7 4.1 4.1 4.1 3 3.8 3.8 3.8 8 4.2 4.2 4.2 7 4.2 4.2 4.2 1 4.7 4.7 4.7 5 3.9 3.9 3.9 5 3.9 3.9 3.9 7 4.1 4.1 4.1 9 4.4 4.4 4.4 5 4.0 4.0 4.0 5 4.0 4.0 4.0 6 4.0 4.0 4.0 6 4.1 4.1 4.1 5 4.0 4.0 4.0 7 4.1 4.1 4.1 3 3.6 3.6 3.6 8 4.3 4.3 4.3 4 3.9 3.9 3.9
Company Sanitized. Does not contain TSCA CB!
!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24
Day 25
Male, VII - 250 mg/kg/day
643194 3.8 3.8 643252 3.7 3.7 643260 3.5 3.5 643315 3.7 3.7 643215 4.2 4.2 643193 4.3 4.3 643298 4.2 4.2 643201 4.3 4.3 643259 3.9 3.9 643174 4.5 4.5 643283 3.7 3.7 643149 4.0 4.0 643178 3.4 3.4 643152 4.6 4.6 643295 3.8 3.8 643289 3.5 3.5 643171 4.5 4.5 643158 4.4 4.4 643249 3.9 3.9 643161 4.2 4.2 643309 4.7 4.7 643248 3.9 3.9 643285 3 .9 3.9 643278 3.8 3.8 643299 3.9 3.9 643274 3.9 3.9 643192 4.2 4.2 643222 4.1 4.1 643160 3.8 3.8 643191 4.2 4.2 643203 4.2 4.2 643282 4.7 4.7 643302 3.9 3.9 643317 3.9 3.9 643225 4.1 4.1 643296 4.4 4.4 643258 4.0 4.0 643316 4.0 4.0 643220 4.0 4.0 643236 4.1 4.1 643165 4.0 4.0 643266 4.1 4.1 643151 3.6 3.6 643234 4.3 4.3 643281 3.9 3.9
Day 26
3.8 3.7 3.5 3.7 4.2 4.3 4.2 4.3 3.9 4.5 3.7 4.0 3.4 4.6 3.8 3.5 4.5 4.4 3.9 4.2 4.7 3.9 3.9 3.8 3.9 3.9 4.2 4.1 3.8 4.2 4.2 4.7 3.9 3.9 4.1 4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
Day 27
3.8 3.7 3.5 3.7 4.2 4.3 4.2 4.3 3 .9 4.5 3.7 4.0 3.4 4.6 3.8 3.5 4.5 4.4 3.9 4.2 4.7 3.9 3.9 3.8 3.9 3.9 4.2 4.1 3.8 4.2 4.2 4.7 3.9 3.9 4.1 4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
INDIVIDUAL DOSE VOLUMI
Day 28
Day 29
Day 30
4.1 4.1 4.1 4.0 4.0 4.0 3.8 3.8 3.8 4.0 4.0 4.0 4.5 4.5 4.5 4.6 4.6 4.6 4.5 4.5 4.5 4.6 4.6 4.6 4.3 4.3 4.3 4.9 4.9 4.9 4.0 4.0 4.0 4.4 4.4 4.4 2.9 2.9 2.9 5.0 5.0 5.0 4.1 4.1 4.1 3.8 3.8 3.8 4.8 4.8 4.8 4.6 4.6 4.6 4.2 4.2 4.2 4.5 4.5 4.5 5.0 5.0 5.0 4.2 4.2 4.2 4.2 4.2 4.2 4.1 4.1 4.1 4.2 4.2 4.2 4.2 4.2 4.2 4.6 4.6 4.6 4.4 4.4 4.4 4.0 4.0 4.0 4.4 4.4 4.4 4.5 4.5 4.5 5.1 5.1 5.1 4.2 4.2 4.2 4.2 4.2 4.2 4.3 4.3 4.3 4.7 4.7 4.7 4.3 4.3 4.3 4.3 4.3 4.3 4.3 4.3 4.3 4.5 4.5 4.5 4.3 4.3 4.3 4.5 4.5 4.5 4.0 4.0 4.0 4.6 4.6 4.6 4.2 4.2 4.2
525
iS (mL) Day 31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
4.1 4.1 4.1 4.1 4.3
4.0 4.0 4.0 4.0 4.3 3.8 3.8 3.8 3.8 4.0 4.0 4.0 4.0 4.0 4.3 4.5 4.5 4.5 4.5 4.7 4.6 4.6 4.6 4.6 4.8
4.5 4.5 4.5 4.5 4.8
4.6 4.6 4.6 4.6 4.9 4.3 4.3 4.3 4.3 4.5 4.9 4.9 4.9 4.9 5.2 4.0 4.0 4.0 4.0 4.2 4.4 4.4 4.4 4.4 4.7 2.9 2.9 2.9 2.9 3.2 5.0 5.0 5.0 5.0 5.3 4.1 4.1 4.1 4.1 4.3 3.8 3.8 3.8 3.8 4.0 4.8 4.8 4.8 4.8 5.1 4.6 4.6 4.6 4.6 4.9 4.2 4.2 4.2 4.2 4.6 4.5 4.5 4.5 4.5 4.9
5.0 5.0 5.0 5.0 5.3
4.2 4.2 4.2 4.2 4.4 4.2 4.2 4.2 4.2 4.4
4.1 4.1 4.1 4.1 4.3 4.2 4.2 4.2 4.2 4.4 4.2 4.2 4.2 4.2 4.5 4.6 4.6 4.6 4.6 4.9 4.4 4.4 4.4 4.4 4.7 4.0 4.0 4.0 4.0 4.2 4.4 4.4 4.4 4.4 4.6 4.5 4.5 4.5 4.5 4.8
5.1 5.1 5.1 5.1 5.4 4.2 4.2 4.2 4.2 4.5
4.2 4.2 4.2 4.2 4.5 4.3 4.3 4.3 4.3 4.5
4.7 4.7 4.7 4.7 5.0
4.3 4.3 4.3 4.3 4.6 4.3 4.3 4.3 4.3 4.6 4.3 4.3 4.3 4.3 4.5 4 . 5 4.5 4.5 4.5 4.5 4.3 4.3 4.3 4.3 4.6
4.5 4.5 4.5 4.5 4.8 4.0 4.0 4.0 4.0 4.2 4.6 4.6 4.6 4.6 4.9
4.2 4.2 4.2 4.2 4.5
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 36 Day 37
Male, VII - 250 mg/kg/day
643194 4.3 4.3 643252 4.3 4.3 643260 4.0 4.0 643315 4.3 4.3 643215 4.7 4.7 643193 4.8 4.8 643298 4.8 4.8 643201 4.9 4.9 643259 4.5 4.5 643174 5.2 5.2 643283 4.2 4.2 643149 4.7 4.7 643178 3.2 3.2 643152 5.3 5.3 643295 4.3 4.3 643289 4.0 4.0 643171 5.1 5.1 643158 4.9 4.9 643249 4.6 4.6 643161 4.9 4.9 643309 5.3 5.3 643248 4.4 4.4 643285 4.4 4.4 643278 4.3 4.3 643299 4.4 4.4 643274 4.5 4.5 643192 4.9 4.9 643222 4.7 4.7 643160 4.2 4.2 643191 4.6 4.6 643203 4.8 4.8 643282 5.4 5.4 643302 4.5 4.5 643317 4.5 4.5 643225 4.5 4.5 643296 5.0 5.0
643258 4.6 4.6 643316 4.6 4.6 643220 4.5 4.5 643236 4.5 4.5 643165 4.6 4.6 643266 4.8 4.8 643151 4.2 4.2 643234 4.9 4.9 643281 4.5 4.5
Day 38
3.2 3.3 3.0 3.2 3.5 3.6 3.6 3.7 3.4 3.9 3.1 3.5 2.4 4.0 3.2 3.0 3.8 3.7 3.5 3.6 4.0 3.3 3.3 3.2 3.3 3.4 3.7 3.5 3.2 3.5 3.6 4.0 3.3 3.3 3.4 3.7
3.4 3.4 3.4 3.4 3.5 3.6 3.1 3.7 3.4
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 41
Day 42
3.2 3.2 3.2 3.4 3.3 3.3 3.3 3.4 3.0 3.0 3.0 3.1 3.2 3.2 3.2 3.4 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.8 3.6 3.6 3.6 3.7 3.7 3.7 3.7 3.9 3.4 3.4 3.4 3.6 3.9 3.9 3.9 4.0 3.1 3.1 3.1 3.2 3.5 3.5 3.5 3.7
2.4 2.4 2.4 2.7 4.0 4.0 4.0 4.1 3.2 3.2 3.2 3.4 3.0 3.0 3.0 3.2 3.8 3.8 3.8 4.0 3.7 3.7 3.7 3.8
3.5 3.5 3.5 3.7 3.6 3.6 3.6 3.7 4.0 4.0 4.0 4.1 3.3 3.3 3.3 3.5 3.3 3.3 3.3 3.4 3.2 3.2 3.2 3.4
3.3 3.3 3.3 3.5 3.4 3.4 3.4 3.5
3.7 3.7 3.7 3.9 3.5 3.5 3.5 3.7 3.2 3.2 3.2 3.3
3.5 3 .5 3.5 3.6 3.6 3.6 3.6 3.7 4.0 4.0 4.0 4.2 3.3 3.3 3.3 3.5 3.3 3.3 3 .3 3.5
3.4 3.4 3.4 3.6 3.7 3.7 3.7 3.8
3.4
3.4
3.4 b
2.9
3.4 3.4 3.4 3.5 3.4 3.4 3.4 3.5 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.8
3.1 3.1 3.1 3.2
3.7 3.7 3.7 3.8 3.4 3.4 3.4 3.4
Day 43
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8
2.9 3.5 3.5 3.5 3.6 3.8 3.2 3.8 3.4
)
DuPont-5386
Day 44
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6 3.8 3.2 3.8 3.4
Company Sanitized. Does not contain
526
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Day 46
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6 3.8 3.2 3.8 3.4
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6 3.8 3 .2 3.8 3.4
Day 47
INDIVIDUAL DOSE VOLUMES
Day 48
Day 49
3.4 3.4 3.5 3.4 3.4 3.3 3.1 3.1 3.1 3.4 3.4 3.4 3.6 3.6 3.6 3.8 3.8 3.8 3.7 3.7 3.7 3.9 3.9 3.8 3.6 3.6 3.5 4.0 4.0 4.0 3.2 3.2 3.2 3.7 3.7 3.8 2.7 2.7 2.7 4.1 4.1 4.3 3.4 3.4 3.4 3.2 3.2 3.2 4.0 4.0 4.1 3.8 3.8 4.0 3.7 3.7 3.7 3.7 3.7 3.8 4.1 4.1 4.2 3.5 3.5 3.4 3.4 3.4 3.5 3.4 3.4 3.4 3.5 3.5 3.6 3.5 3.5 3.6 3.9 3.9 3.9 3.7 3.7 3.7 3.3 3.3 3.4 3.6 3 .6 3.7 3.7 3.7 3.8 4.2 4.2 4.4 3.5 3.5 3.6 3.5 3.5 3.5 3.6 3.6 3.6 3.8 3.8 3.9 2.9 2.9 3.3 3.5 3.5 3.6 3 .5 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.4 3.8 3.8 3.9 3.2 3.2 3.3 3.8 3.8 3.9 3.4 3.4 3.6
527
(mL)
ay 50
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
Day 51
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
Day 52
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
DuPont-5386
Day 53
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
mpany ^an,"t,zef. Does not contain TSCA C M
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215
643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234
643281
3.5 3.3 3.1 3.4 3.6
3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9
3.6
3.5 3.3 3.1 3.4 3 .6
3.8 3.7 3.8 3.5 4.0 3.2 3 .8 2.7 4.3 3.4 3.2 4.1 4.0 3 .7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3 .3 3 .6 3.5 3.6 3.4 3.9 3.3 3 .9
3.6
Day 56
INDIVIDUAL DOSE VOLUMES
Day 57
Day 58
3.6 3.6 3.6 3.4 3.4 3.4 3.2 3.2 3.2 3.4 3.4 3.4 3.7 3.7 3.7
3.1
3.1 b
3.1
3.9 3.9 3.9 3.8 3.8 3.8 3.5 3.5 3.5 4.1 4.1 4.1 3.2 3.2 3.2
3.9 3.9 3.9 2.8 2.8 2.8 4.3 4.3 4.3 2.9 2.9 2.9 2.9 2.9 2.9 4.1 4.1 4.1 4.1 4.1 4.1 3.8 3.8 3.8 3.9 3.9 3.9 3.7 3.7 3.7 3.5 3.5 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.7 3.7 3.7 3.7 3.7 3.7 4.0 4.0 4.0 3.8 3.8 3.8 3.5 3.5 3.5 3.7 3.7 3.7 3.8 3 .8 3.8 4.4 4.4 4.4 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 4.0 4.0 4.0 3.4 3.4 3.4 3.7 3.7 3.7
3.5 3.5 3.5 3.8 3.8 3.8 3.4 3.4 3.4 3.9 3.9 3.9 3.4 3.4 3.4 3.9 3.9 3.9 3.7 a 3.7
528
(niL)
59
3.6 3.4 3.2 3.4 3.7 3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9 3.7
Day 60
3.6 3.4 3.2 3.4 3.7
3.1 3.9 3.3 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3 .8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9 3.7
Day 61
3.6 3.4 3.2 3.4 3.7
3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9 3.7
DuPont-5386
Day 62
3.6 3.4 3.2 3.4 3.7 3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9 3.7
Company Sanitized. Does not contain TSCA CBI
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 64
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171
643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2
3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2
3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
Day 65
INDIVIDUAL DOSE VOLUMES
Day 66
Day 67
3.7 3.7 3.7
3.6 3.6 3.6 3.3 3.3 3.3 3.6 3.6 3.6 3.7 3.7 3.7 3.5 3.5 3.5 4.0 4.0 4.0 4.0 4.0 4.0 3.5 3.5 3.5 4.3 4.3 4.3 3.2 3.2 3.2 3.9 3.9 3.9 2.8 2.8 2.8 4.4 4.4 4.4 2.9 2.9 2.9 3.0 3.0 3.0 4.1 4.1 4.1
4.2 4.2 4.2
3.9 3.9 3.9 3.6 3.6 3.6 4.0 4.0 4.0 3.2 3.2 3.2 3.4 3.4 3.4 3.3 3.3 3.3 3.7 3.7 3.7 3.8 3.8 3.8 3.8 3.8 3.8 3.7 3.7 3.7 3.6 3.6 3.6 3.8 3.8 3.8 3.9 3.9 3.9 4.3 4.3 4.3 3.4 3.4 3.4 3.6 3.6 3.6 3.7 3.7 3.7 4.0 4.0 4.0 3.6 3.6 3.6 3.8 3.8 3.8 3.3 3.3 3.3 3.6 3.6 3.6 3.3 3.3 3.3 4.0 4.0 4.0 3.2 3.2 3.2 3.7 3.7 3.7 3.8 3.8 3.8
529
I
(mL)
68
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1 4.2 3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3 .8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3 .3 3.6 3.3 4.0 3.2 3.7 3.8
Day 69
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1 4.2 3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
DuPont-5386
Day 70
Day 71
3.8 3.8 2.8 2.8 3.3 3.3 3.7 3.7 3.2 3.2 3.6 3.6 4.0 4.0 4.0 4.0 3.7 3.7 4.3 4.3 3.0 3.0 3.9 3.9 2.8 2.8 4.5 4.5 2.5 2.5 3.2 3.2 3.4 3.4
4.3 4.3 3.4 3.4 3.6 3.6 3.7 AK TEST DAY 3.0 3.0 3.3 3.3 3.6 3.6 3.6 3.6 3.8 3.8 3.9 3.9 3.9 3.9 3.6 3.6 3.8 3.8 4.0 4.0 3.7 3.7 2.8 2.8 2.9 2.9 3.8 3.8 3.2 3.2 3.6 3.6 3.8 3.8 3.3 3.3 3.8 3.8 3.5 3.5 4.0 4.0 3.2 3.2 3.3 3.3 3.8 3.8
Company Sanitized. Does not contain T S C A C B l
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 72
Day 73
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2. 8 4.5 2. 5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3.8 3.9 3.9 3.6 3.8 4. 0
3 .7
2.8 2.9 3.8 3.2 3.6 3.8 3.3 3.8
3.5
4.0 3.2 3.3 3.8
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3. 0 3.9 2.8 4.5 2.5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3 .8 3 .9 3. 9 3. 6 3.8 4.0
3.7
2. 8 2.9
3 .8
3.2 3. 6 3.8 3.3 3.8 3.5 4.0 3.2 3.3 3.8
Day 74
INDIVIDUAL DOSE VOLUMES
Day 75
Day 76
3.8 3.8 3.8 2.8 2.8 2 . 8 3.3 3.3 3.3 3.7 3.7 3.7 3.2 3.2 3.2 3.6 3.6 3 . 6 4.0 4 . 0 4.0 4.0 4.0 4.0 3.7 3.7 3.7 4.3 4.3 4.3 3.0 3.0 3.0 3.9 3.9 3.9 2.8 2 . 8 2 . 8 4.5 4.5 4.5 2.5 2.5 2 . 5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3.8 3.9 3.9 3.6 3.8 4.0 3.7 2. 8 2.9 3.8 3 . 8 3.8 3 . 2 3.2 3.2 3.6 3 . 6 3.6 3.8 3.8 3.8 3.3 3 . 3 3.3 3.8 3.8 3.8 3.5 3.5 3.5 4 . 0 4.0 4.0 3.2 3.2 3.2 3.3 3.3 3.3 3.8
530
(iiL)
77
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
Day 78
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
Day 79
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
DuPont-5386
Day 80
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.8 3.8 3.8 3.9 3.9 3.9 3.9 3.1 3.1 3.1 3.1 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.4 3.6 3.6 3.6 3.6 2.9 2.9 2.9 2.9 3.9 3.9 3.9 3.9 3.0 3.0 3.0 3.0 3.8 3.8 3.8 3.8
Company SanRfead. Does not coni,ft, tsca CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 81
Day 82
Male, VII - 250 m g /kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.8 3.4 3.4 3.5 3 .7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3 .9 3.0 3.8
Day 83
INDIVIDUAL DOSE VOLUMES
Day 84
Day 85
3.8 3.9 3.9 3.4 3.8 3.8 3.4 3.4 3.4 3.5 3.7 3.7 3.7 3.9 3.9 3.8 4.0 4.0 3.7 4.0 4.0 4.1 4.2 4.2 3.4 3.7 3.7 4.4 4.4 4.4 3.3 3.3 3.3 4.0 4.1 4.1 2.6 2.9 2.9 4.5 4.7 4.7 3.2 3.2 3.2
3 .8 4.0
4.0
3.9 4.2 4.2
3.1 3.6 3.6
3.8 3.9 3.9
3.4 3.5 3.5
3.6 3.9 3.9
2.9 3.6 3.6
3.9 4.1 4.1
3.0 3.4 3.4
3.8 3.8 3.8
531
(mL)
86
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
Day 87
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
Day 88
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
)
DuPont-5386
Day 89
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
4.0 4.0 4.0 4.0 4.2 4.2 4.2 4.2 3.6 3.6 3.6 3.6 3.9 3.9 3.9 3.9 3.5 3.5 3.5 3.5 3.9 3.9 3.9 3.9 3.6 3.6 3.6 3.6 4.1 4.1 4.1 4.1 3.4 3.4 3.4 3.4
3.8 3.8 3.8
Company Sanitized. Does not contain TSCA CBt
J
CO
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 90
Male, Vii - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282
J \J 4
643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
4.0 4.0 3.5
3.8
4.0 4.2 4.1
4.3 3.8 4.5
INDIVIDUAL DOSE VOLUMES (mL)
532
DuPont-5386
Company sa,,ftfe e i
contain TSCAcBf
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 0
Day 1
Female, II - 0 mg/kg/day
643477 1.7 1.7 643374 1.8 1.8 643406 1.6 1.6 643486 1.8 1.8 643361 1.9 1.9 643463 2.2 2.2 643398 1.7 1.7 643436 1.8 1.8 643362 1.8 1.8 643354 1.6 1.6 643402 1.8 1.8 643383 1.7 1.7 643465 2.1 2.1 643484 1.8 1.8 643384 1.9 1.9 643352 1.9 1.9 643343 1.7 1.7 643459 2.1 2.1 643394 1.9 1.9 643480 2.0 2.0
643319 2.0 2.0 643350 1.9 1.9 643363 2.0 2.0 643397 1.9 1.9 643421 1.8 1.8 643420 2.1 2.1 643419 2 .1 2.1 643414 2.1 2.1 643401 1.8 1.8 643455 1.9 1.9 643378 2.2 2.2
643393 1.9 1.9 643447 1.9 1.9 643478 1.8 1.8 643386 1.8 1.8 643405 2.1 2.1 643425 2.0 2.0
643448 2.1 2.1 643426 1.8 1.8 643415 2.1 2.1 643453 2.0 2.0 643330 1.7 1.7 643336 2.0 2.0 643387 1.9 1.9 643377 2.0 2.0
Day 2
1.7 1.8 1.6 1.8 1.9 2.2 1.7 1.8 1.8 1.6 1.8 1.7 2.1 1.8 1.9 1.9 1.7 2.1 1.9 2.0 2.0 1.9 2.0 1.9 1.8 2.1 2.1 2.1 1.8 1.9 2.2 1. 9 1.9 1.8 1.8 2.1 2.0 2.1 1.8 2.1 2.0 1.7 2.0 1.9 2.0
Day 3
1.7 1.8 1.6 1.8 1.9 2.2 1.7 1.8 1.8 1.6 1.8 1.7 2.1 1.8 1.9 1.9 1.7 2.1 1.9 2.0 2.0 1.9 2.0 1.9 1.8 2.1 2.1 2.1 1.8 1.9 2.2 1.9 1.9 1.8 1.8 2.1 2.0 2.1 1.8 2.1 2.0 1.7 2.0 1.9 2.0
INDIVIDUAL DOSE VOLUMES
Day 4
Day 5
Day 6
1.7 1.7 1.7 1.8 1.8 1.8 1.6 1.6 1.6 1.8 1.8 1.8 1.9 1.9 1.9 2.2 2.2 2.2 1.7 1.7 1.7 1.8 1.8 1.8 1.8 1.8 1.8 1.6 1.6 1.6 1.8 1.8 1.8 1.7 1.7 1.7 2.1 2.1 2.1 1.8 1.8 1.8 1.9 1.9 1.9 1.9 1.9 1.9 1.7 1.7 1.7 2.1 2.1 2.1 1.9 1.9 1.9 2.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 1.9 2.0 2.0 2.0 1.9 1.9 1.9 1.8 1.8 1.8 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.9 1.9 1.9 2.2 2.2 2.2 1.9 1.9 1.9 1.9 1.9 1.9 1.8 1.8 1.8 1.8 1.8 1.8 2.1 2.1 2.1 2.0 2.0 2.0 2.1 2.1 2.1 1.8 1.8 1.8 2.1 2.1 2.1 2.0 2.0 2.0 1.7 1.7 1.7 2.0 2.0 2.0 1.9 1.9 1.9 2.0 2.0 2.0
533
) DuPont-5386
Day 8
Day 9
Day 10 Day 11
0 2.0 2.0 2.0 2.0 1 2.1 2.1 2.1 2.1 9 1.9 1.9 1.9 1.9 9 1.9 1.9 1.9 1.9 1 2.1 2.1 2.1 2.1 4 2.4 2.4 2.4 2.4 9 1.9 1.9 1.9 1.9 0 2.0 2.0 2.0 2.0 1 2.1 2.1 2.1 2.1 7 1.7 1.7 1.7 1.7 9 1.9 1.9 1.9 1.9 9 1.9 1.9 1.9 1.9 2 2.2 2.2 2.2 2.2 9 1.9 1.9 1.9 1.9 2 2.2 2.2 2.2 2.2 1 2.1 2.1 2.1 2.1 9 1.9 1.9 1.9 1.9 3 2.3 2.3 2.3 2.3 3 2.3 2.3 2.3 2.3 3 2.3 2.3 2.3 2.3 3 2.3 2.3 2.3 2.3 1 2.1 2.1 2.1 2.1 3 2.3 2.3 2.3 2.3 3 2.3 2.3 2.3 2.3 0 2.0 2.0 2.0 2.0
3 2.3 2.3 2.3 2.3 4 2.4 2.4 2.4 2.4 5 2.5 2.5 2.5 2.5 8 1.8 1.8 1.8 1.8 1 2.1 2.1 2.1 2.1 4 2.4 2.4 2.4 2.4 3 2.3 2.3 2.3 2.3 -1 2.2 2.2 2.2 2.2 0 2.0 2.0 2.0 2.0 2 2.2 2.2 2.2 2.2 4 2.4 2.4 2.4 2.4 3 2.3 2.3 2.3 2.3 3 2.3 2.3 2.3 2.3 1 2.1 2.1 2.1 2.1 4 2.4 2.4 2.4 2.4 2 2.2 2.2 2.2 2.2
9 1.9 1.9 1.9 1.9 2 2.2 2.2 2.2 2.2 1 2.1 2.1 2.1 2.1 2 2.2 2.2 2.2 2.2
Company SamHzed. Does no, eonla,n T s n i CB)
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 12 Day 13
Female, II - 0 mg/kg/day
643477 2.0 2.0 643374 2.1 2.1 643406 1.9 1.9 643486 1.9 1.9 643361 2.1 2.1 643463 2.4 2.4 643398 1.9 1.9 643436 2.0 2.0 643362 2.1 2.1 643354 1.7 1.7 643402 1.9 1.9 643383 1.9 1.9 643465 2.2 2.2 643484 1.9 1.9 643384 2.2 2.2 643352 2.1 2.1 643343 1.9 1.9 643459 2.3 2.3 643394 2.3 2.3 643480 2.3 2.3 643319 2.3 2.3 643350 2.1 2.1 643363 2.3 2.3 643397 2.3 2.3 643421 2.0 2.0 643420 2.3 2.3 643419 2.4 2.4 643414 2.5 2.5 643401 1.8 1.8 643455 2.1 2.1 643378 2.4 2.4 643393 2.3 2.3 643447 2.2 2.2 643478 2.0 2.0 643386 2.2 2.2 643405 2.4 2.4 643425 2.3 2.3 643448 2.3 2.3 643426 2.1 2.1 643415 2.4 2.4 643453 2.2 2.2 643330 1.9 1.9 643336 2.2 2.2 643387 2.1 2.1 643377 2.2 2.2
Day 14
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2.3 2.4 1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2.2 2.7 2.4 2.3 2.3 2.6 2.5 2.1 2.5 2.4 2.4
Day 15
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2.3 2.4 1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2.2 2.7 2.4 2.3 2.3 2.6 2.5 2.1 2.5 2.4 2.4
INDIVIDUAL DOSE VOLUMES
Day 16 Day 17 Day 18
2.1 2.1 2.1 2.3 2.3 2.3 2.1 2.1 2.1 1.9 1.9 1.9 2.2 2.2 2.2 2.7 2.7 2.7 2.1 2.1 2.1 2.3 2.3 2.3 2.4 2.4 2.4 1.9 1.9 1.9 2.2 2.2 2.2 2.0 2.0 2.0 2.4 2.4 2.4 2.1 2.1 2.1 2.4 2.4 2.4 2.3 2.3 2.3 2.1 2.1 2.1 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.2 2.2 2.2 2.6 2.6 2.6 2.5 2.5 2.5 2.2 2.2 2.2 2.5 2.5 2.5 2.6 2.6 2.6 2.6 2.6 2.6 2.0 2.0 2.0 2.2 2.2 2.2 2.7 2.7 2.7 2.4 2.4 2.4 2.4 2.4 2.4 2.1 2.1 2.1 2.2 2.2 2.2 2.7 2.7 2.7 2.4 2.4 2.4 2.3 2.3 2.3 2.3 2.3 2.3 2.6 2.6 2.6 2.5 2.5 2.5 2.1 2.1 2.1 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.4 2.4
534
) DuPont-5386
1 Day 20
Day 21
Day 22
Day 23
1 2.1 2.4 2.4 2.4 3 2.3 2.4 2.4 2.4 1 2.1 2 . 2 2.2 2.2 9 1.9 2.1 2.1 2.1 2 2.2 2.6 2.6 2.6 7 2.7 2.7 2.7 2.7
1 2.1 2.3 2.3 2.3 3 2.3 2.4 2.4 2.4 4 2.4 2.5 2.5 2.5 9 1.9 2.1 2.1 2.1 2 2.2 2.3 2.3 2.3 0 2.0 2.2 2.2 2.2 4 2.4 2.7 2.7 2.7 1 2.1 2 . 2 2.2 2.2 4 2.4 2.5 2.5 2.5 3 2.3 2.5 2.5 2.5 1 2.1 2.3 2.3 2.3 5 2.5 2.6 2.6 2.6 4 2.4 2.5 2.5 2.5 4 2.4 2.5 2.5 2.5 4 2.4 2.7 2.7 2.7
2 2.2 2.3 2.3 2.3 6 2.6 2 . 6 2.6 2.6 5 2.5 2.6 2.6 2.6 2 2.2 2.3 2.3 2.3 5 2.5 2.8 2.8 2.8 6 2.6 2.9 2.9 2.9 6 2.6 2.8 2.8 2.8 0 2.0 2.1 2.1 2.1 2 2.2 2.4 2.4 2.4 7 2.7 2.9 2.9 2.9 4 2.4 2.6 2.6 2.6 4 2.4 2.6 2.6 2.6 1 2.1 2.3 2.3 2.3 2 2.2 2.4 2.4 2.4 7 2.7 2.8 2.8 2.8 4 2.4 2.7 2.7 2.7 3 2.3 2.5 2.5 2.5 3 2.3 2.6 2.6 2.6 6 2.6 2.7 2.7 2.7 5 2.5 2.7 2.7 2.7 1 2.1 2.2 2.2 2.2 5 2.5 2.7 2.7 2.7 4 2.4 2.5 2.5 2.5 4 2.4 2 . 6 2.6 2.6
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24 Day 25
Female, II - 0 mg /kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.4 2.4 2.2 2.1 2.6 2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7 2.3 2.6 2.6 2.3 2.8 2.9 2.8 2 .1 2.4 2.9 2.6 2.6 2.3 2.4 2.8 2.7 2.5 2.6 2.7 2.7 2.2 2.7 2.5 2.6
2.4 2.4 2.2 2.1 2.6 2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7 2.3 2.6 2.6 2.3 2.8 2.9 2.8 2.1 2.4 2.9 2.6 2.6 2.3 2.4 2.8 2.7 2.5 2.6 2.7 2.7 2.2 2.7 2.5 2.6
Day 26
2.4 2.4 2.2 2.1 2.6 2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7 2.3 2.6 2.6 2.3 2.8 2.9 2.8 2.1 2.4 2.9 2.6 2.6 2.3 2.4 2.8 2.7 2.5 2.6 2.7 2.7 2.2 2.7 2.5 2.6
ay 27
2.4 2.4 2.2 2.1 2.6 2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7 2.3 2.6 2.6 2.3 2.8 2.9 2.8 2.1 2.4 2.9 2.6 2.6 2.3 2.4 2.8 2.7 2.5 2.6 2.7 2.7 2.2 2.7 2.5 2.6
INDIVIDUAL DOSE VOLUMES
ay 28
Day 29
ay 30
2.4 2.4 2.4 2.5 2.5 2.5 2.3 2.3 2.3 2.1 2.1 2.1 2.7 2.7 2.7 2.9 2.9 2.9 2.4 2.4 2.4 2.6 2.6 2.6 2.6 2.6 2.6 2.2 2.2 2.2 2.4 2.4 2.4 2.2 2.2 2.2 2.8 2.8 2.8 2.3 2.3 2.3 2.6 2.6 2.6 2.6 2.6 2.6 2.4 2.4 2.4 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.4 2.4 2.4 2.9 2.9 2.9 2.7 2.7 2.7 2.4 2.4 2.4 2.9 2.9 2.9 3.1 3.1 3 .1 2.9 2.9 2.9 2.3 2.3 2.3 2.6 2.6 2.6 3.0 3.0 3.0 2.9 2.9 2.9 2.7 2.7 2.7 2.4 2.4 2.4 2.5 2.5 2.5 3.0 3.0 3.0 2.8 2.8 2.8 2.7 2.7 2.7 2.7 2.7 2.7 3.0 3.0 3.0 2.8 2.8 2.8 2.4 2.4 2.4 2.9 2.9 2.9 2.7 2.7 2.7 2.7 2.7 2.7
535
) DuPont-5386
Day 33
Day 34
Day 35
4 2.4 2.4 2.6 5 2.5 2.5 2.6 3 2.3 2.3 2.4 1 2.1 2.1 2.2 7 2.7 2.7 2.8 9 2.9 2.9 3.1 4 2.4 2.4 2.6 6 2.6 2.6 2.7 6 2.6 2.6 2.8 2 2.2 2.2 2.3 4 2.4 2.4 2.5 2 2.2 2.2 2.4 8 2.8 2.8 2.7 3 2.3 2.3 2.4 6 2.6 2.6 2.8 6 2.6 2.6 2.8 4 2.4 2.4 2.6 7 2.7 2.7 2.9 7 2.7 2.7 2.8 7 2.7 2.7 2.9 7 2.7 2.7 2.9 4 2.4 2.4 2.5 9 2.9 2.9 3.0 7 2.7 2.7 2.8
4 2.4 2.4 2.5
9 2.9 2.9 3.2 1 3.1 3.1 3.2 9 2.9 2.9 3.1 3 2.3 2.3 2.3 6 2.6 2.6 2.6 0 3.0 3.0 3.2 9 2.9 2.9 3.0 7 2.7 2.7 2.9
4 2.4 2.4 2.4 5 2.5 2.5 2.5 0 3.0 3.0 3.2 8 2.8 2.8 2.9 7 2.7 2.7 2.8 7 2.7 2.7 2.9
0 3.0 3.0 3.0
8 2.8 2.8 2.9 4 2.4 2.4 2.5 9 2.9 2.9 3.0 7 2.7 2.7 2.9 7 2.7 2.7 2.9
Company Sanitized. Does ,, o ,c 0,,ta,n TSCACBI
)>
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36 Day 37
Female, II - Q mg/kg/day
643477 2.6 2.6
643374 2 . 6 2.6
643406 2.4 2.4 643486 2.2 2.2 643361 2.8 2.8
643463 3.1 3.1
643398 2.6 2.6 643436 2.7 2.7 643362 2.8 2.8 643354 2.3 2.3 643402 2.5 2.5 643383 2.4 2.4
643465 2 . 7 2.7
643484 2.4 2.4 643384 2.8 2.8 643352 2.8 2.8 643343 2.6 2.6
643459 2.9 2 . 9
643394 2.8 2.8 643480 2.9 2.9 643319 2.9 2.9
643350 2 . 5 2 . 5 643363 3 . 0 3.0 643397 2.8 2 . 8 643421 2 . 5 2.5
643420 3.2 3.2 643419 3.2 3.2
643414 3 . 1 3 . 1
643401 2.3 2.3 643455 2.6 2.6
643378 3.2 3 . 2
643393 3.0 3.0
643447 2 . 9 2 . 9
643478 2.4 2.4
643386 2 . 5 2.5
643405 3.2 3.2 643425 2.9 2.9
643448 2 . 8 2.8
643426 2.9 2.9 643415 3.0 3.0 643453 2.9 2.9
643330 2.5 2.5
643336 3.0 3 . 0 643387 2 . 9 2 . 9 643377 2 . 9 2.9
Day 38
2.0 1.9 1.8 1.7 2.1
2.3
2.0 2.0 2.1 1.7 1.9 1.8 2.1 1.8
2.1 2.1 2.0
2.1
2.1
2.2 2.2 1.9 2.3 2.1 1.9 2.4 2.4 2.3 1.8 1.9 2.4 2.3 2.2
1.8
1.9 2.4 2.2
2.1
2.2 2.2 2.2 1.9
2.2
2.2
2.1
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 41
Day 42
2 . 0 2.0 2.0 2.0
1.9 1.9 1.9 2.0
1.8 1.8 1.8 1.8
1.7 1.7 1.7 1.7
2.1 2.1 2.1 2.2
2.3
2.3
2.3 b
2.3
2.0 2.0 2.0 2.0
2.0 2.0 2.0 2.1
2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.8
1 . 9 1.9 1.9 1.9
1.8 1.8 1.8 1.8
2 . 1 2 . 1 2.1 2.2
1.8 1.8 1.8 1.8
2.1 2 . 1 2.1 2.0 2 . 1 2.1 2.1 2.1
2.0 2.0 2.0 2.0
2 . 1 2 . 1 2.1 2.3 2 . 1 2 . 1 2 . 1 2.1 2.2 2.2 2.2 2 . 1
2.2 2.2 2.2 2.3
1.9 1 . 9 1.9 2.0 2.3 2 . 3 2.3 2.2 2 . 1 2.1 2 . 1 2.2
1.9 1.9 1.9 2.0 2.4 2.4 2.4 2.5
2 . 4 2.4 2.4 2.5 2 . 3 2 . 3 2 . 3 2.4
1.8 1.8 1.8 1.8
1.9 1 . 9 1.9 2.0
2 . 4 2.4
.4 2.4
2.3 2 . 3 2 . 3 2.3
2.2 2.2 2.2 2.2
1 . 8 1.8 1.8 1.9
1.9 1.9 1.9 2.0
2.4 2.4 2.4 2.6
2.2 2.2 2.2 2.2
2 . 1 2.1 2 . 1 2.1
2.2 2.2 2.2 2.2
2.2 2.2 2.2 2.3
2.2 2.2 2.2 2.3
1.9 1 . 9 1 . 9 2.0 2 . 2 2.2 2.2 2.3
2.2 2.2 2.2 2.2
2 , 1 2 . 1 2 . 1 2.2
Day 43
2.0
2.0 1.8 1.7 2.2
2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0
2.1
2.0 2.3
2.1 2.1
2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9
2.0
2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
Day 44
2.0
2.0
1.8 1.7 2.2
2.3
2.0 2.1 2.1
1.8
1.9 1.8 2.2 1.8
2.0
2.1 2.0 2.3 2.1 2.1 2.3
2.0
2.2 2.2
2.0 2.5
2.5
2.4 1.8 2.0
2.4
23 2.2 1.9 2.0
2.6
2.2
2.
2.2 2.3 2.3
2.0
2.3 2.2 2.2
)
DuPont-5386
Day 45
2.0 2.0 1.8 1.7 2.2 2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8
2.0
2.1 2.0 2.3 2.1
2.1
2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4
4O, .J"3
2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
Company Sanitized. Does not contain TSCA CBI
536
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D a y 46
D a y 47
F e m a le , I I - 0 m g/ k g / d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.0 2.0 1.8 1.7 2.2 2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8
2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
to o
2.0 2.0 1.8 1.7 2.2 2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1
2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
D a y 48
2.0 2.0 1.8 1.7 2.2 2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
INDIVIDUAL DOSE VOLUMES
D a y 49
D a y 50
D a y 51
2.0 2.0 2.0
2.1 2.1 2.1
1.9 1.9 1.9
1.8 1.8 1.8
2.4 2.4 2.4
2.3 2.3 2.3
2.0 2.0 2.0
2.1 2.1 2.1
2.1
2 '. 1
2.1
1.9 1.9 1.9
2.0 2.0 2.0
1.9 1.9 1.9
2.2 2.2 2.2
1.9 1.9 1.9
2.1 2.1 2.1
2.2 2.2 2.2
2.1 2.1 2.1
2.4 2.4 2.4
2.2 2.2 2.2
2.2 2.2 2.2
2.3 2.3 2.3
2.1 2.1 2.1
2.4 2.4 2.4
2.3 2.3 2.3
2.0 2.0 2.0
2.6 2.6 2.6
2.6 2.6 2.6
2.5 2.5 2.5
1.8 1.8 1.8
2.0 2.0 2.0
2.6 2.6 2.6
2.4 2.4 2.4
2.3 2.3 2.3
2.0 2.0 2 . 0
2.0 2.0 2.0
2.7 2.7 2.7
2.3 2.3 2.3
2.1 2.1 2.1
2.3 2.3 2.3
2.4 2.4 2.4
2.4 2.4 2.4
2.0 2.0 2 . 0
2.4 2.4 2.4
2.3 2.3 2.3
2.3 2.3 2.3
537
(m L )
52
Day 53
Day 54
DuPont-5386
Day 55
2.0 2.1 1.9 1.8 2.4 2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2 .1 2.4 2.2 2.2 2.3 2 .1 2.4 2.3 2 .0 2.6 2.6
2.5
1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2 .1 2 .3 2.4 2.4 2 .0 2.4 2.3 2.3
2.0 2 .1 1.9 1.8 2.4 2.3 2.0 2 .1 2 .1 1.9 2.0 1.9 2.2 1.9 2 .1 2.2 2.1 2.4 2.2 2.2 2.3 2 .1 2.4 2.3 2 .0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2 .1
2.3
2.4 2.4 2 .0 2.4 2.3 2.3
2.0 2 .1 1.9 1.8 2.4 2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2 2.2 2.3 2 .1 2.4 2.3 2.0 2.6 2.6
2.5
1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2 .1 2.3 2.4 2.4 2 .0 2.4 2.3 2.3
2.0 2.1 1.9 1 .8 2.4 2.3 2 .0 2 .1 2 .1 1.9 2.0 1.9 2.2 1.9 2 .1 2.2 2 .1 2.4 2.2 2.2 2.3 2.1 2.4 2.3 2 .0 2 .6
2.6 2.5
1.8
2.0 2.6 2.4
2.3 2.0
2.0 2.7
2.3 2 .1 2.3 2.4
2.4
2.0 2.4 2.3
2.3
Company SmBwL Does no, co,,|a|) TSCA^
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 56
Day 57
Female, II - 0 mg/ kg/day
643477 643374
643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.0 2.1 1.9 1.9 2 .5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2.1 2.3 2 .1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2 .1 2.6 2 .7 2.6 2.0 2 .1 2.5 2.5 2 .3 2.0 2.1 2 .7 2.4 2.3 2.4 2.4 2.4 2.0 2.4 2 .4 2.4
2.0 2.1 1.9 1.9 2 .5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2 .1 2.3 2 .1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2 .1 2.6 2.7 2.6 2.0 2 .1 2.5 2.5 2 .3 2.0 2 .1 2.7 2.4 2.3 2.4 2.4 2.4 2.0 2.4 2.4 2.4
Day 58
2.0 2.1 1.9 1.9 2.5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2 .1 2.3 2.1 2.4 2.1 2.3 2.4 2.1 2 .5 2.2 2 .1 2.6 2.7 2 .6 2.0 2.1 2.5 2.5 2.3 2.0 2 .1 2.7 2.4 2.3 2 .4 2.4 2.4 2.0 2.4 2.4 2 .4
INDIVIDUAL DOSE VOLUMES
Day 59
Day 60
Day 61
2.0 2.1 1.9 1 .9 2.5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2.1 2.3 2 .1 2.4 2 .1 2.3 2.4 2.1 2 .5 2.2 2.1 2.6 2.7 2 .6 2.0 2 .1 2.5 2 .5 2.3 2.0 2 .1 2 .7 2.4 2.3 2.4 2.4 2.4 2.0 2.4 2.4 2.4
2.0 2.1 1.9 1.9 2.5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2 .1 2.3 2 .1 2.4 2 .1 2.3 2.4 2 .1 2.5 2.2 2 .1 2.6 2 .7 2 .6 2.0 2 .1 2 .5 2.5 2.3 2 .0 2 .1 2.7 2.4 2.3 2.4 2 .4 2.4 2 .0 2.4 2.4 2.4
2.0 2 .1 1.9 1.9 2.5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2.1 2.3 2.1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2 .1 2.6 2 .7 2.6 2.0 2.1 2.5 2.5 2.3 2.0 2.1 2.7 2.4 2.3 2.4 2.4 2.4 2.0 2.4 2.4 2.4
538
(m L) 62
Day 63
Day 64
DuPont-5386
Day 65
2.0 2.1 1.9 1.9 2.5 2 .5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1 .9 2.1 2.3 2.1 2.4 2 .1 2.3 2.4 2.1 2 .5 2.2 2 .1 2 .6 2.7 2.6 2.0 2.1 2 .5 2 .5 2.3 2.0 2.1 2.7 2.4 2.3 2.4 2.4 2.4 2 .0 2.4 2.4 2.4
2 .1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2 .0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2.1 2.7 2.7 2.6 1.9 2.1 2.6 2 .5 2.4 2.0 2.1 2.7 2.4 2.3 2.4 2.6 2.4 2.1 2 .5 2.4 2.5
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2 .1 2.7 2.7 2 .6 1.9 2.1 2.6 2.5 2.4 2 .0 2 .1 2.7 2.4 2.3 2.4 2.6 2.4 2 .1 2 .5 2.4 2.5
2 .1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2.1 2.7 2.7 2.6 1.9 2.1 2.6 2.5 2.4 2 .0 2 .1 2.7 2.4 2.3 2.4 2.6 2.4 2.1 2 .5 2.4 2.5
Company Sanitized, Does not contain TSCA CB(
!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 66
Day 67
Female, II - 0 mg / kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2 .1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2 .5 2.2 2.1 2.7 2.7 2.6 1.9 2 .1 2.6 2.5 2.4 2.0 2.1 2.7 2.4 2.3 2.4 2.6 2.4 2 .1 2.5 2.4 2.5
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2 .0 2.3 2.2 2.2 2.4 2.2 2 .5 2.2 2 .1 2.7 2.7 2.6 1.9 2 .1 2.6 2.5 2 .4 2.0 2 .1 2.7 2.4 2.3 2.4 2 .6 2.4 2 .1 2.5 2.4 2.5
Day 68
2 .1 2.2 2.0 2.0 2 .6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2 .5 2.2 2.1 2.7 2.7 2.6 1.9 2 .1 2.6 2 .5 2.4 2 .0 2.1 2.7 2 .4 2.3 2.4 2.6 2.4 2.1 2.5 2.4 2.5
INDIVIDUAL DOSE VOLUMES
Day 69
Day 70
Day 71
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2.1 2 .7 2.7 2.6 1.9 2 .1 2.6 2.5 2.4 2.0 2 .1 2.7 2.4 2.3 2.4 2.6 2.4 2 .1 2 .5 2 .4 2.5
2 .1 2.3 2 .1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2.1 2.7 2 .7 2.7 2.0 2 .1 2.6 2.5 2.4 2.0 2 .1 2.8 2.4 2.3 2 .5 2.8 2 .5 2 .1 2 .5 2.5 2.5
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2 .2 2.4 2.2 2 .5 2.3 2 .1 2 .7 2.7 2.7 2.0 2 .1 2.6 2 .5 2.4 2.0 2 .1 2.8 2.4 2.3 2.5 2.8 2 .5 2 .1 2.5 2 .5 2 .5
539
I
(mL) Day 72
Day 73
Day 74
DuPont-5386
Day 7 5
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2 .1 2.7 2.7 2.7 2.0 2.1 2.6 2.5 2.4 2.0 2 .1 2.8 2.4 2.3 2.5 2 .8 2.5 2 .1 2.5 2.5 2.5
2.1 2.3 2.1 2.0 2.6 2 .5 2.2 2.2 2.3 2 .1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2 .1 2.7 2 .7 2.7 2.0 2 .1 2 .6 2 .5 2.4 2 .0 2 .1 2 .8 2.4 2.3 2 .5 2.8 2.5 2.1 2 .5 2.5 2.5
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2 .1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2 .1 2.7 2.7 2.7 2.0 2.1 2.6 2.5 2.4 2 .0 2.1 2.8 2.4 2.3 2.5 2.8 2 .5 2.1 2.5 2.5 2 .5
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2
2 .8 2.4 2.3 2.5 2.8 2.5 2.1 2 .5 2.5 2.5
o-npavsanrazed. Does not contain TSCACBf
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 76
Day 77
E'emale, II - 0 mg/ kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2 .1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2 .1 2.2 2.4 1.9 2.2
2.8 2.4 2.3 2 .5 2.8 2.5 2 .1 2 .5 2.5 2.5
2 .1 2.3 2.0 2.0 2.7 2.5 2.2 2.3 2.3 2 .1 2 .0 2.2 2.4 2 .0 2.3
2.7 2 .4 2 .3 2.6 2 .9 2 .5 2 .1 2 .5 2.5 2 .6
Day 78
2 .1 2.3 2.0 2.0 2.7 2.5 2.2 2.3 2.3 2.1 2.0 2.2 2.4 2.0 2.3
2 .7 2.4 2.3 2.6 2.9 2 .5 2 .1 2.5 2.5 2.6
INDIVIDUAL DOSE VOLUMES
Day 7 9
Day 80
Day 81
2.1
2 .1
2 .1
2.3 2.3 2.3
2.0 2.0 2.0
2.0 2.0 2.0
2.7 2.7 2.7
2.5
2 .5
2 .5
2.2 2.2 2.2
2.3 2.3 2.3
2.3 2.3 2.3
2.1 2.1 2 .1
2.0 2.0 2.0
2.2 2.2 2.2
2.4 2.4 2.4
2.0 2.0 2 .0
2.3 2.3 2.3
2.7
2 .7
2.7
2.4 2.4 2.4
2.3 2.3 2.3
2.6 2.6 2.6
2.9 2.9 2.9
2.5
2 .5
2.5
2.1
2 .1
2.1
2 .5 2.5 2 .5
2.5 2.5 2.5
2.6
2 .6
2.6
540
(mL)
82
Day 83
Day 84
DuPont-5386
Day 85
2 .1 2.3 2.0 2.0 2.7 2 .5 2.2 2.3 2.3 2 .1 2.0 2.2 2.4 2.0 2.3
2 .1 2.3 2.0 2.0 2.7 2.5 2.2 2.3 2.3 2.1 2 .0 2.2 2.4 2.0 2.3
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2 .1 2 .1 2.2 2.4 2 .0 2.3
2.2 2.4 2 .0 1.9 2 .8 2 .6 2.3 2.3 2.4 2 .1 2 .1 2.2 2.4 2.0 2.3
2.7 2.7 2.7 2.7 2.4 2.4 2.4 2.4 2.3 2.3 2.3 2.3 2.6 2.6 2.6 2.6 2.9 2.9 3.0 3.0 2.5 2.5 2.5 2.5 2.1 2.1 2.2 2.2 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.6 2.6 2.5 2.5
'w pany Sanitized, D oes n o , co n tain T sr j , . a .
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 86
Day 87
Female, II - 0 mg/ kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2.1 2.1 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 3.0 2.5 2.2 2.5 2.5 2.5
2.2 2.4 2.0 1.9 2 .8 2 .6 2.3 2.3 2.4 2 .1 2 .1 2.2 2.4 2 .0 2.3
2.7 2.4 2.3 2 .6 3.0 2 .5 2.2 2.5 2.5 2 .5
Day 88
2.2 2.4 2.0 1.9 2.8 2 .6 2.3 2.3 2.4 2 .1 2.1 2.2 2.4 2 .0 2.3
2.7 2.4 2.3 2.6 3 .0 2.5 2.2 2.5 2.5 2.5
INDIVIDUAL DOSE VOLUMES (mL)
Day 89
Day 90
Day 91
Day 92
2.2 2.4 2.0 1.9 2.8 2 .6 2.3 2.3 2.4 2.1 2 .1 2.2 2.4 2.0 2.3
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2.1
2.2 2.5
2.1
1.9 3.0 2.6 2.3 2.4 2.3
2.2
2.2 2 .5
2.1
1.9 3.0
2.6
2.3 2.4 2.3
2.2
2.7 2.4 2 .3 2.6 3.0 2 .5 2.2 2.5 2.5 2.5
541
) DuPont-5386
Company Sanitized. Does nt contain TSCACBi
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Day 2
Female, IV - 2 5 m g / kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372
643400 643395 643457
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8 1.7 2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2 .1 2.2 2 .0 1 .7 1 .9 2.0
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
AK TEST
2.1 1.7 1.9 1.8 1.7 2 .1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2 .0 2.1 2.2 2.0 1.7 1.9 2.0
DAY
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8 0 2.1 1.7 1.9 1 .8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1 .9 1 .9 2.0 2.1 2.2 2.0 1 .7 1.9 2.0
Day 3
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
INDIVIDUAL DOSE VOLUME
Day 4
Day 5
Day 6
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1 .9 1.8 1.7 2 .1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2 .1 2 .2 2.0 1 .7 1.9 2 .0
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2 .1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2 .1 2.2 2.0 1.7 1.9 2.0
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0
ni
2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2 .0 2.1 2.2 2.0 1.7 1.9 2.0
542
IS (m L ) Day 7
Day 8
Day 9
DuPont-5386
Day 10
Day 11
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2.0 2 .0 1 .9 2.4 2.2 2.3 2.3 2.2 2 .6 2.1 2.5 2.2 2.3 2.2 2.3 2.2 2.5 2.2 1.9 2.1 2.3
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2 .0 1.9 1.9 2 .0
2.2 1.9 2.0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2.3 2.2 2.3 2.2 2 ,5 2.2 1.9 2.1 2.3
1.9 2.3 1.9 2.2 2 .1 2.3 2.1 2.0 1.9 1.9 2 .0
2.2 1.9 2.0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2 .1 2.5 2.2 2.3 2.2 2.3 2.2 2.5 2.2 1.9 2.1 2.3
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2.0 2 .0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2.3 2.2 2.3 2.2 2.5 2.2 1.9 2.1 2.3
1.9 2.3 1.9 2 .2 2 .1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2 .0 2 .0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2.3 2.2 2.3 2.2 2.5 2.2 1.9 2.1 2.3
Company Sanitized. Doe* ____________________ 65 not contain TSCAr.R.
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 12
Day 13
Female, IV - 2 5 m g / kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2.0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2.3 2.2 2.3 2.2 2 .5 2.2 1.9 2.1 2.3
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2.0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2 .1 2 .5 2.2 2.3 2.2 2 .3 2.2 2.5 2.2 1 .9 2.1 2.3
Day 14
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2 .1 2.1
2.4 2.1 2.2 2.3 2 .1 2.6 2.4 2.5 2.5 2.4 2 .7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2 .0 2.3 2.5
Day 15
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2 .5
INDIVIDUAL DOSE VOLUMES
Day 16
Day 17
Day 1 8 `
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2 .1
2.4 2.1 2.2 2.3 2 .1 2.6 2.4 2 .5 2.5 2.4 2.7 2.3 2.7 2.3 2 .5 2.4 2.6 2.4 2 .5 2.4 2 .0 2.3 2 .5
2.0 2.5 2.3 2.4 2.2 2.4 2 .1 2.2 2.2 2.1 2 .1
2.4 2.1 2.2 2 .3 2 .1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2 .0 2.3 2.5
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2 .4 2.5 2.4 2 .0 2 .3 2.5
543
)
(mL)
Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2 .1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2 .1 2.1
2.4 2 .1 2.2 2.3 2 .1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2 .0 2.3 2 .5
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2 .3 2.3 2.3
2.7 2.2 2 .5 2.4 2.4 2 .8 2 .6 2.7 2.7 2.5 3.0 2.4 3 .0 2.6 2.7 2 .6 2.8 2.7 2 .8 2.6 2.1 2 .5 2.6
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3 .0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6 2 .1 2.5 2.6
2.2 2 .8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2 .5 2.4 2.4 2.8 2 .6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2 .6 2.8 2.7 2.8 2.6 2 .1 2.5 2.6
Company Sanitized. Does not contain TSCA C B l
i)I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_____________________________________________________________ DuPont-5386
Day 24
Day 25
Female, IV - 2 5 mg / kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6 21 2.5 2 .6
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6
n, j1.
2.5 2.6
Day 26
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3 .0 2.4 3.0 2.6 2.7 2 .6 2.8 2.7 2.8 2.6 2.1 2.5 2 .6
Day 27
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2 .6 2.8 2.7 2.8 2.6 2.1 2.5 2.6
INDIVIDUAL DOSE VOLUMES (mL)
Day 28
Day 2 9
Day 3 0
Day 31
2.4 2.8 2.7 2.9 2.4 2.7 2.4 2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2 .6 2 .7
2.4 2.4 2.4 2.8 2.8 2.8 2.7 2.7 2.7 2.9 2.9 2.9 2.4 2.4 2.4 2.7 2.7 2.7
2 . 4 SE TEST DAY 2 9
2.6 2.6 2.6 2.4 2.4 2.4 2.4 2.4 2.4 2.3 2.3 2.3
2.7 2.7 2.7
2.3 2.3 2.3
2.5 2.5 2.5
2.6 2.6 2.6
2.5 2.5 2.5
2.9 2.9 2.9
2.9 2.9 2.9
2.8 2.8 2.8
2.9 2.9 2.9
2.8 2.8 2.8
3.1 3.1 3.1
2.6 2.6 2.6
3.1 3.1 3.1
2.6
2 .6
2.6
2.8 2.8 2.8
2.7 2.7 2.7
3.0 3.0 3.0
3.0 3.0 3.0
2.9 2.9 2.9
2.8 2.8 2.8
2.3 2.3 2.3
2.6 2.6 2.6
2.7 2.7 2.7
Day 32
2.4 2.8 2.7 2.9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
Day 33
2.4 2.8 2.7 2.9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
Day 3 4
Day 3 5
2.4 2.8 2.7 2.9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2 .6 2.7
2.5 3.0 2.8 2.9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3.0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
Company Sanitized. Does not contain TSCA CB! 544
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 3 6
Day 37
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.5 3.0 2.8 2.9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3.0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
2.5 3.0 2.8 2.9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3.0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
Day 3 8
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2 .1 1.8 2.0 2.1
INDIVIDUAL DOSE VOLUMES (mL)
Day 3 9
Day 40
Day 41
Day 42
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2 .1 1.8 2.0 2.1
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1 .9'
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2 .1 1.8 2.0 2.1
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2 .3 2.3 2.1 1.8 2.0 2.1
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2 .5 2.2 1.9 2.0 2.2
Day 43
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
Day 4 4
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
DuPont-5386
Day 45
1 .9 2 .3 2 .1 2 .3 2 .1 2 .3
2 .0 2 .0
1 .9 1 .9
2 .1 1 .9 2 .1 2 .1
2 .0
2 .4 2 .1 2 .2 2 .4 2 .2 2 .8 2 .2 2 .5 2 .1 2 .3 2 .2 2 .4 2 .4 2 .5
2 .2
1 .9
2 .0 2 .2
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 46
Day 47
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452
643475 643372 643400 643395 643457
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1 .9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2 .2 1 .9 2.0 2.2
Day 48
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2 .2 1.9 2.0 2.2
INDIVIDUAL DOSE VOLUMES
Day 49
Day 50
Day 51
2.0 2.3 2.2 2.3 2.1 2.3
2.0 2.3 2.2 2.3 2.1 2.3
2.0 2.3 2.2 2.3 2.1 2.3
2.1 2.1 2.1 2.0 2.0 2.0 2.0 2 .0 2 .0 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2 .1 2.2
546
)
(mL)
52
Day 53
Day 54
DuPont-5386
Day 55
2.0 2.3 2.2 2.3 2 .1 2.3
2 .1 2 .0 2.0 2.0
2.3 1.9 2 .1 2.2 2 .1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2 .1 2.2
2 .0 2.3 2.2 2.3 2 .1 2.3
2 .1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.0 2.3 2.2 2.3 2.1 2.3
2 .1 2.0 2 .0 2.0
2.3 1.9 2.1 2.2 2 .1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2 .5 2.0 1.9 2 .1 2.2
2.0 2.3 2.2 2.3 2.1 2.3
2 .1 2.0 2.0 2 .0
2.3 1 .9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
Company Sanitized. Does not contain TSCA CB1
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 56
Day 57
Female, IV - 2 5 m g / kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2.0 2 .1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2 .9 2 .2 2.7 2.2 2 .4 2.3 2.6 2.5 2.4 2 .2 2.0 2.1 2.2
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2 .0 2.1 2.2 2 .1 2.4 2.3 2.3 2 .5 2.2 2 .9 2.2 2 .7 2.2 2.4 2 .3 2 .6 2 .5 2.4 2.2 2.0 2 .1 2.2
Day 58
2 .1 2.4 2.4 2.4 1.8 2.4
2.2 2 .1 2.0 1.9
2.2 2 .0 2.1 2.2 2.1 2.4 2.3 2.3 2 .5 2.2 2 .9 2.2 2.7 2 .2 2.4 2.3 2 .6 2.5 2.4 2.2 2.0 2.1 2 .2
INDIVIDUAL DOSE VOLUMES
Day 59
Day 60
Day 61
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2 .0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 20 2.1 2.2
2.1 2.4 2.4 2.4 1 .8 2.4
2.2 2.1 2.0 1.9
2.2 2 .0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2 .9 2.2 2.7 2.2 2.4 2.3 2 .6 2 .5 2.4 2.2
zo,. <nj
2 .1 2.2
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2 .0 2.1 2.2 2 .1 2.4 2.3 2.3 2.5 2.2 2 .9 2.2 2.7 2.2 2.4 2.3 2.6 2 .5 2.4 2.2 2.0 2 .1 2.2
547
)
(m L )
62
Day 63
Day 64
DuPont-5386
Day 65
2 .1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2.0 2 .1 2.2 2 .1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2 .3 2 .6 2 .5 2.4 2.2 2 .0 2 .1 2.2
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2 .1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2 .1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2 .5 2.2 2.0 2.2 2.3
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2 .1 2.1 2.0
2.3 2 .1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
Company Sanitized, Does no! contain TSCA CBt
)
11-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 66
Day 67
Female, IV - 2 b m g / kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438
643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2 .1 2.5 2.3 2.5 2.2 2.3
2.2 2 .1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2 .3 2.2 2.5 2.3
2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2 .0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2 .2 2.3
Day 68
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2 .1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
INDIVIDUAL DOSE VOLUMES
Day 69
Day 70
Day 71
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2 .1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3
2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2 .3
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2 .1 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2.0 2.2 2.3
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2 .0 2.2 2.3
548
(m L )
72
Day 73
Day 74
DuPont-5386
Day 75
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2 .1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2 .0 2.2 2.3
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 b
2.3 2.7 2.2 2.4 2.3 2.7 2.6 2 .5 2.3 2.0 2.2 2.3
2 .1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2.0 2.2 2.3
2 .1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2 .1 2.0
2.3 2.1 2.3
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 76
Day 77
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479
643403 643376 643422 643452 643475 643372 643400 643395 643457
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2.1 2.3
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2 .1 2.2
Day 78
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2 .0
2.3 2 .1 2.2
INDIVIDUAL DOSE VOLUMES (mL)
Day 7 9
Day 80
Day 81
Day 82
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2 .1 2.2
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2 .3 2 .1 2.2
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2 .0
2.3 2 .1 2.2
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2 .1 2.2
Day 83
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2 .1 2.2
Day 84
2.2 2 .7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2 .1 2.3
DuPont-5386
Day 8 5
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2 .0
2.3 2.1 2.3
Company Sanitized. Does not contain TSCA CB
549
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 86
Day 87
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2.1 2.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2.1 2.3
Day 88
INDIVIDUAL DOSE VOLUMES (mL)
Day 89
Day 90
Day 91
Day 92
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2 .1 0.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2 .0
2.3 2 .1 2.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2
2.2 2.7 2.5 2 .7 2.2 2.4
2.3 2.3 2.2
2.2 2.7 2 .5 2.7 2.2 2.4
2.3 2.3 2.2
DuPont-5386
Company Sanitized. Does not contain TSCA CB 550
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
1 .9 1.8 1.7 1.7 1.9 2.1
2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1 .7 1.9 1.9 1 .9 2.0 2.0 2.0 1.8 1.9
1.9 1.8 1.7 1.7 1.9 2.1
2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
Day 2
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1,9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
Day 3
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1 .7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
INDIVIDUAL DOSE VOLUMI
Day 4
Day 5
Day 6
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1 .7 1.9 1.9 1.9
2.0 2.0 2.0 1.8 1.9
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7 1.7 1 .8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1 .9 2.0 2.0 2.0 1.8 1 .9
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7 1.7 1.8 1.8 1.8 1 .6 1.9 1.8 1.8 2.2 1.9 1.9
2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
551
)
IS (mL) Day 7
Day 8
Day 9
DuPont-5386
Day 10
Day 11
2.1 2.0 2 .0 2 .0 2.2 2 .6 2.3 1.8 2.0 1.9 2.1 2.0 2 .1 1.8 2.3 2.1 2 .1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2 .0 2.1 2 .1 2.0 2.2 2 .2 2.2 2 .1 2.2
2.1 2.0 2.0 2.0 2.2 2 .6 2.3 1.8 2.0 1.9 2 .1 2.0 2 .1 1.8 2.3 2 .1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2 .1 2.2 2 .0 2 .1 2 .1 2 .0 2.2 2.2 2 .2 2 .1 2 .2
2.1 2 .0 2.0 2 .0 2.2 2.6 2.3 1.8 2.0 1.9 2 .1 2.0 2.1 1.8 2.3 2 .1 2 .1 2.4 2.2 2.2 2.2 2 .1 2.0 2.4 2 .1 2.2 2 .0 2 .1 2 .1 2 .0 2.2 2.2 2 .2 2 .1 2.2
2 .1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2 .0 1.9 2.1 2.0 2 .1 1.8 2.3 2 .1 2.1 2.4 2.2 2.2 2.2 2 .1 2 .0 2.4 2 .1 2.2 2.0 2 .1 2.1 2.0 2.2 2.2 2 .2 2 .1 2.2
2.1 2.0 2.0 2 .0 2.2 2.6 2.3 1.8 2.0 1.9 2.1 2.0 2.1 1.8 2.3 2 .1 2 .1 2.4 2.2 2.2 2.2 2 .1 2 .0 2.4 2.1 2.2 2 .0 2.1 2 .1 2.0 2.2 2.2 2 .2 2 .1 2.2
Company Sanitized. Does not contain TSCA CBI
!I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12
Day 13
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2.0 1.9 2.1 2.0 2 .1 1.8 2.3 2 .1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2 .1 2.2 2 .0 2 .1 2 .1 2.0 2.2 2.2 2 .2 2 .1 2.2
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2.0 1.9 2.1 2.0 2.1 1.8 2.3 2.1 2.1 2.4 2.2 2.2 2.2 2 .1 2 .0 2.4 2 .1 2.2 2 .0 2 .1 2 .1
2.0 2.2 2 .2 2 .2 2 .1 2.2
Day 14
2.3 2.2 2.2 2 .1 2.3 2.8 2.5 2 .0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2 .5 2.3 2.2 2.6 2 .3 2.5 2 .1 2.3 2.3 2.3 2.3 2.5 2 .4 2.3 2 .5
Day 15
2.3 2.2 2.2 2.1 2.3 2.8 2 .5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2 .5 2.3 2.2 2.6 2.3 2.5 2 .1 2.3 2.3 2.3 2.3 2 .5 2.4 2.3 2 .5
INDIVIDUAL DOSE VOLUMI
Day 16
Day 17
Day 18
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2 .5 2.3 2.2 2 .6 2 .3 2.5 2.1
2.3 2.3 2 .3 2.3 2 .5 2.4 2.3 2 .5
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2 .5 2.3 2.2 2.6 2.3 2.5 2 .1 2.3 2.3 2.3 2.3 2 .5 2 .4 2.3 2.5
2.3 2.2 2.2 2 .1 2.3 2.8 2.5 2.0 2.1 2.1
2.3 2.1 2.2 2 .0 2.4 2.3 2.2 2 .8 2.4 2.3 2 .5 2.3 2 .2 2 .6 2 .3 2.5 2.1 2.3 2.3 2.3 2.3 2 .5 2 .4 2 .3 2 .5
552
IS (mL)
Day 19
Day 20
2.3 2.2 2.2 2 .1 2.3 2.8 2.5 2.0 2 .1 2 .1
2.3 2 .1 2.2 2 .0 2.4 2.3 2.2 2 .8 2.4 2.3 2.5 2.3 2.2 2 .6 2.3 2.5 2 .1 2.3 2 .3 2.3 2.3 2 .5 2.4 2.3
2.3 2 .2 2.2 2.1 2.3 2.8 2.5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2 .8 2.4 2.3 2.5 2.3 2.2 2.6 2.3 2.5 2 .1 2.3 2.3 2.3 2.3 2.5 2.4 2.3 2 .5
DuPont-5386
21 Day 22
Day 23
2 .5 2 .4 2 .3 2 .3 2 .6 2 .9
2 .7
2 .1 2 .2
2 .3
2 .5
2 .3 2 .4
2 .2
2 .7
2 .5 2 .4
2 .8
2 .5
2 .4 2 .7 2 .3 2 .3 2 .9 2 .4 2 .7 2 .2 2 .4 2 .5 2 .4 2 .5
2 .6
2 .5 2 .4 2 .6
2 .5 2.4 2.3 2.3 2.6 2.9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2 .3 2.3 2.9 2.4 2.7 2.2 2.4 2 .5 2.4 2.5 2.6 2.5 2.4 2.6
2.5 2.4
2.3 2.3 2 .6 2 .9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2 .5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2 .9 2.4 2 .7 2.2 2.4 2.5 2.4 2.5 2 .6 2 .5 2.4 2.6
lO
<N
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 24
Day 25
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416
643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2 .5 2.4 2.3 2.3 2.6 2.9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2 .5 2.4 2.7 2.3 2.3 2.9 2.4
2.7
2.2 2.4 2 .5 2.4 2 .5 2 .6 2.5 2.4 2 .6
2.5 2.4 2.3 2.3 2.6 2 .9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2.9 2.4
2.7
2.2 2.4 2.5 2.4 2 .5 2.6 2.5 2.4 2.6
Day 26
2.5 2.4 2.3 2.3 2.6 2.9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2.9 2.4 2.7 2.2 2.4 2.5 2.4 2 .5 2 .6 2.5 2.4 2.6
Day 27
2.5 2.4 2.3 2.3 2.6 2.9 2.7 2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2 .5 2.4 2.7 2.3 2.3 2.9 2.4 2.7 2.2 2.4 2.5 2.4 2 .5 2 .6 2.5 2.4 2.6
INDIVIDUAL DOSE VOLUMES
Day 28
Day 29
Day 30
2.6 2.6 2.6
2.4 2.4 2.4
2.5 2 .5 2 .5
2.5 2.5 2.5
2.7
2 .7
2.7
3.0 3.0 3.0
2.8 2.8 2.8
2.2 2.2 2.2
2.3 2.3 2.3
2.4 2.4 2.4
2.5 2.5 2.5
2.0 2.0 2.0
2.4 2.4 2.4
2.3
2 .3
2.3
2.8 2.8 2.8
2.6 2 .6 2 .6
2.6 2.6 2.6
3.0 3.0 3 .0
2.6 2.6 2.6
2.6
2 .6
2 .6
2.8
2 .8
2 .8
2.6 2.6 2.6
2.4 2.4 2.4
3.1
3 .1
3.1
2.6 2.6 2.6
2.9 2.9 2.9
2.5 2.6 2.5 2.6 2.6 2.8 2.6 2.4 2.8
2 .5 2.6 2.5 2 .6 2 .6 2 .8 2 .6 2 .4 2 .8
2 .5 2 .6 2 .5 2.6 2 .6 2 .8 2 .6 2.4 2 .8
553
) DuPont-5386
Day 33
Day 34
Day 3 5
6 2.6 4 2.4
2.6 2.4
5 2.5 5 2.5 7 2.7
2.5 2.5 2.7
0 3.0
3.0
8 2 .8 2.8
2 2.2
2.2
3 2.3
2.3
4 2.4
2.4
5 2.5
2.5
0 2.0
2.0
4 2.4
2.4
3 2.3
2.3
8 2.8
2.8
6 2.6
2.6
6 2 .6 2 .6
0 3.0
3.0
6 2.6
2.6
6 2.6
2.6
8 2.8
2.8
6 2.6
2.6
4 2.4
2.4
1 3 .1 3.1
6 2 .6 2 .6
9 2.9
2.9
5 2 .5 2 . 5
6 2.6
2.6
5 2.5
2.5
6 2.6
2.6
6 2.6
2.6
8 2.8
2.8
6 2.6 4 2.4
2.6 2.4
8 2.8
2.8
2.7 2.6 2.6 2.6 2 .8 3.2 2.9 2.4 2.4 2.5 2.6 2.0 2.5 2.2 2.8 2.8 2.6 3.1 2.8 2.7 2.9 2.7 2.5 2.8 2.6 3.0 b
2.5 2.7 2.7 2.7 2.7 2.9 2.8 2.6 2.9
Company Sanitized. Does not contain TSC A CB l
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36
Day 37
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.7 2.6 2.6 2.6 2.8 3.2 2.9 2.4 2.4 2.5 2.6 2.0 2.5 2.2 2.8 2.8 2.6 3.1 2.8 2.7 2.9 2.7 2 .5 2.8 2.6 3.0 2.5 2.7 2.7 2.7 2.7 2.9 2 .8 2.6 2.9
2.7 2.6 2.6 2.6 2.8 3.2 2.9 2.4 2.4 2 .5 2.6 2.0 2.5 2.2 2.8 2.8 2.6 3.1 2.8 2.7 2.9 2.7 2 .5 2.8 2.6 3.0 2 .5 2.7 2.7 2.7 2.7 2 .9 2 .8 2.6 2 .9
Day 3 8
2.0 2.0 2.0 2.0 2.1 2.4 2.2 1.8 1.8 1.9 1.9 1.5 1.9 1.7 2.1 2.1 2.0 2.3 2.1 2 .1 2.2 2.0 1.9 2 .1 2.0 2.2 1.9 2.0 2.0 2.0 2 .1 2.2 2 .1 2.0 2.2
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 4 0
Day 41
Day 42
2.0 2.0 2.0 2.0 2 .1 2.4 2.2 1.8 1.8 1.9 1.9 1.5 1.9 1.7 2 .1 2.1 2.0 2.3 2.1 2 .1 2.2 2.0 1.9 2 .1 2.0 2.2 1.9 2 .0 2 .0 2 .0 2 .1 2.2 2 .1 2 .0 2.2
2.0 2.0 2 .0 2.0 2 .1 2.4 2.2 1.8 1.8
1-9 . 1.9 1 .5 1.9 1.7 2.1 2.1 2.0 2.3 2.1 2.1 2.2 2 .0 1.9 2 .1 2.0 2.2 1.9 2.0 2 .0 2.0 2 .1 2.2 2.1 2.0 2.2
2.0 2.0 2.0 2.0 2 .1 2.4 2.2 1.8 1.8 1.9 1 .9 1.5 1.9 1.7 2.1 2.1 2.0 2.3 2 .1 2.1 2.2 2.0 1.9 2.1 2.0 2.2 1.9 2 .0 2 .0 2.0 2 .1 2.2 2 .1 2 .0 2.2
2.1 2.0 2.0 2 .1 2 .1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2 .1 2.1 2.2 2 .1 2.0 2 .1 2.0 2.3 2.0 2 .1 2 .1 2 .1 2.1 2 .3 2 .2 2 .0 2.3
Day 43
2.1 2.0 2.0 2.1 2 .1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2 .0 1.9 2.3 2.2 2.1 2.4 2 .1 2.1 2.2 2.1 2 .0 2 .1 2 .0 2.3 2.0 2 .1 2 .1 2 .1 2.1 2.3 2.2 2 .0 2.3
Day 44
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2 .1 2 .0 2.3 2.0 2 .1 2 .1 2.1 2.1 2.3 2 .2 2.0 2.3
DuPont-5386
Day 45
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2 .1 2.0 2.3 2 .0 2.1 2.1 2.1 2.1 2.3 2 .2 2 .0 2.3
lompany Sanitized. Does not contain TSC A CBl
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 46
Day 47
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9
1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2 .1 2.2 2.1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2.1 2.1 2.3 2 .2 2.0 2.3
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2 .1 2 .1 2.2 2.1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2 .1 2 .1 2.3 2 .2 2 .0 2.3
Day 48
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2 .1 2 .1 2.3 2 .2 2 .0 2.3
INDIVIDUAL DOSE VOLUMES
Day 49
Day 50
Day 51
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2 .1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2 .1 2.2 2.2 2.3 2.3 2 .1 2.3
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2.1 2 .3
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2 .1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2.1 2.4 2 .1 2.2 2 .1 2.2 2.2 2.3 2 .3 2.1 2.3
555
)
(m L )
52
Day 53
Day 54
DuPont-5386
Day 55
2.1 2.1 2.0 2 .1 2.2 2.4 2.2 1.9 1 .9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3 2.3 2.2 2.0 2 .3 2.1 2.4 2.1 2.2 2 .1 2.2 2.2 2.3 2 .3 2.1 2 .3
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1 .9 2.0 1.7 2.0 1.9 2.3 2.2 2 .1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2 .1 2.2 2.2 2.3 2 .3 2.1 2.3
2.1 2 .1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2 .1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2 .1 2.3
2 .1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3 2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2 .3 2.1 2.3
Company Sanitized. Does not contain TSCA CBI
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 56
Day 57
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.1 2.2 2.0 2.1 2.2
2.4 2.3 1.9 1.9
2.0 2.1
1.7
2.0
1.9
2.2
2.3
2.1
2.3
2.2
2.3 2.3
2.2 2.1
2.3
2.1
2.4
2 .1
2.3
2.2 2.2 2.2
2.4
2 .3 2.0
2.3
2.1 2.2 2.0 2.1 2.2
2.4
2 .3
1.9 1.9
2.0 2.1 1.7 2.0
1.9
2.2 2 .3 2.1
2.3
2.2
2.3 2.3
2.2 2.1
2.3
2 .1
2.4
2.1
2.3
2.2 2.2 2.2
2.4 2.3
2.0
2.3
Day 58
2.1 2.2 2.0 2.1 2.2
2.4 2.3 1.9 1.9
2.0 2.1 1.7 2.0
1.9
2.2
2.3
2 .1
2.3
2.2
2.3 2.3
2.2 2.1
2.3
2.1
2.4
2.1
2.3
2.2 2.2 2.2
2.4 2.3
2.0
2.3
INDIVIDUAL DOSE VOLUMES
Day 59
Day 60
Day 61
2.1 2.2 2.0 2.1 2.2
2.4 2.3 1.9 1.9
2.0 2.1
1.7
2.0 1.9 2.2
2.3
2.1
2.3
2.2 2.3
2.3
2.2 2.1 2 .3 2.1
2.4
2.1
2.3
2.2 2.2 2.2
2.4
2 .3 2.0
2.3
2.1 2 .2 2.0 2.1 2.2
2.4 2.3 1.9 1.9
2.0 2.1
1.7
2.0
1.9
2.2
2.3
2.1
2.3
2.2
2.3 2.3
2.2 2.1
2.3
2.1
2.4
2.1
2.3
2.2 2.2 2.2
2.4
2 .3 2.0
2.3
2.1 2.2 2.0 2.1 2.2
2.4
2 .3
1.9 1 .9
2.0 2.1
1.7
2.0
1.9
2.2
2.3
2.1
2.3
2.2
2.3
2 .3 2.2 2.1
2.3
2.1
2.4
2.1
2.3
2.2 2.2 2.2
2.4
2.3 2.0
2.3
556
I
(mL)
62
Day 63
Day 64
DuPont-5386
Day 65
2.1 2.2 2.0 2.1 2.2
2.4 2.3 1.9 1.9
2.0 2 .1
1.7
2.0
1.9
2.2
2.3
2.1
2.3
2.2
2.3 2.3
2.2 2.1
2.3
2.1
2.4
2.1
2.3
2.2 2.2 2.2
2.4
2.3 2.0 2.3
2.2 2.2 2.0 2.2 2.2
2.5 2.3
2.0 2.0 2.1 2.1 1.8 2.1
1.9 2.3 2.3
2.2
2.4
2.2
2.3 2.3
2.2 2.0
2.4
2.1
2.5
2.1
2.3
2.1
2.3
2.1
2.4 2.3
2.1
2.4
2.2 2.2 2.0 2.2 2.2
2.5
2 .3 2.0 2.0 2.1 2.1 1.8 2.1
1.9 2.3 2.3
2.2
2.4
2.2
2.3 2.3
2.2 2.0
2.4
2.1
2.5
2.1
2.3
2.1
2.3
2.1
2.4 2.3
2.1
2.4
2.2 2.2 2.0 2.2 2.2
2.5 2.3
2.0 2.0 2.1 2.1 1.8 2 .1
1.9 2.3 2.3
2.2
2.4
2.2
2.3 2.3
2.2 2.0
2.4
2.1 2.5 2.1
2.3
2.1
2.3
2.1
2.4 2.3
2.1
2.4
Company Sanitized. Does not contain T S C A C B t
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 66
Day 67
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357
643331 643427 643470 643434 643349 643454 643333 643460
2.2 2.2 2.0 2.2 2.2
2.5 2.3
2.0 2.0 2.1 2.1 1.8 2.1
1.9 2.3 2.3
2.2
2.4
2.2
2.3 2.3
2.2 2 .0
2.4
2.1 2.5 2.1
2.3
2.1
2.3
2.1
2.4 2.3
2.1
2.4
2.2 2.2
2.0 2.2 2.2
2.5 2.3
2.0 2.0 2.1 2 .1 1.8 2.1 1.9
2.3 2.3
2.2
2.4
2.2 2 .3
2.3
2.2 2.0
2.4
2.1 2.5 2.1
2.3
2.1
2.3
2.1
2.4 2.3
2.1
2.4
Day 68
2.2 2.2 2.0 2.2 2.2 2.5
2.3
2.0 2.0 2.1 2.1 1.8 2.1
1.9 2.3 2.3
2.2
2.4
2.2 2 .3
2.3
2.2 2.0
2.4
2.1 2.5 2.1 2.3 2.1
2.3
2.1 2 .4
2.3
2.1
2.4
INDIVIDUAL DOSE VOLUMES
Day 69
Day 70
Day 7 1
2.2 2.2 2.0 2.2 2.2
2.5 2.3
2.0 2.0 2.1 2.1 1.8 2.1 1.9
2.3 2.3
2.2
2.4
2.2
2.3 2.3
2.2 2.0
2.4
2.1
2.5
2.1
2.3
2 .1 2 .3 2.1
2.4 2.3
2.1
2.4
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2
1.9
2.1 2.0
2.3 2.4
2.2
2.4
2.2
2 .4 2.4 2.3
2.1
2.5
2.1
2.4
2.2
2.4
2.2
2.3
2.1
2.4 2.4
2.1
2.4
2.2 2 .3 2.0
2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2
1.9
2.1 2.0
2.3 2.4
2.2
2.4
2.2
2.4 2.4 2.3
2 .1 2.5 2 .1
2.4
2 .2
2.4
2 .2
2.3
2.1
2.4 2.4
2.1
2.4
557
)
(mL) 72
Day 73
Day 74
DuPont-5386
Day 7 5
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2
1.9
2.1 2.0
2.3 2.4
2.2
2.4
2.2
2.4 2.4 2.3
2 .1 2.5 2.1
2.4
2.2
2.4
2 .2
2.3
2.1
2.4 2.4
2.1
2.4
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2 . 12.0 2.2 2.2
1.9
2.1 2.0
2.3 2.4
2.2
2.4
2.2
2.4 2.4 2.3
2.1 2.5 2.1
2.4
2.2
2.4
2.2
2.3
2.1
2.4 2.4
2.1
2.4
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2
1.9
2.1 2.0
2.3 2.4
2.2
2.4
2.2
2.4 2.4 2.3
2.1
2.5
2.1
2.4
2.2
2.4
2.2
2.3
2.1
2.4 2.4
2.1
2.4
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2 1.9 2.1 2.0
2.3
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 76
Day 77
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 6 4 34 /0 643434 643349 643454 643333 643460
2.2
2.3
2.0
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2
1.9
2.1 2.0
2.3
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2
1.9
2.1 2.0
2.4
Day 78
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.1 2 .0 2.2 2.2 1.9 2 .1 2.0
2.4
INDIVIDUAL DOSE VOLUMES (mL)
Day 79
Day 80
Day 81
Day 82
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.0 1.9 2.1 2.0
2.4
2.2
2.4
2 .1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 b 2.2
1.9
2 .1 2.0
2.4
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2
1.9
2.1 2.0
2.4
2.2 2.4 2.1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2
1.9
2.1 2.0
2.4
Day 83
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2
1.9
2.1 2.0
2.4
Day 84
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0
2.2
2.3 1.9
2.2 2.0
2.3
DuPont-5386
Day 85
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0
2.2
2.3 1.9
2.2 2.0
2.3
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 86
Day 87
Female, VI - 1 0 0 mg/ kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0 2.2
2.3 1.9
2.2 2.0
2.3
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0 2.2
2.3 1.9
2.2 2.0
2.3
Day 88
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0 2.2
2.3 1.9
2.2 2.0
2.3
INDIVIDUAL DOSE VOLUMES (mL)
Day 89
Day 90
Day 91
Day 92
2.2
2.4
2.1
2.3
2.3
2.4 2.4
2.0 2.0 2.2
2.3 1.9
2.2 2.0
2.3
2.2
2.4
2.1
2.3 2.3 2.4 2.4
2.0 2.0 2.2
2 .2
2.4
2.1
2.3 2.4
2.5
2.4
2.1 2.0 2.1
2.2
2.4
2.1
2.3 2.4 2.5 2.4
2.1 2.0 2.1
DuPont-5386
Company Sanitized. Does not contain TSCA CBI
))
H-24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Day 2
Female, VIII - 2 5 0 mg/ kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
1.9
2.0 2.0 1.8
1.7 1.7
1.7 1.9 1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9 1.9
2.0 2.1 2.1 2.0
1.7 1.9
2.2 2.0
1.9
1.8 2.1
1.9
1.8
1.9 1.9
2.0
1.7 1.9 1.7
1.9
2.0 2.0 1.8 1.7
1.7 1.7 1.9
1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9
1.9 2.0 2.1 2.1 2.0
1.7
1 .9 2.2 2.0
1.9
1.8 2 .1 1.9 1.8
1.9 1.9
2.0
1.7
1.9
1.7
1.9
2.0 2.0 1.8
1.7 1.7 1.7 1.9
1.8 2.0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9
1.9 2.0 2.1 2.1 2.0
1.7 1.9
2.2 2.0
1.9
1.8 2.1 1.9 1.8
1.9 1.9
2.0 1.7 1.9 1.7
Day 3
1.9
2.0 2.0 1.8
1.7 1.7 1.7 1.9
1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9
1.9 2.0 2.1 2.1 2.0
1.7 1.9
2.2 2.0
1.9
1.8 2.1
1.9
1.8
1.9
1.9 2.0
1.7 1.9 1.7
INDIVIDUAL DOSE VOLUMI
Day 4
Day 5
Day 6
1.9
2.0 2.0 1.8
1.7 1.7 1.7 1.9
1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9
1.9 2.0 2.1 2.1 2.0
1.7 1.9
2.2 2.0
1.9
1.8 2.1
1.9
1.8
1.9 1.9
2.0
1.7
1.9
1.7
1.9
2.0 2.0 1.8
1.7 1.7 1.7 1.9
1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9 1.9
2.0 2.1 2.1 2.0
1.7 1.9
2.2 2.0
1.9
1.8 2.1 1.9 1.8
1.9 1.9
2.0
1.7
1.9 1.7
1.9
2.0 2.0 1.8
1.7
1.7 1.7
1.9
1.8 2.0
1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8
1.9 1.9
2.0 2.1 2.1 2.0
1.7
1.9 2.2 2.0 1.9 1.8 2.1 1.9 1.8
1.9
1.9 2.0
1.7 1.9 1.7
560
I
2S (mL)
Day 7
Day 8
Day 9
2.1
2.4
2.2 2.0
1.9 1.9 1.9
2.1 2.1 2.1
1.9 2.2
2.1
1.9 2.5 2.3 2.0 2.5
2.1 2.2
2.3 2.0 2.3
2.0 2 .2 2.2
2.3 2.5 2.5 2.3 2.0
2.2
2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9
2.2
1.9
2.1
2.4
2.2 2.0
1.9 1.9
1.9 2.1 2.1 2.1
1.9
2.2 2.1
1.9 2.5 2.3
2.0
2.5
2.1 2.2
2.3
2.0
2.3
2.0 2.2 2.2
2.3
2.5 2.5 2 .3 2.0 2.2
2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3
1.9 2.2
1.9
2.1
2.4
2.2 2.0
1.9 1.9 1.9
2.1 2.1 2.1
1.9
2.2 2.1
1.9 2.5 2.3
2.0
2.5
2.1 2.2
2.3
2.0
2.3
2.0 2.2 2.2
2.3 2.5 2.5 2.3
2.0 2.2
2.4 2.3
2.1 2.0
2.5
2.1 2.0 2.1 2 .2
2.3 1.9
2.2
1.9
DuPont-5386
10 Day 1 1
2.1
2.4
2.2 2.0
1.9 1.9 1.9
2.1 2.1 2.1
1.9
2.2 2.1
1.9 2.5 2.3
2.0
2.5
2.1 2.2
2.3
2.0
2.3
2.0 2.2 2.2
2.3 2.5
2.5
2.3
2.0 2.2
2.4 2.3
2.1 2.0
2.5
2.1
2.0 2.1
2.2
2.3 1.9
2.2
1.9
2.1
2.4
2.2 2.0
1.9 1.9 1.9
2 .1 2.1 2.1 1 .9 2.2 2.1
1.9 2.5 2.3
2.0 2.5 2.1 2.2 2 .3 2.0
2.3
2.0 2.2 2.2
2.3 2.5
2.5
2.3
2.0 2.2
2.4 2.3
2.1 2.0 2 .5 2.1 2.0 2.1 2.2
2.3 1.9
2.2
1.9
Company Sanitized. Does not contain TSC A CBf
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12
Day 13
Day 14
Female, VIII - 2 5 0 mg/ kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1
2.4
2.2 2.0
1.9 1.9
1.9 2.1 2.1 2.1
1.9
2.2 2.1
1.9 2.5 2.3
2.0 2.5 2.1 2.2
2.3
2.0
2.3
2.0 2.2 2.2
2 .3 2.5
2.5
2.3
2.0 2.2 2 .4
2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9
2.2 1.9
2.1
2.4
2.2 2.0
1.9 1.9 1.9
2.1 2.1 2.1
1.9
2.2 2.1
1.9
2.5
2.3
2.0
2.5
2.1 2.2
2.3
2.0
2.3
2.0 2.2 2.2
2.3 2 .5
2.5
2.3
2.0 2.2
2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3
1.9 2.2
1.9
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1 2 .4 2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3
2.4 2.2 2.6 2.2
2.4 2.3
2.5 2 .7 2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3 2.3 2.3 2.4
2 .4 2.2
2.4
2.2
Day 15
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3 2.5
2.7 2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3
2.3
2.3
2.4
2.4
2 .2
2.4
2.2
INDIVIDUAL DOSE VOLUM:
Day 16
Day 17
Day 18
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3
2 .5
2.7
2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3 2.3 2.3
2.4
2.4
2.2
2.4
2.2
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3
2.5
2.7
2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3 2.3 2.3 2.4 2.4
2 .2
2.4
2.2
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3
2.5
2.7
2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3 2.3 2.3 2.4 2.4
2.2
2.4
2.2
561
ES (mL) Day 1 9
Day 2 0
Day 21
Day 2 2
DuPont-5386
Day 23
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3
2.5
2.7
2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3 2.3 2.3 2.4 2.4
2.2
2.4
2.2
2.3
2.6
2.5
2.2 2.2 2.0 2.1
2.4 2.4 2.4
2.1
2.4
2.2 2.0
2.7 2.4
2.1 2.8 2.2
2.3 2.4
2.2 2.6 2.2
2.4 2.3
2 .5
2.7
2.8 2.6 2.2
2.3
2.8 2.6
2.3
2.2
2.7 2.3
2 .3
2.3
2.4
2.4
2.2
2.4
2.2
2.4 2.9
2.6 2.2
2.3 2.3 2.3
2.6
2.5 2.5 2.3
2 .5
2.3
2.2
2.9 2.5 2.3 3.0 2.4 2.5
2.6
2.4
2.8
2.4
2.6
2.4
2 .6
2.9
2.9
2.7 2.4 2.5 2.9
2 .7
2.5
2.2
2.9 2.3 2.4 2.4
2 .5 2.6 2 .2 2 .6
2.3
2.4 2.9
2.6 2.2
2.3 2.3 2.3
2.6
2.5 2.5 2.3 2.5 2.3
2.2
2.9 2.5 2.3 3.0 2,4 2.5
2.6
2.4
2.8
2.4
2.6
2.4
2 .6
2.9
2.9
2.7 2.4 2.5 2.9 2.7 2.5
2.2
2.9 2.3 2.4 2.4
2 .5 2.6 2.2 2.6
2.3
2.4 2.9
2.6 2.2
2.3 2.3 2.3
2.6
2.5
2.5
2.3 2.5 2.3
2.2
2.9 2.5 2.3 3.0 2.4 2.5
2.6
2.4
2.8
2.4
2.6
2.4
2.6
2.9 2.9 2 .7 2.4 2 .5
2.9
2.7 2.5
2.2
2.9
2 .3
2.4 2.4
2.5 2.6 2.2 2.6
2.3
Company Sanitized. Does not contain TSCA CB!
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24
Day 25
Day 2 6
Female, VIII - 2 5 0 m g / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.4 2.9
2.6 2.2
2.3 2.3 2.3
2.6
2.5 2.5 2.3
2.5
2.3
2.2
2.9 2.5 2.3 3.0 2.4 2.5
2.6
2.4
2.8
2.4
2.6
2.4
2.6
2.9
2 .9
2.7 2.4
2.5 2.9
2.7 2.5
2.2 2 .9
2.3 2.4 2.4 2.5
2.6 2.2 2.6
2.3
2.4 2.9
2.6 2.2
2.3 2.3 2.3
2.6
2.5 2.5 2.3
2.5
2.3
2.2 2.9
2.5 2.3 3.0 2.4
2.5 2.6
2.4
2.8
2.4
2.6
2.4
2.6
2.9
2 .9
2.7 2.4
2.5
2.9 2.7 2.5
2.2 2 .9
2.3 2.4 2.4 2.5
2.6 2.2 2.6
2.3
2.4
2.9 2.6 2.2
2.3 2.3 2.3
2.6 2.5
2 .5 2.3
2.5 2 .3 2.2
2.9 2.5 2.3 3.0 2.4
2.5 2.6
2.4
2.8
2.4
2.6
2.4
2.6
2.9 2.9 2.7 2.4
2.5 2 .9 2 .7 2 .5 2.2 2 .9
2.3 2.4 2.4 2.5
2.6 2.2 2.6
2.3
Day 27
2.4
2 .9 2.6 2.2
2.3 2.3 2.3
2.6
2.5
2.5
2.3
2.5
2.3
2.2 2.9
2.5 2.3 3.0 2.4
2.5 2.6 2.4 2.8
2.4
2.6
2.4
2.6 2.9
2.9 2.7 2.4 2.5 2.9 2.7 2.5
2.2 2.9
2.3 2.4 2.4
2.5 2.6 2.2 2.6 2.3
INDIVIDUAL DOSE VOLUMI
Day 28
Day 2 9
Day 30
2.5 2.9
2.7
2.3
2.5
2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7
2.5
3.1 2.5 2.7
2.8
2.5
2.9 2.5
2.7
2.6 2.8 3 .1
3 .1
2.8
2.5
2.5 3 .0
2.9 2.5 2.3
2 .9
2.5
2.5
2.4
2.6 2.8
2.3 2.7
2.5
2.5 2.9 2.7 2.3
2.5
2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7
2.8
2.5
2 .9 2.5 2 .7 2.6 2.8 3 .1
3.1
2.8 2.5 2 .5
3.0 2.9 2.5 2.3
2 .9
2.5
2.5
2.4
2.6 2.8
2.3 2.7 2.5
2.5
2.9 2.7 2.3
2.5
2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2.5 3.1
2.5
2.7
2.8
2.5 2.9
2.5
2.7
2.6 2.8 3 .1 3 .1 2.8 2.5 2.5
0
2.9 2.5 2.3
2.9
2.5 2.5 2.4
2.6 2 .8
2.3 2.7
2.5
562
:S (mL)
31
Day 3 2
Day 33
Day 3 4
DuPont-5386
Day 3 5
2.5 2.9 2.7 2.3
2.5 2.3
2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2.5 3.1 2.5
2.7 2.8 2.5 2.9
2.5
2.7 2.6 2.8 3 .1 3 .1 2.8
2 .5 2.5 30
2 .9 2.5 2.3
2.9 2 .5
2.5
2.4
2.6 2.8
2.3
2 .7
2.5
2.5
2.9 2.7 2.3
2.5
2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7
2.8
2.5 2.9
2.5
2.7
2.6 2.8
3.1
3 .1 2.8 2.5
2.5 3.0
2.9 2.5
2.3 2.9 2 .5 2.5 2.4
2.6 2.8
2.3 2.7 2.5
2.5 2.9
2.7 2.3
2.5
2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7
2.8 2.5 2.9
2.5 2.7
2.6 2.8 3 .1 3 .1 2.8
2 .5
2.5
3 .0 2.9 2.5 2.3 2.9
2.5
2.5 2.4
2.6 2.8
2.3 2.7 2.5
2.5
2.9 2.7 2.3 2.5 2.3 2.4 2.7
2.8
2.7 2.4
2.6
2.4 2.4 3.0 2.7 2 .5 3 .1 2.5 2.7
2.8 2.5
2.9 2 .5 2.7
2 .6 2.8 3 .1 3 .1 2.8
2.5
2.5
3.0
2.9 2.5
2.3
2 .9
2.5 2.5 2.4
2.6 2.8
2.3 2.7
2.5
2.7 3.2
2.8
2.4
2.6
2.5
2.6
2.7
2 .9 2.8
2.5
2.6 2.6
2.4 3.1
2.8
2.5 3.1
2.6 2.8
3.0
2.6
3.0
2.6
2.9 2.7 2.9 3.2 3.3 3.0
2.6 2.8 3 .1
3.0
2.6
2.4
3 .1 2.6
2.5 2.5 2.7
2.8
2.4
2.8
2.5
Company Sanitized. Does not contain TSC A CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 3 6
Day 37
Day 3 8
Female, VIII - 2 5 0 m g / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.7 3.2
2.8
2.4
2.6 2.5 2.6
2.7
2.9 2.8 2.5 2.6 2.6
2.4
3 .1 2.8 2.5
3.1
2 .6 2 .8 3 .0 2.6 3 .0 2.6
2.9 2.7 2.9 3.2 3.3 3.0
2.6 2.8 3 .1 3 .0 2.6
2.4
3 .1 2.6 2.5
2.5 2.7
2 .8
2.4
2.8
2.5
2.7 3.2
2.8
2.4
2.6
2.5
2.6
2.7
2.9 2.8
2.5
2.6 2.6
2.4 3.1
2 .8
2 .5
3 .1 2.6 2.8
3.0
2.6
3 .0
2.6
2.9 2.7
2.9
3.2 3.3 3.0
2.6 2.8 T1
3.0
2.6
2.4
3 .1 2.6 2.5 2.5
2.7
2 .8
2.4
2.8 2.5
2.0
2.4
2.1 1.8 1.9
1.9 1.9
2.0 2.2 2.1
1.9
2.0
1.9
1.8
2.3
2.1
1.9 2.4 1.9
2.1 2.2 2.0 2.2
1.9
2.2 2.0 2.2
2.4 2.4 2.3
1.9 2.1
2.3
2.2 2.0 1.8
2.3 1.9 1.9 1.9
2.0 2.1 1.8 2.1
1.9
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 4 1
Day 42
2.0
2.4
2.1 1.8
1.9 1.9
1.9 2.0 2 .2 2.1
1.9
2 .0
1.9
1.8
2.3
2.1 1.9
2.4 1.9
2.1 2.2 2.0 2.2
1.9
2.2 2.0 2 .2
2.4 2.4 2.3
1.9 2.1
2.3
2.2 2.0 1.8
2.3
1.9
1.9
1.9 2.0 2.1 1.8 2 .1
1.9
2.0
2.4
2.1 1.8
1.9 1.9 1.9
2.0 2.2 2.1
1.9
2.0
1.9
1.8
2.3
2.1
1.9 2.4 1.9
2.1 2.2 2 .0 2.2
1.9
2.2 2.0 2.2
2.4 2.4 2.3 1.9
2.1
2.3
2.2 2.0 1.8 2 .3
1.9 1.9 1.9
2.0 2 .1 1.8 2.1
1.9
2.0
2.4
2.1 1.8 1.9
1.9 1.9
2.0 2.2 2.1
1.9
2.0
1.9
1.8
2.3
2 .1
1.9 2.4 1.9
2.1 2.2 2.0 2.2
1.9
2.2
2.0 2.2
2.4 2.4 2.3 1.9
2.1 2.3 2.2 2.0 1.8 2.3
1.9 1.9 1.9
2.0 2 .1 1.8 2.1 1.9
2.1
2.5
2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4 2.5 2.3
2.0 2.1 2 .4
2.3
2.0
1.9 2.4
2.0 2.0
1.9
2.1
2.3 1.9
2.2 2.0
Day 43
2.1 2.5 2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4 2.5 2.3
2.0 2.1 2 .4 2.3 2.0
1.9 2.4
2.0 2.0
1.9
2.1 2 .3
1.9
2.2 2.0
Day 44
2.1 2.5 2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4 2.5 2.3
2.0 2.1 2 .4
2.3
2.0
1.9 2.4
2.0 2.0
1.9
2.1
2.3 1.9
2.2 2.0
DuPont-5386
Day 4 5
2.1
2.5
2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4
2 .5
2.3
2.0 2.1 2 .4 2.3 2.0
1.9 2.4
2.0 2.0
1.9
2.1
2.3 1.9
2.2 2.0
Company Sanitized. Does not contain TSCA CBI 563
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 46
Day 47
Female, VIII - 2 5 0 m g / kg/day
643341 643370
643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467
643443 643417 643413 643338 643335 643468 643440 643430 643431
643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1
2.5
2.2 1.9 2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4 2.5 2.3
2.0 2.1 2. 4
2.3
2.0
1.9 2.4
2.0 2.0
1.9
2.1
2.3 1.9
2.2 2.0
2.1
2.5
2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2.0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4
2.5
2.3
2.0 2.1 2 .4
2.3
2.0 1. 9
2.4
2.0 2.0
1.9
2.1
2.3 1.9
2.2 2.0
ay 48
2.1
2.5
2.2
1.9
2.1 2.0 2.0 2.1 2.2 2.1
1.9
2.0 2.1
1.9 2.4
2.2 2.0
2.4
2. 0 2.1
2.3
2.0
2.3 1.9 2.3
2.1 2.2
2.4 2.5 2.3
2.0 2.1
2.4 2.3
2.0
1.9 2.4
2.0 2.0 1. 9 2.1
2.3 1.9
2.2 2.0
INDIVIDUAL DOSE VOLUMES
Day 49
Day 50
Day 51
2.1
2.5
2.2
1.9
2.0 2.0 2.0 2.1
2.3
2.2 2.0 2.1 2.2 1.8
2.4
2.1 2.0 2. 5 2.0 2.2
2.4
2.1
2.4
2.1
2.4 1.7
2.2
2.5
2.5
2.3
2.0 2.2
O1 . *A3 2.4
2. 1 1. 9 2.2 1. 6 2. 0
1.9
2. 2
2.3
1. 9 2. 3 2.0
2.1
2.5
2.2
1.9
2.0 2.0 2.0 2.1
2.3
2.2 ' 2.0
2.1 2.2 1.8
2.4
2.1 2.0
2.5
2. 0 2.2
2.4
2.1
2.4
2.1
2.4 1.7
2.2 2.5
2.5 2.3
2. 0 2.2
2.4 2.4
2.1
1.9
2.2 1.6 2.0
1.9
2.2
2.3 1.9 2.3
2.0
2.1
2.5
2.2
1.9
2.0 2.0 2.0 2.1
2.3
2.2 2.0 2.1 2.2 1.8
2.4
2. 1 2.0
2.5
2.0 2.2
2.4
2.1
2.4
2.1
2.4 1.7
2.2
2.5
2.5
2.3
2.0 2.2 2. 4
2.4
2. 1 1. 9 2.2
1.6 2.0
1.9
2.2
2.3 1.9 2.3
2.0
564
)
(mL)
Day 52
Day 53
Day 54
DuPont-5386
Day 55
2.1
2 .5
2.2
1.9
2.0 2.0 2.0 2.1
2.3
2.2 2.0 2.1 2.2 1.8
2.4
2.1 2.0
2.5
2.0 2.2
2.4
2.1
2.4
2.1
2.4 1.7
2.2
2.5 2.5 2.3
2.0 2.2
2.4 2.4
2.1
1.9
2.2 1.6 2.0
1.9
2.2
2.3 1.9 2.3
2.0
2.1 2.1
2.5 2.5
2.2 2.2
1.9 1.9
2 .0
2.0
2.0 2.0
2.0 2.0
2.1 2.1
2.3 2.3
2.2 2.2
2.0 2.0
2.1
2.1
2.2 2.2
1.8 1.8
2.4 2.4
2 .1
2.1
2.0 2.0
2.5 2.5
2.0 2.0
2.2 2.2
2.4 2.4
2.1 2.1
2.4 2.4
2 .1
2.1
2.4 2.4
AK TEST DAY 53
2.2 2.2
2 .5 2.5
2.5 2.5
2.3 2.3
2.0 2.0
2.2 2.2
2.4 2.4
2.4 2.4
2.1 2 . 1
1.9
1.9
2.2 2.2
1.6 1.6
2.0
2 .0
1.9 1.9
2.2 2.2
2.3 2.3
1.9 1.9
2.3 2.3
2.0 2.0
2.1 2.5 2.2
1.9
2.0 2.0 2.0 2.1
2.3
2.2 2.0 2.1 2.2 1.8
2.4
2.1 2.0
2.5
2.0 2.2
2.4
2.1
2.4
2.1
2.4
2.2
2.5
2.5
2.3
2.0 2.2
2.4 2.4
2.1
1.9
2.2 1.6 2.0
1.9
2.2
2.3 1.9
2.3 2.0
Company Sanitized. Does not contain TS C A CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 56
Day 57
Female, VIII - 2 5 0 m g / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1 2.5
2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1 1.3
2.5
2.1 2.0 2 .5 2.0 2.2
2.4
2.0 2.2 2.0
2.4
2 .2 2.5 2.5 2.2 2.0 2.2 2 .4
2.3
2.1
1.9
1.8 1.7 1.8
1.9
2.1
2.3 1.9
2.2 2 .0
2.1
2.5 2.3 1.9
2.2 1.9 2.0 2.1
2.3 2.3
2.0 2.1 2.1 1.3 2.5 2.1 2.0
2.5
2.0 2.2
2.4
2.0 2.2 2.0
2.4
2 .2 2.5
2.5
2.2 2.0 2.2 2.4
2.3
2.1
1.9
1.8
1.7
1.8
1.9
2.1
2.3 1.9
2.2 2.0
Day 58
2.1 2.5
2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1
1.3 2.5
2.1 2.0 2.5 2.0 2.2
2.4
2.0 2.2 2.0 2 .4
2.2 2.5 2.5 2.2 2.0 2.2 2.4
2.3
2.1
1.9
1.8
1.7
1.8
1.9
2.1
2.3
1.9 2.2 2.0
INDIVIDUAL DOSE VOLUMES
Day 59
Day 60
Day 61
2.1
2.5 2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1
1.3
2.5 2.1 2.0
2.5
2.0 2.2
2.4
2.0 2.2 2.0
2.4
2.2
2.5 2.5
2.2 2.0 2.2
2.4 2.3
2.1 1.9 1.8 1.7 1.8
1.9
2.1
2.3 1.9
2 .2 2.0
2.1 2.5
2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1
1.3 2.5
2.1 2.0
2 .5
2.0 2.2
2.4
2.0 2.2 2.0
2.4
2.2 2.5
2.5
2.2 2.0 2.2
2.4 2.3
2.1
1.9
1.8 1.7 1.8
1.9
2 .1
2.3 1.9
2.2 2.0
2.1 2.5
2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1
1.3
2.5 2.1 2.0
2 .5
2.0 2.2
2.4
2.0 2.2 2.0
2.4
2.2 2.5
2.5
2.2 2.0 2.2
2.4 2.3
2.1
1.9
1.8
1.7
1.8
1.9
2.1
2.3 1.9
2.2 2.0
565
(mL) 62
Day 63
Day 64
DuPont-5386
Day 65
2.1 2.5
2.3 1.9
2.2
1.9
2.0 2.1
2.3 2.3
2.0 2.1 2.1
1.3
2.5 2.1 2.0
2.5
2.0 2.2
2.4
2.0 2.2 2.0
2.4
2.2
2 .5 2.5
2.2 2.0 2.2 2 .4
2.3
2.1
1.9
1.8 1.7 1.8
1.9
2.1
2.3 1.9
2 .2 2.0
2.1
2.3 2.3 1.9
2.1
1.9
2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8
2.5
2.1 2.0
2.4
2.1 2.2
2.3
2.0 1.8 2.0 2.5
1.9 2.5 2.5
2.1
1.9 2.3 2.4 2.3
2.1 2.0
2.3 1.9
2.0 1.6 2.2 2.0 1.9 2.0 2.0
2.1
2.3 2.3 1.9
2.1
1.9
2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8
2.5
2.1 2.0
2.4
2.1 2.2
2.3
2.0 1.8 2.0
2.5
1.9 2.5 2.5
2 .1
1.9 2.3 2.4 2.3
2.1 2.0
2.3 1.9
2 .0 1.6 2.2 2 .0 1.9 2.0 2.0
2.1
2.3 2.3 1.9
2.1
1.9
2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8
2 .5
2.1 2.0
2 .4
2.1 2.2
2.3
2.0 1.8 2.0
2.5
1 .9 2 .5 2.5
2 .1
1.9 2.3 2.4 2.3
2.1 2.0
2.3
1.9 2.0 1 .6 2.2 2.0 1.9 2.0 2.0
Company Sanitized. Does not contain TSCA CBI
1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 66
Day 67
Female, VIII - 2 5 0 mg / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1
2.3
2 .3
1.9
2.1
1.9
2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8
2.5
2.1 2.0
2.4
2.1 2.2
2.3
2.0 1.8 2.0
2.5
1.9
2.5 2.5 2.1
1.9
2 .3
2.4 2 .3
2.1 2.0
2.3 1.9
2.0 1.6 2 .2 2.0
1.9
2 .0 2.0
2.1
2.3 2.3 1.9
2.1 1.9 2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8 2.5 2.1 2.0 2 .4 2.1 2.2
2.3
2.0 1.8 2.0 2.5
1.9
2.5
2.5
2.1
1.9
2 .3 2.4 2 .3 2.1 2.0
2.3 1.9
2.0 1.6 2.2 2.0 1.9 2.0 2.0
Day 68
2.1
2.3 2.3 1.9
2.1
1.9
2.0 2.0
2.4
2.1 2.0 2.2 2.2 1.8 2.5 2.1 2.0
2.4
2.1 2.2
2.3
2.0 1.8 2.0 2.5
1.9
2.5 2.5 2.1 1.9
2.3 2.4
2 .3 2.1 2.0
2.3
1.9 2.0 1.6 2.2 2.0 1.9 2.0 2.0
INDIVIDUAL DOSE VOLUMES
Day 69
Day 7 0
Day 71
2.1 2.1
2 . 3 2.2
2.3 2.3
1.9 1.9
2.1 2.2
1 . 9 2.0
2.0 2.1
2.0 2.1
2.4 2.4
FD TEST DAY 69
2.0
1.9
2.2 2.2
2.2 2.2
1.8 1 . 9
2 . 5 2.6
2.1 1 . 7
2.0 1 . 9
2.4 2.4
2.1 2.1
2.2 2.2
2 . 3 2.2
2.0
1.5
1.8 1 . 5
2.0
1.7
2 . 5 2.1
1.9
2.5 2.5 2.1
1.9 2.3 2.4 2.3
2.1 2.0 2 .3
1.9
2.0 1.6 2.2 2.0
1.9
2.0 2.0
2.2
2.4 2.4
2.2 2.0 2 .4
2.5
2.1 2.0 2.0
2.4 1.9
2.0 2.0 2.2 2.0 2.0 2.2 2.1
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4
1.9
2.2 2.2
1.9
2.6
1.7 1.9 2.4
2.1 2.2 2.2 1.5
1.5 1.7
2.1
2.2
2.4 2.4
2.2 2.0
2.4
2.5 2.1 2.0 2.0
2.4 1.9
2.0 2.0 2.2 2.0 2.0 2.2 2.1
566
(mL)
72
Day 73
Day 74
DuPont-5386
Day 75
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4
1.9
2.2 2.2
1.9
2.6
1.7 1.9 2.4
2.1 2.2 2.2
1.5 1.5 1.7
2.1
2.2
2.4 2.4
2.2 2.0 2 .4
2.5
2.1 2 .0 2.0
2.4 1.9 2.0
2.0 2.2 2.0 2.0 2.2
2 .1
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4
1.9
2.2 2.2
1.9
2.6
1.7
1.9
2.4
2.1 2.2
2.2 1.5
1.5
1.7
2.1
2.2
2.4 2.4
2.2 2.0
2.4
2.5 2.1 2.0 2.0
2.4 1.9
2.0 2.0
2.2
2.0 2.0 2.2 2.1
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4
1.9
2.2 2.2
1.9
2.6
1.7 1.9 2.4
2.1 2.2 2.2
1.5 1.5 1.7
2.1
2.2
2.4 2.4
2.2 2.0 2r 2.5 2.1 2.0 2.0
2.4 1.9
2.0 2.0 2.2 2.0 2.0
2.2
2.1
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4 1.9
2.2 2.2
1.9
2.6
2.0
2.4 1.9
2.0 2.0 2.2 2.0 2.0 2.2 2.1
Company Sanflized. Does no! contain TS C A CB1
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 7 6
Day 7 7
Female, VIII - 2 5 0 mg / kg/ day
643341 643370 643446 643435 643466 643332 643404
643408 643359 643340 643487
643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1 2.2
2.3 1.9
2.2 2.0 2.1 2.1
2.4
1.9
2.2 b 2.2
1.9
2.6
2.0 2.2
2.3 1.9
2.1 2.0 2.0 2.1 2.5
1.7
2.2
1.9
1.8 2.1
2.0 2.0
2.4 2.4
1.9
1.9
2.0 2.0
2.0 2 . 1
2.2 2.2
2.0 2 . 1
2.0 1.8
2.2 2 . 3
2.1 1 . 9
Day 7 8
2.0 2.2
2.3 1.9
2.1 2.0 2.0 2.1 2.5
1 .7
2.2
1.9
1.8 2.1
2.0
2.4 1.9
2.0 2.1 2.2 2.1 1.8
2.3 1.9
INDIVIDUAL DOSE VOLUMES
Day 7 9
Day 80
Day 81
2.0 2.2
2.3 1.9
2.1 2.0 2.0 2.1
2.5
1 .7
2.2
1.9
1.8 2 .1
2.0 2.2
2.3 1.9
2.1 2.0 2.0
2.1 2.5
1.7
2.2
1.9
1.8 2.1
2.0 2.2
2.3 1.9
2.1 2.0 2.0 2.1 2 .5
1.7
2.2
1 .9
1.8 2.1
2.0
2.4 1.9
2.0 2.1 2.2 2.1 1.8
2.3 1.9
2.0
2.4 1.9
2.0 2.1 2.2 2.1 1.8
2.3 1.9
2.0
2.4 1.9
2.0 2 .1 2.2 2.1 1.8
2.3 1.9
567
(m L )
82
Day 83
Day 84
DuPont-5386
Day 8 5
2.0 2.2
2.3 1.9
2.1 2.0 2.0 2.1
2.5
1.7
2.2
1.9
1.8 2.1
2.0 2.2
2.3 1.9
2.1 2.0 2.0
2.1
2.5
1.7
2.2
1.9
1.8 2.1
2.2
2.5 2.4 1.9
2.2 2.1 2.1
2.3 2.5
2.0
2.3 2.3
2.0
2.5
2.2 2.5
2.4 1.9
2.2 2.1 2.1
2.3 2.5
2 .0
2.3 2.3
2.0
2.5
2.0 2.0 2.0 2.0
2 . 4 2 . 4 2.6 2.6
1.9
1.9
2.1
2.1
2.0 2.0 2.2 2.2
2 . 1 2.1 2 . 1 2 . 1
2.2 2.2 2 . 3
2.3
2 . 1 2.1 2 . 3
2.3
1 . 8 1.8 2.0 2.0
2.3 2.3 2.5 2.5
1.9
1.9
2.1
2.1
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 86
Day 87
Female, VIII - 2 5 0 mg/ kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346
64344S
643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
2.2
2.5 2.4 1.9
2.2 2.1 2.1
2.3 2.5
2.0
2.3 2.3
2.0
2.5
2.0 2.6 2.1 2.2 2.1
2.3 2.3
2.0
2.5
2.1
2.2 2.5
2.4
1.9 2.2 2.1 2.1
2.3 2.5
2.0
2.3 2.3
2.0 2.5
2.0 2.6 2.1 2.2 2.1
2.3 2.3
2.0 2.5 2.1
Day 88
2.2
2.5 2.4 1.9
2.2 2.1 2.1
2.3 2 .5
2.0
2.3 2.3
2.0
2.5
2.0 2.6 2.1 2.2 2 .1
2.3 2.3
2 .0
2.5
2.1
INDIVIDUAL DOSE VOLUMES (mL)
Day 89
Day 90
Day 91
Day 92
2.2 2.2 2.2 2.2
2 . 5 2 . 5 2.6 2.6
2 . 4 2 . 4 2.2 2.2
1.9
1.9
1.9
1.9
2.2 2.2 2.2 2.2
2.1
2.1
2.1
2.1
2.1 2.1 2.0 2.0
2.3 2.3 2.3 2.3
2 . 5 2 . 5 2.6 2.6
2.0
2.3 2.3
2.0
2.5
2.0 2.6 2.1 2.2 2.1
2.3 2.3
2.0
2.5
2 .1
DuPont-5386 Company Sanitized. Does not contain TSCA CBt
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX C INDIVIDUAL BODY WEIGHTS
Company Sanitized. Does not contain TSCA CBI 569
H -24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS
EXPLANATORY NOTES
DuPont-5386
Critical Dates
D ay 7 4 jy|a]e an(j fema]e rats designated for reproduction evaluations were co-housed. Body weights collected during the cohabitation and post-mating periods are reported in the Reproductive Toxicology section.
Day 91 Male rats designated for the 90-day exposure period were sacrificed.
Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day o f non-fasted body weight data collection for rats designated for the one-month recovery
period. Day 125 Male and female rats designated for the one-month recovery period were sacrificed
Day 175 Last day o f non-fasted body weight data collection for rats designated for the 3-month recovery period.
Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
Abbreviations
AK Accidentally Killed FD Found Dead SE Sacrificed in extrem is
Company Sanitized. Does not contain TSCA GBI 570
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Male, I -- 0 mg/ kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
278.0 237.5 237.1 262.8 282.1 246.7 235.8 253.6 254.9 254.0 264.6 263.0 244.5 274.2 236.7 246.4 277.8 237.8 207.6 249.3 265.9 243.4 231.5 257.2 253.4 268.6 252.9 244.2 244.9 240.4 251.3 281.7 236.4 245.1 242.2 298.8 243.1 254.1 256.0 227.0
211.2
227.3 220.3 248.7 265.6
Day 7
347.0 296.9 291.5 313.3 345.3 311.5 290.4 323.7 320.6 304.8 321.1 309.7 292.8 336.3 291.4 296.4 341.8 282.6 255.6 300.5 311.9 285.4 279.3 317.0 306.4 335.4 315.7 307.5 295.6 294.8 313.7 352.7 277,9 290.7 300.1 357.6 297.0 311.4 315.6 286.3 261.4 284.3 268.7 291.4 322.1
Day 14
INDIVIDUAL BODY
Day 2 1
Day 28
4 0 9 .. 3
3 4 7 ..2 340 .0
3 5 6 .. 7
409 .6 3 6 1 .6
340 .4 383 .9
3 7 7 .6 3 5 0 ..2 3 7 7 ..0 338 .8 3 4 2 ..8
383 .7
3 4 3 ..2
3 4 5 .. 3 3 9 1 .5
3 1 6 .6
2 9 8 .. 9
3 4 7 ..8 3 5 9 .0 3 2 6 ..2
3 3 6 .. 3 3 8 2 .. 3
3 5 1 ..0
3 9 3 ,.3 3 6 4 .. 9
356 .2
3 5 0 .. 4
3 4 8 ..8
3 5 8 ..7 4 2 2 .,7
3 2 1 ,.0
3 3 6 .. 3
3 4 6 ..6
4 2 6 .. 4 3 5 2 .. 7
3 7 2 ..2
3 7 0 .. 4 3 4 3 ..9 3 0 3 ..5
3 3 1 .,6
3 0 5 .7
3 3 4 .6
3 7 0 .. 7
4 5 1 .2
392 .9 381 .3
4 0 9 .0 4 5 9 .2 4 1 3 .8
362 .3 431 .3 422 .4
392 .1
433 .9 381 .3 396 .9
429 .6 384 .1
382 .5 432 .3
352 .1 330 .0 392 .6
402 .9
3 5 9 .2
375 .5
4 2 5 .2
392 .3
4 4 3 .0
4 1 5 .. 5 401 .4 3 8 9 .. 9 3 8 9 .. 5
3 9 6 .. 8
4 6 6 .. 9
3 6 0 ..2
3 6 7 ,. 4 3 8 0 .. 9
4 6 7 ,.6 4 0 4 ..2
4 2 1 .. 4
4 2 6 ..6 3 8 9 ..2
3 3 8 ,, 4
3 6 5 ..0 3 3 4 ..2
3 6 9 .. 7
4 0 7 ..6
497 .6
423 .9 419 .4
447 .6
511 .4
459 .6 3 8 3 .1
468 .9
459 .8 4 2 7 .6
468 .7
396 .6
416 .7 464 .4 414 .4
4 1 2 .6 4 7 3 ..6
371 .3 351 .7 427 .3
434 .6 3 8 9 ..8 4 0 7 .6
4 7 0 .. 9 423 .7
4 8 2 ..2 4 4 5 ..2
4 3 4 .. 9 4 1 7 .. 9 4 1 5 .. 4
4 3 4 ..0
n5 0 2 .
3 9 0 .. 9
3 9 6 ..2 4 0 7 .. 6
5 0 1 ..7 4 3 1 ..4 4 5 2 ..5 4 6 3 .. 9 433 .7 3 7 0 ,, 3
3 9 1 .,1
3 6 6 ..5
3 9 7 .. 1 4 4 7 ..8
571
WEIGHTS (g)
Day 3 5
Day 42
Day 49
522.6 455.5 442.7 473.2 53 5 . 6 488.3 409.2 492.0 483.3 444.7 504.2 410.7 440.4 489.6 438.3 445.1 501.1 388.2 373.4 451.9 456.5 420.4 442.7 499.1 445.2 524.1 473.0 464.8 435.3 432.1 464.8 542.2 406.0 413.9 426.8 533.1 456.5 493.0 490.3 471.4 391.1 415.9 396.8 433.7 468.8
5 4 9 .7 483 .5
463 .6 504 .0
5 7 1 .7 514 .2 4 2 6 .9
5 2 0 .1
5 1 2 .9
4 7 1 .0 524 .6 428 .1
4 7 5 .7
5 2 2 .0
4 6 1 .4
4 5 9 .8 5 3 5 .2 410 .2
403 .1 4 8 0 .0 478 .7 434 .9
4 7 2 .2
5 3 1 .5 464 .3 548 .7 493 .2
4 9 7 .1 4 5 5 .0
4 5 4 .4 4 8 6 .7
5 6 5 .8
4 2 9 .5
4 4 0 .8 4 6 0 .0
562 .4
490.6
517 .7
5 1 6 .2 502 .6 418 .0
426.5
4 2 0 .8
4 5 9 .3 4 9 4 .1
571.4 501.2 474.5 517.2 584.1 521.8 430.0 515.9 515.0 492.5 545.3 450.8 489.4 542.2 474.4 481.2 555.9 422.3 412.5 493.7 506.2 455.5 489.0 558.3 488.8 574.8 514.0 525.7 478.1 490.8 502.6 600.1 446.6 474.4 479.3 577.3 510.1 543.6 534.6 531.3 436.4 436.8 437.4 481.9 500.7
DuPont-5386
Day 56
589.6 530.7 492.2 538.3 599.1 549.9 443.8 545.3 539.1 492.2 561.8 452.3 489.5 564.1 491.5 498.7 578.0 437.6 428.9 503.9 529.5 461.7 516.2 583.4 507.0 600.3 539.2 545.5 495.4 528.8 526.7 620.2 463.8 495.9 501.9 592.1 537.3 560.1 569.2 549.6 450.9 416.9 455.2 477.8 521.4
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY EIGHTS (g)
Day 63
Day 7 0
Male, I - 0 mg / kg / day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147
643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
607.0 554.5 496.9 546.8 622.4 565.9 461.8 568.6 556.6 512.5 558.0 476.2 489.4 582.8 502.5 508.0 597.3 452.8 442.9 525.7 548.2 480.5 536.5 606.7 518.8 619.7 553.9 571.0 514.1 551.5 539.4 646.7 479.4 515.0 523.1 609.6 545.9 573.9 586.1 568.3 466.6 401.9 471.1 495.0 542.5
621.5 570.0 508.2 563.6 632.0 584.2 474.4 583.2 566.5 528.8 583.0 490.3 501.0 600.6 508.3 509.9 620.1 463.8 451.8 533.9 558.2 506.4 557.2 628.5 533 .2 643.8 568.9 589.1 524.1 568.0 564.1 676.8 490.4 530.2
540.0 634.0 570.3 592.2 607.0
5 7 9 .8
480.7 416.8 481.9 504.0 557.6
Day 74
603.0 510.3 512.4 629.2 469.0 458.8 534.3 568.8 504.9 563.1 624.9 531.3 644.0 573.1 586.3 531.5 593.7 562.4 682.3
478.3
Day 77
625.0 582.2 516.7 575.1 640.7 596.8 475.8 600.7 582.7 532.8 575.4 505.9 511.4
505.6 544.4 545.0 641.7 579.1 600.4 620.8 594.0 496.4 378.9 495.6 564.4
Day 84
Day 90
637.6
5 9 4 .8
522.5 584.9 657.5 607.1 485.5 613.5 600.6 551.0 589.5 524.7 511.0
640.6 601.4 524.1 593.0 665.2 602.7 492.0 628.9 610.2 546.8 573.8 530.6 522.9
Day 9 8
560.0 609.2 547.9 523.9
507.0 550.0 559.9 643.8 599.8 598.8 629.3 607.2 504.3 402.4
515.2 590.1
5 1 0 .. 5
5 5 7 ..8 5 7 2 ..6 6 6 1 ..1
6 0 5 ,. 5
6 0 8 ..8 6 3 4 ..6 6 1 6 ..0 5 0 8 ..2
4 1 3 .. 3
5 2 2 .. 0
595 .4
5 2 5 ..6 5 7 7 ..0
5 7 7 .. 3
6 8 5 ..8 6 3 7 ..0 6 3 2 ..1
6 4 9 .. 7 6 4 0 .. 5 5 2 2 .. 5
4 4 8 .. 1
5 3 6 .. 6
Day 1 0 5
576.6 631.3 533.8 528.2
5 2 6 .. 7
5 9 4 ..0
5 9 1 ..4
6 9 6 ..6
6 4 5 .3
6 5 4 ..2 6 6 3 ..2
6 5 7 .. 4 532 .4 417 .3 544 .3
DuPont-5386
Day 112
587.3 648.2 546.4 533.8
5 3 3 .. 0
6 0 2 .,7
6 1 8 ..6 7 0 0 .. 1
6 5 4 .. 4 6 6 4 .. 3 6 7 3 .. 9 6 6 7 .. 9
544 .0
448 .3 554 .5
C o m p a n y S a n itize d . Does not contain TSCA CBI 572
) H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
ay 1 1 9
Day 1 2 6
Male, I - 0 m g / kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254
643145 643204
596.0 601.4 547.3
5 3 3 .8
536.4 609.3 621.1 702.0 661.4 678.7 673.0 671.7 539.2 434.2
578.7 622.5 548.2 538.2
555.3
Day 133
600.9 636.3 556.5 548.9
549.0
Day 1 4 0
Day 1 4 7
600.0 657.5 578.8 553.5
610.7 672.6 593.0 569.2
5 6 9 . 0 57 3 . 0
546.0
Day 154
616.7 678.3 601.7 579.6
558.4
Day 1 6 1
620.1 693.2 606.0 579.4
573.3
Day 1 6 8
618.8 697.8 621.4 574.1
583.2
1
DuPont-5386
Day 1 7 5
632.6 720.7 644.4 585.5
594.1
Company S a n itize d . Does not contain TSCA CBI 573
1)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 1 8 1
Male, I - 0 mg/ kg/day
643241
643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
606.2 687.8 617.5 576.9
557.8
574
)
DuPont-5386
Company Sanitized. Does not contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
!
INDIVIDUAL BODY
Day 0
Day 7
Male, III - 2 5 mg / kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
239.1 214.9 227.0 246.5 276.0 259.3 273.4 254.7 240.6 261.6 229.4 259.8 216.0 272.6 245.5 205.8 263.6 261.9 258.0 192.6 251.8 261.5 261.6 231.5 242.3 242.7 273 .5 256.8 241.7 252.6 255.0 241.1 262.6 269.4 228.7
302.6 272.0 277.8 300.7 346.4 326.3 332.3 302.4 302.8 313.9 281.6 316.0 259.7 319.4 299.3 255.4 331.6 310.9 322.2 243.1 309.3 325.0 320.0 278.3 292.7 305.5 340.7 318.7 297.3 315.8 312.5 287.6 322.4 327.0 282.5
Day 14
Day 2 1
Day 28
3 5 0 .. 3
3 2 3 ..6
3 2 5 .. 4
3 4 5 .. 8
4 0 7 .. 7 3 8 6 .. 4
390 .6 3 5 9 ..8 3 6 2 .. 0
3 7 0 .. 9
3 2 7 ..0 3 6 4 ..2 301 .6 3 6 8 ..2
352 .5
302 .0 3 9 6 .0
350 .4 3 7 4 .. 9
2 9 4 ..6
3 6 5 .. 3
3 7 4 .. 6 3 8 4 .2
3 3 7 .. 7 3 4 7 .. 4
3 5 7 .. 8
4 0 2 .. 4 3 7 9 .. 9 3 4 0 .. 9
3 7 7 .2
3 5 5 ..7 3 2 9 .. 5 3 6 8 .. 7
383 .1 323 .1
3 8 4 .. 9 3 5 7 .. 9 3 5 4 .. 9
3 8 6 .2
450 .9
4 2 4 .. 1 4 2 9 .0
3 7 7 .. 9 3 9 5 .. 4 4 1 0 .. 4 3 5 6 .. 7 4 1 3 .. 5
331 .0
4 0 1 .. 3 391 .4
337 .8
4 3 8 .. 5
3 8 0 .0 412 .6 3 2 9 ..2 4 1 5 ..2
415 .9 421 .9
3 7 2 .. 1
375 .3 402 .5 447 .9 4 1 8 .. 5 3 6 9 .. 5
4 2 0 ..1
3 9 1 .. 5
3 5 8 .. 1
4 0 4 .. 3 416 .9
3 5 6 .. 1
4 2 3 ..0 3 9 7 .. 1 3 9 4 ..8 424 .0
4 9 3 .. 7
4 6 4 .. 8 4 6 5 ..1 4 1 1 ..6 4 3 7 .. 0
4 4 3 .. 9
3 8 4 .. 8 4 4 9 .. 6 365 .6 4 2 1 ..8
422 .9
369 .6
4 7 9 .. 3 410 ,3
4 4 9 .. 1 3 6 6 .. 6
4 5 5 .. 3 460 .9
4 4 9 .. 8
4 1 1 .. 4
4 1 6 .. 0
4 3 9 .. 7
4 8 9 .6
4 5 9 .. 9 384 .5
4 5 1 ..4 4 1 8 .2
3 8 1 .. 9
4 4 4 ..8
4 5 6 .. 9 3 8 8 .. 9
575
)
WEIGHTS (g)
Day 3 5
Day 4 2
Day 4 9
DuPont-5386
Day 56
4 7 0 ,.2 4 3 3 ..2
4 1 2 .. 3 4 5 7 ,. 9
5 4 0 ,.2
4 9 8 .. 7 5 0 4 .. 4
4 3 3 .. 6 4 7 8 .. 1 4 6 2 ..1 4 1 1 ..0
4 7 5 .. 5
3 8 8 .. 1 4 5 6 ..8 4 6 1 .. 6 3 9 7 .. 0 5 0 5 ..2
433 .9
4 7 8 ..6
3 8 5 .. 9 4 8 7 .. 5 4 8 7 .. 4
4 8 7 ,.0
4 4 3 .. 3 4 5 3 .. 5
4 7 4 .. 8
5 2 2 .. 3 4 9 0 .. 4
3 9 6 ,.2 4 8 7 ..2 4 4 0 ..8
4 0 9 .. 5 4 8 0 .. 5 4 8 9 .. 3
4 1 6 ..2
4 7 7 ,.0
462 .5 4 3 4 .. 7
483 .0 5 6 0 .. 1
5 2 0 .. 4
5 2 7 .8
4 4 6 .. 3 5 0 9 .. 5
4 7 9 ..6
4 2 8 .. 5
4 9 4 .6
407 .9
4 6 8 .8
4 7 9 .. 7
4 1 2 .. 1
5 2 2 .. 5
4 4 4 .8
4 9 8 .. 5
4 0 9 ..2 5 1 6 ..2 5 0 5 ..8
5 0 3 .. 9 4 5 7 .. 3
4 6 0 .. 1 4 9 2 .. 0 5 3 6 ..6
5 1 3 .. 4 4 1 3 .. 5 5 0 0 ,. 3 4 6 2 .,4 4 2 2 .. 4 5 0 5 .. 7
5 1 1 ..2 4 3 0 ,. 1
4 9 0 .. 5
4 7 2 .6
444 .7
4 8 9 .0
5 7 0 .. 3
5 2 9 ..1 5 3 6 .6
445 .4 5 1 8 .. 4
4 8 0 .8
446 .9
5 0 2 ..0
407 .3 487 .3
4 9 9 .0 4 2 2 .8 5 4 7 .8
461 .7
5 1 3 .0 4 2 4 .6 5 3 5 .8
510 .3
5 2 4 .0 4 8 6 .6 470 .1
5 1 3 .. 4 5 6 3 .. 7 5 3 1 .. 7
4 2 0 ..6 5 0 8 ..6 4 7 5 .0
428 .4
5 3 0 ..2 5 3 2 ..8
4 5 6 ..4
5 1 1 ..6 5 0 2 ..0 4 5 9 ..8
5 0 2 ..5
6 0 1 ..8 5 5 3 ..1 5 6 4 ..2 4 5 7 ..0 5 3 4 ..6
4 9 7 .. 9
4 4 4 ..1
5 2 2 .. 3
4 2 0 .. 1
4 9 6 .. 7 5 2 2 .. 4
4 3 6 ..0
5 8 2 .. 7 4 7 3 .. 4 5 2 3 ,, 3 4 3 8 .. 4 5 5 3 .. 3 5 3 1 .. 7
5 4 6 ..0
5 0 6 .. 9 4 9 2 .. 3 5 3 2 .. 3
582 .2
5 5 1 .. 9 4 3 6 .. 4
5 2 0 ..8
4 8 8 .. 9 3 9 2 .. 3 5 4 7 ..5 5 4 9 ..3 4 7 0 ..9
Company Sanitized. Does no! contain TSCA CBI
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 63
Day 7 0
Male, III - 2b mg/ kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
524.4 513.5 487.6 520.8 625.8 564.5 589.3 468.4 554.5 495.5 448.4 535.0 426.4 512.2 540.9 448.0 602.5 489.3 546.0 456.7 582.8 548.6 569.2 526.3 511.4 549.2 589.5 568.2 433.2 537.4 502.2 440.6 565.1 572.6 479.7
528.6 529.0 504.8 534.8 646.0 588.3 603.8 482.3 553.3 514.6 459.8 554.8 438.1 530.6 553.4 466.8 614.3
4 9 5 .6
564.5 474.3 600.0 557.6 591.6 552.5 525.4 562.8 605.3 591.3 441.2 553.7 516.6 460.8 576.7 586.0 493.3
Day 74
464.4 627.9 498.8 562.9 469.4 604.5 574.2 594.0 559.7 536.0 566.0 624.1 593.3 461.8 555.7 523.6 480.3 585.6 587.9 495.4
Day 77
544.9 544.5 520.7 537.5 663.3 600.9 622.6 488.9 557.5 525.3 466.6 553.1 444.8 537.2 547.1
Day 84
Day 90
540.5 561.0 538.4 536.4 685.3 625.9 635.0
4 9 9 .6
576.5 541.1 471.6 565.6 461.3 543.1 553.5
514.0 573.3 549.4 541.3 699.3 630.5 651.5 507.7 573.7 543.5 483.2 567.1 464.0 549.6 562.8
Day 98
489.9 581.8 482.5 564.1 579.5
Day 1 0 5
500.1 597.1 485.5 578.7 587.6
)
DuPont-5386
Day 1 1 2
508.4 580.5 490.4 597.1 607.7
Company Sanitized. Does not contain TSC A CBI 576
1
f
)
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations___________________________________________________________ DuPont-5386
INDIVIDUAL BODY WEIGHTS (g)
Day 1 1 9
Day 1 2 6
Male, III - 25 mg/ kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
509.3 565.5 471.9 609.8 606.0
509.9 572.8 479.5 590.0 574.3
Day 1 3 3
521.6 595.9 503.7 581.0 603.1
Day 1 4 0
518.4 605.8 503.3 604.0 617.6
Day 1 4 7
525.8 623.0 514.4 617.7 628.8
Day 1 5 4
532.0 620.3 511.9 630.9 637.5
Day 1 6 1
534.7 626.3 517.1 638.6 644.0
Day 1 6 8
541.9 635.2 529.6 653.5 650.3
Day 17 5
550.2 640.2 531.8 672.8 653.7
Company Saniffcetf. Does not contain TSCA CBl
577
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g
Day 1 8 1
Male, III - 2 5 mg/ kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167
643223 643233 643183 643219 643263
523.6 618.7 514.8 644.7 620.2
DuPont-5386
Company Sanitized. Does not contain TSCA CB1
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY
Day 0
Day 7
Male, V - 100 mg/ kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157
643238 643227 643164 643154 643156 643208 643190
229.7 230.7 236.3 260.0 280.3 260.0 263.1
271.8 236.3 253.3 231.9 267.5
210.0
280.8 239.5 206.6 248.0 275.5 244.2 241.3 248.4 271.2 249.9 231.1 255.1 244.3 256.6 241.6 257.0 262.7 250.5 243.9 266.4 245.0 273.7
275.3 288.5 297.5 321.5 353.1 321.8 328.2 323.6 302.8 302.9 277.3 306.7 252.5 333.0 286.7 266.7 310.5 327.6 303.7 311.3 310.4 337.7 303.2 276.2 311.6 307.8 314.2 295.0 307.2
330.3 325.4 297.9
330.2 302.6 333.5
Day 14
Day 21
Day 28
3 1 1 .. 4 347 .9
3 5 5 ..8 373 .2
4 1 3 ..5
3 7 0 ..2
3 7 1 ., 5
3 6 5 ..2 3 4 7 ..1 3 4 1 ..1 3 2 6 ..1 3 5 6 ..6
2 8 6 ..5
3 7 7 .. 1
3 2 4 .. 4 3 1 5 ..4
3 7 2 ,.2
3 7 3 .. 7
3 4 7 ..0
3 7 3 .. 9 3 7 0 .. 9 3 9 8 .. 3
3 5 6 ..6 3 1 3 ..6
3 6 1 .. 5
3 6 1 ..8
372 .5
3 4 7 ..0
3 4 9 .. 9
3 8 0 .. 1 3 8 2 ..1
3 4 0 .. 4 3 8 1 .. 4 3 4 7 .. 3
3 8 4 ,.1
3 5 2 .. 4
3 8 6 ..2
3 8 5 .. 5 4 2 8 .. 9 4 4 9 .. 9 4 2 3 ,. 3
4 1 0 .. 1 4 0 7 .2
3 8 7 .. 3 3 7 4 .. 5
3 6 7 .. 6 3 9 4 ..2
327 .5 409 .5
366 .0 3 5 6 ..1
421 .5
420 .0
383 .5
422 .1 418 .1 450 .8 392 .8
3 4 8 .. 4
4 0 3 ..0 402 .1
420 .5
3 8 7 .2
396 .5 411 .4
426 .5 387 .0 428 .0
390 .3 422 .4
3 8 5 .. 1 4 2 0 ..0
4 1 8 .. 7
4 6 2 ..6 4 7 7 ..0 4 5 3 ..1 4 3 1 ..8
4 4 7 .. 9 4 0 8 .. 9 4 0 4 .. 5
4 0 0 ..8
4 3 1 .. 5 361 . 4 4 3 7 .. 5
3 8 4 .. 6
3 9 4 .. 4
463 .8 4 5 2 ..0 4 0 3 .. 6
466 .4
4 5 1 .2 488 .1
426 .7 3 7 8 .. 3 4 3 9 .. 3 4 4 2 .. 9 4 6 0 .. 7 421 .9
411 .0
448 .5
4 7 1 .1 4 1 5 ..0 4 6 7 .. 0
411 .9 450 .4
579
)
WEIGHTS (g)
Day 3 5
Day 42
Day 4 9
DuPont-5386
Day 56
3 9 5 .. 5 4 4 7 .. 4
4 4 4 ..2
4 9 4 .. 4 4 9 6 ..7 4 8 0 .. 4
4 5 2 ..1 4 6 9 ..6 4 3 6 .,2 4 2 0 ..0 4 2 0 ..2 4 6 6 ..1
3 8 9 .. 5
4 6 2 ..1
397 .7
4 2 0 ..1
4 9 6 .. 5 479 .7
4 1 8 .. 1 4 8 2 .0
483 .7
5 2 2 .6
447 .3 3 9 1 .. 4 4 6 6 .. 3
4 6 6 .. 1
480 .4
4 5 3 .2
434 .9 469 .4
499 .8 437 .8
492 .5
433 .8 4 8 1 .2
4 0 8 .. 9
4 6 9 .2
4 6 6 .3
5 1 2 .8
5 2 6 .. 4
5 0 3 .,8 4 7 7 ..8 4 8 8 ..0 4 5 1 ..8
4 3 6 .. 4
4 3 9 ..8
4 8 0 .. 7 4 1 1 .. 9
4 9 0 ..6 4 1 8 ..0
4 4 2 .. 7
5 1 3 ..6 4 9 5 ..2 4 3 3 ..0
488 .3 5 0 1 .. 5
545 .1 4 6 9 .6
4 0 3 .. 4 4 8 4 .. 5
4 9 6 ..6 5 1 3 .. 1
4 7 8 .. 9 460 .5 500 .7 5 1 9 .. 7
4 5 9 ..2
5 1 8 .. 3
4 5 8 .8 502 1
4 2 2 ..1 4 8 1 .1 4 7 5 .2 5 2 3 ..8
4 8 0 .. 4
5 0 9 ..0 4 9 2 ,.6 5 0 0 ,.2
4 5 9 .. 5
4 4 6 ..2
4 4 9 ,. 4 4 9 8 .. 9 4 3 5 ,. 9 5 1 8 .. 5 443 .3 466 .4 5 2 8 .. 5 512 .3
4 3 9 ..0
507 .9
5 3 3 .6
565 .4 490 .9
418 .6 5 0 4 .1 5 ] 1 .8 5 3 9 .6
503 .9
4 8 8 .2 531 .6
546 .4
4 8 0 .6
549 .9 481 .7
5 2 1 .2
4 4 0 ..1 4 9 6 ..8
4 8 1 .. 7 5 3 8 .3
5 0 4 ..2 5 3 2 ..2 5 0 5 .,1 5 2 1 ..0
4 7 4 .. 9
4 5 0 ..1 4 4 7 ..0
5 1 5 ,,8
4 4 7 .. 5 5 3 3 .. 3
4 4 0 .. 1
485 .4 5 4 8 ,. 9
5 2 7 ..2 4 6 3 ..6
5 1 9 .. 5 5 3 5 .. 7 578 .5
494 .6 4 3 7 .. 0
5 2 1 .. 7 5 2 9 .. 4
5 5 7 .6
522 .3 511 .5 548 .9
5 6 6 .2 4 9 4 ..2
5 7 4 .. 7 500 .5 538 .7
company Sanitized, Does not contain TSCA C B I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 63
Day 7 0
Male, V -- 100 mg/ kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
458.6 520.0 494.5 549.9 527.4 526.3 516.8 541.3 485.0 467.1 448.5 532.6 471.8 541.8 460.9 502.2 567.2 544.7 486.8 529.0 545.3 597.9 520.1 459.4 540.3 546.4 583.6 555.1 528.7 561.0 581.6 509.0 598.7 519.4 567.0
472.1 532.4 508.7 563.5 545.3 454.6 531.0 560.5 496.1 471.5 469.4 536.5 484.2 570.7 473.7 511.2 582.9 573.3 502.0 544.7 568.2 607.6 514.6 469.9 559.1 564.3 601.7 575.1 547.4 577.4 602.5 516.2 615.1 529.6 562.5
Day 74
514.2 588.1 573.8 513.4 551.5 570.1 605.8 508.5 468.8 561.0 570.6 612.3 576.5 547.3 589.1 602.9 514.9 610.9 529.4 561.8
Day 7 7
Day 84
Day 90
470.0 543.5 511.3 570.8 555.9 397.4 538.2 562.2 501.5 480.8 475.8 544.8 490.8 590.3 472.9
485.1 548.3 519.3 575.6 562.6
\K TEST DAY
476.3 542.8 513.3 491.0 486.1 534.0 501.8 599.8 489.0
77
492.6 554.5 526.4 593.3 572.4
529.3 541.2 520.6 490.7 488.4 532.7 498.4 599.1 496.3
Day 98
506.9 545.3 496.8 588.8 501.8
Day 1 0 5
514.8 427.7 509.2 613.1 502.8
DuPont-5386
Day 112
515.4 463.3 513.5 63 8 . 1 496.8
,`ompany Sanitized. Does not contain TS C A C B t
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 1 1 9
Day 1 2 6
Male, V - 1 0 0 mg/ kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224
643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156
643208
643190
497.5 515.1 503.2 636.4 506.4
517.7 539.7 461.5 631.3 505.3
Day 1 3 3
510.3 555.0 504.4 635.1 520.8
Day 1 4 0
523.2 574.0 527.3 657.0 521.1
ly 147
Day 154
535.0 587.4 544.4 676.0 532.0
548.3 609.0 556.8 688.4 533.0
Day 161
555.9 611.1 557.1 706.6 542.4
Day 168
569.3 620.0 563.7 738.4 548.5
DuPont-5386
Day 175
574.5 626.5 579.6 7 57.2 555.4
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 1 8 1
Male, V - 1 0 0 mg/ kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
555.3 608.8 558.5 729.9 534.3
DuPont-5386
Company Sanitized. Does not contain TSCA CBl
582
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY
Day 0
Day 7
Male, VII - 2 5 0 mg / kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
238.2 224.4 230.1 236.0 267.2 265.5 251.8 266.4 242.1 275.9 238.2 261.9 226.2 286.4 250.2
211.8
263.8 264.8 249.1 255.7 285.9 256.2 249.3 235.1 239.6 237.1 261.3 260.1 244.4 273.4 2 52 .4 277.8 246.7 250.3 263.9 274.6 234.0 236.7 249.0 246.7 239.2 248.3 234.2 281,8 239.4
296.9 287.0 281.8 289.8 326.9 335.0 325.1 334.3 294.4 348.3 294.3 313.8 274.0 353.0 303.9 268.2 334.8 337.4 307.1 319.2 367.2 310.3 307.8 293.7 300.4 298.9 322.5 321.7 297.8 335.9 315 5 349.2 303.2 302.3 326.3 340.6 301.5 296.6 311.4 312.8 299.5 312.4 284.8 343.2 299.2
Day 14
336.6 332.4 320.5 330.8 372.9 383.2 379.6 379.8 344.4 394.7 342.9 356.5 306.3 412.6 340.2 307.3 394.0 388.3 355.1 362.8 419.8 350.0 350.4 337.6 350.8 348.7 374.0 366.1 331.5 381.9 366.7 410.4 353.5 350.8 371.9 391.8 352.8 350.5 360.1 362.7 354.3 367.0 326.3 384.9 342.7
Day 21
382.6 372.1 352.4 372.3 417.5 433.3 424.0 429.6 392.9 449.4 371.5 400.3 338.0 464.9 381.6 350.7 452.4 435.2 390.6 418.9 472.0 392.0 386.0 378.3 391.3 390.7 419.7 413.4 375.7 423.0 417.0 472.5 393.9 393.4 407.9 438.5 401.4 398.2 401.7 410.4 399.1 412.8 364.6 427.2 387.8
Day 28
410.4 404.1 379.5 402.8 448.1 461.1 452.9 462.1 427.9 485.4 398.4 438.8 293.0 504.9 406.6 380.3 481.7 463.2 421.9 453.0 504.2 419.9 418.6 408.7 418.1 422.9 459.2 444.6 401.0 443.7
4 5 3 .8
510.6 423.4 423.0 433.1 469.3 431.7 429.9 432.6 445.4 432.0 451.1 396.0 458.1 422.6
583
WEIGHTS (g)
Day 3 5
Day 4 2
Day 49
DuPont-5386
Day 56
432 .4 433 .9
3 9 5 ..6 4 2 8 ..6 4 6 8 .,1
4 7 9 .. 9 4 7 8 .. 7
4 9 4 ..2
4 5 1 .. 3 5 1 9 .. 7 4 1 9 .. 7 4 6 6 .. 9 3 1 8 .. 3 5 3 1 .. 9
4 3 2 .8
404 .3 5 0 9 .. 5 494 .3 462 .4 4 8 6 .. 5 5 2 9 .. 5
4 4 2 ..6
440 .5 4 2 7 .. 5
4 4 1 .2 4 5 3 .2
491 .9 471 .4
4 2 2 .8 4 6 0 .. 0 481 .1 5 3 6 .8
445 .5 446 .3 454 .4
4 9 5 .8 4 5 6 .2 4 5 5 .8
447 .4
4 5 3 ,.8
460 .5 482 .7
4 1 5 .6
494 .4
451 .1
448 .2
4 5 4 .7 4 1 2 .. 4
4 4 7 ..8 4 7 8 ..6 5 0 1 ..6
4 9 2 .. 4 5 1 5 .. 9 4 7 3 .. 5 5 3 1 ..7
4 2 9 ..6
4 9 7 .. 5 3 5 7 ,. 7 5 5 1 .. 7
4 5 2 ..6 4 2 0 .2
5 3 8 .. 4 512 .5 491 .5
4 9 9 ..0
5 4 6 .. 7 4 6 0 .. 5
4 5 3 ,.6
4 5 5 .. 7
4 6 5 .2
472 .4 514 .7
4 9 0 .6 435 .8 4 7 6 ..8 497 .0
5 5 7 .. 7 463 .3
464 .2 4 7 5 .2
507 .4
391 .0
471 .5 460 .5 4 6 6 .. 9 4 7 5 .. 4
504 .1 4 2 6 .2 505 .0
459 .7
463 .5
440 .2
4 1 0 .4 4 4 7 .. 5 4 7 3 .. 4 5 0 3 ., 5
4 9 6 ..8
5 0 2 .. 7
4 7 1 ..6
5 3 4 .. 4 4 2 0 ,. 4
5 0 9 ,. 1 3 5 4 ..8 5 7 0 ..6 4 5 6 ..0 426 .6 5 4 3 .2 5 3 3 .8 4 9 8 .0
5 1 1 .. 7 558 .3
457 .8
460 .7 449 .7
4 7 7 .0
484 .5
5 2 3 .2 4 9 5 .6
450 .4
4 8 8 .8
505 .9 586 .7 474 .5
473 .1 4 7 7 .6
518 .9
4 3 9 .6 485 .6
471 .7
4 8 1 .2
458 .4 519 .9 437 .9
5 2 5 .8 483 .8
4 8 0 .8
4 5 4 .9 4 2 6 .4
4 5 1 .1 493 .0 4 1 7 .0
5 2 3 .. 4 5 1 0 .. 7 4 6 1 .. 7
5 4 5 ..2
4 3 0 .. 5 5 1 5 .. 7
3 6 9 ..1
5 7 0 ..5
3 9 1 ..6
3 8 3 .. 9 5 4 4 .. 4 5 4 9 .. 3
513 .0 5 1 7 ..0
4 9 9 .. 3 4 7 0 ,, 7 4 6 8 .. 7 4 7 8 .. 5 4 9 0 .. 5
4 9 5 .. 0 5 2 7 .. 8
5 1 0 ,. 3
4 6 4 .. 1 4 9 5 ..0 5 1 0 ..0
5 8 3 .. 4
4 8 1 .. 8
4 7 9 .. 3 4 8 1 .. 7
5 3 4 ..8
4 5 6 ..7
4 9 6 .6
462 .3 5 0 5 .. 3
4 5 8 ..2
5 2 5 .. 5
4 4 8 .. 8
5 2 5 .. 9 496 .5
Company Sanitized. Does not contain TSCACBf
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS {g )
Day 63
Day 7 0
Maie, VII - 2b0 m g / kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149
643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
487.4 4.7 7 . 1 445.3
4 7 3 .8
497.7 470.9 532.0 532.0 469.7 568.0 423.1 514.8 368.7 587.5 389.3 398.5 548.8 558.9 514.5 482.2 531.7 426.0 457.2 444.8 489.0 501.4 507.5 494.7
4 7 3 .8
508.7 519.4 579.0 458.2 477.3 497.9 539.4 479.0 505.6 437.7 481.6 434.2 534.5 431.8 489.4 508.1
501.3 369.1 446.4 489.8 426.3 485.5 537.0 532.0 495.7 578.6 394.7 523.6 369.4 595.6
3 3 7 .8
423.4 453.0 573.0 457.9 478.4 487.8 396.8 439.9 474.1 480.2 502.0 518.2 520.8 480.4 511.1 530.9 499.3 375.0 393.0 511.2 427.7 480.1 504.8 444.3 500.0 460.8 537.4 427.7 437.7 510.8
Day 74
Day 77
373.5 513.8 561.0 491.4 462.4
AK TEST DAY 70
430.7 434.7 488.8 438.6 454.9 529.3 515.9 472.5 512.5 487.3 559.5 414.4 459.2
511.7
502.9 451.7 453.5 463.5 487.2 506.9 492.7 549.4 453.6 580.3 440.3 527.4 351.7 595.9 420.7
509.0 515.4 416.0 502.3 455.7 485.3 393.2 525.3 396.1 504.5
Day 84
518.8 502.2 458.6 497.2 515.2 537.3 530.1 564.4 498.0 590.3 443.4 547.2 386.9 624.5 432.9
Day 90
532.9 530.3 463.6 501.1 533.1 562.2 544.4 576.8 509.9 596.3 471.1 543.9 394.5 628.3 456.8
528.1 563.5 473.8 521.7 470.0 518.5 481.1 549.2
4 5 4 .6
512.2
545.3 581.2 498.5 528.7 476.1 543.5 508.2 564.1 458.5 503.6
Day 98
482.4 549.7 408.2 643.9 454.9
555.1 593.9 512.8 538.2 483.6 545.0 536.6 576.8 476.0 536.2
Day 1 0 5
497.2 543.2 407.9 661.0 457.9
568.1 610.2 532.9 557.9 485.4 553.3 532.6 580.3 477.6 548.4
DuPont-5386
Day 112
471.8 548.0 413.9 678.4 454.9
570.1 618.5 537.0 568.4 498.2 578.2 544.9 593.2 482.1 550.9
Zowpany Sanitized. Does not contain TSCACBf
584
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 1 1 9
Day 12 6
Male, VII - 2 5 0 mg/ kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
483.5 554.9 411.6 694.2 466.1
576.3 627.0 539.7 575.0 515.5 570.9 560.3 591.6 495.6 566.1
493.1 550.8 421.1 708.0 477.0
Day 13 3
511.7 574.8 429.9 726.3 487.8
Day 140
526.6 582.0 446.5 728.7 499.4
Day 1 4 7
547.4 609.1 454.5 743.7 513.4
Day 1 5 4
560.7 610.6 460.9 750.7 528.9
Day 1 6 1
567.8 622.9 470.7 756.5 551.5
585
DuPont-5386
Day 1 6 8
Day 1 7 5
585.2 637.2 479.4 782.9 554.0
596.1 643.6 484.4 782.6 546.5
Company Sanilfeed. Does not contain TSCA
CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 1 8 1
Male, VII - 2 5 0 mg/ kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
575.2 619.1 457.7 770.5 522.5
586
DuPont-5386
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY
Day 0
Day 7
Female, II - 0 mg/ kg/day
643477 643374 643406 643486 643351 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
173.9 184.0 161.9 181.9 189.3 224.2 174.1 182.1 184.2 162.0 178.9 167.2 213.8 177.2 190.9 185.0 170.9
212. 5
188.6 197.8 197.9 186.0
202.8
185.6 184.2 207.1 209.9 209.5 176.5 191.1
221.0
194.8 191.3 177.5 183.8 214.9 202.5 209.3 183.1 205.4 203.0 172.6 201.4 191.5 197.9
202.3
212.6
185.0 185.2 214.0 243.9 188.9 201.4 208.4 173.4 193.2 189.9 219.3 194.5 215.3 214.3 185.4 228.4 226.2 226.6 228.3 206.9 234.0 225.3 203.9 234.3 243.5 246.8 183.6 213.2 241.8 228.2 224.8
201.2
216.5 240.1 231.0 229.9 207.8 243.7 223.1 188.2 216.4
211.0
217.5
Day 14
213.3 230.6 207.7 190.6 222.4 265.8 209.5 225.0 236.4 191.7 221.3 204.0 243.7 210.7 236.1 229.7 210.4 248.5 238.0 239.1 241.9 219.7 256.4 249.2 215.5 250.7 263.2 261.6 204.5 223.4 272.9 244.9 240.8 209.6 224.3 265.7 243.4 229.8 231.4 256.1 252.2 206.3 247.9 236.9 237.7
Day 21
Day 28
236.3 240.1 216.1 208.4 258.1 268.1 229.0 243.1 253.7
210.1
233.9
220. 5
266.7 216.6 249.1 253.6 228.8 257.1 251.0 253.8 268.5 229.4 261.7 262.7 234.4 279.8 286.5 279.7 205.7 240.7 286.9 257.4 257.0 227.7 239.7 283.8 266.5 245.3 259.8 273.9 269.6 220.9 265.0 254.7 264.4
239.5 246.9 226.2 208.0 272.6 292.2 243.0 258.1 258.8 217.9 239.9 219.5 278.2 233.0 261.6 262.2 241.5 273.3 266.2 270.1 273.2 243.2 288.6 270.7 238.9 285.6 305.0 291.4 227.2 255.4 300.7 286.9 269.9 236.6 251.7 304.6 278.5 270.4 273.1 301.4 279.1 239.0 290.6 274.2 273.5
587
WEIGHTS (g)
Day 3 5
Day 42
Day 4 9
DuPont-5386
Day 56
2 6 4 .. 5 2 5 6 .. 5
2 4 3 ..6 2 2 1 .,8 2 8 4 ..2
3 0 5 ., 4
2 6 2 ..2
2 7 1 .. 7
2 7 6 .. 8 2 2 6 ..2
2 4 8 .3
2 3 8 .,0 2 7 4 ..2
2 3 6 ., 7
2 7 9 ..6 2 8 0 ..2 2 6 2 ..6
2 8 5 .. 3
2 7 7 .,0 2 8 6 ..8
2 9 3 ,. 7 2 5 3 .. 5
3 0 2 ,.6 2 7 7 ..2
2 5 3 .. 9 319 .5
3 2 4 ..2
3 0 7 .. 3
2 3 4 .,0 2 5 7 ..2 3 2 1 ..8
3 0 0 .. 3 2 8 9 ,. 4 2 4 3 ,. 3
2 5 4 ..8
3 1 8 .. 5 2 9 2 ., 7 2 8 1 .. 9 2 9 1 .. 4
2 9 6 ..6 2 9 0 ..8 254 .1
2 9 8 .. 5
2 9 4 .,2
2 8 5 .. 9
2 7 1 ..1
2 6 8 .. 4
2 4 5 ..8 2 2 6 ..2 2 9 3 ..1
3 0 9 .. 4 2 6 0 .. 7
2 7 4 ..1
2 8 2 .. 4
2 4 3 ,.8
2 5 1 .. 4 2 4 4 .. 3
2 8 7 ..1
2 3 9 .. 9
2 7 1 .. 6 2 8 4 ..2 2 6 3 ..2
3 0 3 .. 4 2 7 7 .. 3 2 8 4 .. 5 3 0 3 .. 7
2 6 2 .0 2 9 7 ..6
287 .7 2 6 6 .. 3
3 3 1 .2
3 3 6 .. 5
3 1 9 ,6 2 3 9 ..8
2 6 4 ,. 7
3 2 2 ..6
3 0 9 .. 3
299 ,1
n2 4 8 .
2 6 5 ..8
3 4 0 .. 3 2 9 8 .. 9 282 .5
297 .1 3 0 7 .6
3 0 7 .. 7
2 6 1 .8 3 1 1 .8 2 9 3 .1
2 9 9 .. 4
2 7 2 .. 7 2 7 9 .. 9
2 5 5 ..2 2 3 7 ,.6 3 1 8 ..8
3 0 8 .. 3
2 7 2 .0 2 7 6 .8 2 8 5 .2
259 .4
2 6 7 .. 0
2 5 9 ,. 7 2 9 7 .. 7
2 4 9 ..6
2 8 4 .. 3 295 .4 2 7 4 .. 4
3 1 6 .6 291 .1
289 .9 3 0 9 .. 9
274 .8 3 1 5 ..1
301 .9 270 .9
347 .8
349 .3 3 3 0 .. 3 2 4 4 .. 3
2 7 2 .6
3 4 4 .. 7 319 .4
3 0 7 .. 8 2 6 1 .0
269 .7
3 5 4 .6
307 .3 280 .5 301 .9 315 .4
3 1 5 .2
266 .3
318 .1 3 0 7 .0
309 .7
2 7 0 ..8 2 8 2 ..6 2 5 9 .,8 2 5 6 ..2 3 3 1 ..0
3 2 7 ,. 7
2 8 8 ..1
2 9 5 .. 9
2 9 2 ..0 2 6 5 ..0 2 6 4 ..8 2 7 5 ..1
3 0 5 .. 4 2 4 6 .. 7 2 8 1 .. 9
3 0 0 ,.6
2 8 2 .. 9
3 2 1 ,.1 2 8 0 ..6
300 .3
3 1 9 .. 1
2 8 5 .. 7
3 3 5 .. 0 2 9 3 .6 2 7 5 ,.6 3 5 2 .1 3 5 9 ,.1 3 4 0 ..8 2 6 4 ..2
2 7 4 .. 3 3 3 6 .. 3
3 2 9 .. 8 3 1 1 ..8 2 6 9 ..2
2 8 0 .. 3 357 .7
3 1 7 ..8
300 .5 3 1 8 .. 9
326 .1 3 1 9 ..1 2 7 0 .6
315 .9
3 1 7 ..8
3 2 2 .. 5
ompany Sanitized. Does not contain TSCA CB1
)I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 70
Female, Ii - 0 mg/ kg/day
643477 643374
643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421
643420 643419
643414 643401
643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
281.2 292.0 269.3 260.1 342.4 333.9 296.2 288.4 303.9
2 7 2 .8
270.0 278.4 301.6 2 5 1 .9 295.6 298.5 2 7 0 .5 313.1 287.6 298.5 316.1 288.8 328.8 296.3 279.2 358.5 360.0 344.4 249.6 276.1 343.3 333.1 320.0 271.9 282.2 3 5 4 .1 316.2 310.2 321.8 347.8 320.1 276.1 329.7 323.0 338.8
285.9 304.5 276.6 264.3 353.0 336.2 297.9 298.9 305.2 280.0 274.9 290.1 314.4 255.6 299.1 306.6 288.4 323.6 293.9 294.6 318.4 292.4 327.9 304.9 286.5 358.2 358.2 355.4 263.0 278.1 342.8 335.7 325.9 268.0 282.2 367.3 3 2 6 .1 310.7 3 3 3 .9 373.1 333.4 281.3 329.7 333.3 338.4
Day 74
INDIVIDUAL BODY
Day 77
Day 84
307.9
2 7 7 .6
320.8 287.6
3 0 2 .6
321.2 294.2 323.5 306.4 284.3 354.9 361.2 351.7 265.9 276.5 345.5 332.8 325.0 267.4 2 7 7 .0
284.0 3 1 3 .1 2 7 3 .0 263.3 359.9 336.7 295.6 301.7 309.7
2 8 3 .8
271.2 297.3
3 1 4 .8 2 6 0 .0
303.2
358.9 324.2 310.6 341.8 381.4 330.6 279.8 328.3 330.3 342.4
2 8 6 .8
313.7 2 7 2 .5 257.9 378.1 341.3 303.8 307.2 315.8
2 8 4 .8
286.0 296.9 3 2 4 .1
2 6 8 .0
311.0
3 6 0 .0 325.4
3 1 2 .6
349.9 395.9 334.7 2 8 8 .5 33 2 .9 3 3 9 .9
3 3 9 .6
WEIGHTS (g)
Day 91
Day 98
DuPont-5386
Day 1 0 5
Day 11 2
2 9 7 .. 9 3 2 7 .. 7
2 8 0 .. 6
2 4 9 .. 7
3 9 5 ,,0
3 5 1 .. 3
3 0 9 ..2
3 2 3 .. 9 312 .4
286 .8 280 .1 301 .1 3 2 4 ..8
267 .4 299 .3
2 8 0 ,.8
282 .9
3 2 9 ..8
2 6 6 .. 7
3 1 9 .. 0
2 9 0 ..0
263 .4
3 3 0 ..2 2 7 4 ..8
3 1 6 .. 7
295 .5
279 .6
3 3 9 .. 4 283 .7 313 .3
3 6 5 .. 3 3 3 3 .. 7 3 1 5 .. 4 3 5 1 .,7
4 0 0 ..2 3 3 2 ..0
2 3 4 .. 3
3 2 8 ..2
3 3 9 .. 4
3 4 6 ..1
377 .7 3 3 3 .. 3
3 4 6 ..0 3 5 9 ..8
4 1 8 .. 5 3 5 2 .. 3 2 6 9 .. 3 3 4 6 .. 5
349 .8 3 4 9 .,0
3 8 5 .. 9
3 4 7 ,,2
3 5 0 .. 7 3 7 3 .. 3 4 2 6 .. 3 3 5 5 .. 3 2 8 7 ,. 3
3 2 6 .. 1 3 6 7 ..2
3 6 1 ..7
3 8 9 .2 374 .8 350 .0
387 .4 447 .5 364 .9 301 .3
SE TEST :DAY 369 .0 374 .0
Company Sanitized. Does not contain TSCA CB?
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 1 1 9
Day 1 2 6
Female, II - 0 mg/ kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
287.9 280.1 318.3 287.1 319.1
278.4 281.8 319.5 281.6 301.8
389.5 384.6 350.9 395.3 450.3 368.2 301.9
SE TEST DAY
365.1 378.5
105
Day 1 3 3
293.4 296.8 331.6 296.9 323.4
INDIVIDUAL BODY WEIGHTS
Day 140
ly 1 4 7
Day 1 5 4
293.8 303.9 329.2 290.9 321.1
298.5 313.5 334.5 302.0 328.0
295.0 322.1 349.1 295.1 320.2
Day 16 1
299.2 322.7 352.3 314.9 325.3
Day 1 6 8
305.0 340.6 356.5 311.9 334.0
DuPont-5386
Day 175
303.8 334.0 355.8 314.1 333.0
Company Sanitized. Does not contain TS C A CBI
)) )
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_________________________________________ __ ______ _________ DuPont-5386
Day 1 8 1
Female, j. 1 - 0 mg / kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453
643330 643336 643387 643377
294.9 312.7 345.9 294.6 315.0
INDIVIDUAL BODY WEIGHTS (g)
Company Sanitized. Does not contain TSCA CBI 590
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
Day 14
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437
643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
175.0
201.1
174.8 193.5 184.4
194.5 193.2
175.9 179.6 175.9 184.6 173.3 208.1 168.6 192.5 183.9 169.8 208.9 200.3 205.8
202.8
196.6 225.8 185.1 224.1 194.4 194.4 190.4 195.7 205.7 217.1 204.9 165.8 189.6 198.5
189.2 231.6 194.6 218.3 207.5 228.9 208.1 202.3 194.8 186.6 202.4
AK TEST DAY 0
224.3 187.7 204.3 196.2 185.7 237.1 218.2 225.2 230.0 215.2 262.3 206.4 251.8 219.9 228.8 219.8 230.4 218.5 251.8 223.3 189.0 209.2 225.8
201.5 254.6 233.7 240.2 215.6 238.2 209.3 219.8 216.2 209.7 214.9
239.8 205.8 223.1 227.6 214.4 255.4 237.1 247.8 254.8 237.3 273.5 226.6 270.8 228.9 251.3 237.0 256.1 244.2 249.4 242.0 199.8 230.4 245.3
INDIVIDUAL BODY
Day 21
Day 28
223.6 284.1 247.0 268.4 236.2 264.3 233.8 242.6 230.8 227.7 225.2
269.2 218.0 246.3 242.2 239.4 275.7 258.7 266.7 274.1 249.4 302.3 242.2 298.1 256.2 273.9 256.7 276.5 274.0 276.7
26 3 . 6 212. 9
253.0 255.0
240.3 283.8 265.5 285.2 240.3 274.9 236.7 256.0 244.4 239.4 228.9
270.0 231.8 253.8 256.1 247.4 291.9 291.2 278.7 287.5 279.3 314.5 261.8 305.3 264.5 282.1 268.8 300.1 300.6 288.2 276.4 228.2 256.8 267.1
591
WEIGHTS (g)
Day 35
Day 42
249.5 303.4 275.9 294.2 262.0 288.1
SE TEST DAY 2 9
270.0 258.1 248.0 247.9
257.3 307.5 282.5 305.4 275.2 301.2
266.3 264.3 258.9 254.2
279.4 239.2 260.0 268.5 260.8 304.4 294.0 284.8 299.1 286.0 351.5 270.4 319.3 278.4 296.8 274.4 313.3 305.0 303.7
285.2 241.3 268.9 275.1
283.5 253.1 275.6 280.0 273.3 314.2 285.1 295.3 317.5 298.1 366.9 289.1 334.5 285.4 306.4 293.5 325.4 315.9 329.3 290.5 247.3 271.0 289.3
Day 49
270.2 312.3 293.3 308.7 280.6 312.6
278.5 266.4 267.1 260.4
303.0 254.4 281.5 287.8 277.8 324.0 311.8 299.6 324.0 297.6 380.6 299.1 336.9 289.3 322.7 296.5 335.0 323.2 336.5 267.3 251.2 282.9 291.5
)
DuPont-5386
Day 56
274.3 321.1 316.6 322.5 245.9 315.2
287.1 284.4 271.2 254.0
296.1 265.7 283.3 290.5 281.0 319.8 301.9 303.1 327.3 299.3 387.5 297.5 354.2 298.4 320.1 305.3 349.6 329.0 322.6 298.2 263.4 282.3 292.7
Company Sanitized. Does not contain TSC A CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 70
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
283.6 334.4 304.9 330.6 292.7 312.4
290.8 279.5 274.3 268.7
308.4 275.7 289.3 289.7 287.8 327.6 309.2 298.6 330.8 302.6 392.2 296.2 355.4 301.4 3 1 7 .5 305.7 355.1 344.7 339.2 298.9 272.4 287.6 300.2
281.6 349.3 319.6 341.4 306.2 316.7
289.9 295.4 285.8 271.5
312.3 282.5 303.5 302.5 294.6 328.9 314.2 309.9 335.1 313.8 398.6 305.9 365.2 295.7 318.8 307.8 356.7 343.7 331.6 305.3 266.8 293.4 310.1
Day 74
301.2 292.5 328.3 312.9 306.0 337.8 305.3 395.9 302.5 368.6 307.5 274.5 311.1 360.7 341.2 341.2 310.8 269,0 294.6 303.2
INDIVIDUAL BODY WEIGHTS (g)
Day 77
Day 84
Day 9 1
288.3 355.7 322.6 349.5 298.3 319.8
294.8 300.6 295.2 267.6
304.9 278.7 298.3
291.1 361.8 331.7 348.7 295.8 325.7
304.5 299.7 299.8 273.0
304.7 284.7 300.4
286.8 359.1 328.6 353.5 290.1 323.4
303.1 303.1 296.5 280.9
312.6 294.6 302.8
Day 98
288.4 330.0 294.7 309.3
Day 1 0 5
283.7 329.7 297.8 319.4
DuPont-5386
Day 112
290.3 339.8 312.3 325.9
Company Sanitized. Does no! contain TS C A CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 1 1 9
Day 1 2 6
Female, IV - 2 5 mg/ kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
293.3
346.9 317.0 325.5
289.2
345.8 315.7 320.1
Day 1 3 3
298.2 358.8 321.9 330.6
INDIVIDUAL BODY WEIGHTS (g)
Day 1 4 0
Day 1 4 7
Day 1 5 4
294.8
365.1 329.7 344.4
307.3
376.2 326.5
3 4 4 .8
314.6
371.9 340.6 349.9
Day 1 6 1
309.8 380.4 334.1 353.0
Day 1 6 8
313.3 387.9 337.7 355.6
DuPont-5386
Day 1 7 5
319.4 389.6 343.4 351.5
;enipany Sanitized. Does not contain TSCA CB1 593
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Female
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
Day 1 8 1 2 5 mg/ kg/day
299.7 368.1 326.8 343.1
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
Company Sanitized. Does not contain TSCA CB!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
Female, VI - 100 mg/ kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
1 8 6 .5
184 .6
1 7 1 .5
173 .6
194 .9
2 1 4 .8 2 0 3 .2 164 .8 174 .8
1 6 6 .7
1 8 4 .6
1 8 0 .3 184 .9
1 6 1 .6
1 9 2 .7 1 7 9 .7
178 .2
2 1 8 .7 193 .5
1 8 6 .8 202 . 1 1 7 7 .0 1 7 5 .8
20 8 .5 1 8 3 .3
210 . 7
1 6 6 .3
1 9 2 .8
187 .4 1 8 5 .5 1 9 9 .9
201.3 200. 7 1 8 4 .6 1 9 4 .0
212 .. 9 2 0 3 ..1
198 .5
202 .,4 220 ..2
2 5 5 ..4 2 2 8 .. 9 1 8 0 .. 3
1 9 7 ..1 1 9 1 .,8 2 1 3 ..6 202 .. 4 2 0 6 ..0 1 8 4 ..6 2 2 6 ,. 1 2 12..1
2 0 6 .. 3
2 3 7 ,.1 2 1 6 ..6 2 1 5 ..2 2 2 2 ..8
2 0 5 ..0 200 ..8
2 4 0 .. 9
2 0 6 ..6 220 ..8 1 9 6 ..0 2 1 1 ..6 2 1 0 ..6
1 9 8 ..9
2 20..0 22 1 ., i 2 1 9 ,, 1
2 0 6 ..3
224 .8
Day 14
2 3 0 .. 5
2 2 1 ..6 2 2 1 ..2
2 1 3 ,. 3
2 3 4 ..2
2 7 6 .. 3
2 5 0 ..1 1 9 7 ..1 2 0 7 ..6 212 .. 9
2 3 2 .. 9
2 0 7 ..8
2 1 8 .. 5
2 0 1 ..6 2 3 6 ..1 2 3 3 .. 1 223 .6 2 7 5 ..6
2 3 6 ,. 5
2 3 1 .. 0
2 5 3 .. 3 2 2 9 .. 4
2 1 8 .6
259 .5
2 2 8 .8 253 .6 2 1 3 ..2
2 2 7 .. 4
2 3 2 ,. 6
2 2 6 ,. 9 2 2 8 .. 4 2 4 9 .. 5
2 4 4 .. 1 2 2 9 .. 1
2 4 8 .. 5
INDIVIDUAL BODY
Day 2 1
Day 28
2 4 7 ..8
2 4 3 .. 7 2 3 0 .. 7
2 3 3 ..0 2 5 8 ,.0 2 9 4 ..8
2 7 2 .. 3 2 1 4 .. 9 2 1 9 .. 9
2 3 4 ..8 2 5 0 .,0 2 3 4 ..6
2 3 6 .. 7
2 2 2 ..1 2 6 6 ..0
2 5 2 .. 5 2 3 9 ..9 2 7 8 .. 4
2 5 2 ..6 2 4 1 ..2
2 6 7 .. 7
2 3 4 .. 1 2 2 6 .0
2 8 5 .. 9
244 .2
2 7 3 .. 9 2 1 9 .. 7 2 4 0 .. 7
2 4 8 ..6
2 4 0 ,. 9
2 5 0 ..6 2 6 1 .. 8
2 5 3 .. 5 2 3 9 .. 7 2 6 1 .. 3
2 6 1 ..8
2 4 0 .. 7
2 4 6 .. 6
2 4 8 .. 9 2 6 8 .. 4
300 .1
2 8 2 .. 4 2 2 3 .. 3 2 3 2 ,. 9
2 4 3 .. 8 2 5 3 .. 0
1 9 8 ..4
244 .1 2 3 3 .0
279 .9 2 6 3 .. 7 2 6 0 .. 9 300 .3 263 .9 261 .5
280 .8
262 . X
243 .6 3 1 1 .0
257 .9 293 .9 245 .7
2 5 6 .8 2 5 1 .8
261 .5 262 .9
2 8 1 .6 2 6 3 .6
243 .9
275 .1
595
)
WEIGHTS (g)
Day 35
Day 4 2
Day 49
DuPont-5386
Day 56
2 7 1 ., 3
2 6 2 ..6
2 6 2 .. 5
2 6 4 ..0
2 7 9 .. 4 3 2 4 .. 3
2 8 7 ,,8
2 3 6 .. 7
2 4 2 ..0 2 4 8 ..0
2 5 9 .. 9 1 9 6 .. 4
2 4 9 ..2 222 . 3 2 7 9 .0
2 7 8 .. 5 2 6 3 .. 9 3 0 7 .. 3
2 7 5 .. 1
2 7 3 .. 7 293 .4 267 .5 251 .3 284 .4
2 6 4 .2
297 .9
2 5 4 .1 2 7 0 .. 6
2 7 0 .. 3
269 .2
273 .5 294 .9 279 .9 260 .7
2 8 9 ..0
2 8 0 ..8 2 6 2 ..8 2 6 1 ..6
2 8 3 ..5
2 7 9 ,.6
3 3 1 .. 7
2 9 4 ..8
2 5 5 .. 7
2 5 9 ..0 2 6 6 ,,2
2 7 0 .. 9
1 8 8 .. 6 2 6 3 ..6
2 4 8 ,. 7 3 0 0 .. 4 2 9 6 ..5 2 7 5 .. 4 3 1 9 .. 7
2 8 3 ..2 2 7 7 ..8
2 9 2 .. 4 283 .5
267 .8
275 .3 269 .3
3 1 0 .. 8 2 7 3 .. 1
2 8 4 ,. 7 2 8 2 .. 3
2 8 5 ..2 2 7 7 ..2 3 0 0 .6
296 .4 263 .3 3 0 2 .. 4
2 7 8 .. 3
2 8 4 ..1
2 6 9 ..5 2 8 5 .. 5 2 8 7 .. 3 3 1 4 ,. 7 2 9 9 .. 7
2 5 1 ..1 2 5 0 .,8
2 5 5 ., 7
2 7 3 ,,0 2 2 4 .8 2 6 8 ..6
2 5 6 .5
3 0 7 ..0
2 9 6 .. 9
2 8 3 ..0
3 2 2 .. 4 2 8 9 .5
3 0 3 ..2
310 .7 290 .7 267 .3 308 .9
2 7 5 .6 3 1 7 ..0
2 7 4 .9 2 9 9 .. 4 2 8 2 .. 3 289 .4
2 9 3 .2 306 .8
305 .5
2 7 5 .0
3 1 0 .. 4
2 7 9 .6
293 .3
268 .8
2 8 4 ..5
2 9 6 ..8
3 2 3 .. 3 303 .5 2 4 9 .. 5 2 5 7 ..7 2 6 7 .. 3
2 7 5 ..0 2 3 1 ,,8 2 6 9 ..2
2 5 9 ,. 9 2 9 3 .. 4
3 0 6 ., 1
2 8 4 .. 9
3 1 1 ..2 2 9 6 .. 2 3 0 4 .0
308 .3 290 .5
275 .8
304 .4
2 8 3 .8 3 2 1 ..2 2 8 4 ..0 3 0 0 .. 6 2 8 7 .. 6
291 .3 292 .5
313 .4 309 .1 2 7 2 .2
313 .5
C om pany Sanitized. D oes not co n tain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 7 0
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
289.7 290.2 272.4 297.5 292.2 327.7 305.1 264.3 262.5 274.2 285.9 238.9 274.3 251.7 307.2 305.6 290.1 318.3 293.9 309.2 308.6 299.4 269.8 319.2 284.1 330.6 285.5 307.5 284.5 305.4 284.7 316.7 304.0 275.8 317.1
290.8 312.1 272.6 305.7 304.5 320.5 315.7 274.5 264.9 290.8 296.4 252.4 282.7 264.8 300.3 316.3 293.2 315.6 292.5 313.7 315.1 306.1 278.1 338.6 280.4 325.5 288.0 317.3 290.3 308.8 281.6 313.4 313.6 284.2 316.9
Day 74
316.2 296.9 314.7 290.6 310.0 323.7 311.0 274.0 298.5 274.5 327.7 291.0 317.5 286.8 310.7 291.6 315.1 309.9 280.5 315.3
INDIVIDUAL BODY WEIGHTS
Day 77
Day 84
Day 91
295.4 315.7 278.2 307.6 302.7 324.3 314.9 275.9 263.4 290.4 293.6 257.3 284.2 260.8 317.6
294.0 315.0 276.7 311.5 305.7 316.9 320.3 271.2 270.1 293.3 302.8 254.5 298.9 261.2 311.3
295.7 319.2 281.9 313.0 315.0 328.1 318.3 277.0 270.6 286.1 300.7 258.5 296.6 261.3 314.5
Day 98
306.2 270.7 298.2 256.5 301.6
Day 1 0 5
306.5 276.0 301.9 267.9 305.8
DuPont-5386
Day 1 1 2
318.8 270.9 311.1 227.2 314.1
Company Sanitized. D oes not contain TSCA CBI
) I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations__________________ ________________________________ _
DuPont-5386
Day 1 1 9
Day 1 2 6
Female, VI - 1 0 0 m g / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337
643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
321.8 220.9 312.3 242.5 313.6
317.8 263.9 311.3 248.1 325.1
Day 1 3 3
317.5 277.8 329.7 265.7 316.3
INDIVIDUAL BODY WEIGHTS (g)
Day 1 4 0
Day 1 4 7
Day 1 5 4
Day 1 6 1
323.5 278.1 321.6 265.2 327.2
333.9 281.1 327.2 269.6 342.7
334.4 281.5 342.6 283.6 338.3
339.7 291.7 338.9 280.0 348.5
Day 1 6 8
341.4 293.1 342.1 281.5 351.7
Day 1 7 5
348.0 294.2 342.2 283.3 3 6 4 .6
Company Sanitized. Does not contain TSCA CBI
597
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 181
Female, VI - 1 0 0 mg / kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
327.2 286.1 328.1 277.7 356.8
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
CSmPa"y Ssm1fee<t D "Ol contain TSCACBr
)>
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
Female, VIII - 2 5 0 m g / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
186.4
202.6
195.9 181.0 168.9 173.1 166.9 191.2 184.7 196.2 169.0 196.1 180.8 164.2 224.7 197.0 181.1 217.9 181.7 197.2 205.9 175.6
211.6
181.8 190.6 188.2 196.4 209.8 206.8 201.9 172.8 193.0 215.0 204.2 189.5 175.6 205.8 188.1 178.2 186.6 189.9 203.8 168.8 192.9 171.0
212.8
239.1 221.5 198.5 192.0 187.3 190.0 211.5
212.0
213.7 194.4 215.4
210.2
185.1 246.4 226.2 201.7 250.1 208.0
220.0
230.4 196.4 234.6 198.0
220.0
215.3 227.8 245.4 253.5 233.3 196.1 215.4 237.4 227.7 213.7 197.7 251.0 210.9 203.9 207.0 215.8 229.6 189.3
221.5
190.9
Day 14
233.2 261.6 246.1 216.8 217.0
202.0
211.3 240.5 239.1 244.9 210.4 236.2
220.6
204.0 266.1 240.3 213.8 278.8
221.6
234.7 244.6 223.4 261.2 223.5 243.6 234.9 249.3 271.6 275.5 256.6 217.5 232.4 275.6 258.2 232.5 224.4 274.7 230.8 227.9 226.9 235.4 244.6 217.8 244.5 220.3
INDIVIDUAL BODY
Day 21
Day 2 8
244.7 294.3 256.2 224.9 234.4 227.1 227.2 257.6 249.3 252.2 231.3 250.6 227.3
222.6
291.6 252.2 230.6 298.3 242.8 251.0 264.1 237.1 284.3 235.3 261.0 237.1 261.7 293.6 292.2 268.0 236.5 250.4 288.9 272.6 245.3 222.7 288.9 230.3 242.4 235.8 254.4 255.8
221.8
256.7 230.8
252.1 289.3 268.3 234.3 251.6 232.4 244.1 268.5 278.2 269.5 240.8 259.1 236.8 238.4 300.9 270.5 245.8 314.8 251.7 265.5 281.5 250.6 290.3 246.3 274.8 259.4 281.8 310.1 313.9 276.1 253.8
757 1
299.7 289.3 249.2 232.8 289.7 252.4 246.9 235.6 262.5 275.1 230.0 270.1 245.1
599
)
WEIGHTS (g)
ay 3 5
Day 42
Day 4 9
DuPont-5386
Day 56
2 6 6 .. 7 3 1 8 .3 2 8 2 .. 7
2 4 1 ..2 2 5 7 .. 1
2 5 1 .. 3 2 5 7 .. 4
2 7 0 .. 6
2 8 9 ,. 4
2 8 2 ..0
2 5 2 ,. 7
2 6 2 ..6
2 5 5 .. 5
240 .6 3 1 0 ..2 278 .2 2 5 1 .6 3 1 4 .. 6
2 5 7 .. 9 278 .4 2 9 6 .. 5 261 .7
298 .1 2 5 7 ..8
288 .5 267 .9 2 9 0 .. 7 321 .3
3 2 6 .1
301 .4
2 5 9 .6
275 3
3 1 0 .2
297 .3
263 .1
241 .7 312 .7
2 5 9 .2
251 .5 247 .7
269 .1 2 8 4 .2 235 .1
280 .7
2 5 4 .0
2 7 6 .0 3 3 4 ..2 289 .1 2 4 8 ..6 2 7 9 .,8
2 6 8 .7 2 6 0 .. 3 2 8 5 .. 3
2 9 4 ,.2 2 8 0 ..0
2 5 9 .. 7
2 6 7 ..0 2 7 5 ..6
2 5 3 ,. 4
3 2 0 ..1 2 8 7 ..0 2 6 1 .6 3 2 2 ..6 2 6 2 .. 1 2 8 3 ..2
3 0 6 .. 4
2 7 0 ..6
308 .5 2 5 6 .. 3 3 0 4 .. 4 2 8 0 .. 4 2 8 7 .. 5
3 2 5 ..2 3 3 0 ..2 3 0 6 .8
2 6 3 .. 7
2 8 4 .8 3 1 6 .6 3 0 9 .. 1 2 6 6 ..1
251 .5
3 1 8 ,.8 2 6 4 ..2 2 6 9 .6
2 5 0 .. 9 2 7 6 ,. 5 300 .4
2 5 0 ..6 2 8 7 .8
266 .9
2 7 4 .. 7
3 3 8 ..0
292 .7 2 5 2 .. 3
2 7 2 ..8
2 6 1 ., 3 2 6 6 .. 3 2 8 5 .. 7
3 0 7 ..0 2 9 7 ..1
2 6 4 .. 4 2 7 4 .. 7
2 9 4 ,.6
2 3 9 .. 3 3 2 6 .. 5
2 8 6 .. 1 2 6 2 .2 3 3 9 ..8 2 7 0 .. 1 2 8 8 ..6 3 2 0 .. 1
2 7 4 .. 9
3 1 4 .8
2 7 3 ,. 7 3 1 5 .. 4
2 3 2 ..2 2 9 4 .8
3 3 6 .. 7
3 3 3 .2 311 .8 2 6 9 .2
297 .3
317 .1
315 .5
2 8 3 .6
259 .9 287 .3 219 .7
272 .0
258 .3 289 .9
313 .1 257 .1 3 0 5 .0 2 6 9 .6
279.5 329.9 302.5 254.3 287.5 252.4 269.5 286.6 310.1 300.5 271.3 273.7 276.4 178.9 333.3 284.9 261.4 336.5 271.6 292.2 319.9 269.2 290.1 268.3 325.4
AK TEST DAY
297.2 334.2 331.9 292.2 266.6 299.4 323.9 305.6 281.0 256.4 238.7 230.1 235.9 255.3 281.8 312.1 251.5 293.1 271.4
Company Sanitized. Does not contain TSCA CBI
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 63
Day 70
Female, VIII - 2 5 0 m g / kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 543456 643423 643345 643351 643358 643444 643474 643441 643481
283.2 308.7 307.5 251.8 280.2 246.8 268.6 272.0 317.7 274.4 265.1 287.2 290.1 235.9 334.5 275.8 260.3 323.0 276.1 295.1 313.1 267.2 240.7 269.8 328.3
2 5 1 .4 332.5 332.0 279.3 249.8 310.3 324.1 305.6 279.2 265.8 306.1 249.6 268.3 210.5 288.1 270.3 254.3 263.5 271.8
285.9 297.0 307.5 250.0 291.0 268.7 274.4 284.0 325.5
FD TEST DAY
252.3 292.4 291.1 247.5 342.4 231.5 255.4 320.5 279.0 292.5 298.3 204.8 195.7 229.9 281.5
297.8 324.5 325.9 288.7 261.0 315.7 332.2 279.8 263.7 263.7 324.2 248.7 268.2 262.0 287.1 262.8 261.6 299.5 274.2
Day 7 4
214.9 229.0 326.6 283.5 289.5 283.0 261.7 269.0 278.6 325.4 310.2 331.4 297.6 267.5 232.5 316.9 326.0 297.9 221.0
INDIVIDUAL BODY
Day 77
Day 84
2 6 9 ..9 2 8 9 .. 4 3 0 1 ..9
2 5 7 .,0
2 7 5 .. 9
2 6 4 ,.2
2 6 2 .. 7
2 8 5 ..1
3 2 8 .. 9
2 3 0 .. 7
2 8 7 ..0 2 5 6 ..0 2 4 4 ..0 2 8 5 ..8
2 9 9 .. 5
3 3 1 .. 1 3 1 3 .. 6 2 5 7 ..8
288 .9 279 .4
278 .1
3 0 2 ,. 7 339 .7
272 .7 308 .7
3 0 0 .2
264 .3
330 .1
265.2 319.4 250.2 262.2 276.3 290.8 283.4 238.9 307.7 255.5
268.1 345.7 279.1 290.0 275.6 309.7 311.7 267.9 328.2 274.3
600
WEIGHTS (g)
Day 9 1
Day 98
Day 1 0 5
2 9 9 .0 3 4 8 .6
2 9 6 .9 2 5 4 ..5
2 9 7 ..6
2 7 7 .,4 2 6 8 .. 3
3 0 2 ..8 3 4 9 ..8
2 7 4 ..0
3 1 2 .. 3 3 0 8 .. 7 2 6 1 .. 5 3 4 7 ..9
276 1
298 7
317 6
272 7
369 5
280.6 298.7 324.0 271.5 384.6
DuPont-5386
Day 1 1 2
284.3 303.2 326.8 285.8 398.5
276.7 337.1 283.5 280.5 280.0 323.1 313.9 269.3 336.0 285.9
275 329 288 296 283 333 303 280 350 296
1
2
9 9 3
1 2 2
7 3
275.2 335.1 297.0 307.9 292.1 350.1 307.9 275.1 354.2 301.9
277.7 333.4 310.5 328.3 300.2 358.7 308.9 282.5 368.9 311.8
Company Sanitized. Does not contain TSC A CBI
II
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 119
Day 126
Female, VIII - 250 mg/kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
286.2 308.6 325.5 283.6 404.8
277.7 340.7 309.7 328.5 301.5 372.2 323.0 280.1 382.3 313.6
280.8 310.4 331.7 290.9 411.1
Day 133
288.9 331.5 343.4 289.1 416.6
INDIVIDUAL BODY WEIGHTS (g)
Day 140
ly 147
Day 154
292.1 348.6 335.9 291.3 422.0
305.5 365.2 348.0 296.9 431.4
318.0 373.2 357.9 297.0 437.3
Day 161
316.4 384.4 364.6 302.4 442.6
Day 168
316.7 363.1 373.9 297.6 444.5
)
DuPont-5386
Day 175
322.9 359.2 376.9 298.6 450.8
Company Sanitized. Does not contain TSCA CB
601
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 181
Female, VIII - 250 mg/kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
312.0 341.1 368.9 286.1 429.7
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386 Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX D INDIVIDUAL FOOD CONSUMPTION
Company Sanitized. Does not contain TSCA CW
603
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL FOOD CONSUMPTION
EXPLANATORY NOTES
DuPont-5386
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co-housed.
Last day o f food consumption data collection for rats designated for reproduction evaluation.
Day 83-89 Rats designated for the 3-month recovery period were temporarily housed in metabolism cages for urine and feces collection. Food consumption data was not collected for these animals during this period.
Day 91 Male rats designated for the 90-day exposure period were sacrificed.
Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day o f food consumption data collection for animals designated for the one-month recovery
period.
Day 125 Male and female rats designated for the one-month recovery period were sacrificed
Day 175 Last day o f food consumption data collection for animals designated for the 3-month recovery period.
Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
Abbreviations
AK Accidentally Killed FD Found Dead SE Sacrificed in extrem is
company Sanitized. Does not contain TSCA CBI
604
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL! t'UUJJ uuNSUMPTION
Day 7
Day 14
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 6431S5 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147
643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
28.6 25.0 25.4 25.8 29.3 26.5 25.0 29.4 27.7 23.8 25.3 24.0 24.1 28.4 24.3 23.3 26.8 22.9 22.4 23.6 26.0 22.7 24.7 28.6 26.3 29.7 26.5 26.5 25.2 24.4 28.4 29.7 21.5 23.8 25.2 30.0 26.6 24.3 27.3 26.5 23.0 25.3 24.4 23.2 27.7
31.1 26.4 27.7 25.9 30.4 28.6 27.4 33.6 29.4 25.4 27.2 22.1 27.2 29.1 27.0 25.8 27.7 22.6 23.8 25.7 25.3 24.1 27.2 31.8 27.9 32.6 27.7 26.1 26.6 25.8 31.8 33.2 23.0 23.5 27.0 32.9 29.1 27.7 30.4 28.3 25.5 27.0 23.5 24.6 28.2
Day 21
28.7 27.4 27.0 29.1 32.5 30.5 25.2 32.2 31.7 25.3 29.9 25.7 30.5 31.5 28.8 26.2 29.0 24.7 23.9 27.4 27.0 25.0 27.8 30.6 28.8 33.2 29.0 29.4 27.7 28.9 31.4 32.0 24.9 22.7 25.7 31.8 30.4 28.5 31.7 29.6 25.7 28.2 24.6 26.3 27.4
Day 28
31.4 27.0 28.8 29.6 33.0 31.2 24.6 31.7 31.2 26.9 30.0 22.2 29.0 30.6 27.6 26.5 30.9 24.1 23.2 28.0 26.9 24.8 28.4 31.7 30.5 32.1 28.7 28.3 26.4 27.0 32.0 32.4 25.3 24.0 25.1 31.0 29.4 27.1 29.4 29.9 24.9 27.4 24.2 25.5 30.3
Day 35
31.3 29.2 28.4 29.0 33.6 32.1 25.5 30.9 30.5 25.8 32.3 26.4 29.3 29.5 27.7 26.4 30.3 23.9 23.8 28.2 27.3 25.1 29.2 30.4 29.9 32.8 27.3 28.1 25.2 25.3 30.8 31.9 23.9 23.8 25.2 31.6 28.7 29.2 29.6 32.7 27.2 28.1 27.3 29.2 29.8
Day 42
31.5 30.1 27.4 30.3 34.6 31.2 24.9 31.7 31.6 26.5 29.8 27.1 29.9 31.1 29.2 27.5 30.0 24.2 25.8 29.3 27.0 24.8 30.1 33.1 27.5 31.6 27.4 28.6 24.8 27.3 31.3 32.4 24.9 25.2 27.2 31.4 29.6 27.7 29.0 33.2 28.0 24.4 25.3 27.2 29.9
605
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
29..2 26..5 26 .8 28 .4 30..1 27 .1 25..4 28..8 30..0 28..3 30..4 28..7 30 .7 32 .8 29 .0 29 .1 32..0 23 .8 24 .5 27 .7 28 .2 25,.5 31 .2 34..8 31 .1 34 .3 29..2 31..6 27 .6 30 .4 31..2 35 .9 25 ,.9 27..3 27 .7 31..9 30 .1 30..1 29..6 32 .2 27 .2 26..9 26..8 29..4 27 .8
31..2 32.,0 28..6 30 ..8 34 .,6 31..6 26. 8 33..2 34..2 25. 1 30..9 27 .6 30 .0 30 .2 27..3 27 .6 29..6 23 ,.0 25..1 26 .3 28 .3 24..0 29 ,.3 33 .5 30..0 34..3 29..3 30 .,6 26..5 31..2 31..2 35 .2 25 .5 26..5 29..5 30..3 29 ,9 28 ..7 31..2 30 .7 27..0 24.,0 26..2 27..6 28 .8
33..3 33 .1 29..4 28..5 37..4 31..3 27..5 34..3 33 ,.8 24..7 23..0 26..6 24..0 31..3 26..5 26 .6 29..8 22 .8 25 .6 28 .6 28 .5 24..2 29 .8 35..0 29 .2 34 .3 28..8 30,.0 26 .9 31 .0 30..8 35 .0 26 .5 27..8 28 .7 33 .1 30 .4 29 .7 30,.1 30..4 28..0 12..8 26 .1 26..3 29..9
29,.5 30..4 26..9 30..3 33 .3 32 .5 27..2 33..2 29 .9 27 .4 29..3 25 .4 26..7 32..5 26..9 22 .9 30,.1 23 .5 24 .2 27 .1 27 .8 26..2 29..8 34..2 28 .5 34 .1 28 .9 30 .0 26 .2 32 .2 32..7 35 .9 25 _9 27..3 29..0 32..6 32..8 28 .7 30..6 29..7 27,.9 19..9 26 .1 27,.4 28 .5
impany Sanitized. Does not contain TSC A CB1
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 74
Day 77
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
34.0 28.7 30.9 32.2 26.0 26.1 27.7 30.6 27.0 31.2 33.4 28.5 35.6 30.6 32.5 30.1 38.5 33.1 40.3
24.7
30.2 28.6 27.3 30.7 32.5 29.7 25.9 34.2 32.8 27.3 25.2 30.3 26.4
26.4 28.0 28.0 30.4 32.8 23.5 30.1 28.4 26.3 17.3 25.0 27.7
Day 84
29.0 29.0 27.0 30.7 33.6 29.7 26.3 32.5 32.2 26.7 27.9 30.4 25.9
24.2 26.6 27.8 30.1 32.0 24.9 28.1 28.4 26.9 15.9 24.9 30.4
INDIVIDUAL FOOD CONSUMPTION
Day 90
Day 98
Day 105
28.5 27.5 25.2 28.3 33.1 25.1 25.5 32.7 31.5 22.9 21.2 27.8 24.6
26.9 31.1 27.9 26.4
27.4 31.0 29.0 27.3
23.8 27.2 28.2 29.4 29.2 25.6 28.5 27.6 24.6 24.2
25.0 28.8
24.9 27.4 26.3 33.5 33.1 28.7 29.1 30.8 26.8 25.4
27.0
24.0 28.2 28.6 32.6 31.6 31.6 29.6 32.6 28.0 12.4
26.3
606
(g/day)
Day 112
Day 119
Day 126
DuPont-5386
Day 133
23 .6 31..0 27 .6 26..0
28 6 17 1 25 8 24 6
27.6 28.5 27.4 26.1
27.4 28.1 29.5 25.0
23.5 27.8 29.9 31.4 32.5 31.3 29.0 32.3 27.2 28.2
28.7
23 1 27 4 29 7 29 5 32 8 30 8 27 3 30 6 25 4 14 4
26 1
27.1
27.5
Company Sanitized. Does not contain TSCA CBf
I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 140
Day 147
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
28.3 33.1 29.3 21.3
27.7
29.2 30.7 30.2 26.0
13.9
Day 154
29.9 31.7 31.4 26.8
32.4
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
Day 168
Day 175
Day 181
33.0 33.9 32.2 28.5
29.7 30.2 31.8 27.5
29.2 34.5 33.1 27.4
24.7 28.8 27.5 24.3
34.7
28.4
29.8
23.7
607
) DuPont-5386
,,ampany Sanitized. Does not contain TSCA CBi
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
29..4 23..2 23..6 25..6 23 .8 26..7 27 .2 25..0 25 .4 26 .4 24 .4 23 .2 23 .6 23 .5 24 .8 19 .1 29 .3 24 .6 29 .8 22 .1 26 .5 28 .0 28 .9 24 .4 23 .6 26 .3 30 .2 28 .2 27..7 27 .0 26 .5 7.3 .0
">"!7.-"J3
28 .7 26..0
29..9 24 .9 26..6 25..6 30 .9 30 ,.9 29..1 24..9 28..6 28..1 25..4 27 .9 24,.2 25..6 26 .4 21 .2 32..4 25..4 29 .6 24 .1 27 .8 29 .2 33 .7 27 .7 26..7 28 .3 33 .2 31 .4 27..7 29 .6 25 .6 23 .5 28 7 28 .6 27 .0
Day 21
29..3 26..3 25..6 27..7 32 .3 31,.7 29..3 23..3 29..2 29 .3 25..4 31 .1 24..1 25..9 27..2 21 .5 32 ,.8 25 .7 30 .4 24 .2 29 .2 31 .1 33 .4 25 .8 26 .0 31 .8 34 .5 30 .3 26 .4 29 .8 25 .2 22 .9 28 .5 28 .0 27 .4
INDIVIDUAL FOOD CONSUMPTION
Day 28
Day 35
Day 42
29..9 26..6 26..3 28..6 32 .,7 31..2 29,.1 23,.6 29.,4 28..7 25..0 30 .9 24 .9 25..4 26 .4 21 .6 32..1 26..7 30 .3 25 .5 30..2 31 .9 31 .6 27 .6 27..7 30 .1 35 .4 32 .5 23..7 29 .8 24 .6 22 .6 29..2 28 .5 28 .0
32..8 28.,4 26..0 29..8 35.,4 34.,0 31..2 26..0 32..1 28..7 26..6 33..3 27..4 27 ,.1 30..4 23 .9 31..1 27..0 32 .0 24 .3 30..6 30..8 32 .2 27 .4 28..9 32..7 34..0 32 .0 19 .7 29 .8 26 .5 24 .2 29 .5 29 .4 28 .6
29 .0 29 .0 27 .2 29..2 33 .6 34..9 31..7 24..4 32 .4 28 .1 25..5 33..4 28 ,.1 25..4 28 .4 22 .9 31,.6 25 .3 31..1 25 .2 30..8 29 .0 32 .3 25 .5 26,.0 30..3 32 .5 30 .8 27..7 29 .3 27 .0 23 .2 31 ,2 29 .3 28 .3
608
)
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
27 .4 25..3 24 .8 26..1 30 .0 29 .5 28 .6 23 .4 27 .8 25..6 27 .7 30 .1 22 .0 26..7 29 .5 22 .9 32 ,.7 25..7 30 .4 25..3 31..2 13..2 33 .2 28..4 25..2 31..0 35..2 31..9 25. 0 29..1 27 .8 23 .8 32..1 29 .5 28 .9
30 ,.7 29..7 26 .3 29..2 35..5 34,.4 33 .1 25 .1 31 .4 28 .6 25 33 .0 25..8 26..3 30 .4 23 .2 34 .0 25..1 29 .5 26 .0 30,.5 28 .8 33 .1 28 .7 29..1 31 .4 35 .4 32 .0
2 4 ..9
29 .2 27 .6 14..2 31,.1 29..6 29 .2
29 .3 28..4 27 ,.8 29..3 35.,1 32..5 34..0 24..1 30..1 24 .4 23 .3 30..5 25..3 26..6 29..9 23 ,.3 32 .7 26..0 31,.5 25..8 31..8 29..4 32..9 27..7 29..2 31..8 33 .8 30 .6 21..5 30..8 27 .3 23 .6 30..8 30..2 29 .0
27 .1 28..6 28 .3 28 .0 33 .,3 35,.0 31..9 22..8 26..1 27..2 24..8 33 .0 24..3 27..4 28 .8 23..2 32..1 25..0 32 .0 25 .9 32,.0 29..0 34 .4 28 .5 29..4 32 .2 32 .8 32 .5 22..8 30..6 26..6 24 .9 30..2 30 .2 28 .8
company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 74
Day 77
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
22.3 33.9 25.8 29.7 25.0 31.1 33.3 32.1 30.3 29.7 29.9 36.2 32.8 33.6 32.0 28.8 270 31.1 30.9 27.8
29.3 28.9 27.4 24.6 33.0 33.4 30.8
22.1
25.6 26.3 24.2 29.8 22.9 25.3 27.0
Day 84
25.0 29.7 29.8 26.6 33.8 32.8 30.9 23.2 28.8 28.6 24.4 28.2 24.7 26.1 26.0
INDIVIDUAL FOOD CONSUMPTION ig/day)
Day 90
Day 98
Day 105
Day 112
20.5 27.9 29.8 24.1 30.6 32.6 30.4 23.4 27.7 26.0 23.2 24.6 22.5 24.8 26.7
24.0 29.3 25.3 26.0 29.3
26.2 31.3 24.4 28.7 28.0
26.3 27.0 25.3 30.3 29.7
Day 119
26.2 27.0 18.4 29.0 28.9
Day 126
25.9 27.4 25.0 26.8 26.1
DuPont-5386
Day 133
26.5 32.7 28.3 16.2 28.9
"'ompany Sanitized. Does not contain TSCA CB1
609
{1-24516 : Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 140
Day 147
Male, III - 25 mg/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
25.0 30.6 26.9 31.4 29.6
26.7 31.7 27.7 31.4 30.2
Day 154
28.6 30.9 29.1 31.9 32.7
INDIVIDUAL FOOD CONSUMPTION (g/'day)
Day 161
Day 168
Day 175
Day 181
27.1 29.7 26.9 29.2 31.2
26.9 30.6 27.5 29.7 31.3
27.5 30.2 26.3 30.0 30.9
23.1 27.4 23.0 25.8 25.2
DuPont-5386
Company Sanitized. Does no! contain TS C A CBl
_
!)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
23,.8 25..9 26..8 26..5 29..5 25..9 28 .9 28 .0 26..1 24..1 22 .4 23 .4 20..8 24 .6 21..6 23 .4 26..3 27 .6 27 .,6 29 .3 26,.4 28..4 24..9 22 .5 28..1 27 .8 26..7 25..8 28 .3 26..9 27 .3 25..5 28,,4 26 .3 28 .0
23 .1 30. 2 29. 5 27 .7 32 .3 28 ,.0 30. 8 27 .8 26..9 24.,5 25..5 27 .1 21..6 27 .9 22 .8 25..1 30..7 29..2 28 .2 31..8 29..1 32 .,7 27 .5 24..4 29,.4 30..2 30 .0 28 .9 26..4 30..1 30. 3 27 .3 30..0 27 ,4 30..0
Day 21
INDIVIDUAL FOOD CONSUMPTION
Day 28
Day 35
Day 42
25..3 28 .7 27 .2 30..4 28 .7 28 .5 29 .6 27. 2 26..3 24.,9 26..2 27 .,4 22 .9 28..1 24 .5 24 .9 31..7 29..2 27..8 31..9 29 .7 33..5 26 .1 24 .6 29 .8 30..2 30..2 29 .4 27 .8 28..4 29 .4 27 .9 29 .9 26 .1 28 .9
25. 8 2 8 .0 28 .1 29. 6 29. 7 29 .7 28. 8 28. 7 25. 4 26..0 26..8 28. 3 26..1 28 ..9 24..0 26. 1 32..8 30..6 27..8 35..4 30. 3 33 ..4 27..8 24..2 31..2 30..9 30..9 32 .3 28..5 30. 1 31. 5 28 ..3
.6 25 .9 29..3
24. 4 31. 3 29 .5 29 .6 58 .6 29 ..8 29. 0 28. 6 27..3 24..8 27 ..0 30..6 27..3 29..4 24 ..1 26. 5 32..8 30 ..8 28 ..1 33 .0 31..3 33 .,6 28..2 24..8 31..5 29 ..1 30..0 30 ..6 28 ..6 2 8 .5 31. 1 27 .9 32 .,8 27 ..7 30 .9
22 .9 30..0 30..1 29 .1 31..8 30 .2 31..0 28,.4 27..6 25..1 26..4 29 .1 26,.6 31..6 23 .8 27..4 31..7 30 .0 27 .8 32 .1 30 .4 33 .5 29 .4 23 .8 30 .0 30..3 31 .1 30 .5 28 .0 29..5 32 ,.6 27 .1 31 .4 28 .5 30 .2
611
)
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
22..9 28. 6 2 6 .4 25. 8 15 .1 27 .4 28. 8 26. 7 24..5 23.,4 26..9 29..7 27..9 31..1 28..4 29..8 31..9 29..5 26..7 32 .1 30 .9 32 .9 29..0 25..4 30 .7 30..3 32..4 31..1 31..2 31..2 31..6 27..1 33 .3 28..9 30..2
24.,5 30..8 27 .6 28..8 27 .1 31.,8 30..8 30.,8 26..6 26..1 26 .9 29..9 26..8 31..4 25 .3 27..0 32..2 30..4 28 .5 31 .0 30 .7 33 .9 27 .1 25 .3 31 .4 31..6 31..3 31 .0 30 .5 30..2 30,.6 26 .0 34 .5 29 .8 31 .6
26..2 30. 8 28..8 29 ..0 30..7 27..7 30..8 31.,3 25..6 26..1 21..4 28 .3 27 ,.6 27..1 25 .4 29..2 32..5 30..7 30 .3 29 .6 29 .5 31..3 27 .2 27 .6 31 .9 31 .5 33 .7 32 .1 29 .2 35..5 30..6 26 .3 34 .1 28 .7 33 .1
25..3 30. 4 28. 1 28..0 30..7
8..5 32..6 30..7 25..6 24..6 26..6 27 .8 27 .1 30..9 26..3 26..5 31..9 32..8 29..0 30 .9 30..9 30..8 25 .0 26 .5 32 .4 31 .0 33..0 33 .7 31 .5 29..6 32..3 26..4 34 .4 27 .8 29 .7
:om pany S anitized D o not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 74
Day 77
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267
643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
25.7 32.1 28.2 28.5 28.8 30.6 29.8 23.5 22.8 30.4 35.5 32.3 29.5 29.6 34.6 20.8 28.5 29,1 30.6 26.4
23.3 30.2 26.7 26.5 28.6
6.8 32.0 30.1 24.6 24.0
26.6
26.9 25.1 29.7 24.7
Day 84
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 90
Day 98
Day 105
Day 112
23.4 27.3 27.0 25.0 27.9 AX TEST DAY 77 16.9 24.6 24.5 24.9 27.1 20.0 25.1 31.4 24.8
23.6 27.8 25.8 25.7 29.7
26.8 19.5 23.7 22.5
28.1
2 0 .5 23.7 24.9 23.4
31.1 26.5 21.8 23.0 24.6
29.9 1.4
24.6 31.2 24.7
27.7 18.5 23.7 32.9 22.2
Day 119
22.5 28.9 20.5 31.0 24.7
Day 126
29.1 30.1 15.3 29.4 23.6
DuPont-5386
Day 133
27.1 29.8 28.4 24.6 26.6
Com pany Sanitized. Does not contain TSCA CBI
612
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 140
Day 147
Male, V - 100 mg/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
27.7 13.7
32.5 33.5 26.7
30.6 32.3 31.4 36.3 28.1
Day 154
30.3 33.8 30.0 35.0 26.9
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
Day 168
Day 175
Day 181
29.6 32.5 28.0 36.4 27.8
30.3 32.2 27.6 40.3 27.8
28.0 30.3 30.0 37.8 27.2
24.2 27.5 26.4 32.1 24.7
DuPont-5386
Company Sanitized. Does not contain TSCA CBI 613
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
26..4 25..9 25,,4 23 .6 26..6 26..6 26..7 28 .3 25..1 30..8 23 .8 24 ,.9 23 .1 29 .0 24 .2 23 .4 30..7 29..5 25..8 25..6 32 .5 27..7 25..0 25..2 26..4 24 .7 28 ,.4 28 .3 28..0 26..4 26,. 1 29..2 24 ..7 25..9 27 ..5 29..8 24 ..7 24 ..7 25 .. 6 26..6 25 .4 28 .. 1 20 ., 9 35 ..7 20.. 5
25..1 27..5 26..0 24 .0 27..5 28..8 29..2 29,.8 27 .7 33 .0 26..3 28.,1 25..2 31..1 26.,7 25..8 33 .5 31..9 27..6 27 .7 34..6 27 .1 27..3 26..5 28..6 26..9 29 .7 27 .4 27 .7 28..6 29.. 1 32 . H 27 ..4 29 .6 29..3 31..3 28 ..6 29 ..2 29 .,7 28 ..4 29 .6 3 1 .. 6 22 .. 6 29..9 27.,7
Day 21
INDIVIDUAL FOOD CONSUMPTION
Day 28
Day 35
Day 42
25. 6 26..6 25..4 24.,9 26..9 29..4 27.,3 28..7 28 .3 32 .3 24..8 26..9 24 ,.0 31..7 27..7 25..7 33..1 30,.5 24..9 30..5 33 .4 28..8 26..4 25..7 27..6 26..9 30..2 28 .4 29.,2 28..0 29..8 34 .. 7 27..7 29 .. 8 28.. 0 31.. 5 28..3 27 .. 8 27.. 5 29.. 1 27.. 9 30 .. 0 21.. 8 29 . 9 26..2
25..6 29..1 27 .2 27..5 28 .5 28..9 27 .,3 29 .5 29..2 32..4 25..6 30 .0
9..1 32..6 27 ,.8 26..8 33 .6 30..3 27..4 30..6 32..0 30..3 29..3 26 .3 27 .6 27 .0 29 .7 28 .8 30..0 26..3 30..6 34 ..2 27 .3 30,.7 29 .0 32 .4 27 ..6 28.. 9 26 . 6 29.. 8 28..7 31 .. 5 24..4 30 . 6 28..1
25..1 30..4 26..0 26..0 27 .7 27..6 27..5 29 .7 30 ,,2 34,.1 25 .3 31 .6 20 .7 33 .2 29 .5 27 .8 35 .5 31 .0 31 .5 31 .7 33 .2 31 .4 29 .5 28 .4 28 .4 29 .7 30 .2 29 .2 30 .6 27 .2 30 .3 33 . 5 26 .3 28 .8 29 . 2 31 . 0 27 . 2 28 .6 26 .0 27 .8 28 . 6 32 . _L 23 . 6 31 .3 28 .1
25..0 29. 0 26..8 26.,0 27..5 29..6 27 .1 30 .3 30..1 35..1 24 .0 32 .5 25..5 32 .9 29..7 27..6 34 .9 31..9 30.,7 28 ,.8 31..3 30,.7 28..5 26..8 28 .3 28 .0 31,.7 29..5 30..2 26..8 29.. 1 33 ..2 26..5 29..0 27 .3 29 . 5 12..7 27 ..6 25 .9 27..6 27 ..6 23 .. 7 22 ..4 28 . 8 28..1
614
(g/day)
Day 49
24..8 19..3 22..6 21..1 23 .2 24..7 24..2 22 .8 23 .4 26..5 21 .6 28 .9 20 .8 32 .5 26,.9 25..6 29 .1 32 .4 28..2 29..0 29 .6 27 .0 27,.2 22..6 25 .9 26 .0 28 .0 28 .0 30 .7 27 .2 27..1 31 .8 25..8 26 .1 24 .7 30 .4 24 .5 27..5 24 .5 26 .4 19 .8 30 .0 23 .0 28 .8 26 .8
Day 56
27 .5 23 .9 24 .5 22 .8 26..4
9..9 28..0 26 .5 23 .1 31..0 24 .3 29..2 24.,5 31..3 12 .5 13 .6 32 .5 32..4 29..5 27 .4 18 .4 27 .6 26..8 29 .5 28..2 24,.7 27 .0 29..2 30 ,.1 25..2 27..3 29..1 25.,1 26..1 26 .2 30,.9 28 .0 28 .0 21..8 30 .0 23 ,.9 28 .7 23 .7 26..0 28..7
Day 63
27 .0 30. 2 25..2 26..4 25..3 23..2 27..9 29..3 22..6 33..4 19..9 23 .2 23 .4 27 .4 14..5 23 .5 31..6 29..2 25..3 17..4 28..9 15..8 24..9 21..0 22..9 24..3 19,.8 22 .5 28..3 25..8 27..5 26..2 19..1 20 .6 29 .8 28..3 27..1 27 .3 18..2 22 .2 21..3 27 .9 20 .7 16 .8 28..0
DuPont-5386
Day 70
29 .9 4 .0
25. 8 27 .5 13 .6 24. 7 27. 2 27 .4 30..0 31. 1 14 .7 27..4 24. 4 28..0 12 .2 28..0 12 .0 28..5 14..6 23..0 23..4 14.,0 20..8 28.,5 22 .2 24 .6 23 .6 27 .9 26,.3 26..0 26..4
5..2 6..4 6..4 29..1 4 .4 24..5 25 .4 19 .6 26 .9 28..1 26 .0 22 .0 12 .3 25 .8
om pany Saoffized. D oes not com eta TSCA CB.
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 74
Day 77
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
28.8 25.4 25.9 22.8 31.8 21.0 20.0 30.8 18.9 28.8 29.1 28.5 18.6 27.9 28.8 10.1 34.3 27.4 26.7 18.7
AX TEST DAY 70
27.8 25.3 31.6 15.5 13.5 27.6 27.7 23.2 26.7 16.9 36.4 25.3 37.4
26.2 30.2 11.6 25.6 26.9 22.3 10.4 23.8 13.9 28.0 27.3
Day 84
INDIVIDUAL FOOD CONSUMPTION
Day 90
Day 98
Day 105
26.9 29.5 24.7 26.9 29.1 28.5 27.0 29.0 26.7 27.4 23.0 25.8 20.8 31.4 22.0
27.4 29.9 24.1 21.0 28.8 27.8 23.9 26.7 26.1 27.8 24.5 20.5 18.8 26.4 24.3
24.2 25.5 20.7 30.3 23.4
25.4 23.3 19.4 31.5 25.0
26.6 32.4 27.2 26.1 22.9 31.0 31.7 26.5 18.1 29.6
26.0 31.3 26.9 24.0 22.6 29.5 30.0 27.4 20.1 17.5
26.3 30.3 25.1 26.5 22.5 23.5 27.2 27.5 21.1 26.7
27.4 31.3 26.6 29.9 21.0 25.5 25.3 25.1 21.9 25.8
615
g/'day)
112
Day 119
Day 126
DuPont-5386
Day 133
18.9 24.0 19.6 31.7 23.9
20.5 24.7 19.5 32.4 22.9
23.1 26.2 20.7 31.5 24.2
23.0 27.3 21.3 32.0 25.4
26..7 30..5 23 .5 27..8 21 .6 27 .7 24 .8 25 .7 20 .4 23 .1
26..8 29..5 23 .7 27..3 24 .6 24 .6 26..7 27..8 23 .6 25 .8
Com pany Sanitized. Doas noi contain TSCA CBI
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
)
Day 140
Day 147
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
27.0 28.8 24.6 29.9 24.3
28.9 31.0 24.1 31.0 28.8
Day 154
30.5 30.5 24.6 32.4 29.4
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
Day 168
Day 175
Day 181
30.6 30.5 25.4 35.9 31.0
31.6 31.5 25.7 34.9 30.7
29.2 29.9 23.7 33.1 28.5
25.9 25.8 20.8 31.1 22.8
J
DuPont-5386
company Sanitized. Does not contain TSCACB
616
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Female, il - 0 mg/kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643 393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
18 .9 19..8 17 ,.0 14. 8 18. 3 18. 9 16..4 18.,7 18 .9 15 .9 15,.4 17 .5 17 ,.2 16..8 16..6 18 ,.7 17 .3 17 .7 20 .2 18..6 18 .5 17 .3 20 .0 17 .5 18..1 19 .8 22 .2 19..8 14..6 17 .7 21..2 20 7 18 ,.9 18..4 18..5 22 .0 20 .X 22..6 19 .i 21.,8 19..3 21 .4 18..8 19..2 18 .8
18 .5 19..6 17 .7 13 .4 18 .9 20..7 18..2 18 .9 19..8 16,.5 20 .5 17 .1 20..7 16 .9 19..0 20,.7 19..8 20..2 20 .6 21 .4 19..5 18..0 22..0 22..0 19 .4 22 .1 23 .4 22..7 17 .8 18 .8 23 .5 22..8 20..9 19..7 19 .1 24 .7 22..0 20 .9 19..9 24..0 22 .2 18 .7 21..6 19..9 18 .9
Day 21
INDIVIDUAL FOOD CONSUMPTION
ay 28
Day 35
Day 42
19 .8 18 .3 17 .2 15..8 22 .3 21..0 18..0 18 .6 20 .5 18..4 19 .0 18 .9 20..2 17 .9 17..8 21..0 19 ,.5 18 .8 19..4 20 .8 20 .9 12 .8 20 .6 20 .7 18 .8 24 .7 24,.2 21 .8 16 .7 18 .9 22 .2 22 _5 19..5 18..9 17 .7 22 .9 21 .1 19 .6 20 .9 22..4 21 .4 19 .5 22..1 21 .2 19..8
18. 8 18..0 19 .0 14. 4 20. 1 20..8 18..1 22..3 19,.2 16 .7 20..3 16..6 19..2 15 .3 17 ,.7 20,,7 19..1 19 .4 18,.7 20..0 21..0 17..5 22..6 19 .3 17..4 22 .2 22 .3 19 ,.7 18..0 18..2 20 .6 24.,6 20 .3 16..5 17 .1 23 .9 21 .1 19..5 20 .2 24 .2 21..0 18 .8 22..2 22..4 19 .8
21..9 18 .5 19..1 15. 9 21..5 21..7 20..9 21..3 20..9 17 .8 22.,2 19..8 20 .3 17 ,.9 21 .4 22 .2 22 .3 21..5 21..0 21..7 22..9 18..6 22 .7 19..4 18..8 27 .6 25..7 22 .5 17..9 17 .7 22..3 23 .4 22 .0 17..4 17 .4 24 .7 19 .5 20 ,.7 22 .1 22 .1 21..8 21 .3 21..8 23 .4 21..2
20. 4 21. 9 18 .4 17. 0 19. 8 19. 9 18..2 18 .4 22 .,0 19 .4 23 .0 20 .,4 19..9 15 .6 17..1 20,.3 19 .8 22 ,.8 18 .7 19..7 21 .0 18..9 21..4 20 .0 20 .5 25 .9 24 .8 22 .5 16..9 18 .9 21 .3 22 .6 21 .8 17..6 17 .5 24 .7 21 .5 20..8 20..0 21..4 21..1 19 .3 21..1 23 .1 20 .3
617
I
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
18 ,5 18 .2 18..0 16..7 26..1 19..4 18..8 17 .6 19 .1 20..4 25 .2 22 ,.6 21..7 18..1 19 .3 21..1 21..1 22 .1 21..1 20 .7 2 0 ..9 18..8 21..9 21,.3 18..8 27 .2 24 .9 23 .3 19 ,.3 18..2 22 .6 22,,7 21..2 18 .4 18..5 24..1 20..2 19 .7 20..2 20,.7 20 .8 19.,2 21..2 24..0 20..3
18..8 20 .1 19..8 20..5 24..4 23..8 22..1 21..4 21..5 21,.2 23 .1 24..4 22 .0 16 .9 18 .8 20..0 20..5 19..6 17 .0 20 .7 21..9 20..5 24..7 19..1 20 .3 24 .2 23 .9 22 .7 19..9 18..0 20 .2 24..0 21..1 17..6 18.,5 24..0 20..6 22..5 20..6 21..6 20..5 19..6 20..0 23..5 21..7
20. 6 22 .4 20 .6 19 .2 24 .,9 22..7 21. 3 18..8 21..9 20 .9 20 .8 21..9 20..9 17 .2 19,.8 20 .3 16 .8 20..1 19 .8 20 .0 2 0 ..6 20..4 22 .8 19..0 19 .0 24..9 23 .3 23 .5 18 ,.2 19..2 21..9 22 .0 22 .,7 18..3 19..0 22.,0 21..3 23 .8 21..3 26.,3 21..0 19 ,.9 21..2 22 .,8 22 .8
18 .6 22..4 19..2 19 ,.5 24..5 21..5 21.,8 20.,7 21,.0 18..7 22..1 23 .6 22..3 18..5 18..9 20..0 19,.8 21..1 18 .7 20 .3 21..4 19..1 21..9 18..8 19..7 22 .2 21..2 23..1 18..3 18 .5 21 .3 23 .1 20..3 17..5 18..3 22 .8 20..8 20..0 22 .9 30..2 20..7 20 .3 22 .3 22..7 21..5
mpany Sanitized. Does not contain TS C A CPI
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 74
Day 77
Female, II - 0 mg/kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
23.4 19.2 21.4 19.0 23.3 22.5 19.8 22.1 23.2 20.5 24.4 24.5 23.9 21.1 19.4 24.5 23.3 23.5 19.8 19.2
17.7 24.2 18.6 16.6 25.0 23.1 23.2 21.0 21.0 20.2 20.5 25.5 20.9 19.0 19.5
20.8 20.8 20.7 21.5 27.8 18.7 19.2 18.7 22.3 21.7
Day 84
INDIVIDUAL FOOD CONSUMPTION
Day 91
Day 98
Day 105
19.2 20.2 33.5 16.2 24.9 21.3 22.7 21.8 20.7 19.9 21.7 21.1 21.2 16.0 18.6
20.0 22.2 18.5 13.3 24.4 19.7 20.4 21.9 19.3 19.9 20.3 20.3 18.5 16.4 16.6
21.0 17.7 21.1 16.2 18.7
20.4 10.7 20.5 18.1 17.5
21.0 19.8 22.3 22.5 29.5 19.9 19.3 21.6 20.3 19.3
21.9 18.6 17.3 18.5 25.4 18.5
7.9 19.2 20.2 19.7
21.4 19.4 25.2 19.6 27.1 21.1 14.2 20.3 22.7 20.1
21.9 23.9 24.3 22.3 27.0 20.8 22.9 15.8 26.8 23.2
618
)
(g/day)
Day 112
Day 119
Day 126
DuPont-5386
Day 133
21.0 18.9 17.5 17.3 18.4
20.8 19.9 16.5 17.2 15.9
21.0 21 .3 19.7 19.0 15.9
23.9 22.1 20.7 19.3 20.1
21.5
22.5
25.1
24.9
22.7
21.2
23.1
24.1
27.8
27.0
21.3
22.3
22.5
21.2
SE TEST DAY 105
22.5
20.9
22.6
25.0
jompany Sanitized. Does not contain TSCA CBI
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 140
Day 147
Female, II - 0 mg/kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
21.9 23.1 18.9 17.9 18.9
23.2 23.7 21.9 20.7 19.8
Day 154
24.1 26.9 24.8 19.7 20.7
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
Day 168
Day 175
Day 181
25.3 27.1 23.6 23.0 21.9
23.2 27.8 22.8 19.8 19.0
22.0 22.2 21.9 18.7 19.6
21.3 19.3 20.6 15.7 18.7
)
DuPont-5386
Company Sanitized. Does not contain TSCACBI
619
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Female, IV - 25 mg/kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
15.8 20.6 18.6 19.3 19.1 19.1 15.4 17.2 15.9 16.2 17.6 AK TEST DAY 0 19.0 17.1 16.0 16.8 15.5 18.7 17.2 18.4 20.0 18.0 21.9 16.9 22.2 18.6 18.1 17.6 21.2 18.8 22.9 17.7
17.3 17.7 39.0
16.4 22.0 23.1 20.0 18.4 18.1 14.7 17.8 16.3 17.9 17.1
20.1 18.3 17.4 20.2 17.4 19.0 18.7 20.3 21.7 18.9 22.0 17.5 18.7 20.1 19.6 18.3 23.2 21.4 19.9 20.1 17.3 19.0 39.6
Day 2
INDIVIDUAL, LOUD CONSUMPTION
Day 28
Day 35
Day 42
18 0
23 6
21 2
23 8
18 9
21 5
18 4
19 17
46
18 7
17 9
21 7 18 8 18 7 19 9 18 8 19 6 18 7 20 9 20 2 20 7 23 6 ]7 5 22 5 22 0 21 7 19 0 24 0 23 5 19 5 21 3 18 9 19 9 40 0
17 .5 20..6 22 .3 23..2 17..9 21..0 17 .0 19..3 16.,8 18 .9 17..2
20..2 18,.5 17..9 19..9 18 .0 20.,6 21..1 21..3 21..4 22..5 24..6 19..4 22..2 21..8 18..2 17 .9 24..1 23 .2 20 .0 19 .7 18 .5 17 .9 39..9
18..6
20..4
23 .8
21..5
23 .1
22..0
22 .2
22..7
20..0
21.,7
21..5
22..8
SE TEST DAY 29
21..0
19 .9
19 .3
18..7
20.,8
20 .6
20,.1
19..0
20,,3 18 .3 18..8 21..7 19 .2 21..4 20..1 21..7 20..9 20 .9 28..4 20..1 21,.7 20..7 19..2 18..3 22 .2 22..7 21..0 20,.2 19..2 18 .0 37..4
20..5 21..2 18..9 20..2 18 ,.4 22..2 17 .8 22..0 22 .1 23 ,.3 27 .8 19..8 22 .8 21..1 20..9 18..3 22 .9 21 .5 22..7 20..9 19..1 18 .4 36..7
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
19..5 20..4 23 .0 19..7 19,.3 21..7
21..7 18.,0 18..0 19..6
22 .0 19 .6 18..1 20 ..5 17..6 20..2 21.,9 21.,4 20..9 19..3 26..1 20..7 24..7 22..0 22 .5 18..5 24..2 21..8 23. 1
8..3 20 ..1 18. 2 38..6
20 .0 23 .3 25..7 22 .5 12 .,6 21..6
20..7 23 .6 19,.8 19..1
20 .7 19..7 26..0 19..9 18 .4 19..8 18 .5 20..0 21..5 18 .1 23 .3 17 ,.7 23 .,9 22 .1 20 .0 18..6 24 ,.3 21..1 19 .2 22 .9 19..9 18 .6 38..3
21..0 23 .7 23 ..4. 21..7 17 .7 21..7
21..1 20,.7 21 .3 20 .5
22..0 20..4 19.,6 18..8 18..7 20,.3 19..0 20..3 21 .8 18 .1 22 .6 19 .5 24..7 23 .7 18 .9 18..0 23 .0 22..4 21..9 21,.1 20..9 19.,7 20 .3
20. 2 28..7 24. 2 21..9 20..5 20..4
21..3 21..4 20..9 18..9
20.,9 20..1 19..3 20..5 17 .3 17..5 19..8 19..6 20 .7 19..2 21..6 18..2 23..5 20..7 18..3 16..6 22 .2 20 .9 20.,4 20..3 18 .0 18..6 18..5
Company Sanitized. Does not contain TSCA CB i
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Female, IV
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643411 643483 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403
643376
643422 643452 643475 643372 643400 643395 643457
' 74 Day 77
25 mg/kg/day
20.5 28.5 22.6 21.2 18.6 21.1
22.1 21.5 20.3
21.1 19.8 19.6 21.0 21.0 23.0 18.4 21.9 20.3 24.9 25.5
8.8 19.8 25.9 22.6 26.8 22.5 21.9 21.5 20.0
17.9 19.1 19.7 18.1
Day 84
20.0 29.1 24.4 21.6 16.4 20.4
21.6 19.6 20.3
19.5 18.9 20.0 18.5
INDIVIDUAL FOOD CONSUMPTION (g/'day)
Day 91
Day 98
Day 105
Day 112
17.0 23.8 21.5 20.0 16.0 18.8
19.8 21.6 18.3
18.2 17.7 18.6 15.6
18.7 21.4 18.5 17.5
18.6 21.2 20.6 19.7
19.0 22.5 21.5 19.9
Day 119
19.8 22.0 20.9 18.8
Day 126
19.8 22.5 21.7 18.5
DuPont-5386
Day 133
18.7 22.7 20.9 19.3
Company Sanitized. Does not contain TSCA CBr
I)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 140
Day 147
Female, IV - 25 mg/kg/day
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643411 643483 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
20.0 23.4 22.5 22.1
22.5 24.0 21.2
21.2
Day 154
22.2
24.4 23.6 22.1
Day 161
20.9 23.7 20.6 20.0
Day 168
20.8 23.6 22.0 20.5
Day 175
21.2 23.9 21.6 17.7
Day 181
16.7 20.3 18.4 17.4
DuPont-5386
Jsmpany Sanitized. Does not contain TSCA CBI
622
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
r'ema1e , Vi - 100 mg /kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
18.,6 17,.5 16 .1 18 .9 18 .5 21..7 17 .7 13 .5 16 .4 16,.9 17 ,.1 16 .0 17 ,.4 15.,1 17 .7 18,.3 18,.6 20..4 17 .8 17 ,.8 17..0 17..9 1 8 ..1 2 1 ..5 17..9 17 .7 17 ,.8 17 .1 18 .5 18 .0 17 .9 18 .0 20 .3 18..6 19 ,.7
18 .9 16..7 17 ,.4 19.,1 19. 5 21..7 18.,9 15..5 16..1 18..1 18..6 16 ,5 17 .4 16.>i 17.,2 19..1 20 .0 21..5 19..4 18..5 18 .9 19..5 17..3 20..9 19..9 19,.9 16..7 17 ,.0 18..3 20..0 17 .7 18..5 19..6 18..1 19..7
Day 21
19. 1 18. 9 17 .8 20..0 20. 9 22 .2 19 .3 16 .0 16..7 19 .8 20 .5 19 .8 19 ,.5 17..7 20..5 21.,2 22..7 20 .2 19 .9 19..3 19..7 19..0 19..3 22..9 21..3 23 .,7 17 .9 18 .4 20..2 20..4 19 .6 ^o 4 20. 6 19..8 20 .7
INDIVIDUAL FOOD CONSUMPTION
Day 28
Day 35
Day 42
19 .7 17 .5 17 .1 21..6 21.,9 22 .3 19..5 17 .4 18 .1 21..3 19..3
6 .6 19 . 16..8 21..5 23 .0 21 .2 22 .3 19..3 19..7 18 .3 21 .6 19..4 24..3 22 .2 22 .2 20 .1 18 .7 19 .9 21 .0 19 .1 21..4 20..4 18 .2 20 .9
19.,6 19 ..0 18..9 21,,8 19..4 23 ..1 1.7..9 17 ,.2 16,.6 19.,1 18.,0
9 .7 18 .8 15..8 20..2 22..2 19..9 22 .8 18 .2 21..3 19..2 21 .2 18..6 18,.2 19..8 21 .7 18..1 19..5 20..3 20 .7 19..4 19..8 20..6 18,.9 21..2
17. 9 17. 4 16 .,7 21..8 18. 8 20 .2 18..1 17 .4 17..6 20 .1 17..0 10..5 18..5 17..6 19. 21..7 20..1 20 .3 19..3 20..0 18,.5 20..3 19..3
7 .0 19 .2 19..1 19..l 18 ,6 18 .7 19,.9 18..3 19 .0 21..4 17 .2 19 .8
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
16..3 2 1 ..4 18 .1 19..8 18.,6 16..5 17..0 14 ..6 16..5 17 .9 18 ,9 17 ,1 18 .9 19..9 2 1 ,,8 2 2 ..2 19 ..8 2 1 ..6 19 .5 2 2 .9 19.. 8 2 1 .7 19.. 2 25..2 2 1 .0 23 .4
20 .6
2 0 ..2 19..5 2 1 .9 22 .0 2 1 :6 24 .1 19.. 0 22 .7
19..3 2 2 .,7 17 .4 2 1 .9 2 2 ,.5 2 1 .9 18 .9 16..9 19 .0 2 1 .0 2 1 .1 22 .7 19 .1 18..7 19..3 23 .3 20 .7 2 0 .0 18.. 8
21 .1
19 .3
21 .6
19 .1 19 .9
21 .2
24 .2
20 .2
20 .9 19 .7 20 .3 19 .8
20 .2
23 .4 19 .3 21 .1
2 0 .,3 2 0 .6 19.,4 2 1 ..8 19.. 8 2 0 .4 19.. 6 17 ..0 18 .2 2 0 .8 2 0 .5 12 .1 17.. 2 16.. 2 2 1 .3 2 0 .5 18 .7
20 .2
18 .0
21 .1
18 .0 23 .4 18.. 0 22 .4 18 .9
20 .8
18 .1 2 0 ..2 18 .0 22 .4 17 .6 19 .8
21 .2 20 .0
20 .7
18. 0 23. 2 18. 9 2 2 ..0 2 0 .3 16..1 19..2 17 ,.5 18..0 2 1 ..8 2 0 .6 2 1 ..0 18..0 19..7 2 0 .4 2 1 .9 19..5 19.. 8 17 ..1 2 1 .5 19.. 6 2 1 .4 18.. 8 24..5 18..5 2 0 ..8 17..4 19.. 6 18..4
21 .8
17 .4 19..0 2 2 .5 19 .7 19 .4
Jompan, t a t o * Dm s ,, olcon|a|n TSCA cM
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 74
Day 77
Female, VI - 100 mg/kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2 1 .0
20.9 18.9 17.6
2 1 .2 2 1 .1
23.8 19.2
9.8 19.1 22.3 2 0 .5
2 1 .2
19.2 24.2 21.4 20.3
2 2 .2 2 0 .2
2 0 .9
18 5 20 5 18 6 22 7 19 6 18 4 17 2 17 8 17 4
20 1 20 8
16 5 19 5 16 9 23 9
Day 84
18.2 19.1 17.3 20.5 21.5 15.5 18.9 17.4 17.3 19.8
2 2 .2
17.9 19.9 17.7 20.4
INDIVIDUAL FOOD CONSUMPTION (g/dayj
Day 91
CCTOi
Day 105
Day 112
16.6 20.9 16.7 19.3
2 1 .0
18.8 17.9 14.5 15.3 15.4 17.1 15.7 17.6 15.0 18.1
17.7 18.2 17.0 14.2 18.1
19.3 15.3 19.5 17.8 19.3
20.9 16.4
2 0 .2 1 0 .1 2 1 .8
Day 119
20.9 7.4
2 0 .6
15.5 20.3
Day 126
2 0 .1
23.4 19.5 16.8 23.2
DuPont-5386
Day 133
19.2 19.0 2 2 .5 18.2
2 2 .6
Company S a n itize d . Does noi contain TSCACBf
624
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 140
Day 147
Female, VI - 100 mg/kg/day
643322 643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2 2 .6
30.7
2 0 .0
18.5
2 2 .2
22.4 29.3 23.0
2 1 .0
26.6
Day 154
2 1 .0
18.4 23.6 20.4 23.2
INDIVIDUAL FOOD CONSUMPTION (g/'day)
Day 161
Day 168
Day 175
Day 181
2 2 .9 25.6 21.3 18.4 24.9
2 2 .8
20.5
2 1 .1
18.0 24.2
21.7 18.0 20.7 18.8 25.8
18.4 32.5 19.0 19.2 23.7
DuPont-5386
L ompany Sanitized. Does not contain TSCACBI
625
))
H-24516: Subchromc Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
Day 14
Female, VIll - 250 mg/kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
17 .5 2 1 .3 17 .7 16..7 15..8 15..8 15.. 6 18 .1 16,.7 16..7 16..3 16 .8 17 ..6 15 .4 19 .7
20 .0
15..1 19..9 17 .3 18 .2 18..9 17.. 2 19 .6 1.6 .5 18..5 18.. 0 19..0 22 .3 2 1 .4 2 0 .8 17..2 18 .4 19..3 17..9 37.. 6 16 .0 20 .9 17 .1 19..2 14..9 18..6 17 ,.9 16..7 20 .1 17..9
18..2 2 2 ,,6 19..1 2 0 ..0 16..9 18 .3 17 ,.9 2 0 .4 19 ..0 19 .7 17..0 18 .2 18 .5 2 0 .9 18.. 2 23 .3 2 1 ..2 2 1 .1 18..9 18.. 6 2 0 .0 19.. 0 2 1 .3 19.. 0 19.. 2 18 .4 19..4 23 .3 2 2 .5 19..8 18..2 18 .8 2 2 .0 19..7 18 .9 17..7 20 .9 17 .6 18 ..8 18..3 18 .5 18 .5 17 .4 19 .2 18 .0
Day 21
19,.0 25,.9 2 0 .3 19 ..1 19 .1 18..1 18..3 2 0 .3 19.. 0 19 ,.3 17.. 8 19 .0 18 .1 19.. 6 23 .2
20 .6
17.. 0 2 0 .4 19 .5 19 .6 2 2 ,.5 22 .3 25,.4
22 .0
2 1 ..6 19 .7 22 .4 26 .2 23 .9 2 2 .4 2 2 .1 2 2 .0 24 .4 2 1 .9 2 1 .4 IS .2 23 .3 17 .8 21 .6 19 .4 22 .1 2 1 .5 17 .8 20 .9 2 1 .5
INDIVIDUAL FOOD CONSUMPTION
Day 28
Day 35
Day 42
17.6 23.3 19.5 17.7 20.4 17.9
2 0 .0
20.4 21.4 20.3 17.9 18.5
2 0 .1
19.9 21.5 21.5 17.8
2 0 .6
19.7 19.2
2 1 .8
19.0
2 1 .2
19.4 19.4
2 0 .2 2 0 .8
26.8 25.7 21.9 20.4 18.7 23.0 20.5 17.9 17.3 2 0 .5 18.4 18.5 18.5 19.4
2 0 .6
16.4 18.6 18.7
18.9 24.3 19.2 17.2 19.2 20.3 20.5 19.9 20.9
2 1 .6
17.7 17.8 22.3 19.6 23.3 2 2 .9 18.6 19.7 19.6 19.5 23.2 19.3
2 2 .1 2 0 .6
21.5 19.0
2 1 .6
26.6 25.1 24.2 20.5 20.3 22.9
2 1 .8 2 1 .1
17.9 2 2 .9 17.7
2 0 .2
18.2 18.4
2 1 .2
17.8 19.7 19.3
18.0 23.8 17.4 18.2
2 0 .1
18.8 17.9 20.7 18.7 19.8 17.4 14.9 22.4 19.7
2 1 .6
22.7 16.6 20.4 18.7 19.3
2 1 .6
17.9
2 0 .2
18.8
2 2 .1
19.1 19.2 24.2 24.6
2 0 .1
19.5 18.4
2 0 .1
20.4 18.7 16.7
2 1 .0
16.5 20.7 16.2 17.7 22.5 17.5
2 0 .2
19.9
626
(g/day)
Day 49
Day 56
Day 63
DuPont-5386
Day 70
17 ..6 23..1 17 .7 16.. 6 17 .4 15..3 16..8 2 0 ,.3 2 0 .0 2 1 .3 16..1 17 .2 23 ..6 14 .5 2 1 .3 2 1 ..0 18..3 2 1 ..6 2 0 .3 2 0 .3 2 2 .5 19.. 2 19.. 8
20 .8
2 2 ..0 1 0 ..2 19..1 25 .8 2 2 ,.7 2 1 ..6 18..4 2 0 ..2 2 1 .4 2 0 .5
22 .2
18 .4 15 .6
6 ..8 16..9 18 .1 18 .9 2 2 .9 17 .3 19 .8 19 .0
18. 5
19. 0
2 0 ..6
15. 8
2 1 ..0
19. 0
17.,5
18.,1
2 1 ..3
19. 8
17..3
15..2
2 1 ..6
19.,7
19..3
15..7
2 1 ..5
2 2 .3
24 ,.5
12 .4
18,.7
15..8
19..5
32..8
2 0 ,.2
2 2 .4
2 .5
19..4
23.. 8
2 1 ,.6
2 1 .3
15..4
18.. 2
16.. 2
2 2 .7
17 .7
20 .1
19 .1
21 .1
19 .1
23 ..2
19..0
17 .3
14.. 6
16 .1
6 .4
21 .5
18 .4
2 2 ,.8
19..9
AK TEST DAY 53
19 .8
12 ..8
26 .8
25 .7
24 .6
2 1 .9
17,. 0
13 .3
19..3
1 2 ..6
2 2 ..2
2 1 .4
22 .0
18 .9
19.. 2
18 ..8
21 .0
19 .8
18 .9
18 .0
7 .3
2 1 .9
1 2 .3
2 0 .5
1 1 .4
19 .5
17 .5
10 .3
18 .8
21 .2
24 .7
1 1 .4
18 .9
17 .6
16 .1
10 .5
19 .4
18 .5
18.7
1 1 .0
18.7 17.2 18.5 19.6 18.9 19.2 21.3 FD TEST
1 2 .6
18.6 20.9 17.0
2 1 .0
9.7 14.7 15.4 18.5 18.1 13.0
1 .8
1.9
1 0 .2 1 2 .1
26.8 24.7 19.4 17.7 18.9 19.5 18.0
1 0 .0
15.4 17.1 25.8 16.6 17.3
2 1 .8
17.9 9.7
16.8 16.4 19.4
e itpany Sanitized. Does no! contain TSCA CB!
))
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_____
Day 74
Day 77
Female, VIII - 250 ir.g/kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
6.8 9.5 18.2 20.6 20.0 16.3 25.5 28.3 22.6 40.1
52.1 26.2 14.4 13.1
8.4 21.0 18.2 20.6
4.0
15.8 15.4 17.8 17.4 16.3 16.2 14.8 18.9 23.6 1 2 .9 15.5
1 0 .6
16.8 5.1
19 .i 2 0 .3
12 .2
17..7 2 0 .9 19..1 17 .4 13 .4 26 .3 14 .8
Day 84
2 1 .6
29.2
2 0 .1
16.9 19.8 24.6 25.3 2 2 .9 23.4 19.7
2 2 .1
23.1 2 0 .9 24.3
2 1 .4 24 .2 23 .3 23 .3 17 .3 22 .1 29 .2 21 .3 25 .3 2 1 .3
INDIVIDUAL nOOd CONSUMPTION
Day 91
Day 98
Day 105
18.4 25.7 14.0 14.1 16.9 18.5 15.5 18.9 24.4
16.6 17.7 20.4 17.1 24.3
16.9 15.6 19.9 17.6 26.9
17.0 14.8
2 1 .1
17.1 27.2
18 .1 18 .1 18 .0 18..0 16..1 2 0 .7
20 .2
16 .8 23 .4 18 .1
24..7 19 .1 18..3 2 0 .7 16..4 2 1 ..0 16 .7 16 .8 24 .3 2 0 .4
24 ..2 18 .7 18 .5 2 1 .4 18 .8 23 .1 20 .0 16 .4
26 .2 20 .4
627
)
(y/duy)
Day 112
Day 119
Day 126
DuPont-5386
Day 133
16.8 14.8 17.4
2 0 .1
25.8
16.9 16.4 18.6 18.5 24.0
16.2 17.4 18.0 18.2 22.9
15.8 19.6 18.9 16.4
2 1 .0
20.4 17.6 18.3 20.9 17.8
2 0 .1
18.3 16.9
2 2 .1
19.2
1 2 .1
19.1 19.0 22.9 17.3 23.0
2 1 .0
17.3 22.3
2 0 .2
Company Sanitized. Does not contain TSCA CBI
)})
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
___________________________________________________ DuPont-5386
Day 140
Day 147
Female, VIII - 250 mg/kg/day
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
17,4 24.5 17.1
2 1 .6
21.3
19.7 25.2 19.9
2 2 .8
23.7
Day 154
21.3 25.7 21.5
2 0 .1
26.0
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
Day 168
Day 175
Day 181
2 0 .1
26.5
2 1 .1
21.3 23.8
20.4 22.4
2 2 .6
20.9 24.9
19.5 18.4 22.7 19.3 23.3
19.0
19.4
18.5 18.3
2 2 .0
Company Sanitized. Does not contain TSCCBI 628